tegafur has been researched along with uracil in 1546 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 253 (16.36) | 18.7374 |
| 1990's | 459 (29.69) | 18.2507 |
| 2000's | 588 (38.03) | 29.6817 |
| 2010's | 223 (14.42) | 24.3611 |
| 2020's | 23 (1.49) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, IK; Kimura, T; Tateoka, Y; Watanabe, K; Yamamoto, I | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Borisov, VI | 1 |
| Chao, LY; Saunders, PP | 1 |
| Fujii, S; Ikenaka, K; Kitano, S; Shirasaka, T | 1 |
| Fujita, K; Igawa, M; Kakehi, Y; Konami, T; Nishio, Y; Takenaka, I; Tomoyoshi, T; Usui, T; Yoshida, O | 1 |
| Kamata, T; Kojima, J; Monna, T | 2 |
| Furukawa, Y; Hayashi, J; Hidaka, N; Kato, M; Ohashi, N; Sanda, M; Yajima, Y | 1 |
| Suzuki, M; Takahashi, M; Tanaka, J; Yoshida, K | 1 |
| Furuta, N; Kondo, I; Masuda, F; Nakada, J | 2 |
| Babaya, K; Hiramatsu, T; Hirao, Y; Maruyama, Y; Okajima, E; Ozono, S; Samma, S; Sasaki, K; Watanabe, S | 1 |
| Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Kuroda, Y; Nakamura, Y; Ohkuma, R; Ohsato, K; Yamamoto, H; Yamanouchi, A | 2 |
| Fujita, I; Kiyama, T; Kyono, S; Mizutani, T; Nishi, K; Okazaki, S; Okuda, T; Onda, M; Teramoto, T; Tokunaga, A | 1 |
| Inaba, S; Kawai, K; Kondo, Y; Ogino, A; Tsuchiya, K; Ueda, Y; Umeda, T | 1 |
| Hosoda, Y; Miyakawa, T; Okamura, H; Okubo, S; Oshima, Y; Shiina, E; Shimizu, M; Suda, Y; Tokura, Y; Uchida, K | 1 |
| Baba, E; Fukushima, T; Kataoka, A; Kondo, Y; Masuko, H; Ohmori, K; Ohsawa, S; Sawaguchi, Y; Shiroto, H; Takahashi, T | 1 |
| Ibuki, Y; Igarashi, M; Ito, T; Kimura, H; Kosuge, T; Nagayama, M; Nogami, Y; Ohwada, N; Tsukagoshi, T; Yazaki, K | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Hamada, N; Inomata, T; Nishioka, A; Ogawa, Y; Ogoshi, S; Sawada, A; Tanaka, Y; Terashima, M | 1 |
| Hizuta, A; Iwagaki, H; Mimura, H; Moreira, LF; Orita, K; Sakagami, K | 1 |
| Matsuda, M; Taguchi, H; Takaoka, K | 1 |
| Funakoshi, A; Kono, A; Shimazoe, T | 1 |
| Akao, S; Ishikawa, H; Iwami, N; Kiumi, F | 1 |
| Kusumoto, T; Miyagi, M; Nakashima, T | 1 |
| Miyazaki, N; Saito, Y; Tomioka, M; Yamamoto, M | 2 |
| Hosobe, T; Kawashima, Y; Kobari, T; Masuda, F; Mori, Y; Torii, S | 1 |
| Akagi, M; Kakegawa, T; Maehara, Y; Shimazu, H; Sugimachi, K; Tomita, M | 1 |
| Hirose, T; Koh, Y; Nakamura, T; Nakayoshi, A; Namatame, K; Ookubo, M; Sasaki, E; Shimada, K | 1 |
| Hamabe, Y; Ikuta, H; Katoh, M; Kuroda, D; Osawa, M; Saitoh, Y; Usami, M | 1 |
| Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J | 1 |
| Koiso, K; Nemoto, R; Nishijima, Y; Uchida, K | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Akino, H; Isomatu, Y; Kanimoto, Y; Miwa, Y; Okada, K; Suzuki, Y | 1 |
| Fujii, S; Iwamoto, S; Kotake, H; Mashiba, H; Murai, N; Okuno, F; Sawada, Y; Yurino, N | 1 |
| Aoyama, H; Chiba, Y; Fukushi, G; Fukushi, M; Kimura, M; Matsukawa, M; Sakata, Y; Sato, T; Sawada, Y; Wada, K | 1 |
| Hareyama, M; Morita, K; Saito, A; Shibata, M | 1 |
| Aida, Y; Endo, Y; Hirai, H; Maeyama, S; Sunaga, T; Taga, H; Takakuwa, T; Uchikoshi, T | 1 |
| Fujii, M; Iwai, S; Kochi, M; Konomi, K; Tanaka, T; Wakabayashi, K; Yamagata, M | 1 |
| Fujita, K; Munakata, A | 2 |
| Hatada, K; Katakura, A; Kouda, H; Noma, H; Shiozaki, Y; Takaki, T; Tonogi, M; Yamane, G | 1 |
| Houjou, T; Kadota, K; Mori, N; Wada, T; Watatani, M; Yasutomi, M | 1 |
| Fujimaki, M; Kurokawa, M; Kuroki, Y; Ochiai, H; Okamoto, M; Tazawa, K; Yamashita, I | 1 |
| Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H | 1 |
| Fukuoka, H; Nomura, S; Ogawa, T; Sakanishi, S; Takeda, M | 1 |
| Kawaguchi, Y; Nakano, K; Oie, S; Okabe, H; Saito, H; Taguchi, T; Takechi, T; Takeda, S; Uchida, J | 1 |
| Hayashi, H; Hazama, S; Murakami, T; Oka, M; Suzuki, T | 1 |
| Hizuta, A; Kataoka, K; Kawaguchi, H; Matumoto, M; Miyagi, K; Nagata, Y; Sou, J; Takahashi, M; Yamamoto, M; Yunoki, S | 1 |
| Akaza, H; Homma, Y; Isurugi, K; Kameyama, S; Kanemura, M; Kawabe, K; Kawamura, T; Kitajima, K; Murahashi, I; Okada, K | 1 |
| Eida, K; Hirano, T; Ishii, T; Ishikawa, H; Kotake, Y; Kusano, H; Nakagoe, T; Shimizu, T; Shimoyama, T; Tomita, M | 1 |
| Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Taira, A; Yamamoto, H; Yamanouchi, A | 1 |
| Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y | 1 |
| Furukawa, H; Hara, T; Taniguchi, T | 1 |
| Ito, T; Izumi, T; Kiyohashi, A; Kurihara, M; Ohkubo, T; Sasai, T; Suga, S; Takahashi, H; Yaosaka, T; Yoshida, S | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Ban, Y; Ito, Y; Kawada, Y; Kuriyama, M; Maeda, S; Shinoda, I; Tada, K; Takahashi, Y; Takeuchi, T; Yamamoto, N | 1 |
| Fujii, M; Sakabe, T; Sawa, H; Tanaka, T | 1 |
| Gotoda, H; Kinami, Y; Miyazaki, I; Saito, H; Takashima, S; Tomita, F; Yamaguchi, A | 1 |
| Hinotsu, S; Koiso, K; Nemoto, R; Nishijima, Y | 1 |
| Fujimoto, H; Ohkusa, T; Ohtomo, K; Yamamoto, N | 1 |
| Eida, K; Hirano, T; Ishii, T; Ishikawa, H; Kotake, Y; Nakagoe, T; Nogawa, T; Shimizu, T; Tobinaga, K; Tomita, M | 1 |
| Anada, E; Fujimura, T; Fujita, H; Haryo, S; Sawasaki, K; Shima, Y; Shiota, S | 1 |
| Arima, S; Futami, K; Ikuno, T; Kawahara, K; Koto, T; Okamoto, T; Yamasaki, K; Yamasaki, S; Yoshimura, S | 1 |
| Ishizawa, T; Iwashige, H; Maenohara, S; Mure, H; Shimazu, H; Takao, S; Yamada, K | 1 |
| Aito, K; Hara, S; Kumazawa, J; Morita, I; Ohmori, A; Ohta, Y; Sagiyama, K; Sakamoto, K; Takesue, T; Ueda, T | 1 |
| Kayama, T; Ogawa, A; Sakurai, Y; Sato, K; Wada, T | 1 |
| Kato, M; Kinoshita, K; Miwa, K; Ohyama, S; Sawa, T; Segawa, M; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K | 1 |
| Fujita, F; Fujita, M; Taguchi, T; Takeda, S; Uchida, J; Yamada, Y | 1 |
| Kikuchi, K; Kunii, Y; Kunitomo, K | 1 |
| Ueda, T | 1 |
| Akimoto, T; Hasegawa, M; Honjo, J; Huruta, M; Kawaharada, U; Kazumoto, T; Niibe, H; Yamakawa, M; Yonome, I | 1 |
| Fukami, K; Katsuta, K; Kiyota, R; Matsumura, M; Matsuyama, H; Nobori, T; Ogawa, K; Ohyama, M; Shima, T; Yano, H | 1 |
| Horiuchi, M; Kaneko, S; Komiyama, S; Miyake, H; Ogasawara, H; Sugita, M; Tsukuda, M | 1 |
| Aoki, Y; Horiuchi, Y; Kamikawa, R; Kyokane, K; Miwa, Y; Nagai, H; Ninomiya, E; Noro, T; Suga, S; Yasue, K | 1 |
| Taguchi, T | 7 |
| Oie, S; Okabe, H; Takeda, S; Yamada, Y | 1 |
| Nakano, K; Oie, S; Saito, H; Takechi, T; Takeda, S; Yamada, Y | 1 |
| Amemiya, A; Emoto, T; Fujii, M; Han, N; Itou, A; Iwasaki, T; Tsujimura, T; Yoshikawa, K | 1 |
| Aida, I; Nishida, M; Sekiguchi, I; Suzuki, M; Tamada, T | 1 |
| Ejiri, S; Hisazumi, H; Kanda, S; Katsumi, T; Kitagawa, K; Mikawa, I; Miyagi, T; Naito, K; Nakamura, T; Saka, A | 1 |
| Sekiguchi, I; Suzuki, M; Tamada, T | 1 |
| Kaji, Y; Kinoshita, K; Nonaka, A; Shimauchi, M; Wakisaka, S | 1 |
| Arai, K; Awane, Y; Kitamura, M; Miyashita, K | 1 |
| Fujita, M; Fujita, Y; Ota, J; Sakamoto, Y; Sugimoto, T; Taguchi, T | 1 |
| Houjo, K; Kawano, N; Moriya, Y; Sugihara, K | 1 |
| Baba, H; Kakeji, Y; Kohnoe, S; Maehara, Y; Sugimachi, K; Watanabe, A | 1 |
| Hara, I; Kameyama, Y; Sakaki, Y; Tateishi, A; Yamada, N | 1 |
| Koda, K; Kure, T; Matsunaga, T; Miyazaki, E; Morii, K; Morita, K; Nakajima, K; Nakazawa, O; Terada, S; Tsuji, Y | 1 |
| Kasahara, N; Kato, T; Kawachi, Y; Kawasaki, T; Kudo, H; Kuwa, K; Okamoto, R; Sagara, T; Sakamoto, S; Tominaga, S | 1 |
| Fukatsu, H; Hirata, N; Honda, N; Muramatsu, T; Segawa, A; Senda, H; Yamada, Y | 1 |
| Anai, H; Korenaga, D; Maehara, Y; Ohi, Y; Okada, Y; Okubo, K; Sugimachi, K | 1 |
| Asakura, T; Fukuda, M; Imaki, S; Kanasugi, K; Komoriyama, H; Morikubo, M; Okamura, R; Tsukikawa, S; Watanabe, H; Yamaguchi, S | 1 |
| Imai, S; Morimoto, H; Nio, Y; Shiraishi, T; Tobe, T; Tseng, CC; Tsubono, M | 1 |
| Arima, S; Fukamura, T; Haruta, J; Hashimoto, M; Jyozaki, H; Okamoto, K; Shimura, H; Umeno, T | 1 |
| Kawada, S; Kondo, H; Ootani, I; Sato, T; Shibata, T; Suzuki, H | 1 |
| Akimoto, M; Hara, M; Hasegawa, J; Kawamura, N | 1 |
| Mai, M; Ogino, T; Ohta, T; Ooi, A; Takahashi, Y | 1 |
| Hayashi, K; Ishikawa, T; Ishinoda, Y; Iwaki, Y; Kisanuki, H; Kitamura, T; Maruyama, T; Nakamura, H; Okamoto, T; Shigehira, M | 1 |
| Asano, M; Fukuzaki, H; Imai, K; KumaKura, M; Mashimo, T; Yamanaka, H; Yoshida, M; Yuasa, H | 1 |
| Abe, R; Honda, K; Kanazawa, M; Nomizu, T; Tsuchiya, A; Watanabe, F; Yamaki, Y | 1 |
| Fujioka, T; Hasegawa, M; Ishikura, K; Koike, H; Kubo, T; Nomura, K; Okamoto, T; Tanji, S | 1 |
| Horiuchi, M; Kikuchihara, M; Kubota, A; Kubota, T; Miyake, H; Sawaki, S; Takahashi, H; Takeyama, I; Tsukuda, M; Yao, K | 1 |
| Kamano, T; Takahashi, H | 1 |
| Iwata, H; Matsumoto, A; Nabeshima, S; Nishio, S; Oda, H; Oda, T; Seki, N; Takeuchi, M; Terado, T; Yokoyama, M | 1 |
| Ando, T; Haruta, J; Kanayama, K; Kuwahara, Y; Okada, T; Sakai, T; Sasano, Y; Sato, Y; Tachino, H; Tahara, H | 1 |
| Kikuchi, K; Wakui, A | 1 |
| Deguchi, S; Hokama, A; Kurihara, K; Muto, Y; Nomura, K; Toda, T | 1 |
| Clarke, PI; Malik, ST; Osborne, R; Reznek, R; Slevin, ML; Talbot, D; Wrigley, PF | 1 |
| Fujimura, T; Hasegawa, K; Kato, M; Kinoshita, K; Miyata, T; Ohyama, S; Sawa, T; Takekawa, S; Ueda, N; Watanabe, T | 1 |
| Harada, N; Kanda, K; Kida, H; Narita, K; Uchimura, M; Waki, S | 1 |
| Hisamatsu, K; Ihara, T; Kirimoto, K; Matsuda, M; Nanba, K; Okamoto, E; Suemitsu, H; Yamada, M | 1 |
| Ito, N; Koda, K; Kure, T; Matsumoto, S; Nakazawa, O; Oda, M; Terada, S; Terui, T | 1 |
| Irie, G; Kamada, T; Matsuoka, Y; Shirato, H; Takamura, A; Tsuji, H; Tsujii, H | 1 |
| Endo, Y; Futagawa, S; Hirai, H; Iino, S; Sugiura, M; Taga, H | 1 |
| Chiba, T; Hiura, M; Kaneko, H; Kawamurra, S; Moriwaki, S; Tanaka, M; Yokoyama, T | 1 |
| Kusuyama, H; Numa, H; Okada, K; Sakamoto, S | 1 |
| Asada, I; Furutani, M; Harada, T; Hayashi, S; Kitao, T; Matsushita, T; Shirosaki, H; Tanaka, T | 1 |
| Aoki, Y; Asae, M; Ichimiya, G; Imai, T; Kakihara, M; Kashitani, M; Katsumi, M; Ooshima, K; Tabuse, Y; Tanimura, H | 1 |
| Hieda, S; Ishihara, M; Noguchi, M; Sawaguchi, K; Ueno, N; Yabushita, H | 1 |
| Horiuchi, Y; Ibayashi, J; Koyama, Y; Nagai, H; Ohkita, T; Suga, S | 1 |
| Iwasaki, A; Matsuda, M; Nakano, E; Seguchi, T; Sonoda, T; Sugao, H; Tada, Y; Yoshioka, T | 1 |
| Irie, G; Kamada, T; Matsuoka, Y; Takamura, A; Tsuji, H; Tsujii, H; Usubuchi, H | 1 |
| Anai, H; Kido, Y; Korenaga, D; Kusumoto, H; Kusumoto, T; Maehara, Y; Okamura, T; Sakaguchi, Y; Sugimachi, K | 1 |
| Fukada, H; Itoh, Y; Kageyama, T; Mori, H; Ohyabu, H; Sugimori, K; Tsuji, M | 1 |
| Inoue, K; Mitani, K; Morishita, Y; Yamashita, K | 1 |
| Ikeda, H; Katoh, H; Nagamachi, Y; Nakano, GI; Sakamoto, K | 1 |
| Endo, F; Ishii, T; Kito, T | 1 |
| Hata, T; Hikita, M; Horinaka, T; Ikeda, S; Murayama, K; Tanaka, T; Yoshida, T | 1 |
| Hosoi, H; Kitagawa, M; Sinmyo, K; Susaki, H; Suwa, H; Yamaguchi, K | 1 |
| Asaki, S; Goto, Y; Kikuchi, T; Koizumi, M; Mochizuki, F; Nomura, N; Ohkubo, T; Satoh, J; Taima, T; Toyota, T | 1 |
| Hayashi, T; Kitagawa, S; Nakagawa, M; Yamada, T | 1 |
| Hirayama, R; Iwama, T; Kasahara, N; Kawachi, Y; Kawasaki, T; Kudo, H; Kuwa, K; Okamoto, R; Sagara, T; Sakamoto, S | 1 |
| Ishikawa, M; Sasaki, K; Sasaki, M; Takayanagi, Y | 1 |
| Azuumi, Y; Mieno, H; Motoori, T; Okabe, H; Saigenji, K; Uesugi, H | 1 |
| Hozumi, T; Imamura, Y; Irie, K; Katou, J; Matsushita, K; Okutani, T; Oya, M; Yasutake, K; Yoshimura, Y | 1 |
| Hamada, J; Hosokawa, M; Kobayashi, H; Li, XB; Takeichi, N | 1 |
| Fujii, S; Fukushima, M; Shimamoto, Y; Shirasaka, T | 1 |
| Imai, S; Nio, Y; Ohgaki, K; Shiraishi, T; Tobe, T | 1 |
| Fujimura, T; Fushida, Y; Kamata, T; Miyazaki, I; Takegawa, S; Urade, M; Yonemura, Y | 1 |
| Hirosawa, H; Katayama, K; Matsuki, N; Sakuma, H; Sawa, T; Takano, N; Tanaka, T; Tomita, F; Ueno, K; Uogishi, M | 1 |
| Kimura, M; Koida, T | 2 |
| Furusawa, M; Hara, Y; Kono, A | 1 |
| Qi, WB | 1 |
| Masuda, F; Mori, Y; Nakada, J | 1 |
| Akatsuka, Y; Ando, T; Hayakawa, M; Kokubu, K; Kuwahara, Y; Morise, K; Sakai, T; Sato, Y; Tahara, H; Thin, K | 1 |
| Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Komi, N; Kondo, T; Kunitomo, K; Ogawa, N; Taguchi, T; Uchino, J | 1 |
| Akimoto, T; Furuta, M; Honjo, J; Kawaharada, U; Kazumoto, T; Niibe, H; Yamakawa, M; Yonome, I | 1 |
| Hayashi, S; Kamejima, N; Kasugai, T; Kataoka, M; Kureyama, Y; Masaoka, A; Mitsui, T; Taniwaki, S; Tsuji, H; Watarai, N | 1 |
| Koike, T; Nakajima, T; Sato, T; Sato, Y; Shibusawa, M; Tsuno, K | 1 |
| Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K | 1 |
| Imai, K; Kawashima, K; Kitaura, K; Kobayashi, M; Koya, J; Mashimo, T; Shimizu, N; Takahashi, H; Yajima, H; Yamanaka, H | 1 |
| Arakawa, H; Furuya, M; Inoue, Y; Koizumi, R; Masamune, O; Mukojima, T; Nakamura, J; Nasu, H; Ookubo, M; Yamada, N | 1 |
| Ono, T; Sawaki, S; Sudo, K; Tsukuda, M; Yanoma, S | 1 |
| Aoki, H; Ishibashi, M; Itoh, S; Kadowaki, A; Kogure, H; Tagaya, N; Tajima, T; Tajima, Y; Tomita, T | 1 |
| Furukawa, M; Ohoka, H; Sakashita, H; Umeda, R | 1 |
| Kosaka, T; Miwa, K; Miyazaki, I; Oyama, S; Takegawa, S; Yamaguchi, A; Yonemura, Y | 1 |
| Ando, J; Kosaka, A; Sumiyoshi, K | 1 |
| Nishida, M; Sekiguchi, I; Suzuki, M; Tamada, T | 4 |
| Hirano, F; Hirayama, A; Honjo, K; Moriya, H; Sakai, N; Uehara, S | 1 |
| Ito, Y; Matsuoka, S; Misawa, K; Nagafuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Uchino, J; Une, Y | 1 |
| Jin, ML | 1 |
| Aramaki, K; Hayashi, T; Johsen, T; Matsuura, H; Nasu, Y | 1 |
| Fujii, M; Hosoda, H; Inuyama, Y; Kohno, N; Takaoka, T; Tanaka, J | 1 |
| Hayashi, K; Hidaka, Y; Kitamura, T; Maruyama, T; Nakamura, H; Nakatsuru, K; Shigehira, M; Tsuda, K | 1 |
| Kuroda, K; Maeda, S; Nagase, T; Nakagawa, C; Nakanishi, T; Nishikawa, M; Tokunaga, K | 1 |
| Suenaga, M | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Irimoto, M; Kumada, H; Murashima, N; Nakajima, M; Nakamura, I; Takeuchi, K; Yoshiba, A | 1 |
| Enami, N; Kawakura, K; Maeno, K; Miyabe, N; Ueno, H | 1 |
| Ito, T; Izumi, T; Kurihara, M; Sasaki, J | 1 |
| Goto, S; Horiuchi, Y; Nagayo, T; Ohkita, T; Shimaji, T; Suga, S; Yokoyama, Y | 1 |
| Fujita, M; Furukawa, H; Hirose, N; Imaoka, S; Ishikawa, O; Iwanaga, T; Koyama, H; Ohigashi, H; Sasaki, Y; Shibata, T | 1 |
| Hayakawa, M; Hayashi, N; Kaneshiro, K; Morise, K; Oka, Y; Suga, S; Suzuki, T; Tsunekawa, H; Umemura, K; Yoshida, H | 1 |
| Arase, Y; Chayama, K; Gunji, T; Ikeda, K; Irimoto, M; Kumada, H; Yoshiba, A | 1 |
| Kato, T; Ota, K | 1 |
| Fujita, F; Fujita, M; Hirai, T; Taguchi, T | 1 |
| Fujii, S | 1 |
| Kawahara, T; Nakayama, H; Takatsuka, Y | 1 |
| Fujimoto, K; Ishitsuka, H; Matsuura, N; Miwa, M; Ninomiya, Y; Ryu, M | 1 |
| Eda, H; Fujimoto, K; Fukuda, H; Ishitsuka, H; Miwa, M | 1 |
| Ohyama, K | 1 |
| Matsuki, N; Miyata, R; Miyazaka, I; Noto, H; Ogino, S; Ohyama, S; Sakuma, H; Sawa, T; Yagi, M; Yonemura, Y | 1 |
| Kawakami, H; Nakanishi, T | 1 |
| Horiuchi, Y; Ina, K; Suga, S | 1 |
| Hojo, F; Inoue, I; Kimura, K; Nakamura, Y; Nakanishi, S; Noda, Y; Shimizu, E; Sone, S; Yagi, M; Yamasaki, K | 1 |
| Ando, B; Ando, S; Ibayashi, H; Inoue, K; Koga, S | 1 |
| Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M | 1 |
| Imai, Y; Inada, M; Inui, Y; Kawata, S; Matsuda, Y; Minami, Y; Miyoshi, S; Noda, S; Saito, R; Tamura, S | 1 |
| Oguma, S; Ouchi, K; Owada, Y; Sakai, K; Sato, R; Sato, T | 1 |
| Inoue, S; Kato, H; Okada, Y; Takahashi, K; Yamanaka, A | 1 |
| Kagaya, H; Matsuoka, S; Miyata, S; Nagabuchi, E; Sato, Y; Uchino, J; Une, Y; Yakura, Y | 1 |
| Fujiwara, K; Inoue, K; Kaneshige, E; Kobashi, Y; Kono, I; Sekiba, K; Tanimura, T | 1 |
| Hirata, T; Tsuruhara, Y; Yamauchi, S | 1 |
| Oiwa, T; Saito, H | 1 |
| Nio, Y; Ohgaki, K; Tobe, T; Tsuchitani, T | 1 |
| Kimura, M; Koida, T; Sugihara, S | 1 |
| Hayakawa, M; Morise, K; Ohno, R; Saito, H | 1 |
| Eguchi, K; Hoshi, A; Keicho, N; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Arima, S; Futami, K; Kinashi, M; Shigeta, M; Shimura, H | 1 |
| Adachi, M; Sasaki, M | 1 |
| Kamiya, H; Nagai, S; Sakai, K; Sato, K | 1 |
| Aota, M; Daitoh, N; Jinno, K; Nakayama, S; Yokomise, H | 1 |
| Aga, Y; Kagawa, S; Kurokawa, K; Takigawa, H | 1 |
| Kawahara, M; Matsuo, T; Nagamatsu, Y; Nakarai, I; Shinoda, A | 1 |
| Fujii, S; Miyauchi, S; Seiro, T; Shirasaka, T; Yamamoto, M; Yamamura, M | 1 |
| Hattori, T; Hirabayashi, N; Niimi, K; Niimoto, M; Nishiyama, M; Nosoh, Y; Tohge, T; Yamaguchi, M | 1 |
| Mizukoshi, O; Nishimura, H; Tachibana, M; Yasuda, N; Yoshimatsu, M | 1 |
| Anai, H; Kusumoto, H; Maehara, Y; Masuda, H; Sugimachi, K | 1 |
| Kimura, K; Seki, H; Takahashi, H | 1 |
| Asagoe, T; Hanaue, H; Kitano, Y; Kurosawa, T; Miyakawa, S; Nemoto, A; Shikata, J; Takada, T; Yamamoto, H; Yasuda, H | 1 |
| Konami, T; Konishi, T; Pak, K; Takayama, H; Tomoyoshi, T | 1 |
| Ichiki, H; Izumi, T; Kurihara, M; Miyasaka, K; Orima, H; Sasaki, Y; Tasaka, K | 1 |
| Iwama, T; Kasahara, N; Kawachi, Y; Kawasaki, T; Kudo, H; Mishima, Y; Murakami, S; Okamoto, R; Sakamoto, S; Yaegashi, K | 1 |
| Amano, T; Fujimoto, Y; Imada, T; Matsumoto, A; Noguchi, Y; Tamura, S; Yamamoto, Y | 1 |
| Futatsuki, K; Kamano, T; Komita, T; Watanabe, H | 1 |
| Hattori, T; Hirabayashi, N; Niimi, K; Niimoto, M; Nishiyama, M; Nosoh, Y; Toge, T; Wang, DC; Yamaguchi, M | 1 |
| Kikuchi, R; Mai, M; Takahashi, Y; Ueno, M | 1 |
| Abe, T; Horiike, S; Inazawa, J; Misawa, S; Nishigaki, H; Okuda, T; Taniwaki, M; Tsuji, H; Yashige, H; Yokota, S | 1 |
| Kanda, M; Kitagawa, T; Mutoh, E; Namiki, M; Okamura, K; Okano, S; Sohma, M; Suzuki, Y; Takeda, S; Utsumi, M | 1 |
| Ina, K; Iwase, H; Masuda, T; Morise, K; Ohashi, M; Suga, S | 1 |
| Hashizume, H; Horiuchi, Y; Ichihara, S; Ina, K; Suga, S; Suzui, N; Takahashi, Y; Usami, Y; Yasue, K; Yokoyama, Y | 1 |
| Hyo, N; Imura, S; Kishimoto, M; Kumoi, T; Ogasawara, H; Toda, K | 1 |
| Kamiwatari, M; Kosya, S; Nagata, Y; Shiokawa, H; Ueda, T; Yamada, E; Yamamoto, S | 1 |
| Hayakawa, M; Morise, K; Oka, Y; Saito, H | 1 |
| Abe, R; Arima, S; Fukuyama, N; Hisatsugu, T; Nakamura, Y; Ohkuma, R; Ohsato, K; Simura, H; Yamamoto, H; Yamanouchi, A | 1 |
| Hongo, H; Ishizu, K; Kondo, N; Kurata, S; Kuroda, Y; Misumi, K; Nakayasu, K; Ohfuji, K; Shinagawa, H | 1 |
| Inoue, H; Ogawa, J; Shohtsu, A | 1 |
| Kida, Y; Kobayashi, T; Tanaka, T | 1 |
| Aoki, Y; Fukunaga, H; Katsumi, M; Kawaguchi, T; Konishi, R; Oka, S; Takifuji, K; Tamaki, Y; Yukawa, H | 1 |
| Kimura, K; Ota, K; Taguchi, T | 2 |
| Hirakawa, K; Ioka, J; Ishibashi, H; Kitagawa, Y; Nakajima, H; Ochiai, K; Shirono, K; Tanabe, S; Tomita, K | 1 |
| Fujimura, T; Fushida, S; Hisazumi, H; Kamata, T; Miwa, K; Miyazaki, I; Nakajima, K; Takegawa, S; Urade, M; Yonemura, Y | 1 |
| Arai, R; Fukushi, A; Hirayama, M; Koda, K; Kure, T; Morita, K; Nakazawa, O; Terada, S; Terui, T; Yoshizaki, N | 1 |
| Kagami, Y; Narimatsu, N; Nishio, M; Saitoh, A; Sakurai, T | 1 |
| Kisu, T; Mori, H; Muto, Y; Uchida, Y; Yamaoka, K | 1 |
| Eida, K; Hasegawa, H; Ishii, T; Nakao, S; Noguchi, K | 1 |
| Kondo, I; Masuda, F; Mochizuki, A; Nakada, J; Suzuki, M | 1 |
| Honda, M; Hosoya, Y; Mukae, K; Murahashi, I; Takasaki, E | 3 |
| Ishikawa, M; Kumazawa, H; Rei, S; Saito, H | 1 |
| Fukushima, S; Sakuramoto, T; Sugawara, T | 1 |
| Akaza, H; Aso, Y; Isurugi, K; Kameyama, S; Kawabe, K; Kawamura, T; Koiso, K; Niijima, T; Shoji, F; Yokoyama, M | 1 |
| Fukuyama, E; Kamano, T; Kubo, Y; Kurihara, M; Miyoshi, K; Nakano, S; Oda, K; Sasai, T; Suwa, T; Taguchi, S | 1 |
| Sagara, T | 1 |
| Asagoe, T; Hanaue, H; Kitano, Y; Kurosawa, T; Miyakawa, S; Nemoto, A; Shikata, J; Yamoto, H | 1 |
| Adachi, S; Ishida, M; Kanazawa, K; Misawa, Y; Takeuchi, S; Yoshiya, N; Yuzawa, H | 1 |
| Ishizawa, T; Shimazu, H; Takao, S; Yamada, K | 1 |
| Furukawa, M; Kamide, M; Ohoka, H; Umeda, R | 1 |
| Fukushi, A; Hirayama, M; Koda, K; Kure, T; Morita, K; Nakazawa, O; Takahashi, H; Terada, S; Terui, T; Yoshizaki, N | 1 |
| Iwamoto, S; Kasai, Y; Kimoto, M; Mure, T; Nagano, H; Nobutou, H; Sano, K; Seo, Y; Shimizu, H; Yamamoto, Y | 1 |
| Fujita, Y; Nishioka, B; Otsuji, E; Takahashi, T; Yamaguchi, T; Yamane, T | 1 |
| Hara, Y; Hayasida, S; Ichikawa, T; Koshido, Y; Matsuyama, H; Nagata, K; Sacho, T; Sakatoku, J; Yamamoto, N; Yasui, H | 1 |
| Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N | 1 |
| Fukuoka, H; Goto, A; Kitamura, H; Murai, T | 1 |
| Hagino, S; Katayama, K; Matsuki, N; Note, M; Sakuma, H; Sawa, T; Sawazaki, K; Ueno, K; Uogishi, M; Yagi, M | 1 |
| Fujimoto, T; Ishida, T; Kurogoh, F; Ohyanagi, H; Okumura, S; Saitoh, Y; Shimada, Y; Tagashira, Y; Uchida, K; Yamamoto, M | 1 |
| Kayajima, T; Ohi, Y; Shirahama, T; Yanase, I | 1 |
| Kasahara, N; Kawachi, Y; Kawasaki, T; Kudo, H; Kuwa, K; Murakami, S; Okamoto, R; Sagara, T; Sakamoto, S; Tsukada, K | 1 |
| Abe, T; Horiike, S; Misawa, S; Nishigaki, H; Takeda, S; Takino, T; Taniwaki, M; Tsuda, S; Tsuji, T; Yashige, H | 1 |
| Anai, H; Kusumoto, H; Kusumoto, T; Maehara, Y; Sugimachi, K | 2 |
| Furuta, M; Iizuka, N; Kondo, I; Machida, T; Masuda, F; Mori, Y; Nakada, J; Onishi, T; Suzuki, M | 1 |
| Arai, Y; Endo, T; Kido, C; Miyake, Y; Ozawa, H; Sato, Y | 1 |
| Hamada, J; Hosokawa, M; Kobayashi, H; Komatsumoto, M; Li, S; Okayasu, T; Takeichi, N; Tanabe, T | 1 |
| Iwano, I; Kato, K; Kikuchi, Y; Kita, T; Kizawa, I; Miyauchi, M; Oomori, K | 1 |
| Abe, M; Amano, T; Imada, T; Matsumoto, A; Tamura, S; Yamamoto, Y | 1 |
| Nomoto, K; Taniguchi, M; Togami, M; Tsuru, S | 1 |
| Fukuda, I; Furukawa, H; Hiratsuka, M; Imaoka, S; Iwanaga, T; Kameyama, M; Koyama, H | 1 |
| Hattori, T; Hirabayashi, N; Niimi, K; Niimoto, M; Nishiyama, M; Saeki, T; Takagami, S; Wang, DC; Yamaguchi, M; Yoshinaka, K | 1 |
| Higaki, M; Hoshino, M; Imamura, K; Inoue, K | 1 |
| Baba, T; Furukohori, N; Itoh, T; Kawata, K; Kimura, T; Munakata, A; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y | 1 |
| Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A; Tsurumi, T | 1 |
| Momiki, S; Shiba, M; Urabe, N; Yamaguchi, Y | 1 |
| Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A | 2 |
| Kikuchi, K; Kunii, Y; Mori, Y; Nitta, A; Saitou, T; Takahashi, N | 1 |
| Goya, T; Kaji, Y; Kinoshita, K; Kodama, T; Maruoka, N; Moriyama, T; Nonaka, A; Oyama, H; Shimauchi, M; Wakisaka, S | 1 |
| Horiuchi, M; Nakarai, I; Nasu, K; Shinoda, A | 1 |
| Fukushi, G; Itoh, T; Kimura, M; Kimura, T; Kishibe, T; Saitoh, S; Sakata, Y; Suzuki, H; Tamura, Y; Tsushima, K | 1 |
| Fujita, S; Hozawa, J; Matsubara, A; Mori, I; Saito, H; Tanita, J | 1 |
| Mai, M; Ohta, T; Takahashi, Y | 1 |
| Ariyoshi, T; Maruden, A; Morita, K; Sutou, H; Takenouchi, T; Yamashita, K | 1 |
| Aoike, A; Hosokawa, T; Kawai, K; Koyama, K; Nakamura, K; Nishi, Y; Rokutan, K; Yoshida, A | 1 |
| Honjo, H; Oka, T; Okada, H; Yasumura, T | 1 |
| Furusawa, M; Inokuchi, K; Matsusaka, T; Noda, S; Oka, N; Okamura, T; Saku, M; Sugimachi, K; Teraoka, H; Toda, T | 1 |
| Iizuka, N; Kondo, I; Machida, T; Masuda, F; Mori, Y; Nakada, J; Onishi, T; Suzuki, M | 1 |
| Hashimoto, T; Iigima, N; Iwasaki, M; Kameya, S; Narita, M; Sato, M; Sou, M; Takeshita, T | 1 |
| Bando, T; Sato, M; Walid, A; Yanagawa, T; Yoshida, H | 1 |
| Eida, K; Fukuda, Y; Hirano, T; Ishii, T; Kotake, Y; Kusano, H; Nakagoe, T; Shimizu, T; Shimoyama, T; Tomita, M | 1 |
| Hatano, T; Hayakawa, M; Igarashi, M; Kashiwabara, N; Koyama, Y; Miyazato, T; Osawa, A; Saito, S; Sato, K | 1 |
| Ina, K; Iwase, H; Matsuoka, S; Matsuura, T; Morise, K; Nomoto, K; Suga, S; Takeda, N | 1 |
| Arai, Y; Endo, T; Kido, C; Ota, K; Suyama, K | 1 |
| Iizuka, N; Machida, T; Masuda, F; Mori, Y; Nakada, J; Ohnishi, T; Suzuki, M | 2 |
| Ikeda, M; Kaneshige, E; Kohno, I; Matsuoka, I; Noda, K; Sawaragi, I; Sekiba, K; Sugawa, T; Teshima, K; Yamagata, S | 1 |
| Kamiya, H; Nagai, S; Sakai, K; Sawada, T; Tsukasaki, K | 1 |
| Fujii, M; Hirokawa, T; Horiuchi, M; Inuyama, Y; Kaneko, S; Miyake, H; Ooyama, W; Takeda, C; Tanaka, J; Uchida, M | 1 |
| Aiko, A; Fukuma, K; Ikuta, Y; Inoue, S; Matsuura, K; Okumura, A; Onitsuka, Y; Shibata, S; Tanaka, T; Yoshimura, T | 1 |
| Hisazumi, H; Kosaka, S; Misaki, T; Miyagi, T; Miyazaki, K; Naito, K; Shimada, K | 1 |
| Hashimoto, T; Kamata, T; Katayama, K; Miyata, R; Miyazaki, I; Nakajima, K; Saito, Y; Sawa, T; Takegawa, S; Yonemura, Y | 1 |
| Segawa, T; Toide, K; Unemi, N | 1 |
| Babaya, K; Hirao, Y; Matsuki, H; Moriya, A; Nakatsuji, F; Okajima, E; Samma, S; Tabata, S; Watanabe, S; Yoshie, T | 1 |
| Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M | 1 |
| Hashizume, H; Horiuchi, T; Ina, K; Iwase, H; Kimura, K; Matsuoka, S; Matsuura, T; Suga, S; Takada, N; Yamada, K | 1 |
| Abe, S; Fujita, K; Murayama, T; Sayama, T | 1 |
| Akaza, H; Isurugi, K; Kishi, H; Koseki, K; Niijima, T; Umeda, T | 1 |
| Hirano, H; Kawai, Y; Nishiyama, M; Sugiyama, Y; Taniguchi, H; Uematsu, A; Yanase, H | 1 |
| Ohwada, M; Sekiguchi, I; Suzuki, M; Tamada, T | 1 |
| Ikeya, T; Ishikawa, H; Izuo, M; Kaneko, H; Miyamoto, Y; Seki, M; Takeshita, M; Tozuka, S; Usui, R | 1 |
| Fujii, M; Hosoda, H; Inuyama, Y; Saito, S; Takaoka, T; Tanaka, J | 1 |
| Fujioka, Y; Harada, K; Kiya, K; Kodama, Y; Okamoto, H; Uozumi, T | 1 |
| Fujii, M; Hosoda, H; Inuyama, Y; Kohno, N; Takaoka, T; Tnaka, J | 1 |
| Kimura, K; Suga, S | 1 |
| Fujii, S; Shirasaka, T | 2 |
| Matsumoto, S; Nogaki, H; Tamaki, N; Taomoto, K | 1 |
| Ishii, K; Kagaya, T; Koike, D; Odake, Y; Ohyama, K; Saitoh, T; Takebe, T; Takiyama, Y | 1 |
| Enomoto, S; Kusama, M; Nagura, H; Ono, T; Utsunomiya, Y | 1 |
| Bekki, E; Hashimoto, I; Kasai, Y; Mikami, J; Nakamura, T; Nakanishi, Y; Nishi, H; Nishindai, H; Sawada, Y; Yoshimoto, M | 1 |
| Kimura, K; Suga, S; Yokoyama, Y | 2 |
| Fujii, S; Hoshino, A; Kamiya, O; Kimura, K; Kojima, T; Nagata, K; Ohara, K; Sugihara, T; Suzuki, M; Yamada, M | 1 |
| Akiyama, J; Sagara, Y; Takeda, Y | 2 |
| Haruno, A; Kunimune, Y; Morita, K; Unemi, N; Yamamoto, J; Yamashita, K; Yoshimura, Y | 1 |
| Fujii, S; Harada, N; Miyauchi, S; Nakamura, H; Nishioka, N; Shirasaka, T; Tanaka, H; Yu-Qin, W | 1 |
| Arai, Y; Machida, T; Masuda, F; Tashiro, K | 1 |
| Akimoto, M; Fukui, I; Isaka, S; Ito, Y; Kawai, H; Shida, K; Shimazaki, J; Yamanaka, H; Yokokawa, M; Yoshida, K | 1 |
| Izumi, T; Kurihara, M; Maruyama, T; Sasaki, Y; Shirakabe, H | 1 |
| Fujioka, Y; Harada, K; Kiya, K; Okamoto, H; Uozumi, T | 1 |
| Fujita, F; Fujita, M; Taguchi, T | 1 |
| Byfield, JE; Hornbeck, CL; Tang, SG | 1 |
| Fujita, H | 1 |
| Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M | 1 |
| Hatae, M; Hokanishi, H; Terahara, M | 1 |
| Fujii, S; Fukushima, M; Ikenaka, K; Kitano, S; Maehara, Y; Nakamura, H; Shirasaka, T | 1 |
| Isobe, K; Kimura, K; Kitamura, M; Kubo, K; Shimaji, T; Suga, S; Suzuoki, Y | 1 |
| Fujii, S; Marunaka, T; Minami, Y; Nagamachi, M; Umeno, Y; Yoshida, K | 1 |
| Marunaka, T; Umeno, Y | 1 |
| Sakurai, Y | 1 |
| Kawaguchi, Y; Masuda, H; Nagayama, S; Yasuda, A | 1 |
| Haruno, A; Toide, K; Unemi, N; Yamamoto, J; Yoshimura, Y | 1 |
| Kanbara, H; Kawashima, Y; Kitade, F; Kurokawa, A; Okada, K; Okajima, K; Sakuramoto, K; Yamada, S | 1 |
| Tschiersch, B | 1 |
| Komi, N; Korematsu, H; Kunitomo, K; Kuwashima, T; Tamura, T; Toyosaki, M; Yoshikawa, H | 1 |
| Hirota, T; Okazaki, N; Tajiri, H; Yamaguchi, H; Yoshida, S; Yoshimori, M | 1 |
| Asahi, T; Kaneshige, T; Kumon, H; Matsumura, Y; Ohmori, H; Ozaki, Y; Tsushima, T; Yoshimoto, J | 1 |
| Higashi, Y; Nomoto, C; Suemasu, K | 1 |
| Furue, H | 1 |
| Fujioka, A; Nakano, K; Okabe, H; Saito, H; Takeda, S; Toko, T; Unemi, N | 1 |
| Okabe, H; Takeda, S; Toko, T; Unemi, N; Yuasa, C | 1 |
| Ikeda, S; Mitsuishi, K; Mori, H; Nakamura, H; Ootsuka, K; Tanaka, S; Tomita, A; Umeno, T | 1 |
| Demachi, H; Konishi, K; Kuroda, Y; Tsugawa, K; Tsuji, M; Yabushita, K | 1 |
| Adachi, K; Ao, T; Endo, T; Kawakami, T; Koshiba, K; Mashimo, S; Uchida, T; Yokoyama, E | 1 |
| Fukatsu, H; Honda, N; Miyagawa, Y; Segawa, A; Yamada, Y | 1 |
| Ezaki, K; Hayahara, N; Iritani, M; Kashihara, N; Maekawa, T; Morikawa, Y; Nishijima, T; Senju, M; Tsujita, M; Yamaguchi, M | 1 |
| Higashigawa, M; Ido, M; Inagaki, S; Kagawa, Y; Kakito, H; Kojima, M; Ohkubo, T; Ooi, K; Sakurai, M | 1 |
| Hoshino, K; Mitsuya, T; Morioka, M; Noguchi, Y; Notake, Y; Okuyama, D; Shimizu, A; Takahashi, J; Watanabe, S; Yoda, A | 1 |
| Akao, S; Ishikawa, H; Kiumi, F; Oya, M | 1 |
| Fukuma, T; Ikeda, T; Kobayashi, F; Kurosaki, M; Marumo, F; Sakamoto, N; Sakamoto, S; Sato, C; Tozuka, S | 1 |
| Hirata, K | 1 |
| Fukuda, T; Hasegawa, H; Numata, H; Sakamoto, H | 1 |
| Hirano, K; Kanehira, E; Kawakami, K; Kawashima, S; Nagasato, A; Omura, K; Shirasaka, T; Tawaraya, K; Watanabe, S; Watanabe, Y | 1 |
| Maehara, Y; Satoh, J; Shibata, Y; Shimizu, TS; Sugihara, S; Uchida, T | 1 |
| Furukawa, H; Goto, S; Hiratsuka, M; Iwanaga, T; Kito, T; Nakajima, T; Nakazato, H; Ohta, K; Okabayashi, K; Yamamura, Y | 1 |
| Suda, Y; Uchida, K | 1 |
| Akazawa, S; Fukuyama, Y; Hasegawa, K; Hayakawa, M; Kimura, K; Koizumi, W; Kurihara, M; Sasai, T; Sato, A; Takahashi, M | 1 |
| Hiroshige, K; Ikeda, T; Korenaga, D; Nishizaki, T; Sugimachi, K; Takenaka, K; Yoshida, K | 1 |
| Nagaoka, S; Tawara, K; Yoshigi, J; Yoshimura, Y | 1 |
| Kurebayashi, J; Sonoo, H | 1 |
| Harada, S; Matsuo, M; Miyata, M; Obara, T; Oikawa, H; Ping, L; Takahashi, T; Yanagisawa, T | 1 |
| Asoh, H; Hara, N; Ichinose, Y; Ohta, M; Takanashi, N; Tayama, K; Yano, T; Yokoyama, H | 1 |
| Arase, Y; Chayama, K; Ikeda, K; Koida, I; Kumada, H; Saitoh, S; Tsubota, A | 1 |
| Hasegawa, K; Ishida, H; Kamigaki, T; Morita, S; Ohashi, O; Saitoh, Y; Takase, S; Yamamoto, M | 1 |
| Chen, JA; Honda, M; Hosoya, Y; Imai, T; Maeda, S; Suzuki, T; Takasaki, E | 1 |
| Ikeda, K; Shibata, N; Tamai, M | 1 |
| Conti, JA; Jeffers, S; Leichman, CG; Leichman, LP; Muggia, FM; Saltz, LB; Spiess, T; Young, CW | 1 |
| Milla, A; Sanchiz, F | 1 |
| Arima, H; Arita, S; Hachisu, T; Hisikawa, E; Kashiwabara, H; Matsumoto, M; Sakamoto, K; Yaguchi, H; Yokoyama, T | 1 |
| Akaishi, O; Hanai, A; Kikuchi, K; Matsuzaki, H; Oikawa, H; Ozasa, T; Seo, K; Tsukikawa, S; Yamaguchi, S; Yamamura, T | 1 |
| Aida, I; Kasuga, Y; Ohwada, M; Sato, I; Suzuki, M; Tamura, T | 1 |
| Ikuta, H; Shibagaki, F; Tsuji, Y | 1 |
| Chao, C; Imada, T; Maehara, T; Matsumoto, A; Miyazaki, T; Morinaga, S; Takehana, T | 1 |
| Horiuchi, Y; Ina, K; Iwase, H; Kaneko, H; Kuroiwa, A; Kusugami, K; Morise, K; Oka, Y; Shinoda, M; Suga, S | 1 |
| Arimoto, T; Kishimoto, H; Takahashi, Y; Urade, M; Yanagisawa, T; Yoshioka, W | 1 |
| Kinoshita, S; Kobayashi, N; Matsuda, R; Shimahara, Y; Takatsuki, H; Yoshida, Y | 1 |
| Ban, K; Higashi, H; Ishihara, S; Kitazaki, M; Machida, T; Masuda, K; Matsumoto, M; Noma, M; Ota, M; Shida, H | 1 |
| Higaki, T; Ito, Y; Kono, S; Moriguchi, M; Nakata, Y; Oishi, H; Seki, N; Takahashi, T; Takano, S; Watanabe, Y | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Kishimoto, S; Nakano, H; Ohigashi, H; Sasaki, Y | 1 |
| Fujita, I; Kiyama, T; Mizutani, T; Oguri, T; Okuda, T; Onda, M; Shimizu, Y; Teramoto, T; Tokunaga, A; Yoshiyuki, T | 1 |
| Ishizawa, S; Masuyama, K; Oonishi, Y; Sawataishi, M; Suzuki, S; Wakaki, K; Yamazaki, K | 1 |
| Wakui, A | 1 |
| Abe, R; Kiman, K; Kimijima, I; Nihei, M; Sakonji, M; Satomi, T; Suzuki, S; Tanaka, T | 1 |
| Kanemitsu, T; Katoh, K; Koike, A; Kojima, T; Matsumoto, K; Nagata, H; Naruse, T; Suzumura, K | 1 |
| Abbruzzese, JL; Ajani, JA; Bready, B; Jones, DV; Lassere, Y; Markowitz, AB; Patt, YZ; Pazdur, R; Rhodes, V; Sugarman, SM | 1 |
| Kitada, K; Mochida, A; Nakamura, H; Omori, S | 1 |
| Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M | 1 |
| Akaza, H; Hattori, K; Hayashi, T; Kasaya, S; Koiso, K; Nemoto, R; Nishijima, Y; Shiga, T; Shimazui, T; Uchida, K | 1 |
| Arizono, S; Kajiura, N; Konishi, T; Kubota, K; Makuuchi, M; Nakao, K; Oka, T; Teruya, M; Tsushima, H | 1 |
| Monden, Y; Morimoto, T; Sakai, S; Sasa, M | 1 |
| Kanetake, H; Minami, Y; Saito, Y; Sakai, H | 1 |
| Asakura, A; Fukuda, H; Hagiwara, T; Kobayashi, A; Kotani, A; Nemoto, K; Sakamoto, H; Sunada, O; Takaku, S; Tamura, M | 1 |
| Kanazawa, Y; Kurogi, S; Masuda, K; Noda, Y; Shinohara, S | 1 |
| Baba, H; Furusawa, M; Kakeji, Y; Maehara, Y; Okuyama, T; Sugimachi, K | 1 |
| Horiuchi, M; Inuyama, Y; Kamata, S; Kaneko, S; Komiyama, S; Ogasawara, H; Okuda, M; Tsukuda, M; Uchida, M; Uemura, T | 1 |
| Endo, T; Hatakeyama, S; Ho, N; Katagiri, J; Onuki, K; Sasagawa, T; Sekine, T; Sugiyama, K; Togashi, M; Tomidokoro, T | 1 |
| Aoki, T; Ashikaga, K; Hirai, K; Kawahara, H; Kimura, C; Kuroda, H; Ono, M; Sato, K; Yamada, Y | 1 |
| Hidaki, T; Kato, T; Sugimori, H; Tazaki, T; Tsukamoto, N; Yakushiji, M; Yamabe, T | 1 |
| Adachi, S; Honma, S; Kodama, S; Maruhashi, T; Nakamura, M; Sudou, N; Takahashi, T; Takeuchi, Y; Tanaka, K; Tokunaga, A | 1 |
| Arima, S; Hisatsugu, T; Ohsato, K; Shimura, H | 1 |
| Fujiyama, S; Hashiguchi, O; Hayashida, T; Ikebe, M; Noumaru, S; Sato, K; Sato, T; Shibata, J | 1 |
| Hayashi, K; Imaoka, T; Kawaguchi, T; Kubo, M; Matsui, Y; Miyauchi, S; Utsunomiya, T | 1 |
| Nomura, Y; Ohsaki, A; Tashiro, H | 1 |
| Honma, H; Kang, K; Tozawa, K; Washida, H; Yamada, Y | 1 |
| Hashimoto, T; Hirano, K; Kanehira, E; Kawakami, K; Omura, K; Shirasaka, T; Watanabe, S; Watanabe, T; Watanabe, Y | 1 |
| Fujioka, A; Ishitani, K; Nakano, K; Nomura, N; Nukatsuka, M; Oh-ie, S; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Dousei, T; Hashimoto, T; Moriguchi, S; Suhara, H; Taketani, S; Taniguchi, M; Ueda, H; Utsumi, T; Yamaguchi, T; Yoshikawa, K | 1 |
| Baba, H; Inutsuka, S; Kohnoe, S; Maehara, Y; Oshiro, T; Sugimachi, K; Takahashi, I; Takeuchi, H | 1 |
| Homma, A; Iizuka, K; Nakamaru, Y; Yonekawa, H | 1 |
| Fukagawa, H; Hirohashi, Y; Iwanaga, A; Iyama, A; Kitahara, K; Miyazaki, K; Mori, M; Sasatomi, E; Tsutsumi, N; Yakushiji, H | 1 |
| Igawa, M; Nakamoto, T; Usui, T | 1 |
| Kurihara, M | 2 |
| Arima, S; Futami, K; Kotoh, T | 1 |
| Akaogi, E; Inagaki, M; Ishibashi, O; Ishikawa, S; Kinoshita, T; Mitsui, K; Morita, R; Okazaki, H; Onizuka, M; Suga, M | 1 |
| Nakano, K; Saito, H; Satake, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Hanai, J; Honjoh, M; Ishikawa, Y; Ohnishi, N; Sakaguchi, H; Takeyama, M | 1 |
| Kubota, T; Nishimura, T | 1 |
| Akimori, T; Izumiyama, F; Kamioka, N; Kawada, M; Kohara, H; Miyagawa, H; Nakatoh, H; Takahashi, T; Utsunomiya, T; Yuube, R | 1 |
| Ito, T; Koreeda, C; Naitoh, Y; Nakagawa, T; Okuno, H; Seki, T; Shiro, T; Tagawa, Y; Wakabayashi, M; Yamamura, H | 1 |
| Eguchi, A; Fukano, M; Furuta, T; Haraguchi, M; Iwao, Y; Tsuboi, S | 1 |
| Hino, F; Urabe, T | 1 |
| Kimura, K; Ko, Y; Kumada, K; Makuuchi, M; Midorikawa, T; Nakano, H; Namatame, K; Sasaki, E; Shimada, K; Takahashi, H | 1 |
| Daniels, M; Díaz-Rubio, E; Estapé, J; Galán, A; García-Conde, J; Guillem, V; Herranz, C; Martín, M; Montero, JM; Ordoñez, A | 1 |
| Itoh, Y; Ohkawa, S; Tamai, S; Tarao, K | 1 |
| Kasahara, N; Kudo, H; Mizuno, M; Mori, T; Nagasawa, H; Sakamoto, S; Sugiura, Y; Suzuki, S | 1 |
| Kumagai, K; Masuo, K; Nishida, Y; Yasui, A; Yoshitoshi, A | 1 |
| Fujita, K; Kaneko, T; Matsushima, H; Nakano, M | 1 |
| Fukuyama, Y; Hasegawa, K; Hayakawa, M; Ishikawa, K; Iwazaki, R; Koizumi, W; Kubo, Y; Kurihara, M; Sasai, T; Yasutake, K | 1 |
| Aoki, T; Fujimori, T; Hirai, K; Kashimura, H; Nimura, H; Sano, Y; Sekine, C; Tadaoka, N; Takayama, S; Tsutsumi, J | 3 |
| Buesa, JM; Cueva, J; Esteban, E; Estrada, E; Fernández, JL; Fernández, Y; Gracia, JM; Palacio, I; Peláez, I; Sanz, A | 1 |
| Hashimoto, T; Ishida, F; Omura, K; Watanabe, Y | 1 |
| Baba, S; Itaya, S; Kobayashi, T; Matsuda, T; Motai, H; Shimada, J; Suzuki, K; Tsuge, I | 1 |
| Hirata, K; Sasaki, K; Shirasaka, T; Yamamitsu, S | 1 |
| Kosaki, G; Kurihara, M; Tominaga, T; Yoshida, Y | 1 |
| Kanno, H; Kitami, K; Nagashima, Y; Senga, Y; Takahashi, T | 1 |
| Furusawa, M; Kakeji, Y; Matsukuma, A; Matsuoka, H; Morita, M; Ohno, S; Seo, Y; Tomoda, H | 1 |
| Itsubo, M | 1 |
| Asoh, H; Hara, N; Ichinose, Y; Matsuoka, Y; Miura, T; Ohta, M; Takanashi, N; Tayama, K; Yano, T; Yokoyama, H | 1 |
| Hishinuma, S; Ikeda, T; Inada, T; Kotake, K; Koyama, Y; Kubota, T; Ogata, Y; Ozawa, I; Shimizu, H | 1 |
| Higashigawa, M; Inagaki, S; Kagawa, Y; Kakito, H; Ohkubo, T; Ooi, K; Sakurai, M; Sumida, K | 1 |
| Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Komi, N; Kondo, T; Maehara, Y; Sugimachi, K; Taguchi, T; Uchino, J | 1 |
| Ishikawa, H; Kusano, H; Miyashita, K; Nakazaki, T; Ogawa, T; Shimizu, T; Shimoyama, T; Yasutake, T; Yoshida, A; Yoshida, K | 1 |
| Azuma, S; Furuta, T; Kato, M; Kuno, T; Nishina, T; Saji, S; Takahashi, K; Tanemura, H | 1 |
| Fujita, F; Fujita, M; Inaba, H; Taguchi, T | 1 |
| Akaza, H; Harada, M; Hayashi, T; Kasaya, T; Koiso, K; Nemoto, R; Nishijima, Y; Uchida, K | 1 |
| Nakano, K; Takechi, T; Takeda, S; Uchida, J | 1 |
| Fukushima, S; Hosaka, M; Kondo, I; Kubota, Y | 1 |
| Kosaka, A; Sakaguchi, T; Watahiki, Y | 1 |
| Kiyohashi, A; Kurihara, M; Ohkubo, T; Suga, S; Yoshida, S | 1 |
| Harada, M; Kimura, A; Koga, K; Miura, I; Nishitani, H | 1 |
| Adachi, I; Hashimoto, T; Ishida, F; Kawakami, K; Matsu, T; Omura, K; Watanabe, Y | 1 |
| Hamanaka, Y; Hayashi, S; Matsuura, Y; Shikata, H; Sueda, T | 1 |
| Sakakibara, N; Watanabe, H | 1 |
| Kano, T; Masaoka, T; Nakamura, T; Ohashi, Y; Sato, K; Suzuki, T; Tenma, K | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Iida, A; Ikeda, N; Komatsu, T; Ookubo, K | 1 |
| Imoto, M; Kakusui, M; Kashima, K; Misawa, S; Takashima, T; Taniwaki, M | 1 |
| Okada, Y; Takeuchi, H; Terachi, T; Yoshida, O | 1 |
| Baccanari, DP; Cao, S; Davis, ST; Joyner, SS; Rustum, YM; Spector, T | 1 |
| Fugimura, T; Fushida, S; Kanno, M; Michiwa, Y; Miwa, K; Miyazaki, I; Nishimura, G; Sato, T; Sugiyama, K; Yagi, H; Yamaguchi, A; Yonemura, Y | 1 |
| Asano, K; Imai, R; Somekawa, Y; Taira, A | 1 |
| Hisatsugu, T; Katano, M; Masumoto, H; Nakamura, M; Sasadomi, E; Yunotani, S | 1 |
| Creaven, PJ; Frank, C; Ho, DH; Kurowski, M; Meropol, NJ; Petrelli, NJ; Rodriguez-Bigas, M; Rustum, YM | 1 |
| Fujii, H; Fukushima, S; Harada, M; Hosaka, M; Kondo, I; Kubota, Y; Miura, T | 1 |
| Hamazoe, R; Hirooka, Y; Ikeguchi, M; Kaibara, N; Maeta, M; Oka, A; Otani, S; Tsujitani, S | 1 |
| Honma, A; Ishikawa, N; Ishikawa, T; Kamimura, T; Oota, H; Ozaki, T; Takeda, K; Yoshida, T | 1 |
| Feld, R | 1 |
| Hitomi, S; Teramatsu, T; Wada, H | 1 |
| Blanco, E; Colmenarejo, A; de la Gándara, I; Espinosa, E; Feliu, J; García-Girón, C; Garrido, P; González-Barón, M; Juárez, F; Martínez-Martínez, B | 1 |
| Fujioka, A; Nakano, K; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Inutsuka, K; Maruiwa, M; Noutomi, M; Ohta, J; Tokuhara, K | 1 |
| Akao, S; Ishikawa, H; Iwami, N; Kiumi, F; Oya, M; Sasaki, K; Terada, H | 1 |
| Fujita, M; Honda, I; Jingu, K; Satomi, D; Tsurumachi, T; Watanabe, K; Watanabe, S; Yamada, S; Yamamoto, H | 1 |
| Fujioka, A; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Matsumoto, K; Onodera, H; Otawa, K; Sato, T; Ukai, K | 1 |
| Fujioka, S; Kato, K; Tomono, H | 1 |
| Inada, T; Kase, S; Kitajima, M; Kubota, T; Kumai, K; Kurihara, N; Watanabe, M | 1 |
| Kikuchi, H; Nasu, M; Ogata, M; Ohtsuka, E; Uno, N | 1 |
| Amano, T; Hayashi, Y; Imada, T; Kubo, A; Maehara, T; Matsumoto, A; Morohoshi, T | 1 |
| Fujita, H; Fujita, K; Fukuda, Y; Fukushima, M; Ishioka, T; Ito, H; Kishibe, S; Kogawa, R; Koie, H; Kudo, T; Machida, S; Maruyama, A; Sato, T; Takashima, K; Tsuge, T; Tsushima, T; Yagihashi, N | 1 |
| Iijima, K; Iwazaki, R; Maehiro, K; Miwa, H; Mizobuchi, N; Okura, R; Ono, Y; Ota, K; Sato, K; Sato, N; Urabe, M; Wada, R | 1 |
| Dohi, K; Goto, T; Haruta, R; Kataoka, T | 1 |
| Kudo, H; Maemura, M; Mitamura, T; Nakayama, T; Sakamoto, S; Sassa, S; Suzuki, S; Yoshimura, S | 1 |
| Fujii, M; Fukuda, S; Inuyama, Y; Kawasaki, K; Kawaura, M; Kohno, N; Tanaka, K | 1 |
| Ichikura, T; Okusa, Y; Tamakuma, S; Tomimatsu, S; Uefuji, K; Yahara, T | 1 |
| Drengler, R; Eckardt, J; Eckhardt, G; Villalona-Calero, M; Von Hoff, D | 1 |
| Ikeda, E; Isomoto, H; Kato, T; Kodaira, S; Okuda, M; Takahashi, T; Teramoto, T; Yamamoto, Y | 1 |
| Hyakuna, Y; Kushibiki, K; Matsuoka, H; Shimada, M; Yokomichi, H | 1 |
| Horiuchi, N; Tamura, R; Yokoi, K | 1 |
| Fujioka, A; Fujita, K; Satake, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Araki, H; Hiramatsu, Y; Kamiyama, Y; Kojima, Y; Nakagawa, A; Nakagawa, M; Ogura, T; Shirasaka, T | 1 |
| Handa, H; Honjo, K; Kawanishi, J; Nakamura, T; Nakayama, N; Ohi, M; Tsuji, Y; Uehara, S; Watanabe, Y; Yoshihito, H | 1 |
| Fujii, M | 4 |
| Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
| Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S | 1 |
| Miura, K; Murayama, H; Sakamoto, J | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y | 1 |
| Kobayashi, K | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Aoki, T; Inoue, Y; Kashimura, H; Nimura, H; Ogata, N; Ohtani, M; Sano, Y; Sekine, C; Takayama, S; Tsutsumi, J | 1 |
| Bready, B; Diaz-Canton, E; Ho, DH; Lassere, Y; Pazdur, R | 2 |
| De Guzman, LM; Fernando, GY; Guancia, AA; Romana, IB; Samson, MC; Villalon, AH | 1 |
| Rustum, YM | 1 |
| Pazdur, R | 3 |
| Blanco, E; Colmenarejo, A; Crespo, MC; de Castro, J; Espinosa, E; Espinosa, J; Feliu, J; Garcia Girón, C; González Barón, M; Juárez, F; Martinez, B; Ordóñez, A | 1 |
| Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P | 1 |
| Fukushima, M; Nakano, K; Saito, H; Satake, H; Takechi, T; Takeda, S; Uchida, J; Unemi, N | 1 |
| Haneda, T; Kamiyama, T; Nakanishi, K; Nishibe, M; Shimamura, T; Uchino, J; Une, Y | 1 |
| Asano, M; Mori, T; Takahashi, K; Yasuno, M | 1 |
| Kouchi, Y; Maeda, Y; Morinaga, H; Ohuchida, A | 1 |
| Ichihara, S; Ichihara, T; Iwase, H; Kusugami, K; Nishio, Y; Saito, H; Shimada, M; Suga, S | 1 |
| Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T | 1 |
| Colmenarejo, A; de Castro, J; de la Gándara, I; Espinosa, E; Espinosa, J; Feliu, J; Fernández, Y; García Girón, C; González Barón, M; Jalón, JI | 1 |
| Aiura, K; Arisawa, Y; Ishii, S; Kakefuda, T; Kitagawa, Y; Kogure, A; Nakagawa, M; Noga, K; Shirasugi, N | 1 |
| Fujimaki, M; Katuyama, S; Kuroki, Y; Okamoto, M; Sakamoto, T; Tazawa, K; Yamashita, I | 1 |
| Hiratsuka, Y; Iguchi, A; Kumazawa, J; Naito, S; Omoto, T; Osada, Y; Sagiyama, K | 1 |
| Chida, E; Fujii, M; Fukuda, S; Furuta, Y; Inuyama, Y; Kanzaki, J; Nagahashi, T; Shirato, H; Yagi, K | 1 |
| Kakegawa, T; Maehara, Y; Ogawa, M; Sugimachi, K; Tomita, M | 1 |
| Iwama, T; Kawachi, Y; Kudo, H; Murakami, S; Okayasu, I; Sagara, T; Sakamoto, S; Tsukada, K | 1 |
| Fuchino, Y; Ikeda, S; Kimura, H; Mitsuishi, K; Tanaka, S; Tomita, A; Umeno, T | 1 |
| Hioki, M; Hirano, S; Hirata, T; Hisayoshi, T; Kutsukata, N; Masuda, S; Yamagishi, S; Yamamoto, S; Yamashita, Y | 1 |
| Tsukagoshi, S | 1 |
| Inaji, H; Koyama, H; Motomura, K; Noguchi, S | 1 |
| Hitomi, S; Otake, Y; Tanaka, F; Wada, H | 1 |
| Kajiyama, M; Kurokawa, H; Miura, K; Murata, T; Tokudome, S; Yamashita, Y | 1 |
| Hata, K; Kaganoi, J; Nanbu, H; Nishitai, R; Ohsumi, K; Tokunaga, Y | 1 |
| Bellmunt, J; Casado, S; Gallardo, E; Ribas, A; Vera, R; Vidal, R | 1 |
| Baba, H; Kakeji, Y; Maehara, Y; Ohno, S; Sugimachi, K | 1 |
| Birkhofer, MJ; Meropol, NJ; Noel, D; Sonnichsen, DS | 1 |
| DeMario, MD; Ratain, MJ | 1 |
| Kodaira, S | 1 |
| Jones, J; Mamounas, EP; Wickerham, DL; Wieand, HS; Wolmark, N | 1 |
| Skillings, JR | 1 |
| Carmichael, J | 1 |
| Abad, A; Aranda, E; Diaz-Rubio, E; Fernandez-Martos, C; Gallén, M; Marcuello, E; Martín, C; Navarro, M; Sastre, J | 1 |
| Diaz-Canton, E; Pazdur, R | 1 |
| Minsky, BD | 2 |
| Codes, M; Dugue, A; Garcia, E; Iglesias, L; Moreno, JA; Murillo, E; Torrija, E; Virizuela, JA | 1 |
| Ayala, F; Casado, A; Diaz-Rubio, E; López-Martin, JA; Martin, M; Nieto, Y; Rodriguez-Lescure, A | 1 |
| Colevas, AD | 1 |
| Diaz-Rubio, E; Garcia Carbonero, I; González-Larriba, JL; Perez Segura, P; Sastre Valera, J | 1 |
| Hitomi, S; Tanaka, F; Wada, H | 1 |
| Ichinose, Y; Kuba, M; Kudoh, S; Morikawa, T; Niitani, H; Yano, T; Yoshimori, K | 1 |
| Belón, J; de Castro, J; Espinosa, E; Feliu, J; García Alfonso, P; García Girón, C; Garrido, P; González Barón, M; Lomas, M; Ordóñez, A; Zamora, P | 1 |
| Hanauske, AR | 1 |
| Kim, BS; Kim, JG; Kim, JS; Kim, YH; Park, YT; Shin, SW | 1 |
| Mani, S | 1 |
| Arikian, S; de Andrade, CA; Delfino, C; Doyle, J; Murad, A; Sinha, N | 1 |
| Isomoto, H; Kohno, S; Matsunaga, K; Mizuta, Y; Oofukuji, M; Osabe, M; Syukuwa, S; Takeno, Y | 1 |
| Koinumaru, S; Matsuda, T; Nakai, Y; Saitoh, J | 1 |
| Baba, K; Fukuda, M; Higuchi, A; Masuyama, S; Matsuda, M; Matsumoto, H; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Uchino, S; Yamashita, H | 1 |
| Watanabe, T | 3 |
| Abe, T; Aiba, K; Furue, H; Hasegawa, K; Horikoshi, N; Kanamaru, R; Kurihara, M; Niitani, H; Ogawa, M; Taguchi, T; Takeda, S | 1 |
| Akao, M; Azuma, M; Inukai, A; Manabe, T; Matsugaki, K; Muramoto, M; Nakai, T; Ogino, K | 1 |
| Diaz-Canton, E; Ho, DH; Lassere, Y; Pazdur, R | 1 |
| Amano, T; Hatori, S; Imada, T; Ito, H; Kondo, J; Maehara, T; Rino, Y; Shiozawa, M; Suzuki, Y; Takahashi, M | 1 |
| Bajetta, E; Bochicchio, AM; Buzzoni, R; Carnaghi, C; Comella, G; Di Bartolomeo, M; Gebbia, V; Ianniello, G; Maiorino, L; Mariani, L; Pinotti, G; Schieppati, G | 1 |
| Ebuchi, M; Kudo, T; Kuwabara, H; Maruyama, M; Sugano, N; Yoshida, T | 1 |
| Fuse, H; Miyagi, T; Mizukami, Y; Namiki, M; Oda, M; Uchibayashi, T; Watanabe, Y | 1 |
| Bandai, Y; Gunji, A; Haga, S; Hiraishi, M; Idezuki, Y; Konishi, T; Murata, N; Nishigaki, M; Shibusawa, M; Shinohara, K; Ushirokouji, Y; Watanabe, H; Yabe, K; Yamamura, T; Yumoto, S | 1 |
| Danjo, Y; Takayanagi, N | 1 |
| Hosokawa, M; Kobayashi, M; Kuramitsu, Y; Li, YQ; Matsushita, K; Obara, M; Ohiro, Y | 1 |
| Ando, A; Asano, N; Bamba, T; Fujiyama, Y; Fukano, M; Inoue, T; Ito, A; Koyama, S; Kubo, M; Sasaki, M; Sato, J; Tsujikawa, T; Yoshioka, U | 1 |
| Fujiwara, Y; Hisa, N; Kume, M; Ogoshi, S; Tanaka, Y; Yoshida, S | 1 |
| Ando, E; Fukuda, H; Fukumori, K; Kato, O; Kusaba, T; Sata, M; Tanaka, M; Tanikawa, K; Yamamoto, H; Yamashita, F; Yano, Y | 1 |
| Akaza, H; Hattori, K; Ishikawa, S; Kawai, K; Kikuchi, K; Kobayashi, T; Koiso, K; Kondo, F; Manabe, F; Matsuki, K; Miyanaga, N; Noguchi, R; Shimazui, T; Suzuki, R; Takeshima, H; Tsuchiya, A; Uchida, K | 1 |
| Kazumori, H; Moritani, M; Sizuku, T; Uchida, Y; Yamamoto, S | 1 |
| Ajani, JA; Takiuchi, H | 2 |
| Punt, CJ | 1 |
| Andoh, M; Hasegawa, K; Sakonji, M; Seike, M; Tsuboi, E | 1 |
| Asano, M; Ito, T; Oshita, H; Saji, S; Tanemura, H; Yamada, M | 1 |
| Maehara, Y; Oda, S; Oki, E; Sakaguchi, Y; Sugimachi, K; Toh, Y; Yamamoto, N | 1 |
| Brown, N; Covington, W; Ho, DH; Huo, YY; Kuritani, J; Lassere, Y; Pazdur, R | 1 |
| Chimori, Y; Ikoma, H; Miyamoto, Y; Nanri, M; Nishioka, B; Oguro, A; Yamane, E | 1 |
| Fukuse, T; Hitomi, S; Miyahara, R; Ohtake, Y; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Eguchi, T; Miyazaki, K; Nakagawachi, T; Nakamura, M; Samejima, R; Shida, T; Yonemitsu, N; Yunotani, S | 1 |
| Ishikawa, K; Kanazawa, T; Kitamura, K; Miyata, M; Nishino, H; Tanaka, H | 1 |
| Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N | 1 |
| Abe, O; Demura, H; Endo, M; Kawamura, E; Kimura, K; Kubota, T; Nakao, I; Saito, T; Sasano, H; Sasano, N | 1 |
| Chan, KK; Groshen, S; Jeffers, S; Leichman, CG; Leichman, L; Muggia, FM; Spicer, D; Wu, X | 1 |
| Ansari, RH; Benner, S; Garcia, JC; Humerickhouse, R; Kugler, JW; List, M; Mani, S; Michelassi, F; Posner, MC; Schilsky, RL; Sciortino, DF; Shulman, KL; Vokes, EE | 1 |
| Brockstein, BE; Haraf, DJ; Humerickhouse, R; Vokes, EE | 1 |
| Bunnell, CA; Winer, EP | 1 |
| Ajani, JA | 1 |
| Brito, R; Hoff, PM; Medgyesy, D; Pazdur, R; Royce, M | 2 |
| Akahoshi, K; Chijiiwa, Y; Hamada, S; Hara, K; Matsui, N; Nakamura, K; Nawata, H | 1 |
| Kimura, S; Naito, Y; Nakajima, T; Ohtake, K; Saku, T; Yoshizawa, M | 1 |
| Aiba, K; Azekura, K; Kokudo, N; Matsubara, T; Moroguchi, A; Nakajima, T; Ohta, H; Sato, T; Seki, M; Takahashi, T; Ueno, M | 1 |
| Benner, SE; Canetta, R; Hoff, PM; Pazdur, R | 1 |
| Goto, R; Ikeuchi, T; Kai, Y; Ota, M; Yoshikawa, H | 1 |
| Meropol, NJ | 1 |
| Birkhofer, MJ; Ferreira, I; Meropol, NJ; Noel, D; Sonnichsen, DS | 1 |
| Kaminishi, M; Shimizu, N; Shimoyama, S | 1 |
| Asoh, H; Fukuyama, Y; Ichinose, Y; Kanematsu, T; Kuninaka, S; Terazaki, Y; Uehara, T; Yano, T; Yokoyama, H | 1 |
| Hara, S; Ikeda, Y; Koseki, S; Morozumi, K; Shibata, S; Yamauchi, T | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Ichikawa, A; Inada, T; Kawakubo, H; Ogata, Y | 1 |
| Kawabata, Y; Nio, Y; Ohishi, T; Sumi, S; Tamura, K; Yano, S | 1 |
| Hashimoto, Y; Iwasaki, K; Oida, I; Ozawa, T; Usami, A; Yamada, M | 1 |
| Kasai, N; Mutoh, Y | 1 |
| Fujii, S; Funahashi, K; Hirota, F; Hosaka, K; Ikeda, A; Inada, Y; Murai, M; Oobayashi, Y; Oota, M | 1 |
| Ashida, H; Iida, S; Kimura, J; Matsumoto, T; Tanaka, A; Teramura, C | 1 |
| Benner, S; DeMario, MD; Fleming, GF; Johnson, S; Lebwohl, D; Mani, S; Melton, K; Ratain, MJ; Vogelzang, NJ; Vokes, EE | 1 |
| González Barón, M | 1 |
| Choi, S; Habelhah, H; Hosokawa, M; Kobayashi, M; Konishi, Y; Nakae, D; Okada, F; Totsuka, Y | 1 |
| del Valle, ML; Rubiales, AS | 1 |
| Haga, S; Hirai, M; Kajiwara, T; Naritaka, Y; Ogawa, K; Otani, Y | 1 |
| Asakura, H; Ebe, Y; Ichida, T; Ishikawa, T; Ishimoto, Y; Naito, M; Nomoto, M; Usuda, H; Yokoyama, J | 1 |
| Hitomi, S; Miyahara, R; Tanaka, F; Wada, H | 1 |
| Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M | 1 |
| Hashimoto, K; Ikai, S; Ito, T; Kawakami, M; Takenaka, H | 1 |
| Inada, K; Kobayashi, K; Nakanishi, H; Nishimura, T; Tatematsu, M; Tsukamoto, T | 1 |
| Akazawa, S; Aki, M; Hashine, K; Kuwahara, M; Sumiyoshi, Y; Takenaka, A; Yamamoto, A | 1 |
| Brito, RA; Hoff, PM; Medgyesy, D; Pazdur, R; Ravandi-Kashani, F; Royce, ME; Zukowski, TH | 1 |
| Goto, M; Iwanaga, T; Kitamura, M; Kito, T; Nakajima, T; Nashimoto, A; Okabayashi, K | 1 |
| Diasio, RB | 3 |
| Abad, A; Antón, A; Aranda, E; Carrato, A; Cervantes, A; Díáz-Rubio, E; Fernández Martos, C; Gallén, M; Marcuello, E; Massuti, T; Navarro, M; Rifá, J; Sastre, J | 1 |
| Ollendorf, D | 1 |
| Colangelo, L; Mamounas, EP; Smith, R; Wickerham, DL; Wieand, HS | 1 |
| Hoff, PM; Pazdur, R | 1 |
| Twelves, C | 1 |
| Borner, M; Geoffrois, L; Hanauske, AR; Ravaud, A; Schellens, JH; Schöffski, P; Wanders, J | 1 |
| Choi, CW; Chun, HJ; Hyun, JH; Kim, BS; Kim, JS; Kim, YH; Seo, JH | 1 |
| Blanke, C; Cohen, A; Dickson, NR; Hande, K; Johnson, D; Nicholson, BP | 1 |
| Benner, S; Borquez, D; Harstrick, A; Klaassen, U; Lang, S; Oberhoff, C; Seeber, S | 1 |
| Dethling, J; Kühnle, H; Lück, HJ; Scholz, U | 1 |
| Adachi, Y; Fukuda, M; Fukuma, E; Nakayama, Y; Nishikawa, T; Ogata, H; Ohta, T; Shimizu, K; Yamaguchi, S | 1 |
| Smith, IE | 1 |
| Déporte-Fety, R; Fumoleau, P; Kerbrat, P; Laguerre, B | 1 |
| Asaishi, K; Hata, Y; Hirata, K; Kubo, Y; Mito, M; Ogita, M; Tanabe, T; Uchino, J | 1 |
| Alvarez, AM; Bonamasa, M; Bruno, M; Coppola, F; Cuevas, MA; Elli, A; Fein, L; Jovtis, S; Lerzo, G; Mickiewicz, E; Pedraza, C; Richardet, E; Suarez, LA; Uranga, G; Ventriglia, M | 1 |
| Asoh, H; Ichinose, Y; Kanematsu, T; Maruyama, R; Uehara, T; Ushijima, C; Wada, S; Yano, T; Yohena, T; Yokoyama, H | 1 |
| Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Mayer, F | 1 |
| Hosaka, M; Kubota, Y; Noguchi, S | 1 |
| Arlauskas, P; Ibrahim, D; Philip, PA; Shields, A; Zalupski, M | 1 |
| Kawada, Y; Kuriyama, M; Ohshima, S; Ono, Y; Shimizu, H; Takahashi, Y | 1 |
| Dethling, J; Hoffmann, W; Martin, C; Schiebe, M | 1 |
| Raben, D; Robert, F; Spencer, S | 1 |
| Crane, C; Hoff, PM; Janjan, N; Lassere, Y; Pazdur, R; Skibber, J | 1 |
| Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
| Fujii, M; Imai, S; Mochizuki, F | 1 |
| Hagiwara, M; Hanai, A; Kanasugi, K; Komoriyama, H; Yamaguchi, S | 1 |
| Futagami, F; Konishi, I; Ninomiya, I | 1 |
| Adjei, AA | 1 |
| Azuma, M; Houchi, H; Ichimaru, K; Ishiki, K; Kujime, T; Minakuchi, K; Shono, F; Umeda, T | 1 |
| Macdonald, JS | 1 |
| Aragón, G; Candal, A; de la Torre, A; de las Heras, M; Magallón, R; Ramos, S; Regueiro, CA; Romero, J; Salinas, J; Tisaire, JL; Valcárcel, FJ; Veiras, C | 1 |
| Kobayashi, M; Morita, T; Muraishi, O; Nukui, A; Sugaya, Y; Suzuki, K; Tokue, A | 1 |
| Blanke, CD; Choy, H; Teng, M | 1 |
| Fujinami, K; Kubota, Y | 1 |
| Basaki, Y; Fukushima, M; Hashimoto, A; Murakami, K; Shibata, J; Yamada, Y; Yonekura, K | 1 |
| Abe, K; Ishikawa, K; Kanazawa, T; Kitamura, K; Miyata, M; Morita, M; Nishino, H; Tanaka, H | 1 |
| Abe, M; Iguchi, C; Nio, Y; Ohishi, T; Sato, Y; Sumi, S; Tamura, K; Watanabe, H; Yano, S | 1 |
| Arrietta, R; Benner, S; Mani, S; Samuels, B; Schilsky, RL; Sciortino, D; Vokes, EE | 1 |
| Fujioka, M; Idezuki, Y; Inokuma, S; Ishida, H; Kamano, T; Kishi, T; Kondo, K; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Odaka, A; Shimomura, K; Suzuki, T; Takeuchi, I; Yamada, H | 1 |
| Fujino, R; Hayashi, N; Hirose, Y; Matsumura, M; Nagano, T; Oshita, M; Otsuka, T; Sumitomo, M; Takai, S; Taki, S | 1 |
| Miyaoka, S; Nagai, N; Ohama, K; Oshita, T; Shigemasa, K; Takehara, K | 1 |
| Horinaga, M; Ikeuchi, K; Kosugi, M | 1 |
| Cao, S; Rustum, YM | 1 |
| Bekradda, M; Cvitkovic, E | 1 |
| Hasegawa, K; Kurihara, M; Matsukawa, M; Muto, Y; Sakonji, M; Takebuchi, K; Watanabe, M | 1 |
| Fujiwara, Y; Itoh, R; Kusunoki, M; Nakagawa, K; Nakao, K; Yamamura, T | 1 |
| Izumi, S; Nakagawa, J; Nishihara, M; Onoda, Y; Shimizu, N; Shiota, K; Suzuka, I | 1 |
| Aiba, K; Horikoshi, N; Ito, Y; Mizunuma, N; Ohsawa, H; Sugiyama, K; Takahashi, S | 1 |
| Ichinose, Y; Kuba, M; Kudoh, S; Niitani, H; Yoneda, S; Yosimori, K | 1 |
| Kawaida, M; Kitahara, S; Kohno, N; Ohmuma, T | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Yamada, Y; Yonekura, K | 1 |
| Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T | 1 |
| Musha, N; Oka, K; Saito, H; Sando, N; Sasaki, M; Setu, M; Setu, Y; Sunami, E | 1 |
| Ishii, M; Kono, T; Negoro, N; Taniguchi, S | 1 |
| Aoki, K; Chiba, S; Hirai, H; Honda, H; Horikoshi, M; Itikawa, M; Kurokawa, M; Machida, U; Masuda, S; Mitani, K; Ogawa, S; Seo, S; Sunaga, S; Yazaki, Y | 1 |
| Fujita, M; Furukawa, H; Hirata, K; Kaibara, N; Kakegawa, T; Kasai, Y; Kitamura, M; Kubota, T; Kunii, Y; Nagawa, H; Nose, Y; Takahashi, Y; Takao, T; Takashima, S; Tomita, M; Wakasugi, J; Yoshino, K | 1 |
| Ajisaka, H; Bando, E; Fujimura, T; Fushida, S; Hayashi, T; Minatoya, T; Miwa, K; Nishimura, G; Taniguchi, K; Yonemura, Y | 1 |
| Nakano, H; Nishinuma, T; Sadou, S; Tsurui, H; Watanabe, A; Watanabe, T; Yamada, T | 1 |
| Fujitomi, Y; Fujiyoshi, K; Yasue, K | 1 |
| Langer, CJ | 2 |
| Hoff, PM; Lassere, Y; Pazdur, R | 1 |
| Fujioka, A; Fukushima, M; Nakano, K; Okabe, H; Saito, H; Sato, K; Takechi, T; Takeda, S; Uchida, J; Unemi, N | 1 |
| Fujita, M; Furukawa, H; Hirata, K; Kaibara, N; Kakegawa, T; Kasai, Y; Kitamura, M; Kubota, T; Kunii, Y; Nagawa, H; Nose, Y; Takahashi, Y; Takao, T; Takashima, S; Toge, T; Tomita, M; Wakasugi, J | 1 |
| Amagase, Y; Imamura, M; Inoue, Y; Itaba, S; Koujima, M; Miyagi, Y; Motosato, K; Sadamoto, Y; Sato, T; Siomichi, S | 1 |
| Amano, J; Hanazaki, K; Koide, N; Matsunaga, Y; Shiohara, E; Terasaki, T | 1 |
| Ando, T; Ina, K; Iwase, H; Kusugami, K; Maeda, O; Mamiya, N; Mizuno, T; Nakamura, M; Nishio, Y | 1 |
| Kuwahara, M; Motohiro, A; Takahashi, N; Tsukamoto, S; Ueda, H | 1 |
| Nashimoto, A; Tanaka, O; Yabusaki, H | 1 |
| Ishikawa, T; Kume, K; Matsusaka, T; Sonoda, K; Tashiro, H; Wakasugi, K; Yamamura, S; Yanaga, K | 1 |
| Bonner, JA; Childs, HA; Newsome, J; Raben, D; Robert, F; Spencer, SA | 1 |
| Damjanov, N; Meropol, NJ | 1 |
| Ajani, JA; Yao, JC | 1 |
| Hirakawa, Y; Kawaguchi, Y; Kuwata, K; Matsushima, E; Nagayama, S | 1 |
| Ando, J; Fujisaki, M; Ikeda, T; Imoto, S; Kobayashi, H; Kojima, M; Oka, S; Tamura, H; Wada, N | 1 |
| Imaizumi, M; Seki, Y; Takeuchi, M; Yamada, K; Yoshioka, H | 1 |
| Laohavinij, S; Maoleekoonpairoj, S; Thavichaigarn, P; Thongprasert, S | 1 |
| Ikeda, Y; Mizuno, H; Nishimura, G; Satake, K; Taguchi, T; Tsukuda, M; Yanoma, S | 1 |
| Ikeda, K; Kawaguchi, Y; Masuda, H; Matsushima, E; Nagayama, S; Yoshisue, K | 1 |
| Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R | 2 |
| Ahmed, F; Bissett, D; Cassidy, J; McLeod, H | 1 |
| Fukuda, J; Hayatsu, M; Hoshina, H; Iida, A; Kaji, M; Miyamoto, T; Miyaura, Y; Nagashima, K; Ono, K; Takagi, R; Tsurumaki, H | 1 |
| Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Matsunaga, T; Nakamura, Y; Nakayama, S; Oota, D | 1 |
| Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M | 1 |
| Asahara, T; Nakahara, H; Nakahara, M; Okajima, M; Yano, M | 1 |
| Fukushima, T; Hiki, Y; Kumada, K; Makuuchi, H; Mitomi, T; Nagasaki, H; Nishiyama, K; Ohki, S; Otani, Y; Sadahiro, S; Shimada, H; Takahashi, T; Takemiya, S; Tsukikawa, S; Yamaguchi, S; Yamamura, T | 2 |
| Kitaoka, A; Ohsumi, K; Tokuka, A; Tokunaga, Y; Yagi, T | 1 |
| Abbruzzese, JL; Benner, S; Cleary, KR; Crane, C; Hoff, PM; Janjan, N; Lassere, Y; Pazdur, R; Randolph, J; Saad, ED; Skibber, J | 1 |
| Chazard, M; Coudray, AM; de Gramont, A; Gespach, C; Louvet, C; Prévost, S; Raymond, E; Tournigand, C | 1 |
| Belón, J; Constenla, M; de Castro, J; Dorta, J; Feliu, J; González Barón, M; Jaraiz, MA; López Alvarez, MP; López Gómez, L; Vicent, JM | 1 |
| Aschele, C; Grossi, F; Guglielmi, A; Puglisi, F; Sobrero, A | 1 |
| Peeters, M; Van Cutsem, E | 1 |
| Aiba, K; Horikoshi, N; Saotome, T; Yoshida, N | 1 |
| Asanuma, F; Kawamura, E; Suzuki, T; Yamada, T; Yamada, Y | 1 |
| Azumi, Y; Hashimoto, Y; Onoyama, H; Saitoh, Y; Sugihara, S; Takao, S; Urakawa, T | 1 |
| Shirasaka, T; Taguchi, T; Tsuji, A; Yamamitsu, S | 1 |
| Hoff, PM | 2 |
| Hamazaki, K; Inagaki, M; Kawashima, T; Morichika, T; Sadamori, H; Shima, Y; Tanaka, N; Uetsuka, H; Yagi, T | 1 |
| Katayama, A; Mafune, K; Makuuchi, M | 1 |
| Köhne, CH; Peters, GJ | 1 |
| Colangelo, L; Lembersky, BC; Mamounas, EP; Smith, RE; Wieand, HS | 1 |
| Hill, M; Price, T | 1 |
| Jakobsen, A | 1 |
| Bastian, G; Chazard, M; Delperro, JR; Fargeot, P; Formento, P; Fraisse, J; Milano, G; Moutardier, V; Renée, N; Seitz, JF | 1 |
| Hegewisch-Becker, S; Hossfeld, DK; Lipp, R; Schilling, G | 1 |
| Ichikawa, W; Nihei, Z; Shirota, Y; Sugihara, K; Uetake, H; Yamada, H | 1 |
| Canzler, U; Kühnle, H; Lück, HJ; Robner, D; Scholz, U | 1 |
| Gregory, RK; Johnston, SR; Miles, D; Smith, IE | 1 |
| Bonneterre, J; Déporte, R; Fargeot, P; Fumoleau, P; Kerbrat, P | 1 |
| Hoff, PM; Janjan, N; Pazdur, R; Saad, ED; Skibber, J | 1 |
| Haller, DG; Minsky, BD; Rosenthal, DI; Saltz, L; Semple, D | 1 |
| Böhlke, I; Bokemeyer, C; Derigs, G; Hartmann, JT; Kanz, L; Mayer, F; Schröder, M; Von Pawel, J | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Shibata, J; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y; Tomita, T; Yamashita, T | 1 |
| Gojo, I; Tkaczuk, KH | 1 |
| Mercke, C | 1 |
| Nakajima, T | 1 |
| Ishizu, K; Makuuchi, H; Sadahiro, S; Suzuki, T; Tajima, T; Tokunaga, N | 1 |
| Haller, D; O'Dwyer, PJ; Redlinger, M; Stevenson, JP; Sun, W | 1 |
| Katai, H; Saka, M; Sano, T; Sasako, M | 1 |
| Shiota, M; Shirai, T; Tateyama, I | 1 |
| Hirakawa, K; Ikeda, K; Ishikawa, T; Kato, Y; Matsumura, Y; Nagatsuka, I; Nakata, B; Ogawa, Y; Ogisawa, K; Onoda, N; Takashima, T; Yashiro, M | 1 |
| Lewis, NL; Meropol, NJ | 1 |
| Harboe, K; Lind, A; Ogreid, D; Todnem, K; Zotova, L | 1 |
| Abe, M; Kosaka, M; Matsumoto, T; Shinohara, M; Tanaka, Y | 1 |
| Hoff, PM; Pazdur, R; Royce, ME | 1 |
| Wada, H | 1 |
| Brown, N; Covington, W; Creaven, PJ; Hayakawa, T; Ho, DH; Huo, YY; Kuritani, J; Lassere, Y; Lin, SN; Meropol, NJ; Pazdur, R; Rustum, YM | 1 |
| Kodaira, S; Nozawa, K; Shatari, T | 1 |
| Hayabuchi, N; Ikeda, S; Iwamoto, M; Nagata, S; Niiya, F; Odou, E | 1 |
| Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Nakayama, S; Oota, D; Shimizu, H | 1 |
| Kobayashi, A; Yamaguchi, M | 1 |
| Fukui, T; Harada, Y; Imazu, T; Miki, T; Nishimura, K; Nonomura, N; Nozawa, M; Okuyama, A; Ono, Y; Sugao, H; Takaha, N | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Hsu, TC; Jiang, JK; Lin, JK; Lin, TC; Liu, JH; Wang, HS; Wang, WS; Yang, SH; Yen, CC | 1 |
| Inui, K; Kawano, Y; Li, M; Miyahara, R; Otake, Y; Tanaka, F; Wada, H; Yamada, T; Yanagihara, K | 1 |
| Fujita, S; Kawasaki, G; Mizuno, A; Yanamoto, S | 1 |
| Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H | 1 |
| Dono, K; Eguchi, H; Gotoh, M; Kishimoto, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Umeshita, K | 1 |
| Dwivedy, S; Hoff, PM; Medgyesy, D; Pazdur, R; Royce, ME; Zukowski, TH | 1 |
| Casado, A; Diaz-Rubio, E; Garcia-Carbonero, I; Garcia-Saenz, JA; Macias, JA; Manrique, I; Martín, M; Oruezabal, M | 1 |
| Haller, D; Sun, W | 1 |
| Furuyama, JI; Hashimoto-Tamaoki, T; Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R | 1 |
| Danno, M; Ishibiki, K; Kumashiro, R; Kunii, Y; Kunitomo, K; Sakamoto, Y; Shiroto, H; Tamura, Y; Yamamura, Y | 1 |
| Aoyagi, S; Hisamatsu, T; Ikezawa, T; Matsuoka, K; Mizuno, Y; Motohashi, Y; Nishida, J; Tatsuno, S | 1 |
| Haseme, E; Kikuchi, K; Ohnishi, Y; Shohkei, O | 1 |
| Kuriyama, M; Ohshima, S; Ono, Y; Sahashi, M; Shimizu, H; Takahashi, Y; Tanaka, T | 1 |
| Ikeda, S; Iwamoto, M; Nagata, S; Niiya, F; Shirouzu, K | 1 |
| Fujimoto, N; Harada, S; Hida, T; Matsumoto, T | 1 |
| de Bono, JS; Twelves, CJ | 1 |
| Alberts, D; Brooks, D; Damle, B; Ferreira, I; Kaul, S; Pazdur, R; Ravandi, F; Sonnichsen, D; Stewart, D | 1 |
| Cunningham, D; James, RD | 1 |
| Español, I; Fernández Ortega, A; Navarro Garcia, M; Zurita Saavedra, AJ | 1 |
| Aabo, K; Hansen, F; Jakobsen, A; Pfeiffer, P; Sandberg, E | 1 |
| Kubota, T | 1 |
| Ishikawa, T; Matsui, S; Matsuki, H; Matsuzawa, J; Mita, Y; Sato, S; Tashiro, K; Tashiro, S | 1 |
| Asakura, H; Genda, T; Ichida, T; Inayoshi, J; Ishikawa, T; Ishimoto, Y; Sugahara, S; Sugitani, S; Tsuboi, Y; Uehara, K; Yokoyama, J | 1 |
| Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K | 1 |
| Iwase, H; Kameya, T; Makuuchi, H; Sadahiro, S; Suzuki, T; Tajima, T | 1 |
| Asao, T; Kuwano, H; Morinaga, N; Shimura, T; Tsutsumi, S | 1 |
| Hyun, JH; Jeen, YT; Kim, BS; Kim, CS; Kim, JS; Kim, YH; Mok, YJ; Shin, SW; Yoon, SY | 1 |
| Adak, S; Amrein, PC; Barton, JJ; Benner, S; Colevas, AD; Costello, R; Gomolin, H; Posner, MR; Read, RR | 1 |
| Chang, W; Kondo, Y; Maeda, S; Matsusaka, S; Okada, T; Oriyama, T; Satake, M; Son, G | 1 |
| Earashi, M; Kobayashi, H; Matsuki, N; Michiwa, Y | 1 |
| Beretta, GD; Labianca, R; Mosconi, S; Pessi, MA; Poletti, P | 1 |
| Ishikawa, T; Kobayashi, M; Matsuki, H; Mita, Y; Tashiro, K; Tashiro, S | 1 |
| Borner, M; Fumoleau, P; Geoffrois, L; Hanauske, AR; Kroon, K; Ravaud, A; Schellens, JH; Schöffski, BP; Wanders, J | 1 |
| Coleman, R; Cunningham, D | 1 |
| Jones, R; Twelves, C | 1 |
| Borner, M; Maroun, J; Scheithauer, W; Twelves, C; Wilke, H | 1 |
| Aguayo, A; Patt, YZ | 1 |
| Akamo, Y; Hasegawa, M; Manabe, T; Takeyama, H; Teranishi, F | 1 |
| Reimer, P; Rückle-Lanz, H | 1 |
| Alonso, V; Antón, A; Escudero, P; Herrero, A; Isla, MD; Martinez-Trufero, J; Mayordomo, JI; Sáenz, A; Tres, A; Zorrilla, M | 1 |
| Higashigawa, M; Kagawa, Y; Kakito, H; Kawasaki, H; Kojima, M; Ohkubo, T; Ooi, A; Sakurai, M | 1 |
| Hashimoto, K; Mizoguchi, H; Mutaguchi, K; Nakamoto, T; Okuchi, T; Usui, T; Yano, A | 1 |
| Ishihama, H | 1 |
| Fujisawa, A; Ikeda, H; Inokuchi, T; Kitamura, A; Nonaka, M; Ohba, S; Tobita, T; Uehara, M | 1 |
| Fujino, H; Ishikura, H; Kinoshita, H; Kondo, K; Miyoshi, T; Monden, Y; Takahashi, Y | 1 |
| Arch-Yaemsuan, P; Boonnuch, W; Chakrapee-Sirisuk, S; Lert-Akayamanee, N; Lohsiriwat, D; Nimmanwudipong, T; Sinlarat, P; Srimuninnimit, V; Vathanophas, V | 1 |
| Lokich, J | 1 |
| Iino, Y | 1 |
| Aoyagi, H; Fukue, M; Ikezawa, K; Kodaira, Y; Maruyama, T; Matsui, S; Monma, E; Nozue, M; Sakamoto, T; Shidara, S; Shimakura, S; Takada, Y; Yoshida, T | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Kitazato, K; Miyadera, K; Okabe, S; Yonekura, K | 1 |
| Fujioka, A; Fukushima, M; Nakagawa, F; Nukatsuka, M; Ohshimo, H | 1 |
| Borner, MM; Caponigro, F; Comella, G; de Boer, RF; de Wit, R; Fumoleau, P; Greim, G; Martin, C; Peters, GJ; Schoffski, P; Sulkes, A; van der Born, K; Wanders, J | 1 |
| Honda, M; Inutsuka, S; Korenaga, D; Nagahama, S; Sugimachi, K | 1 |
| Hatano, T; Hokama, S; Ogawa, Y; Touyama, H | 1 |
| Koyama, S; Shimoda, S; Takeda, N; Tanaka, N; Tsukahara, A; Yajima, K | 1 |
| Ando, K; Fukuzawa, M; Kanou, H; Kimura, T; Nagata, Y; Nezu, T; Shibata, M; Takekawa, M | 1 |
| Holen, KD; Saltz, LB | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
| Baba, S; Hasumi, A; Kato, T; Koike, A; Manabe, T; Maruta, M; Miura, K; Nakazato, H; Nimura, Y; Ohashi, Y; Saji, S; Suzuki, H; Takagi, H; Yamaguchi, A | 1 |
| Ioka, Z; Nakane, Y; Nakano, K; Osaka, Y; Sako, H; Takemura, N; Tanabe, S; Tsuchiya, K | 2 |
| Daijo, H; Hoshino, T; Inokuma, S; Ishida, H; Nakada, H; Ohsawa, T; Takeuchi, I | 1 |
| Ishii, R; Koda, K; Miyazaki, M; Oda, K; Ooshima, H; Suzuki, H; Takiguchi, N | 1 |
| Köhne, CH | 1 |
| Dan, T; Kitayama, Y; Kosaka, H; Maeda, S; Matsusaka, S; Okada, T; Tanabe, H; Yamasaki, H | 1 |
| Fujioka, A; Fukushima, M; Kitazato, K; Nakagawa, F; Nukatsuka, M; Ohshimo, H | 1 |
| Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H | 1 |
| Ikeguchi, M; Kaibara, N; Liu, J; Nakamura, S | 1 |
| Asoh, H; Ichinose, Y; Semba, H; Seto, T; Yamamoto, H; Yoh, K | 1 |
| Bandoh, N; Harabuchi, Y; Hayashi, T; Imada, M; Katayama, A; Nonaka, S | 1 |
| Croockewit, AJ; de Boer, JE; Koopmans, PP; van Loenhout, JW | 1 |
| Aabo, K; Adimi, P; Hansen, F; Jakobsen, A; Keldsen, N; Kjaer, M; Pfeiffer, P; Sandberg, E | 1 |
| Chun, H; Im, YH; Jung, CW; Kang, WK; Kim, JH; Kim, K; Kim, WS; Lee, HR; Lee, JY; Lee, MH; Lee, NS; Lee, WY; Nam, E; Oh, SY; Park, CH; Park, JO; Park, K; Park, SH; Song, SY | 1 |
| Malet-Martino, M; Martino, R | 1 |
| Friedman, M | 1 |
| Benner, SE; Davidson, N; Douillard, JY; Eisenberg, P; Harper, P; Hoff, PM; Lembersky, BC; Maniero, A; Skillings, JR; Thompson, S; Vincent, MD | 1 |
| Borner, M; Carmichael, J; Falk, S; Martin, C; Munier, S; Oza, A; Popiela, T; Radstone, D; Skovsgaard, T | 1 |
| Inagi, K; Nagai, H; Nakayama, M; Okamoto, M; Takahashi, H; Yao, K | 1 |
| Ayabe, H; Fukuoka, H; Hidaka, S; Nakagoe, T; Nanashima, A; Sawai, T; Shibasaki, S; Tanaka, K; Tsuji, T; Yamaguchi, H; Yamashita, H; Yasutake, T | 1 |
| Fukushimab, M; Matsuoka, K; Miyahara, R; Nakagawa, T; Otake, Y; Takata, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Ito, T; Nakamura, A; Sato, A; Taguchi, S; Tomita, T | 1 |
| Shimizu, Y | 1 |
| Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Ohe, S; Watabe, S | 1 |
| Inada, K; Ito, K; Kanemitsu, T; Kato, T; Matsumoto, K; Mizuno, I; Nakai, K; Nakazato, H; Sugiyama, Y; Tatematsu, M; Yamaguchi, A | 1 |
| Batlle, JF; Carpeño, Jde C; García, AG; Grande, AG; Juberías, AM; Olivar, LM; Piñeiro, EH; Sánchez Santos, ME; Uzcudun, AE; Velasco, JC | 1 |
| Arai, Y; Hagisawa, S; Hoshi, S; Namiki, S; Ohyama, C; Ono, K; Saito, S; Satoh, M; Shirasaka, T | 1 |
| Asoh, H; Fukuyama, Y; Ichinose, Y; Ikeda, J; Teruya, T; Ushijima, C; Yamaguchi, M | 1 |
| Hasebe, K; Sasaki, S; Takamura, H; Urade, M; Yagi, M | 1 |
| Azuma, T; Hatada, T; Inoue, Y; Kusunoki, M; Miki, C; Mohri, T; Ojima, E | 1 |
| Chen, JS; Hsu, KC; Tang, R; Wang, JY; Yang, TS | 1 |
| Bolaños, M; Borrega, P; Castro, J; Dorta, J; Escudero, P; Espinosa, E; Feliu, J; González Barón, M; López Gómez, L; Mel, R; Vázquez-Estévez, SE | 1 |
| Dunst, J; Engenhart-Cabillic, R; Hess, CF; Hoffmann, W; Reese, T; Schiebe, ME; Schmidberger, H; Wenz, F | 1 |
| Antón-Torres, A; Aparicio, J; Aranda, E; Bretón, JJ; Carrato, A; Díaz-Rubio, E; Fernández-Martos, C; Navarro, M; Rivera, F; Sastre, J | 1 |
| Hanaoka, N; Tanaka, F; Wada, H | 1 |
| Kawasaki, G; Mizuno, A; Yanamoto, S; Yoshitomi, I | 1 |
| Baba, Y; Imamura, Y; Kubozono, O; Maenohara, S; Moriya, H; Ogura, Y; Tahara, K | 1 |
| Endo, I; Iijima, K; Ikeya, S; Imai, J; Kamiya, T; Kashimura, J; Kuroki, M; Ojima, T; Saito, Y; Sato, K; Takahashi, M | 1 |
| Hatada, T; Inoue, Y; Kobayashi, M; Kusunoki, M; Miki, C; Ojima, E | 1 |
| Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Saguchi, T; Suzuki, T; Yamamoto, T; Yasuda, S | 1 |
| Asaoka, T; Imasato, M; Iwazawa, T; Kanoh, T; Kinuta, M; Matsui, S; Monden, T; Nakano, Y; Okada, K; Okamura, J; Tono, T; Yano, H | 1 |
| Ebuchi, M; Hasegawa, K; Maruyama, M; Nagahama, T; Natui, S; Ochiai, T; Takashima, I | 1 |
| Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Ishizuka, N; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Odaka, A; Ohsawa, T; Suzuki, T; Takeuchi, I; Yamada, H; Yokoyama, M | 1 |
| Boku, N; Fukuda, H; Hyodo, I; Ikeda, N; Miyata, Y; Ohtsu, A; Saito, H; Shimada, Y; Shirao, K; Yamamichi, N; Yamamoto, S; Yoshida, S | 1 |
| Shimizu, C; Watanabe, T | 1 |
| Kakeji, Y; Kohnoe, S; Maehara, Y | 1 |
| Ito, T; Kamachi, H; Kamiyama, T; Kondo, M; Kurauchi, N; Matsushita, M; Nakagawa, T; Nishikawa, M; Ogata, T; Todo, S | 1 |
| Baba, M; Higaki, N; Ishida, M; Kawasaki, H; Nishihara, M; Sasayama, Y | 1 |
| Arai, Y; Ichikawa, Y; Inoue, H; Kamoi, K; Koide, T; Miki, T; Miura, H; Nakai, Y; Nishimura, K; Nonomura, N; Okuyama, A; Shimizu, K; Sugao, H; Takaha, N; Takatera, H; Tokizane, T; Uchida, K; Ukimura, O; Yamaguchi, S | 1 |
| Abe, O; Abe, R; Kasumi, F; Nakazato, H; Nomura, Y; Sugimachi, K; Uchino, J; Yoshimoto, M | 1 |
| Miyazaki, M; Nakamori, Y; Shinohara, K; Taguchi, A; Tominaga, T | 1 |
| Albo Castaño, I; Arbol Linde, F; Durán Pérez-Navarro, A; Juárez Ucelay, F; Marcos Sánchez, F | 1 |
| Glimelius, B | 1 |
| Endo, C; Fujimura, S; Handa, M; Imai, T; Iwanami, H; Kanno, R; Kawamura, M; Koike, K; Kondo, T; Saito, Y; Tsushima, T | 1 |
| Arai, Y; Fukuzaki, A; Hagisawa, S; Hoshi, S; Ohyama, C; Ono, K; Saito, S; Satoh, M | 1 |
| Kido, S; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Motoyama, K; Takei, M | 1 |
| Fumoleau, P; Gall, H; Giaccone, G; Holwerda, U; Noordhuis, P; Peters, GJ; Schornagel, JH; Smid, K; Swart, MS; Turner, SL; Van Gennip, AH; Van Groeningen, CJ; Van Kuilenburg, AB; Voorn, D; Wanders, J | 1 |
| Bonneterre, J; Campone, M; Deporte-Fety, R; Fargeot, P; Fumoleau, P; Kerbrat, P; Urien, S | 1 |
| Goda, F; Hagiike, M; Ishimura, K; Izuishi, K; Karasawa, Y; Maeta, H; Okano, K; Usuki, H; Yachida, S | 1 |
| Abe, K; Fujiwara, H; Gotoh, M; Hoshino, Y; Irinoda, T; Kanzaki, N; Kogure, M; Nakaya, T; Nemoto, T; Ohtani, S; Oyama, K; Saito, K; Takagane, A; Terashima, M; Yonezawa, H | 1 |
| Mayor, S | 1 |
| Azegami, T; Fujimori, S; Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Ohtsuka, A; Tanaka, K | 1 |
| Ikeda, H; Inokuchi, T; Irie, A; Mizoguchi, Y; Shibahara, K; Takebe, Y; Yamada, K | 1 |
| Porschen, R | 1 |
| Hitsuda, Y; Kawasaki, Y; Koshohbu, T; Matsumoto, S; Nakatani, S; Shimizu, E; Yasuda, K | 1 |
| Fujimura, Y; Miyayama, H; Nagao, K; Nakagawa, K; Nishimura, R; Okazaki, S | 1 |
| Bailey, SM; Campbell, S; Cunningham, D; Glasspool, R; Hill, M; Macham, MA; Mackay, HJ; Martin, C; Massey, A; Price, T; Twelves, C; Uzzel, M | 1 |
| Hidaka, H; Koga, T; Nomiyama, H; Yano, T | 1 |
| Ikeya, T; Kawashima, Y; Kawate, S; Kusaba, T; Morishita, Y; Nakajima, T; Nakamura, S; Ohwada, S; Roppongi, T; Takahashi, T; Yokomori, T | 1 |
| Hata, K; Hiraga, T; Ikeda, F; Tamura, D; Ueda, A; Williams, PJ; Yoneda, T | 1 |
| Akiyama, N; Arai, F; Funakoshi, K; Inayoshi, J; Kato, T; Kozakai, I; Motoyama, H; Ohta, T; Saito, Y; Takii, Y | 1 |
| Goto, M; Hamaguchi, T; Matsumura, Y; Muro, K; Nagayama, S; Shimada, Y; Shirao, K; Yamada, Y | 1 |
| Chen, JS; Jan, YY; Lin, YC; Yang, TS | 1 |
| Isomoto, H; Kakegawa, T; Mori, M; Nakagoe, T; Ogawa, M; Sugimachi, K; Takano, S; Tomita, M; Yamada, K | 1 |
| Asche, C; Cripps, C; Letarte, J; Maroun, J; Mukherjee, J; Oza, A; Romeyer, F; Skillings, J | 1 |
| Hanazaki, K; Kawasaki, S; Kobayashi, A; Matsushita, A; Misawa, R; Miwa, S; Miyagawa, S; Nakagawa, K; Nakata, T; Noike, T; Nomura, K | 1 |
| Futamura, N; Matsutomo, M; Sakamoto, K; Tateyama, K; Yasumura, M | 1 |
| Hoff, PM; Saad, ED | 1 |
| Hirayama, R; Ichikawa, W; Nihei, Z; Sasaki, Y; Shirota, Y; Sugihara, K; Takahashi, T; Uetake, H; Yamada, H | 1 |
| Maeda, Y; Sasaki, E; Sasaki, T | 2 |
| Hosokawa, A | 1 |
| Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Mori, T; Takahashi, K; Yamaguchi, T | 1 |
| Doi, T; Ohtsu, A | 1 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Horiuchi, Y; Indo, T; Iwase, H; Iyo, T; Kaida, S; Kato, E; Kusugami, K; Nakamura, M; Nakarai, K; Shimada, M | 1 |
| Brewer, N; Cowan, J; Kaltenthaler, E; Ward, S | 1 |
| Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Itoyama, S; Matsumoto, Y; Miura, T; Mori, T; Murata, N; Nakada, H; Odaka, A; Ohsawa, T; Okada, N; Shirakawa, K; Suzuki, T; Takeuchi, I; Yamada, H; Yokoyama, M | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Maruyama, M; Nagahama, T; Shinoura, H; Takashima, I | 1 |
| Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T | 1 |
| Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Oshima, S; Tsujie, M; Yamamoto, H | 1 |
| Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Ohshima, S; Tsujie, M; Yamamoto, H | 1 |
| Goto, H; Kanda, T; Kawano, K; Yanagisawa, S | 1 |
| Enomoto, M; Higuchi, T; Sugihara, K; Uetake, H | 1 |
| Ahn, JH; Chang, HM; Kang, HJ; Kang, YK; Kim, TW; Lee, JS; Lee, K | 1 |
| Kobayashi, M; Konishi, N; Kusunoki, M; Mohri, Y; Ohmori, Y; Tanaka, K; Tonouchi, H | 1 |
| Asoh, H; Fukuyama, Y; Ichinose, Y; Ikeda, J; Okamoto, J; Okamoto, T; Sakai, M; Ushijima, C | 1 |
| Carlson, RW; Grekowicz, A; Hartman, AR; Lum, BL; Schurman, C; Shapiro, R; Sikic, BI; Stockdale, FE | 1 |
| Hachino, Y; Kawato, N; Makihara, K; Mishima, H; Morimoto, S; Shono, Y; Tabuse, K; Tsuji, T; Tsujinaka, T | 1 |
| Imamura, M; Yamaki, T; Yasuda, M | 1 |
| Civitelli, S; Correale, P; De Martino, A; Fiaschi, AI; Francini, G; Giorgi, G; Lorenzi, M; Marsili, S; Marzocca, G; Messinese, S; Petrioli, R; Pozzessere, D; Sabatino, M; Tani, F; Tanzini, G | 1 |
| Cats, A | 1 |
| Dono, K; Maruhashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Takahashi, Y; Tujie, M; Umeshita, K | 1 |
| Hirano, T; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Mori, M; Shimonishi, T | 1 |
| Algazy, K; Giantonio, B; Hahn, S; Haller, DG; O'Dwyer, PJ; Redlinger, M; Stevenson, JP; Sun, W; Thorn, C; Vaughn, D; Veronese, ML; Whitehead, AS | 1 |
| Funahashi, K; Goto, T; Koike, J; Matsumoto, H; Miki, T; Ryu, M; Saito, N; Shiokawa, H; Teramoto, T; Tokuyama, T | 1 |
| Adachi, M; Ishida, S; Katsuragi, A; Nakayama, A; Suzuki, M; Takeuchi, S | 1 |
| Aoki, H; Aoki, N; Hayashi, S; Hemmi, A; Karube, H; Masuda, H; Nakayama, H; Ogame, H; Sakamoto, N; Wakabayashi, K | 1 |
| Akay, S; Doganavsargil, B; Ozütemiz, O | 1 |
| Berglund, A; Byström, P; Frödin, JE; Glimelius, B; Wilking, N | 1 |
| Folprecht, G; Köhne, CH | 1 |
| Choi, SH; Heo, JS; Im, YH; Jung, CW; Kang, WK; Kim, K; Kim, WS; Lee, J; Lee, JK; Lee, KT; Lee, MH; Lee, SI; Lim, DH; Park, JO; Park, K; Song, SY | 1 |
| Hatta, C; Kakibuchi, M; Kamikonya, N; Ogasawara, H; Okita, J; Saeki, N; Sakagami, M; Terada, T | 1 |
| Aoki, T; Hayashida, Y; Kataba, Y; Kawakita, H; Kinoshita, M; Kubouchi, T; Saito, H; Sato, S; Takagi, M; Tamura, K; Tsuchida, A | 1 |
| Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H | 1 |
| Miyahara, R; Otake, Y; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Kuwahara, M; Motohiro, A; Sakada, T; Ueda, H | 1 |
| Hamajima, N; Hata, E; Ichinose, Y; Kato, H; Ohta, M; Tada, H; Tsuboi, M; Tsubota, N; Wada, H; Watanabe, Y | 1 |
| Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
| Gallo Terán, J; Mesuro Domínguez, N; Rubio Suárez, A; Señaris González, B; Teigeiro Núñez, V | 1 |
| Haga, S; Imamura, H; Kinoshita, J; Ogawa, K; Okabe, T; Shimizu, T; Watanabe, O | 1 |
| Ito, S; Mitsuhata, N; Watanabe, Y | 1 |
| Anazawa, S; Hirai, K; Kawahara, H; Ogawa, M; Sakuyama, T; Sato, K; Takao, Y; Yamazaki, Y; Yokoyama, M | 1 |
| Furukawa, M; Kawano, T; Komatsu, M; Kubota, A | 1 |
| Almenar, D; Aparicio, J; Arlandis, F; Bosch, C; Campos, J; Campos, JM; Climent, MA; Estevan, R; Fernández-Martos, C; Garcera, S; Hernandez, A; Maestu, I; Mengual, JL; Puchades, R; Richart, JM; Tormo, A; Torregrosa, M; Uribe, N; Vicent, JM; Viciano, V | 1 |
| Hashimoto, D; Inokuma, S; Ishida, H; Nakada, H; Ohsawa, T; Shirakawa, K; Yamada, H; Yokoyama, M | 1 |
| Hasumi, K; Katase, K; Kobayashi, Y; Shimizu, Y | 1 |
| Fujihara, M; Fujita, M; Furukawa, Y; Hattori, Y; Ishii, Y; Kuniki, H; Matsumoto, N; Yajima, T; Yamamoto, M; Yamaoka, Y | 1 |
| Au, GK; Chan, RT; Cheng, AC; Choy, DD; Chua, DT; Kwok, CC; Kwong, DL; Kwong, PW; Law, MW; Sham, JS; Wan, KY; Wu, PM; Yau, CC | 1 |
| Collado, A; de Juan, A; del Valle, A; Galdós, P; García-Castaño, A; López-Brea, MF; Rama, J; Rivera, F; Rubio, A; Sanz-Ortiz, J; Vega-Villegas, ME | 1 |
| Alliot, C | 2 |
| Ichinose, Y; Kudoh, S; Nakai, Y; Niitani, H; Nukiwa, T; Semba, H; Yamamoto, H; Yamane, Y; Yoshida, S | 1 |
| Frödin, JE; Glimelius, B; Gyldenkerne, N; Hansen, F; Jakobsen, A; Keldsen, N; Kjaer, M; Pfeiffer, P; Sandberg, E | 1 |
| Abbruzzese, JL; Boku, N; Hoff, PM; Hyodo, I; Loehrer, PJ; Muro, K; Nagashima, F; O'Dwyer, PJ; Ohtsu, A; Shirao, K; Wadleigh, RG; Wadler, S; Yamada, Y | 1 |
| Ferrero, JM; François, E; Milano, G | 1 |
| Altundag, K; Altundag, O; Gunduz, M | 1 |
| Graziano, F | 1 |
| Beretta, GD; Labianca, R; Milesi, L; Mosconi, S | 1 |
| Ikemura, K; Oya, R | 1 |
| Monden, M; Nagano, H; Sakon, M | 1 |
| Hashimoto, K; Higami, T; Itakura, M; Koike, M; Nio, Y; Yano, S | 1 |
| Arikawa, T; Horikoshi, I; Inagaki, H; Ito, N; Kotake, K; Kurokawa, T; Nagata, H; Nonami, T; Owa, Y; Suzumura, K; Tsubamoto, M | 1 |
| Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M | 1 |
| Futagawa, T; Izumi, H; Konno, H; Miyamoto, H; Morio, A; Oh, T; Yamazaki, A | 1 |
| Endo, Y; Mai, M; Sasaki, T; Takahashi, Y; Yamashita, K | 1 |
| Scheithauer, W | 1 |
| Catane, R; Elkayam, R; Koller, M; Kundel, Y; Pfeffer, MR; Symon, Z; Zehavi, M; Zmora, O | 1 |
| Antón-Aparicio, L; Aparicio, J; Constela, M; Dorta, FJ; Feliu, J; Fonseca, E; García-Girón, C; Gonzalez-Baron, M; Lomas, M; Vicent, JM | 1 |
| Baba, Y; Ishikawa, T; Kamimura, T; Mizuno, K; Oota, H; Watanabe, K; Yoshida, T | 1 |
| Hanai, T; Katsuno, H; Koide, Y; Maeda, K; Masumori, K; Matsumoto, M; Sato, H; Utsumi, T | 1 |
| Fukunaga, H; Hata, T; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Takayama, O; Yamamoto, H; Yasui, M | 1 |
| Dono, K; Hashimoto, K; Kubota, M; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Takahashi, H; Umeshita, K; Yamamoto, S | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Koide, A; Maruyama, M; Maruyama, S; Ohbu, M; Takashima, I | 1 |
| Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Sawamura, T; Takeda, Y; Takeno, A; Tsujinaka, T | 1 |
| Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Izumiyama, K; Koshino, T; Sakita, I; Soma, I; Yoshida, T | 1 |
| Damdinsuren, B; Dono, K; Kondo, M; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Nakamura, M; Ota, H; Sakon, M; Umeshita, K; Wada, H; Yamamoto, T; Yang, Y | 1 |
| Akagi, Y; Hashimoto, Y; Ito, K; Mukaida, H; Murakami, Y; Takiyama, W | 1 |
| Itoh, S; Mitsuhata, N; Watanabe, Y | 1 |
| Inada, K; Ishikawa, T; Kamoshida, S; Maeda, K; Matsuoka, H; Shimomura, R; Tsutsumi, Y | 1 |
| Nakagawa, M; Ohta, M; Takao, M; Tanaka, F; Tsubota, N; Wada, H | 1 |
| Chen, JS; Huang, JS; Liau, CT; Lin, YC; Rau, KM; Wang, HM; Yang, TS | 1 |
| Bessho, A; Mogami, H; Nakata, M; Okita, R; Teramoto, N; Yamashita, M | 1 |
| Enomoto, M; Higuchi, T; Iida, S; Sugihara, K; Tsunozaki, H; Uetake, H; Yasuno, M | 1 |
| Fukai, H; Maruyama, A; Matsumoto, H; Sakamoto, H; Takami, M; Takimoto, T; Togo, Y; Yamamoto, T | 1 |
| Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS | 1 |
| Fleming, GF; Gupta, S; Mauer, AM; Ryan, CW; Samuels, BL; Taber, DA | 1 |
| Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW; Yoon, SY | 1 |
| Chan, WK; Chao, Y; Chen, WS; Chi, KH; Jiang, JK; Lee, RC; Li, AF; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH; Yen, SH | 1 |
| Chang, JT; Chen, IH; Hsueh, CT; Liao, CT; Tsai, MH; Wang, CS; Wang, HM; Yeh, SP | 1 |
| Endo, Y; Fukushima, T; Kanazawa, M; Ohki, S; Ohshima, T; Saito, M; Sekikawa, K; Takenoshita, S | 1 |
| Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Fukushima, M; Ishikawa, S; Miyahara, R; Nakagawa, T; Tanaka, F; Wada, H | 1 |
| Abe, O; Abe, R; Akazawa, K; Koyama, H; Miura, S; Noguchi, S; Sugimachi, K; Uchino, J | 1 |
| Beauchamp, RD; Berlin, J; Blanke, CD; Caillouette, C; Chakravarthy, B; Choy, H; Leach, S; Roberts, J; Shyr, Y; Tarpley, J; Tedesco, KL; Teng, M; Wyman, K | 1 |
| Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW | 1 |
| del Giglio, A; Lima, AP | 1 |
| Johnstone, P; Kauh, J | 1 |
| Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 2 |
| Arima, T; Horino, K; Inoue, M; Kaneda, H; Kimura, M; Kume, S; Matsushita, H; Morisaki, T; Nishimura, T; Uemura, K | 1 |
| Alfonso, PG; Castañon, C; Cerezuela, P; Cruz, JJ; González, E; López-Mateos, Y; Méndez, M; Pujol, E | 1 |
| Ahn, JH; Ahn, SD; Cho, KJ; Choi, EK; Choi, SH; Kim, JH; Kim, SB; Kim, SY; Lee, BJ; Lee, SW; Nam, SY; Park, JH; Shin, SS | 1 |
| Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T | 1 |
| Asama, T; Ashida, T; Ayabe, T; Chisato, N; Ebisawa, Y; Kamiya, K; Kasai, S; Kohgo, Y; Kono, T; Tomita, I | 1 |
| Hayakawa, K; Miyake, K; Morimoto, T; Mukaihara, S; Nishino, M | 1 |
| Fujioka, A; Fukushima, M; Ikeda, K; Kitazato, K; Nakagawa, F; Ohshimo, H; Okabe, H; Takechi, T | 1 |
| Kolesar, JM; Wilhelm, L | 1 |
| Ichinose, Y; Okamoto, T | 2 |
| Hatakeyama, K; Muneoka, K; Okumura, S; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Hartmann, JT; Kanz, L; Kopp, HG; Moerike, K | 1 |
| Endo, S; Hashimoto, K; Higami, T; Itakura, M; Koike, M; Maruyama, R; Nio, Y; Tsuji, M; Yamaguchi, K; Yano, S | 1 |
| Furuse, J; Ikeda, M; Ishii, H; Morizane, C; Okusaka, T; Ueno, H | 1 |
| Amano, T; Hiki, Y; Kumada, K; Mitomi, T; Nishiyama, K; Noto, T; Ogawa, N; Oka, H; Oki, S; Otani, Y; Sadahiro, S; Takahashi, T; Takemiya, S; Tsuchiya, S; Yamakawa, T; Yamamura, T | 1 |
| Fujii, H; Hasegawa, S; Hatano, E; Ikai, I; Kawashima, K; Matsumoto, S; Satoh, S; Shimahara, Y | 1 |
| Choi, CW; Choi, IK; Choi, JG; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sul, HR; Sung, HJ; Yoon, SY | 1 |
| Pfeiffer, P | 1 |
| Endo, S; Hasegawa, T; Saito, N; Sato, Y; Sohara, Y | 1 |
| Blanco, G; Bordonaro, R; Cordio, S; Manzione, L; Reggiardo, G; Rosati, G; Tucci, A | 1 |
| Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K | 1 |
| Hatakeyama, K; Kitami, CE; Koyama, Y; Kurosaki, I; Makino, H | 1 |
| Araki, J; Ichinose, Y; Inoue, Y; Itoh, K; Iwamoto, N; Semba, H; Seto, T; Tamanoi, M; Tanaka, F; Yamamoto, H | 1 |
| Arihiro, K; Emi, M; Hironaka, K; Kawabuchi, Y; Ohshita, A; Sakatani, A; Yamaguchi, Y | 1 |
| Akasaka, Y; Hata, Y; Honda, S; Ito, T; Matsuoka, S; Nakajima, N; Ohmori, K; Sano, F; Yokoyama, R | 1 |
| Hasegawa, H; Ishii, Y; Kawano, S; Kawano, T; Kawano, Y; Kitajima, M; Nishibori, H; Okabayashi, K; Yamauchi, T | 1 |
| Burdett, S; Stewart, L | 1 |
| Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
| Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T | 1 |
| Pisters, KM | 1 |
| Kobayashi, M; Kodera, Y; Macdonald, JS; Miyashita, Y; Morita, S; Sakamoto, J; Tsuburaya, A | 1 |
| Kabashima, A; Matsuzaka, T; Nishizaki, T; Ojima, Y; Okita, K; Sakaguchi, Y; Tashiro, H; Yamamura, S | 1 |
| Aoki, F; Asai, K; Fujita, T; Hiyoshi, M; Masaki, Y; Nakamura, Y; Sugizaki, K; Tokuda, E | 1 |
| Fukasawa, M; Kano, N; Kitagawa, M; Kitahama, S; Koneri, K; Kuroki, M; Kusanagi, H; Takeshi, A; Watanabe, Y; Yamamoto, S | 1 |
| Ichimori, T; Ishikawa, M; Ishikura, H; Kimura, S; Okitsu, H; Sakata, A; Seike, J; Yuasa, Y | 1 |
| Fukuda, S; Hazama, S; Kudoh, A; Mizuta, E; Ogura, Y; Oka, M; Sano, A; Shimizu, R; Yoshino, S | 1 |
| Fujimoto, T; Ishibashi, K; Ogawa, K; Umehara, A; Watanabe, K; Yokomizo, H; Yoshida, K; Yoshimatsu, K | 1 |
| Damdinsuren, B; Dono, K; Kato, H; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamura, M; Noda, T; Takeda, Y; Umeshita, K; Wada, H; Yoshioka, S | 1 |
| Amano, M; Hayashida, H; Higaki, N; Itani, Y; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M | 1 |
| Fujiwara, H; Hamabe, Y; Ishida, T; Kaji, M; Mukai, H; Mukubou, H; Onishi, N; Sato, S; Toyokawa, A; Tsujimura, T; Tsukamoto, T; Wakahara, T; Wakita, K; Watanabe, A | 1 |
| Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Yamanaka, H | 1 |
| Bennouna, J; Bordenave, S; Cvitkovic, F; Dorval, E; Douillard, JY; Hebbar, M; Jacob, JH; Malek, K; Paillot, B; Perrier, H; Priou, F; Seitz, JF; Tonelli, D | 1 |
| Barón, MG; Casado, E; Castañón, C; Castro, J; Cruz, M; Feliu, J; Fonseca, E; Jara, C; Jaráiz, AR; León, A; Lomas, M; Sáenz, JG | 1 |
| Bunn, PA; Mitchell, JD; Solomon, B | 1 |
| Ikeda, M; Morizane, C; Okusaka, T; Ueno, H | 1 |
| Goyle, S; Maraveyas, A | 1 |
| Doi, K; Furuhashi, S; Ishihara, A; Ishimoto, T; Kikuchi, N; Ogata, K; Ogawa, M; Ohchi, T | 1 |
| Hamada, K; Izumi, M; Kamio, M; Kobayashi, I; Koyama, T; Makita, F; Minaguchi, S; Ogawa, T; Ohwada, S; Ohya, T; Satoh, Y; Takeyoshi, I; Tanahashi, Y; Togo, Y; Tomizawa, N; Toshihiko, T | 1 |
| Tanaka, F; Wada, H | 1 |
| Akasu, T | 1 |
| Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T | 1 |
| Bhandari, MS; Fardig, J; Olson, K; Pienta, KJ; Smith, DC | 1 |
| Abad, A; Aranda, E; Carrato, A; Díaz-Rubio, E; Gallego, J; Gómez, A; López, E; Manzano, JL; Sastre, J | 1 |
| Chung, KY; Kim, DJ; Kim, KD; Park, I | 1 |
| Horiuchi, C; Ishitoya, JI; Katori, H; Mikami, Y; Taguchi, T; Tsukuda, M | 1 |
| Fujii, T; Habiro, A; Izawa, T; Kohgo, Y; Koizumi, K; Mizukami, Y; Nakano, Y; Okumura, T; Osanai, M; Tanno, S; Yanagawa, N | 1 |
| Francia, G; Kerbel, RS; Lee, CR; Man, S; Munoz, R; Shaked, Y; Wong, J | 1 |
| Abad, A; Aranda, E; Carrato, A; Cervantes, A; Díaz-Rubio, E; Tabernero, J | 1 |
| Colangelo, LH; Colman, LK; Giguere, JK; Jacobs, AD; Lembersky, BC; Marshall, ME; O'Connell, MJ; Petrelli, NJ; Seay, TE; Smith, RE; Soran, A; Wieand, HS; Wolmark, N; Yothers, G | 1 |
| Akasu, T; Kodaira, S; Moriya, Y; Ohashi, Y; Shirao, K; Yoshida, S | 1 |
| Endo, Y; Mitsuya, T; Sanada, Y; Tajiri, T; Uyama, R; Yoshizawa, Y | 1 |
| Hasuo, T; Ikeshima, S; Ishihara, K; Iwatsuki, M; Kuramoto, M | 1 |
| Fujii, K; Iizuka, R; Ikawa, O; Izumi, H; Kakihara, N; Katoh, Y; Matsumura, H; Miyata, K; Ohgaki, M; Shimomura, K; Shimotsuma, M; Tkenaka, A | 1 |
| Ishigame, T; Ishii, Y; Okayama, H; Takahashi, M | 1 |
| Baatrup, G; Jensen, HA; Kronborg, O; Pfeiffer, P | 1 |
| Hatakeyama, K; Muneoka, K; Sakata, J; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Akita, H; Ishida, H; Kabuto, T; Nakaguchi, K; Watanabe, Y | 1 |
| Morimoto, N; Shibaki, T | 1 |
| Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T | 1 |
| Chao, TY; Chao, Y; Chen, LT; Cheng, AL; Hsieh, RK; Kao, WY; Li, CP; Su, WC; Wu, MF; Yeh, KH | 1 |
| Cowan, J; Kaltenthaler, E; Marples, M; Orr, B; Seymour, MT; Ward, SE | 1 |
| Arai, Y; Inaba, Y; Kanemitsu, Y; Muro, K; Nishiofuku, H; Oyama, T; Sato, Y; Sawaki, A; Shimamoto, H; Yamaura, H | 1 |
| Iwamoto, S; Yoshioka, K | 1 |
| Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Miyazawa, H; Uehara, S | 1 |
| Hoki, M; Ito, T; Iwamoto, T; Iwase, K; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y | 1 |
| Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M | 1 |
| Dono, K; Hayashi, N; Monden, M; Nagano, H; Nakahira, S; Nakamori, S; Okami, J; Sakon, M; Takahashi, Y; Takeda, S; Tsujie, M; Umeshita, K | 1 |
| Afchain, P; André, T; de Gramont, A; Segura, C | 1 |
| Fukushima, M; Huang, C; Liu, D; Masuya, D; Nakano, J; Nakashima, T; Ueno, M; Wada, H; Yokomise, H | 1 |
| Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K | 1 |
| Fukushima, M | 1 |
| Furuhata, T; Hirata, K; Horikoshi, N; Ishizuka, H; Nakano, Y; Okazaki, M; Sasaki, K; Shirasaka, T; Sohma, K; Taguchi, T; Tominaga, K; Uno, S; Yamada, Y; Yamaguchi, K; Yamamitsu, S | 1 |
| Yamada, Y | 1 |
| Baba, H; Egashira, A; Ikeda, K; Kakeji, Y; Koga, T; Maehara, Y; Morita, M; Nishida, K; Oki, E; Tokunaga, E; Yoshida, R | 1 |
| Horiuchi, C; Ishitoya, J; Katori, H; Matsuda, H; Mikami, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T | 1 |
| Aoki, M; Ebina, A; Hoshi, Y; Ishiguro, A; Mitobe, S; Munakata, M; Okada, R; Sakata, Y; Shitara, K; Tomioka, R | 1 |
| Machida, H; Suzuki, K; Toda, H; Ushida, S | 1 |
| Akashi, A; Iuchi, K; Kodama, K; Nakagawa, K; Tada, H; Taki, T; Yasumitsu, T | 1 |
| Kamnerdsupaphon, P; Khorprasert, C; Lertsanguansinchai, P; Lorvidhaya, V; Sangruchi, S; Sookpreedee, L; Suntornpong, N; Udompunturak, S; Veerasarn, V | 1 |
| Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T | 1 |
| Inaji, H; Koyama, H; Mori, T; Nakao, K; Oka, T; Oshima, A; Ozawa, K; Saito, Y; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T | 1 |
| Ando, T; Goto, H; Ina, K; Inagaki, J; Ito, A; Kataoka, T; Kato, H; Nagao, S; Niwa, Y; Ohkita, T | 1 |
| Aikou, T; Haraguchi, Y; Ikeda, N; Kamikado, C; Sakamoto, F; Toyoyama, H; Ueno, S | 1 |
| Fuji, K; Hirazuka, T; Ikeda, T; Kahno, T; Mashino, K; Ninomiya, M; Shibahara, K; Yamamoto, M | 1 |
| Aikou, T; Kitazono, M; Kubo, F; Maemura, K; Noma, H; Sakoda, M; Shinchi, H; Takao, S; Ueno, S | 1 |
| Chao, TC; Chen, WS; Lin, PC; Liu, JH; Tiu, CM; Yang, SH | 1 |
| Ezumi, K; Fujie, Y; Fukunaga, H; Hata, T; Hirota, S; Ikeda, M; Ikenaga, M; Monden, M; Ohue, M; Sekimoto, M; Seshimo, I; Shingai, T; Takayama, O; Takemasa, I; Yamamoto, H; Yasui, M | 1 |
| Fukushima, M; Hashimoto, K; Iguchi, C; Itakura, M; Kodama, H; Koike, M; Maruyama, R; Nio, Y; Toga, T | 1 |
| Beijnen, JH; Bosch, TM; Meijerman, I; van Thiel, SW; Vlasveld, LT | 1 |
| Ikemura, K; Imada, H; Inenaga, R; Korogi, Y; Nakamura, S; Onari, N; Oya, R; Takagi, S | 1 |
| Ahmed, SU; Okamoto, M; Oshikawa, T; Sato, M; Tano, T | 1 |
| Amano, M; Fujita, M; Hayashida, H; Higaki, N; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M; Yamashita, S | 1 |
| Amano, M; Hayashida, H; Higaki, N; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M; Yamashita, S; Yoshioka, Y | 1 |
| Craven, O; Palmer, K; Saunders, MP; Sheikh, HY; Sjursen, A; Swindell, R; Valle, JW; Wilson, G | 1 |
| Hanada, M; Noguchi, T; Yamaoka, T | 1 |
| Aitini, E; Bajetta, E; Barone, C; Buzzoni, R; Di Bartolomeo, M; Ferrario, E; Iop, A; Isa, L; Jacobelli, S; Lo Vullo, S; Mariani, L; Pinotti, G; Recaldin, E; Zilembo, N | 1 |
| Cecchini, RS; Ganz, PA; Kopec, JA; Land, SR; Lembersky, BC; Wieand, HS; Wolmark, N; Yothers, G | 1 |
| Collado, A; de Juan, A; del Valle, A; Galdós, P; García-Castaño, A; López-Brea, MF; Mayorga, M; Rama, J; Ramos, FJ; Rivera, F; Rubio, A; Sanz-Ortiz, J; Vega-Villegas, ME | 1 |
| Saito, T; Sasaki, H; Tokunaga, Y | 3 |
| Akamine, S; Honda, S; Kamohara, R; Muraoka, M; Tsuchiya, T; Tsuji, K; Urabe, S; Yamasaki, N | 1 |
| Akagawa, T; Fujioka, S; Hara, T; Hiramatsu, K; Hirata, A; Ito, T; Kato, K; Kutsuna, Y; Machiki, Y; Matsuba, H; Miyata, T | 1 |
| Hyodo, I | 1 |
| Hamada, C; Kato, T; Kodaira, S; Nakazato, H; Oba, K; Ohashi, Y; Saji, S; Sakamoto, J; Yasutomi, M; Yoshida, S | 1 |
| López-Brea, MF; Rivera, F; Vega-Villegas, ME | 1 |
| El-Rayes, BF; LoRusso, P; Manza, SG; Philip, PA; Shields, AF; Zalupski, M | 1 |
| Gega, M; Hashimoto, A; Ikeuchi, H; Kuno, T; Noda, M; Oshima, T; Tanaka, K; Tsukamoto, K; Yagyuu, T; Yamamura, T; Yanagi, H; Yoshikawa, R | 1 |
| Shoji, Y; Toyooka, M | 1 |
| Almond, J; Ralston, S | 1 |
| Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T | 1 |
| Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB | 1 |
| Hanibuchi, M; Sone, S; Tomimoto, H; Yano, S | 1 |
| Aoki, T; Mino, A; Murahashi, K; Nishino, K; Sowa, M; Tachimori, A; Takagaki, K | 1 |
| Komatsu, Y | 1 |
| Arahira, S; Hayashi, R; Kawashima, M; Miyazaki, M; Ogino, T; Tahara, M; Yamazaki, M | 1 |
| Hori, S; Inoue, S; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Fujioka, A; Fukushima, M; Nakano, K; Oka, T; Okabe, H; Saito, H; Sugimoto, Y; Uchida, J | 1 |
| Maeda, Y; Makuuchi, H; Murayama, C; Nakamura, T; Ohizumi, Y; Sadahiro, S; Saguchi, T; Suzuki, T; Tanaka, Y; Yasuda, S | 1 |
| Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T | 1 |
| Artru, P; Bennouna, J; Bugat, R; Delord, JP; Desseigne, F; Douillard, JY; Faroux, R; François, E; Husseini, F; Naman, H; Perrier, H; Piedbois, P; Smith, D | 1 |
| Cardot, JM; Douillard, JY; Etienne-Grimaldi, MC; François, E; Gamelin, E; Milano, G; Renée, N | 1 |
| Bandoh, S; Kanaji, N | 1 |
| Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sung, HJ | 1 |
| Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T | 1 |
| Furukawa, T; Ishii, H; Maruyama, M; Ohata, M; Ohori, M; Saito, N; Sato, H; Tokura, Y | 1 |
| Hoshi, K; Ikeda, Y; Kanbara, T; Kawasaki, Y; Namima, T; Ohnuma, T | 1 |
| Fukunaga, M; Furukawa, H; Gotoh, M; Ishida, H; Ishihara, R; Narahara, H; Okamura, S; Takiuchi, H; Tomita, N; Uedo, N | 1 |
| Date, H; Fujiwara, Y; Hotta, K; Kiura, K; Matsuo, K; Ouchida, M; Soh, J; Suehisa, H; Takata, M; Toyooka, S; Uchida, A | 1 |
| Depisch, D; Föger, A; Gruhsmann, B; Kornek, GV; Lang, F; Lenauer, A; Scheithauer, W; Vormittag, L | 1 |
| Katoh, R; Ooshiro, M | 1 |
| Chen, YM; Chou, KT; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J | 1 |
| Kerbel, RS; Man, S; Munoz, R | 1 |
| Katori, H; Taguchi, T; Tsukuda, M | 1 |
| Arias, F; Belinchón, B; de la Fuente, C; de la Torre, A; Fernández-Lizarbe, E; García-Berrocal, MI; Magallón, R; Mariño, A; Millán, I; Molerón, R; Regueiro, CA; Romero, J; Valcárcel, F; Veiras, M; Vergara, G; Zapata, I | 1 |
| Akamaru, Y; Beppu, N; Ito, A; Kasugai, T; Momiyama, T; Nakamura, Y; Ohno, K; Sugimoto, Y; Tamaoka, N; Watanabe, Y; Yamasaki, Y; Yumiba, T | 1 |
| Bendell, JC; Cohen, DP; Czito, BG; D'Amico, TA; Hurwitz, HI; Kelsey, CR; Lockhart, AC; Petros, WP; Truax, R; Willett, CG | 1 |
| Del Valle, A; Galdós, P; García-Montesinos, B; García-Reija, F; Isla, D; López-Brea, M; Mayordomo, J; Mayorga, M; Rama, J; Rivera, F; Rodríguez-Iglesias, J; Rubio, A; Saiz-Bustillo, R; Sanz-Ortiz, J; Vega-Villegas, ME | 1 |
| Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
| Hino, M; Kamizuru, R; Kudoh, S; Omata, M; Ono, Y; Soma, T; Tanaka, Y; Ueda, Y; Uehara, T | 1 |
| Bennouna, J; Cardot, JM; Château, Y; Douillard, JY; Etienne-Grimaldi, MC; François, E; Gamelin, E; Milano, G; Renée, N | 1 |
| Hirata, K; Hiyama, S; Inui, N; Kimura, H; Kimura, Y; Shirasaka, T; Yamada, Y; Yamaguchi, K; Yamamitsu, S | 1 |
| Baba, K; Matsuda, M; Tashima, R; Yamashita, Y; Yokoyama, S | 1 |
| Bandoh, S; Ishida, T; Kanaji, N | 1 |
| Fujiya, T; Inada, T; Kinoshita, T; Nakajima, T; Nashimoto, A; Ohashi, Y; Sairenji, M; Sakamoto, J; Sasako, M; Yamaguchi, T | 1 |
| Ishikawa, K; Kamijo, A; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T; Tanaka, Y; Yasuda, S | 1 |
| Tanaka, F | 1 |
| Hirata, E; Jin, HH; Komatsu, M; Mukai, K; Nagai, N; Yunokawa, M | 1 |
| Della Vigna, P; Di Meglio, G; Farris, A; Fazio, N; Goldhirsch, A; Lorizzo, K; Nolè, F | 1 |
| Isogai, A; Kubota, S; Matsuoka, H; Nagaya, M; Tsukikawa, S; Watanabe, T | 1 |
| Amadori, D; Cecconetto, L; Fabbri, F; Maltoni, R; Massa, I; Milandri, C; Nanni, O; Passardi, A; Tesei, A; Zoli, W | 1 |
| Ahn, JJ; Baek, JH; Cha, HJ; Jegal, Y; Jeong, AK; Jung, JP; Kim, H; Kim, JW; Kwon, WJ; Min, YJ; Noh, YJ; Park, CR; Park, JH; Seo, KW; Shin, JK; Shin, SJ | 1 |
| Beatty, PA; Benson, AB; Hochster, HS; Luo, W; Lyman, BT; Mulcahy, M; Popa, EC | 1 |
| Bendtsen, VO; Bisgaard, C; Jakobsen, A; Lindebjerg, J; Mortensen, JP; Rafaelsen, SR | 1 |
| Geboes, K; Van Cutsem, E | 1 |
| Hasegawa, H; Kanekiyo, S; Kubo, H; Tada, K; Watanabe, Y | 1 |
| Pinzello, G; Prisco, C; Zavaglia, C | 1 |
| Brugnatelli, S; Corazza, GR; Gattoni, E; Luchena, G; Riccardi, A; Sagrada, P; Scalamogna, R; Tinelli, C; Tronconi, MC | 1 |
| Aoki, K; Hirama, K; Kazunori Ikenaga, S; Maruyama, M; Matsumoto, R; Oguro, H; Sakamoto, Y; Sakuraba, H | 1 |
| Chida, T; Hasegawa, S; Iwafuchi, Y; Kamimura, A; Miyazawa, T; Watanabe, G | 1 |
| Fujita, M; Hara, N; Iwami, F; Izumi, M; Kajiki, A; Kawasaki, M; Miyazaki, N; Motohiro, A; Nakanishi, Y; Ninomiya, K; Takayama, K; Watanabe, K | 1 |
| Fujimoto, T; Kuhara, K; Matsumoto, A; Ogawa, K; Osawa, G; Otani, T; Shimakawa, T; Umehara, A; Yokomizo, H; Yoshimatsu, K | 1 |
| Eguchi, H; Goto, K; Imaoka, S; Ishikawa, O; Kishi, K; Miyashiro, I; Motoori, M; Noura, S; Ogino, T; Ohigashi, H; Ohue, M; Seki, Y; Tomita, H; Yamada, T; Yano, M | 1 |
| Emi, Y; Fukui, Y; Kakeji, Y; Maehara, Y; Oki, E; Sumiyoshi, Y | 1 |
| Aykan, NF; Idelevich, E | 1 |
| Doi, Y; Endo, Y; Ishizuka, S; Kai, K; Matsumoto, Y; Morikawa, T; Nabeyama, A; Nagahiro, W; Nakashima, A; Nobuhisa, T; Sato, S; Watanabe, T; Yamada, T; Yoshida, K | 1 |
| Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T; Yasuda, S | 1 |
| Chang, PM; Chang, SY; Chen, PM; Chu, PY; Huang, JL; Tai, SK; Tsai, TL; Wang, LW; Wang, YF; Yang, MH | 1 |
| Baatrup, G; Bisgaard, C; Hansen, F; Jacobsen, A; Pfeiffer, P; Qvortrup, C; Rasmussen, P; Vestermark, LW | 1 |
| Akagi, Y; Fukushima, T; Ishibashi, N; Mori, S; Murakami, H; Ogata, Y; Shirouzu, K; Ushijima, M | 1 |
| Casado, E; Feliu, J; González-Barón, M; Jensen, HA; Pfeiffer, P; Vestermark, L | 1 |
| Arita, Y; Eriguchi, N; Funakoshi, A; Igarashi, H; Ito, T; Miyahara, T; Mizumoto, K; Muranaka, T; Sakai, T; Shinozaki, H; Sumii, T; Tanaka, M; Ueki, T; Yamaguchi, H | 1 |
| Amano, S; Aramaki, O; Kawasaki, A; Kuboi, Y; Mimatsu, K; Oida, T | 1 |
| Hosotaki, K; Shimamoto, M; Tabira, Y; Tamori, Y | 1 |
| An, J; Ando, K; Arikawa, T; Ito, N; Kotake, K; Kurokawa, T; Nagata, H; Nakao, N; Nonami, T; Suzumura, K | 1 |
| Fukuchi, H; Ichinose, M; Kida, Y; Tanaka, H; Ueda, H | 1 |
| Endo, T; Hasegawa, H; Ishii, Y; Kitagawa, Y; Kubota, T; Ochiai, H; Okabayashi, K | 1 |
| Fujimoto, K; Hirao, Y; Okajima, E; Ozono, S; Tsujimoto, S | 1 |
| Ishikawa, T | 1 |
| Aslan, Y; Buyukberber, S; Camci, C; Kalender, ME; Sevinc, A | 1 |
| Fujii, M; Kochi, M; Takayama, T | 1 |
| Eguchi, K; Ichinose, Y; Maruyama, R; Nakano, M; Okamoto, T; Ota, M; Seki, N; Semba, H; Seto, T; Uematsu, K; Wataya, H; Yamanaka, T | 1 |
| Ikeda, H; Kobayashi, M; Morita, T; Nukui, A; Sugaya, Y; Suzuki, K; Yuzawa, M | 1 |
| Akiyama, I; Fujita, Y; Hasegawa, K; Morimoto, S; Shono, Y; Tabuse, K; Tsuji, T | 1 |
| Abe, K; Itoh, K; Kamiizumi, Y; Kawamura, N; Nakajima, Y; Okamura, M; Yokoyama, R | 1 |
| Nakano, T; Tomimatsu, H | 1 |
| Chen, JS; Chen, YY; Huang, JS; Kao, RH; Lee, KD; Liau, CT; Lin, YC; Rau, KM; Su, YC; Yang, TS | 1 |
| Arakaki, K; Isa, T; Kaneshiro, T; Nakachi, A; Nishimaki, T; Shiroma, H; Teruya, T; Yamamoto, H | 1 |
| Abe, Y; Matsunaga, H; Mikami, R; Mitsuyama, S; Motooka, M; Nasu, T; Nishihara, K; Toyoshima, S; Yamamoto, I | 1 |
| Abbruzzese, JL; Anthony, L; Hoff, PM; Kopetz, S; Langleben, A; Lassere, Y; Rinaldi, D; Thomas, MB; Wolff, RA | 1 |
| Armengol, M; Capdevila, J; Casado, E; de Torres, I; Espin, E; Giralt, J; Landolfi, S; Mañes, A; Navalpotro, B; Sanchez-Garcia, JL; Tabernero, J | 1 |
| Hoshino, S; Maekawa, T; Mikami, K; Sakai, T; Shirakusa, T; Yamashita, Y | 1 |
| Chohnabayashi, N; Horinouchi, H; Nishimura, N; Ono, H; Sugiura, R; Uchiyama, N; Ueda, H | 1 |
| Hisashige, A; Kodaira, S; Yoshida, S | 1 |
| Dhiman, A; Shuler, ML; Sung, JH | 1 |
| Furukawa, K; Ito, H; Kato, A; Kimura, F; Miyazaki, M; Nozawa, S; Otsuka, M; Shimizu, H; Togawa, A; Yoshidome, H; Yoshitomi, H | 1 |
| Ashikawa, K; Ishii, T; Komoriyama, H; Mikami, S; Ohtsubo, T | 1 |
| Kobayashi, Y; Matsuzaki, A; Terauchi, F; Washino, S | 1 |
| Iinuma, N; Misawa, R; Takagi, S; Uchikawa, Y | 1 |
| Kameyama, H; Nakagawa, S; Nashimoto, A; Nomura, T; Takii, Y; Tanaka, O; Tsuchiya, Y; Yabusaki, H | 1 |
| Aoki, K; Hoshikawa, K; Nitta, H; Noda, H; Oyama, K; Wakabayashi, G | 1 |
| Ariche, A; Baruch, NB; Brenner, B; Dinerman, M; Greif, F; Idelevich, E; Kashtan, H; Mavor, E; Miller, R; Shani, A; Susmalian, S | 1 |
| Bang, YJ; Heo, DS; Im, SA; Kim, DW; Kim, MJ; Kim, TY; Lee, SH; Oh, DY | 1 |
| Hanamura, H; Horiuchi, C; Kawakami, M; Matsuda, H; Mikami, Y; Nishimura, G; Satake, K; Taguchi, T; Takahashi, M; Tsukuda, M; Utsumi, A; Watanabe, M | 1 |
| Ikeda, M; Ito, M; Nanami, T; Ohashi, Y; Oshima, Y; Saito, F; Takeyama, T; Watanabe, M; Yajima, S; Yamazaki, K | 1 |
| Hanauske, A; Hilger, RA; Krauss, J; Kredtke, S; Makris, L; Mende, B; Scheulen, ME; Scigalla, P; Strumberg, D; Thyssen, D; Urrea, PD | 1 |
| Iwata, H; Kitaya, T; Kohno, N; Nakagami, K; Ohashi, Y; Sakamoto, G; Sano, M; Shimozuma, K; Sonoo, H; Takashima, S; Tokuda, Y; Tsuda, H; Watanabe, T; Yoshimoto, M | 1 |
| Hirohata, S; Horita, K; Niki, T; Nishisaki, H; Tsuda, M; Yamamoto, Y | 1 |
| Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Tamura, S; Uji, K; Yoshida, A; Yoshimura, M | 1 |
| Takashima, S; Yoshitani, S | 1 |
| Anegawa, G; Hayashi, H; Inoue, F; Sonoda, H | 1 |
| Bennouna, J; Douillard, JY; Saunders, M | 1 |
| Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R | 1 |
| Abo, H; Horiuchi, C; Kawakami, M; Matsuda, H; Mikami, Y; Niho, T; Nishimura, G; Taguchi, T; Takahashi, M; Tsukuda, M; Watanabe, M; Yamomoto, S | 1 |
| Hamada, C | 1 |
| Hattori, T; Itoh, K; Komatsu, N; Mine, T; Okuno, K; Shiozaki, H; Yamada, A | 1 |
| Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K | 1 |
| Bjerregaard, JK; Fristrup, C; Hansen, TP; Jensen, HA; Johansen, J; Mortensen, MB; Nielsen, M; Pfeiffer, P; Schønnemann, KR; Svolgaard, B | 1 |
| Jinta, E; Sakurai, T; Shimizu, S; Suzuma, T; Umemura, T; Yoshimura, G | 1 |
| Kimura, Y; Sumiyoshi, M; Suzuki, T | 1 |
| Fukunaga, M; Furukawa, H; Ishida, H; Kato, T; Miyake, Y; Takemoto, H; Watanabe, Y | 1 |
| Hamaguchi, T; Hirashima, Y; Kato, K; Matsubara, J; Okita, NT; Shimada, Y; Shimoda, T; Shirao, K; Takahari, D; Taniguchi, H; Yamada, Y | 1 |
| Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H | 1 |
| Abe, T; Ikeda, K; Koeda, K; Minakawa, Y; Nitta, H; Obuchi, T; Otsuka, K; Sasaki, A; Shimooki, O; Wakabayashi, G | 1 |
| Kira, M; Takizawa, H; Tangoku, A; Toba, H; Yamai, H; Yoshida, T | 1 |
| Huh, JW; Kim, HR | 1 |
| Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S | 1 |
| Asaga, T; Higaki, K; Inaji, H; Ito, T; Koh, J; Kohno, N; Komichi, H; Koyama, H; Kyono, S; Mitsuyama, S; Nishikawa, H; Ogita, M; Okamura, K; Osaki, A; Park, Y; Saito, T; Suzuki, T; Tanaka, F; Yamazaki, K | 1 |
| Asaka, Y; Hatakeyama, D; Kato, K; Kato, Y; Long, NK; Makita, H; Miyazaki, Y; Shibata, T; Toida, M; Yamashita, T; Yonemoto, K | 1 |
| Ioue, Y; Kusunoki, M; Miki, C; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Yokoe, T | 1 |
| Endo, S; Hashimoto, K; Iguchi, C; Itakura, M; Koike, M; Nio, Y; Nishi, T; Omori, H; Sato, Y; Takamura, M; Takeda, H | 1 |
| Alkis, N; Aslan, UY; Benekli, M; Buyukberber, S; Camci, C; Celenkoglu, G; Coskun, U; Er, O; Ozkan, M; Ozturk, B; Sevinc, A; Tokluoglu, S; Uner, A; Yildiz, R | 1 |
| Cho, YB; Chun, HK; Kim, HC; Lee, WY; Yun, HR; Yun, SH | 1 |
| Noguchi, S; Taguchi, T | 1 |
| Hibino, M; Kitamura, T; Nakamura, M; Okuyama, M; Sasaki, Y; Shindo, Y; Tenma, K | 1 |
| Alici, S; Alkis, N; Benekli, M; Buyukberber, S; Celenkoglu, G; Coşkun, U; Kaya, AO; Ozkan, M; Sevinc, A; Uncu, D | 1 |
| Chiba, A; Fujii, T; Habiro, A; Kohgo, Y; Koizumi, K; Mizukami, Y; Nakamura, K; Nakano, Y; Nishikawa, T; Okumura, T; Sasajima, J; Sugiyama, Y; Tanno, S | 1 |
| Fujimura, S; Hamada, C; Imaizumi, M; Kodama, K; Ohta, M; Tsuboi, M; Wada, H | 1 |
| Suehisa, H; Toyooka, S | 1 |
| Amano, S; Kano, H; Kawasaki, A; Kuboi, Y; Mimatsu, K; Oida, T | 1 |
| Kimura, H; Takamura, H; Watanabe, K | 1 |
| Asai, S; Ishii, Y; Suzuki, S; Takahashi, Y; Takayama, T | 1 |
| Inaji, H; Koyama, H; Ohashi, Y; Sano, M; Suzuki, T; Watanabe, T | 1 |
| Akboru, H; Bati, Y; Isikli, L; Unsal, M; Yoney, A | 1 |
| Furuhata, T; Hosokawa, Y; Ishiyama, G; Iwayama, Y; Kimura, Y; Meguro, M; Mizuguchi, T; Nishidate, T; Okita, K; Sasaki, K; Tsuruma, T | 1 |
| Hara, T; Hiramatsu, K; Hosoya, J; Kato, K; Kimura, A; Kojima, T; Machiki, Y; Otsuji, H; Sakuragawa, T; Tanaka, H; Tsuchiya, T; Yoshida, K | 1 |
| Kamigaki, T; Nakamura, T; Nishimura, H; Sasaki, R; Takase, S; Yamashita, K | 1 |
| Iwanaga, T; Iwasaki, Y; Matsumoto, H; Nakano, D; Ohashi, M; Suzuki, Y; Takahashi, K; Yamaguchi, T | 1 |
| Akagi, K; Dono, K; Fujita, J; Hata, T; Hayashi, S; Ikeda, K; Kagawa, Y; Kawanishi, K; Kitada, M; Munakata, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yasumoto, T; Zenitani, M | 1 |
| Fukumori, D; Kamachi, H; Kamiyama, T; Matsushita, M; Nakagawa, T; Nakanishi, K; Tahara, M; Todo, S; Yokoo, H | 1 |
| Bin, Q; Cao, Y; Gao, F; Li, J; Liao, C | 1 |
| Fukushima, M; Tanaka, F; Wada, H | 1 |
| Nakayama, T; Noguchi, S | 1 |
| Matsui, N; Nakao, K; Tsunoda, A; Tsunoda, Y; Watanabe, M | 2 |
| Booser, DJ; Heim, W; Hortobagyi, GN; Hutchins, L; Kirshner, J; Mason, B; Rivera, E | 1 |
| Higuchi, K; Ishikawa, T; Kamimura, T; Kubota, T; Ohta, H; Seki, K; Yoshida, T | 1 |
| Hida, J; Kitaguchi, H; Nakai, T; Okuno, K; Tokoro, T; Ueda, K; Yoshifuji, T | 1 |
| Chao, Y; Kuo, JY; Lee, RC; Li, AF; Li, CP; Luo, JC; Yang, KC | 1 |
| Gore, I; Hermann, R; Hortobagyi, GN; Ibrahim, NK; Karwal, M; Murray, JL; Watkins, SP; Young, RR | 1 |
| Akagi, J; Baba, H | 1 |
| Kerbel, RS; Lee, CR; Man, S; Tang, TC; Xu, P | 1 |
| Komori, E; Nogami, H; Ogino, A; Sawada, S; Segawa, Y; Shinkai, T; Suehiro, H; Yamashita, M | 1 |
| Arita, M; Kuga, Y; Miwata, T; Moriya, T; Murakami, E; Nishida, T; Numata, Y; Ohya, T; Okanobu, H; Tanaka, T; Yoshimi, S | 1 |
| Hirata, K; Nakamura, Y; Takashima, T; Tayama, Y | 1 |
| Chen, PJ; Cheng, AL; Ding, YH; Hsu, C; Hsu, CH; Lin, ZZ; Shao, YY; Shen, YC | 1 |
| Aizawa, N; Enomoto, H; Hirota, S; Iijima, H; Ikeda, N; Imanishi, H; Ishii, A; Iwai, T; Iwata, Y; Nishiguchi, S; Saito, M; Sakai, Y; Shimomura, S; Takashima, T; Tanaka, H; Yamamoto, T; Yoh, K; Yoshikawa, S | 1 |
| Matsumoto, H; Mori, T; Takahashi, K; Yamaguchi, T; Yasutome, M | 1 |
| Hirai, T; Ito, Y; Kato, T; Kodera, Y; Nakanishi, H; Nakao, A | 1 |
| Kawai, K; Kitayama, J; Nagawa, H; Sunami, E; Yasuda, K | 1 |
| Kawano, T; Kawasaki, G; Mizuno, A; Yamada, S; Yanamoto, S; Yoshitomi, I | 1 |
| Nakao, K; Tsunoda, A; Watanabe, M | 1 |
| Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T | 1 |
| Drenth, AF; Hospers, GA; Mulder, NH; Plukker, JT; Siemerink, EJ | 1 |
| Kusano, M; Matsui, N; Nakao, K; Ooyama, A; Tsunoda, A; Watanabe, M | 1 |
| Hamaya, M; Hojyo, K; Honda, A; Kaneko, H; Kawashima, H; Narabashi, K; Noda, S; Okamoto, N; Onoda, K; Yamada, K; Yokote, K | 1 |
| Abe, M; Kiniwa, M; Matsuo, K; Nakagawa, F; Noguchi, S; Nukatsuka, M; Saito, H; Shibata, J; Uchida, J | 1 |
| Tsunoda, A | 1 |
| Bando, M; Hattori, S; Ishita, T; Kubo, Y; Kumazawa, S; Kurata, N; Machinami, R; Matsumoto, K; Mori, M; Murata, Y; Nakamura, S; Oikawa, Y; Sato, Y; Tamura, N; Yagi, K | 1 |
| Gao, XS; Li, XY; Liu, CX | 1 |
| Chang, SC; Chen, WS; Jiang, JK; Kao, PS; Lee, RC; Liang, WY; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH | 1 |
| Chao, Y; Chen, JS; Chen, LT; Lee, KD; Li, CP; Lin, PC; Lu, CH; Su, WP; Tsai, HJ; Yen, CJ | 1 |
| Iwabuchi, I; Kawaguchi, T; Mayama, I; Ogasawara, M; Tsukui, A | 1 |
| Homma, Y; Kaneko, T; Matsushima, H; Morimoto, H; Tsuzaka, Y | 1 |
| Goto, T; Hamaguchi, R; Kato, R; Maeshima, A; Oyamada, Y; Wakaki, M | 1 |
| Hatano, K; Kawashima, A; Mukai, M; Nagahara, A; Nakai, Y; Nakayama, M; Nishimura, K; Nonomura, N; Okuyama, A; Takayama, H; Tsujimura, A | 1 |
| Busch, OR; Morak, MJ; Nuyttens, JJ; Padmos, EE; Richel, DJ; Schaake, EE; van der Gaast, A; van Eijck, CH; van Tienhoven, G; Vervenne, WL | 1 |
| Emmenegger, U; Francia, G; Hashimoto, K; Kerbel, RS; Man, S; Tang, TC; Xu, P | 1 |
| Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H | 1 |
| Asano, A; Hirasawa, N; Horikawa, Y; Ishihara, S; Itoh, Y; Koyama, K; Murao, T; Naganawa, S; Nomoto, Y; Obata, Y; Sasaoka, M; Suzuki, K | 2 |
| Baba, H; Beppu, T; Okabe, K; Sano, O; Sugiyama, S; Wada, A; Yamanaka, T | 1 |
| Furukawa, A; Kataoka, M; Miyazawa, K; Oeda, Y; Suzuki, D; Tonooka, T; Wakatsuki, K; Yoshioka, S | 1 |
| Akitake, H; Ebisui, C; Fujimoto, T; Hama, N; Kashiwazaki, M; Konishi, M; Maekawa, T; Ohkubo, K; Ohtsuka, M; Taniguchi, M; Tsujie, M; Yoshioka, S | 1 |
| Doki, Y; Hirose, H; Ikeda, M; Ishii, H; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Uemura, M; Yamamoto, H; Yamashita, S | 1 |
| Doki, Y; Hirose, H; Ikeda, M; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S | 1 |
| Ide, Y; Murata, K; Nishigaki, T | 1 |
| Doki, Y; Hirose, H; Ikeda, M; Kagawa, Y; Kim, HM; Mizushima, T; Mori, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S | 1 |
| Fujita, S; Ikeda, N; Kanamura, T; Kojima, Y; Nakagawa, K; Ueno, M | 1 |
| Fujitani, K; Goto, H; Hirao, M; Ikenaga, M; Mishima, H; Miyamoto, A; Miyazaki, M; Nakamori, S; Tsujie, M; Tsujinaka, T; Yasui, M; Yoshida, K | 1 |
| Aoyagi, H; Hamada, S; Hasegawa, K; Kaneko, J; Katsuta, E; Maejima, S; Ohkubo, T; Saguchi, M; Someno, Y; Takahata, T | 1 |
| Amano, R; Hirakawa, K; Inoue, T; Ishikawa, T; Kubo, N; Lee, T; Maeda, K; Muguruma, K; Nagahara, H; Nakata, B; Noda, E; Ohira, M; Onoda, N; Sawada, T; Takashima, T; Tanaka, H; Yamada, N; Yashiro, M | 1 |
| Chen, BB; Cheng, AL; Hsu, C; Hsu, CH; Hsu, CY; Hu, FC; Shen, YC; Shih, TT; Wei, SY; Yu, CW | 1 |
| Hase, K; Hashiguchi, Y; Kajiwara, Y; Mochizuki, H; Naito, Y; Shimazaki, H; Ueno, H | 1 |
| Doi, F; Ishikawa, N; Kohro, T; Kusumoto, C; Kusumoto, M; Matsumoto, T; Toyoda, S | 1 |
| Berger, V; Boisdron-Celle, M; Burtin, P; Calais, G; Campion, L; Carrie, C; Cellier, P; Chevelle, C; Gamelin, E; Leduc, B; Martin, L; Morel, A; Salemkour, A; Vendrely, V; Vié, B | 1 |
| Chen, YM; Chou, KT; Chou, TY; Fan, WC; Lee, YC; Liu, SH; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J; Wu, CH | 1 |
| Bazan, F; Chaigneau, L; Demarchi, M; Dufresne, A; N'guyen, T; Pivot, X; Stein, U; Thierry Vuillemin, A; Villanueva, C | 1 |
| Antón, A; Barnadas, A; Florián, J; Gayo, J; González-Quintás, A; Lao, J; Lomas, M; Margelí, M; Paules, AB; Ramos, M; Ribelles, N | 1 |
| Asmussen, JT; Bjerregaard, JK; Fischer, BM; Hansen, CR; Høilund-Carlsen, PF; Mortensen, MB; Petersen, H; Pfeiffer, P; Vilstrup, MH | 1 |
| Doki, Y; Endo, W; Hasuike, Y; Masutani, S; Monden, M; Mori, M; Morimoto, T; Nakamori, S; Ozato, H; Shibata, T; Takeda, Y; Tohno, K | 1 |
| Kubo, A; Miyazawa, K; Moriyama, M; Motoo, Y; Nakajima, H; Nakaya, N; Sato, I; Shimasaki, T; Suzuki, K; Tanaka, T | 1 |
| Andrassy, RJ; Kulkarni, AD; Moore-Olufemi, SD; Shah, SK; Sundaresan, A; Walker, PA | 1 |
| Ikeda, H; Itoh, T; Kawamoto, K; Takagi, K | 1 |
| Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M | 1 |
| Giannini, OH; González, ME; González, P; Saldaña, B | 1 |
| Hase, K; Hashiguchi, Y; Ishiguro, M; Kobayashi, H; Mochizuki, H; Shinto, E; Ueno, H; Yamamoto, J | 1 |
| Chung, YL; Jen, YM; Lin, YH; Wang, LW; Yen, SH | 1 |
| Aoki, T; Endo, M; Tsuchida, A | 1 |
| Amiot, V; Barrière, J; Chamorey, E; Courdi, A; Ferrero, JM; Figl, A; Follana, P; Hébert, C; Largillier, R; Mari, V; Michel, C; Milano, G | 1 |
| Chang, KJ; Chang, TC; Lai, HS; Lee, PH; Liang, JT; Lin, BR | 1 |
| Endou, Y; Kai, K; Kawai, T; Matsumoto, Y; Miyamoto, M; Nagahiro, I; Nobuhisa, T; Satou, S; Sugiyama, H; Toda, K; Watanabe, N; Watanabe, T | 1 |
| Hara, Y; Kawano, T; Minami, Y; Tominaga, T; Ueda, S | 1 |
| Amano, K; Aratake, K; Hashimoto, T; Hirosawa, T; Itabashi, M; Kameoka, S; Narita, T; Ogawa, S; Seshimo, A | 1 |
| Ikeguchi, M; Kakeji, Y; Maehara, Y; Morita, M; Saito, H; Shirabe, K; Tsujitani, S; Wakatsuki, T; Yano, T | 1 |
| Bjerregaard, JK; Jensen, HA; Mortensen, MB; Nielsen, M; Pfeiffer, P | 1 |
| Bellot, GL; Koh, D; Tan, WH; Tay, LL; Wang, X | 1 |
| Fujii, M; Honda, S; Kuroda, H; Murayama, R; Nagata, N; Sakamoto, Y; Sako, T; Sanefuji, H; Sawatsubashi, T; Shinohara, I | 1 |
| Ahn, JJ; Baek, JH; Cha, HJ; Jegal, Y; Jung, JP; Kim, H; Kim, JW; Kwon, WJ; Lee, YJ; Min, YJ; Noh, YJ; Oh, S; Park, CR; Park, JH; Ra, SW; Seo, KW | 1 |
| Hida, J; Ishimaru, E; Okuno, K; Sugiura, F; Tokoro, T; Ueda, K | 1 |
| Mikami, K; Murata, K; Nishigaki, T | 1 |
| Hamada, H; Hayashi, S; Katsuk, Y; Kina, M; Kuraya, D; Takada, J; Watanabe, K | 1 |
| Hakamada, K; Koyama, M; Morita, T; Morohashi, H; Murata, A; Sakamoto, Y; Tsutsumi, S; Yonaiyama, S | 1 |
| Kume, H | 1 |
| Jensen, HA; Pfeiffer, P; Vestermark, LW | 1 |
| Edagawa, A; Ikeda, Y; Itoh, S; Kakeji, Y; Kawanaka, H; Korenaga, D; Maehara, Y; Oki, E; Okuyama, T; Takenaka, K; Tateishi, M; Tsujitani, S | 1 |
| Allegrini, G; Arrighi, G; Barletta, MT; Bocci, G; Brandi, G; Canu, B; Chericoni, S; Ciarlo, A; Danesi, R; Di Desidero, T; Di Paolo, A; Falcone, A; Fioravanti, A; Fontana, A; Giusiani, M; Kerbel, RS; Loupakis, F; Lucchesi, S; Masi, G; Orlandi, P | 1 |
| Boku, N; Endo, T; Ikejiri, K; Kameoka, S; Kinugasa, Y; Kotake, K; Matsubara, Y; Mochizuki, H; Mochizuki, I; Nakamoto, Y; Shinozaki, H; Sugihara, K; Takagane, A; Takahashi, K; Takahashi, Y; Takii, Y; Takiuchi, H; Tomita, N; Watanabe, M; Watanabe, T | 1 |
| Fukui, Y; Hamada, M; Horimi, T; Nakamura, T; Nishioka, Y; Ozaki, K; Shibuya, Y; Shima, Y; Teraishi, F; Uchida, Y | 1 |
| Hanaoka, Y; Hashimoto, M; Kumamoto, T; Kuroyanagi, H; Matoba, S; Moriyama, J; Sawada, T; Toda, S; Tomizawa, K; Udagawa, H; Watanabe, G | 1 |
| Kawahara, M; Kobayashi, H; Kodama, T; Ohno, Y; Oka, T; Sugishita, T; Takada, A; Takino, Y; Tsukamoto, F | 1 |
| Nagase, H; Okada, K; Sadahiro, S; Suzuki, T; Tanaka, A; Uchida, J | 1 |
| Appelt, AL; Bentzen, SM; Jakobsen, A; Pløen, J; Vogelius, IR | 1 |
| Ishiguro, M; Ishikawa, T; Kanemitsu, Y; Kotake, K; Matsui, S; Mochizuki, H; Shimada, Y; Sugihara, K; Takahashi, K; Teramukai, S; Tomita, N; Ueno, H; Uetake, H; Watanabe, M | 1 |
| Kobayashi, M; Maeda, H; Okamoto, K; Takeshita, A | 1 |
| Bernstine, H; Brenner, B; Goldberg, N; Gordon, N; Groshar, D; Idelevich, E; Kundel, Y; Morgenstern, S; Purim, O; Sulkes, A; Wasserberg, N | 1 |
| Bando, H; Inaki, N; Ishiyama, Y; Kaneko, M; Kotake, M; Kurokawa, M; Matsunaga, M; Yamada, T; Yamamoto, D; Yamamoto, M | 1 |
| Edagawa, A; Hashimoto, K; Higashi, T; Kawanaka, H; Korenaga, D; Morita, M; Nagata, S; Oki, E; Okuyama, T; Saeki, H; Takenaka, K; Tateishi, M; Uchiyama, H; Yaita, H | 1 |
| Albertsson, P; Baeksgaard, L; Damstrup, L; Holländer, C; Lassen, U; Sorensen, M | 1 |
| Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D | 1 |
| Goto, H; Hashizume, K; Ito, T; Kanazawa, H; Katada, N; Katano, Y; Morita, K; Narita, M; Nishimura, D; Okubo, K; Shibahara, H; Shimizu, J; Shiomi, M; Takeuchi, A; Takeyama, T | 1 |
| Hanatani, T; Maekawa, K; Sai, K; Saito, Y; Segawa, K; Sudo, C | 1 |
| Inoue, K; Okuno, K; Sugiura, F; Sukegawa, Y | 1 |
| Chu, Y; Ding, L; Liu, HY; Yu, Y; Zhu, H | 1 |
| Aruga, A; Inoue, Y; Kotera, Y; Matsushita, N; Takeda, K; Yamamoto, M | 1 |
| Iwanami, T; Iwata, T; Kawaguchi, M; Kuwata, T | 1 |
| Chang, SC; Chen, WS; Chu, LS; Jiang, JK; Kuo, YJ; Liang, WY; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, KL; Yang, SH | 1 |
| Enomoto, K; Ito, M; Kurumatani, N; Matsumoto, S; Migita, K; Nakajima, Y; Saeki, K; Takayama, T; Tanaka, T; Wakatsuki, K | 1 |
| Asami, K; Atagi, S; Fujita, Y; Kawaguchi, T; Minomo, S; Okishio, K; Saitou, R; Takata, S; Tamura, A | 1 |
| Baba, S; Ichinohe, K; Ijima, M; Usami, T | 1 |
| Benson, AB | 1 |
| Akizuki, S; Fushiya, N; Nishino, H; Ohnishi, A; Takagi, I | 1 |
| Akazawa, S; Fukawa, T; Fukumori, T; Hamao, T; Hayashi, H; Inai, T; Izaki, H; Kanayama, H; Kawabata, R; Kawano, A; Murakami, Y; Sutou, Y; Takahashi, M; Takemura, M; Yamaguchi, K; Yamamoto, Y | 1 |
| Bajetta, E; Beretta, E; Bertan, C; Biondani, P; Carbone, C; Di Bartolomeo, M; Dotti, KF; Lampis, A; Passalacqua, R; Perrone, F; Pietrantonio, F; Pilotti, S; Rimassa, L | 1 |
| Hanaoka, Y; Hashimoto, M; Kuroyanagi, H; Matoba, S; Moriyama, J; Toda, S; Tomizawa, K; Udagawa, H; Watanabe, G | 1 |
| Kato, T; Kobayashi, A; Nakamura, Y; Nakayama, H; Okamura, R; Wada, S; Yoh, T | 1 |
| Huang, FZ; Jiang, XZ; Liu, XY; Nie, WP; Wang, CF; Wang, YQ | 1 |
| Ajiki, T; Awane, M; Furuyama, H; Ikai, I; Ikezawa, K; Ioka, T; Kanai, M; Kou, T; Kume, M; Kuroda, N; Miyamoto, A; Nagano, H; Ochiai, T; Ogawa, M; Taira, K; Takeda, Y; Takemura, S; Terajima, H; Toyokawa, H; Tsukamoto, T; Yazumi, S | 1 |
| Kamijo, A; Nagase, H; Okada, K; Sadahiro, S; Suzuki, T; Tanaka, A; Uchida, J | 1 |
| Ahn, MS; Cho, YK; Choi, JH; Han, SU; Jeong, SH; Kang, SY; Lee, HW; Lee, KJ; Lee, SY; Lim, HY; Park, JS | 1 |
| Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S | 1 |
| Harada, N; Kaji, S; Kiuchi, Y; Kogo, M; Koike, N; Kurihara, T; Sunaga, T; Suzuki, M; Suzuki, S | 1 |
| Hiro, J; Inoue, Y; Kawamoto, A; Kawamura, M; Kusunoki, M; Mohri, Y; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y | 1 |
| Doki, Y; Haraguchi, N; Hata, T; Mizushima, T; Mori, M; Nakajima, K; Nishimura, J; Takemasa, I; Takeyama, H; Uemura, M; Yamamoto, H | 1 |
| Hirai, K; Kawate, S; Ogawa, H; Sunose, Y; Takeyoshi, I; Totsuka, O; Toya, H; Yoshinari, D | 1 |
| Ezaki, T; Hayakawa, N; Maeda, T; Matsumoto, K; Nakamura, S; Ninomiya, A; Sakamoto, H; Sato, A | 1 |
| Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW | 1 |
| Hida, J; Inoue, K; Kogita, A; Okuno, K; Sugiura, F; Sukegawa, Y; Yoshioka, Y | 2 |
| Chang, CF; Chao, JY; Chiang, FF; Lin, JC; Lin, JF; Wang, HM; Yeh, HL | 1 |
| Chang, SC; Chen, WS; Huang, CS; Jiang, JK; Lan, YT; Liang, WY; Lin, CC; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH | 1 |
| Hyodo, I; Maeba, T; Matsumoto, T; Mizuta, M; Moriwaki, T; Nishina, T; Takahashi, I; Tsuji, A; Watanabe, R; Watanabe, Y | 1 |
| Furuse, H; Ishii, Y; Kai, F; Nagata, M; Otsuka, A; Ozono, S; Sugiyama, T; Suzuki, T; Takayama, T; Yajima, T | 1 |
| Hase, K; Hashiguchi, Y; Ishiguro, M; Kajiwara, Y; Kobayashi, H; Sekizawa, A; Shikina, A; Shinto, E; Ueno, H; Yamamoto, J | 1 |
| Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Miyagawa, S; Oba, M; Saiura, A; Takayama, T; Teruya, M; Yamamoto, J; Yoshimi, F | 1 |
| Ikeda, T; Ikegami, T; Kawanaka, H; Maehara, Y; Mimori, K; Morita, M; Oki, E; Saeki, H; Soejima, Y; Sugimachi, K; Uchiyama, H; Watanabe, M; Yamashita, Y; Yoshinaga, K; Yoshizumi, T | 1 |
| Hashimoto, K; Ikeda, T; Ishida, T; Kawanaka, H; Maeda, T; Maehara, Y; Saeki, H; Tsujitani, S; Uchiyama, H; Yamashita, Y | 1 |
| Chen, CC; Jiang, RS; Liang, KL; Lin, JC; Lin, PJ; Liu, YC; Shih, YT; Twu, CW; Wang, WY; Wu, CT | 1 |
| Ishibe, A; Matsuo, K; Misuta, K; Nakano, A; Tsuchiya, N; Yamagishi, S | 1 |
| Fushimi, K; Takami, M; Tanabe, N | 1 |
| Endo, S; Hidaka, E; Ishida, F; Kida, H; Kudo, SE; Maeda, C; Mukai, S; Nakahara, K; Omoto, T; Takayanagi, D; Takehara, Y; Tanaka, J; Wada, Y | 1 |
| Baba, H; Hamada, C; Kakeji, Y; Katsumata, K; Koda, K; Kodaira, S; Kondo, K; Matsuoka, J; Morita, T; Nishimura, G; Sadahiro, S; Saji, S; Sasaki, K; Sato, S; Tsuchiya, T; Usuki, H; Yamaguchi, Y | 1 |
| Hara, K; Ishii, T; Kondo, H; Koyama, I; Morita, Y; Suzuki, A; Tashiro, J; Yamaguchi, S | 1 |
| Boku, N; Endo, T; Ikejiri, K; Ishiguro, M; Kameoka, S; Kinugasa, Y; Kotake, K; Mochizuki, H; Mochizuki, I; Nakamoto, Y; Nakatani, E; Shinozaki, H; Sugihara, K; Takagane, A; Takahashi, K; Takii, Y; Tomita, N; Watanabe, M; Watanabe, T; Yoshida, M | 1 |
| Bang, YJ; Choi, IS; Han, SW; Im, SA; Kim, JH; Kim, TY; Kim, YJ; Lee, KH; Lee, KW; Oh, DY | 1 |
| Buyse, M; Fukushima, R; Hara, A; Imamura, H; Kobayashi, M; Kojima, H; Miyashita, Y; Morita, S; Nishikawa, K; Nozaki, I; Oba, K; Sakamoto, J; Takahashi, M; Takahashi, N; Takiguchi, N; Tanabe, K; Tatsumoto, N; Tsuburaya, A; Yoshida, K; Yoshino, S | 1 |
| Akaike, M; Fukuda, H; Hamaguchi, T; Kanemitsu, Y; Kato, T; Kubo, Y; Mishima, H; Mizusawa, J; Moriya, Y; Nakamura, K; Ohue, M; Saito, N; Sato, T; Shimada, Y; Takiguchi, N; Takii, Y; Tomita, N; Yamaguchi, S | 1 |
| Appelt, AL; Bentzen, SM; Havelund, BM; Jakobsen, A; Lindebjerg, J; Pløen, J; Rafaelsen, SR; Vogelius, IR | 1 |
| Ando, J; Aogi, K; Fukuda, H; Fukutomi, T; Inoue, K; Iwata, H; Kinoshita, T; Nakamura, K; Shibata, T; Shien, T; Takashima, S | 1 |
| Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I | 1 |
| Ishihara, S; Kazama, S; Murono, K; Nagai, Y; Nishio, K; Sakai, K; Sunami, E; Tanaka, T; Tomida, S; Watanabe, T | 1 |
| Ishiguro, M; Sugihara, K; Yoshida, M | 1 |
| Abali, H; Calıkusu, Z; Seyrek, E; Yavuz, S | 1 |
| Fukumatsu, Y; Katabuchi, H; Mimori, H; Motohara, T; Saito, F; Sakaguchi, I; Shibata, S; Takaishi, K; Tashiro, H; Tohya, T | 1 |
| Hishida, T; Kunitoh, H; Ohashi, Y; Sakurai, H; Shukuya, T; Takamochi, K; Tsuboi, M; Yoh, K | 1 |
| Karasawa, H; Katagiri, M; Katayose, Y; Morikawa, T; Motoi, F; Naito, T; Sato, J; Unno, M; Yabuuchi, S | 1 |
| Itai, S; Izumi, K; Kadono, Y; Kitagawa, Y; Konaka, H; Machioka, K; Maolake, A; Mizokami, A; Namiki, M; Nohara, T; Takahashi, R; Yaegashi, H | 1 |
| Adachi, J; Gotyo, N; Mimura, M; Watanabe, T | 1 |
| Doki, Y; Fukunaga, M; Fukuzaki, T; Hasegawa, J; Hata, T; Ikeda, M; Matsuda, C; Mizushima, T; Mori, M; Murata, K; Nezu, R; Ota, H; Sekimoto, M; Takemasa, I; Tamagawa, H; Tsujie, M; Yamamoto, H | 1 |
| Baba, H; Hamada, M; Ikeda, M; Itabashi, M; Kodaira, S; Kondo, K; Maeda, K; Masuko, H; Morita, S; Nishimura, G; Ogata, Y; Ohge, H; Sadahiro, S; Sakamoto, K; Sasaki, K; Sato, T; Taguri, M; Takahashi, K; Takahashi, T; Tsuchiya, T | 1 |
| Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K | 1 |
| Cheong, CO; Kim, HK; Kim, KS; Lim, JH; Park, JS; Park, SW | 1 |
| Funato, Y; Ito, K; Koyama, T; Oda, M; Yamaguchi, Y | 1 |
| Baba, H; Hamada, C; Kakeji, Y; Katsumata, K; Koda, K; Kodaira, S; Kondo, K; Matsuoka, J; Morita, T; Nishimura, G; Sadahiro, S; Sasaki, K; Sato, S; Tsuchiya, T; Usuki, H; Yamaguchi, Y | 1 |
| Azuma, H; Hirano, H; Inamoto, T; Kiyama, S; Maenosono, R; Matsunaga, T; Minami, K; Nomi, H; Takahara, K; Tsuji, M; Tsujino, T; Yamamoto, I; Yoshikawa, Y | 1 |
| Amagai, K; Denda, T; Higashijima, J; Hiroshima, Y; Hyodo, I; Indo, S; Ishida, H; Maeba, T; Masuishi, T; Mizuta, M; Moriwaki, T; Nakajima, G; Negoro, Y; Nishina, T; Ozeki, M; Sakai, Y; Sato, M; Shimada, M; Takahashi, I; Yamamoto, Y | 1 |
| Egawa, C; Goto, T; Hashimoto, T; Ishida, T; Kagawa, Y; Kato, T; Katsura, Y; Kimura, K; Kusama, H; Matsushita, K; Morimoto, Y; Motoyama, Y; Murakami, K; Nagano, T; Naito, A; Nakatsuka, S; Nitta, K; Ohmura, Y; Ohneda, Y; Okishiro, M; Sakisaka, H; Sato, Y; Takatsuka, Y; Takeda, Y; Takeno, A; Tamura, S; Taniguchi, H | 1 |
| Amaya, K; Kaji, M; Kawahara, Y; Maeda, K; Shimizu, K; Terada, I; Terai, S; Watanabe, T; Yamamoto, S | 1 |
| Akahoshi, S; Iizaka, M; Murakami, S; Nimura, S; Takeguchi, T | 1 |
| Maruyama, T; Okumura, M; Sako, A; Ueda, K; Yasuda, K | 1 |
| Barton, S; Begum, R; Braconi, C; Chau, I; Cunningham, D; Fassan, M; Guzzardo, V; Hawkins, M; Khan, K; Oates, J; Peckitt, C; Rao, S; Starling, N; Tait, D; Thomas, J; Watkins, D | 1 |
| Hwang, SH; Kim, SG | 1 |
| Baba, H; Emi, Y; Hamada, C; Ikejiri, K; Kakeji, Y; Kotake, M; Maeda, K; Maehara, Y; Matsuda, C; Matsuda, H; Munemoto, Y; Murata, A; Oki, E; Saji, S; Sasaki, K; Suenaga, T; Yoshida, K | 1 |
| Akasu, T; Amagai, K; Kojima, H; Komori, K; Matsuda, K; Nagashima, K; Nakamori, S; Ohue, M; Saito, N; Sasaki, Y; Yamada, Y; Yamaguchi, T | 1 |
| Chang, PM; Chen, SC; Yang, MH | 1 |
| Kamijo, A; Nagase, H; Okada, K; Sadahiro, S; Saito, G; Suzuki, T; Tanaka, A | 1 |
| Chen, CT; Chou, YC; Hsiao, CW; Hu, JM; Hu, SI; Jao, SW; Lee, CC; Liu, WT; Wu, CC | 1 |
| Hase, K; Kajiwara, Y; Moriya, T; Shinto, E; Shiraishi, T; Sueyama, T; Ueno, H; Watanabe, T; Yamadera, M; Yamamoto, J | 1 |
| Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Matsuyama, Y; Miyagawa, S; Mizunuma, N; Oba, M; Saiura, A; Takahashi, M; Takayama, T; Teruya, M; Watanabe, T; Yamamoto, J; Yoshimi, F | 1 |
| Chang, SC; Chao, KS; Chen, TW; Chen, WT; Chiang, HC; Chien, CR; Huang, CL; Huang, YC; Ke, TW; Li, CC; Lin, CH; Lin, YC; Wang, HM | 1 |
| Fujioka, H; Ikari, A; Iwamoto, M; Kawaguchi, K; Kimura, K; Maezawa, S; Matsuda, J; Sato, N; Takahashi, Y; Tanaka, S; Terasawa, R; Tominaga, T; Uchiyama, K; Umezaki, N | 1 |
| Chen, Z; Guo, W; Huang, M; Li, J; Li, W; Liu, X; Qiu, L; Wang, H; Zhang, W; Zhao, X; Zhu, X | 1 |
| Iga, N; Ikeda, H; Ishizaki, M; Kawai, H; Nishi, H; Sugimoto, R; Waki, N; Yamashita, K; Yoshida, R | 1 |
| Hara, K; Ishii, T; Kondo, H; Shimizu, H; Suzuki, A; Takemoto, K; Tashiro, J; Yamaguchi, S | 1 |
| Chen, JH; Ho, CL; Hsiao, CW; Huang, WY; Jao, SW; Lee, CC; Lo, CH; Wu, CC; Yang, JF | 1 |
| Doki, Y; Fujita, J; Fujitani, K; Fujiwara, Y; Hirao, M; Imamura, H; Kimura, Y; Moon, JH; Mori, M; Takiguchi, S; Tamura, S; Yano, M | 1 |
| Doki, Y; Hata, T; Ikeda, M; Kato, T; Miyake, Y; Mizushima, T; Mori, M; Nezu, R; Nishimura, J; Sekimoto, M; Takemasa, I; Tsujie, M; Yamamoto, H | 1 |
| Chionh, F; Lau, D; Price, T; Tebbutt, N; Yeung, Y | 1 |
| Hamada, C; Kato, H; Ohta, M; Tsuboi, M | 1 |
| Fujiya, M; Hasebe, T; Honda, S; Nakajima, S; Okumura, T; Sawada, K | 1 |
| Alabiso, I; Alabiso, O; Baratelli, C; Brizzi, MP; Di Maio, M; Forti, L; Ottone, A; Scagliotti, GV; Sonetto, C; Tampellini, M | 1 |
| Kazaoka, Y; Nishio-Nagai, M; Suzuki, S; Ueda, R; Yoshikawa, K | 1 |
| Akamatsu, H; Aoyama, T; Kobatake, T; Kunieda, K; Matsuhashi, N; Morita, S; Nishimura, Y; Oba, K; Okuno, K; Saji, S; Sakamoto, J; Yokoyama, N; Yoshikawa, T | 1 |
| Aiba, K; Baba, H; Boku, N; Ishiguro, M; Itabashi, M; Kotake, K; Kunieda, K; Kusumoto, T; Maeda, A; Mochizuki, I; Morita, S; Okabe, M; Ota, M; Sakamoto, Y; Sugihara, K; Sunami, E; Takahashi, K; Tomita, N; Yamauchi, J; Yoshida, K | 1 |
| Sawada, S; Sugimoto, R; Ueno, T; Yamashita, M | 1 |
| Fuse, T; Katarao, Y; Kimura, Y; Shimizu, Y; Takemura, M; Tanaka, R; Uchiyama, K; Yamamoto, Y | 1 |
| Chang, JS; Chung, SY; Lee, BM; Lee, KJ; Seong, J | 1 |
| Aono, T; Ito, T; Kagimura, T; Masuda, N; Matsunami, N; Miyoshi, Y; Nakayama, T; Noguchi, S; Sagara, Y; Taguchi, T; Takashima, T | 1 |
| Fujii, S; Ishiguro, M; Kajiwara, Y; Kinugasa, Y; Komori, K; Kotake, K; Kotake, M; Kurachi, K; Maeda, A; Matsuda, C; Mochizuki, H; Nakagawa, Y; Nakamoto, Y; Sakamoto, Y; Shimada, Y; Sugihara, K; Takahashi, K; Teramukai, S; Tomita, N; Watanabe, M | 1 |
| Novello, S; Rossi, A | 1 |
| Chang, DC; Chen, G; Chen, MK; Chien, SY; Hsieh, MY | 1 |
| Beppu, T; Fujii, M; Hanamure, Y; Hasegawa, Y; Higaki, Y; Iwae, S; Kawabata, K; Kohno, N; Kubota, A; Nagahara, K; Nakatani, E; Nakatani, H; Taguchi, T; Takemura, H; Terada, T; Teramukai, S; Tomita, K; Tsukahara, K; Yoshino, K | 1 |
| Watanabe, Y | 1 |
| Ito, Y; Kobuchi, S; Sakaeda, T; Takamatsu, D | 1 |
| Araki, T; Fujikawa, H; Hiro, J; Ide, S; Kusunoki, M; Ohi, M; Okugawa, Y; Saigusa, S; Toiyama, Y; Yamamoto, A; Yasuda, H; Yoshiyama, S | 1 |
| Fujii, S; Kashiwabara, K; Semba, H; Tsumura, S | 1 |
| Ando, K; Kusumoto, T; Maeda, K; Maehara, Y; Munemoto, Y; Murata, A; Nakanishi, R; Nakashima, Y; Oki, E; Saeki, H; Shimokawa, M; Takahashi, T | 1 |
| Hsu, TC; Wang, CC | 1 |
| Fushida, S; Hayashi, H; Hayashi, M; Inokuchi, M; Kinoshita, J; Miyashita, T; Nakamura, K; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Sakai, S; Tajima, H; Takamura, H; Terai, S | 1 |
| Chan, LF; Kajiwara, H; Kamei, Y; Miyakita, H; Nagase, H; Okada, K; Sadahiro, S; Saito, G; Suzuki, T; Tanaka, A | 1 |
| Baba, H; Beppu, T; Chikamoto, A; Fukubayashi, K; Hayashi, H; Imai, K; Imamura, YU; Ishiko, T; Miyata, T; Yamashita, YI | 1 |
| Milano, G | 1 |
| Egawa, T; Ikawa, O; Ishiguro, M; Ishikawa, T; Kotake, M; Kurachi, K; Matsuda, C; Matsui, S; Murata, K; Murotani, K; Nakamoto, Y; Nakatani, E; Shinji, S; Sugihara, K; Teramukai, S; Tomita, N; Ueno, H; Uetake, H; Yasumasa, K | 1 |
| Bae, WK; Cho, SH; Chung, IJ; Hwang, EC; Hwang, JE; Jeong, O; Kim, H; Park, YK; Ryu, SY; Shim, HJ | 1 |
| Aoe, M; Date, H; Hotta, K; Morita, S; Nakamura, H; Nakata, M; Okumura, N; Sakamoto, J; Soh, J; Toyooka, S; Yamashita, M | 1 |
| Chao, TY; Chen, JH; Ho, CL; Huang, WY; Lee, JC | 1 |
| Cruz-Muñoz, W; Hileeto, D; Kerbel, RS; Man, S; Muñoz, R; Viloria-Petit, A; Wood, GA; Xu, P | 1 |
| Hosono, M; Ienaga, T; Iwabuchi, S; Kawasaki, K; Okazaki, T; Owada, Y; Tanaka, S | 1 |
| Ito, Y; Kobuchi, S; Matsumura, E; Sakaeda, T | 1 |
| Chen, TC; Jeng, YM; Liang, JT | 1 |
| Brock, C; Christensen, P; Gram, M; Haas, S; Krogh, K; Laurberg, S; Lundby, L; Mohr Drewes, A; Møller Faaborg, P | 1 |
| Akamine, S; Hayashi, T; Inada, K; Kamohara, R; Koga, T; Muraoka, M; Nagayasu, T; Saeki, S; Sugio, K; Suzuki, M; Takenoyama, M; Tokunaga, S; Tsuchiya, T; Urabe, S | 1 |
| Hayashi, M; Inokawa, H; Kawamoto, N; Okada, M; Okita, R | 1 |
| Endo, Y; Hirashita, T; Inomata, M; Itoh, H; Iwao, M; Iwashita, Y; Masuda, T; Shiraiwa, K; Suzuki, Y; Tada, K; Tanaka, R; Uchida, H | 1 |
| Chen, CN; Lai, IR; Yeh, CC; Yen, HH | 1 |
| Chiba, Y; Fukuoka, M; Higashiyama, M; Iked, N; Katakami, N; Mitsudomi, T; Nakagawa, K; Nakanishi, Y; Negoro, S; Nomori, H; Oda, M; Ohta, M; Saka, H; Sawa, T; Semba, H; Seto, T; Shimokawa, M; Tada, H; Yamaguchi, M; Yamashita, M; Yokoi, K | 1 |
| Gemma, A; Honda, K; Ikeda, N; Inoue, T; Kashiro, A; Kubota, K; Kunugi, S; Matsubayashi, J; Meng, X; Motoi, N; Nagashima, K; Noro, R; Okano, T; Seike, M; Shiraishi, H; Takeuchi, S; Usuda, J; Watanabe, S; Wilber, H; Yoshida, Y | 1 |
| Baba, H; Hamada, M; Hyodo, I; Ikeda, M; Itabashi, M; Kondo, K; Kusano, M; Maeda, K; Masuko, H; Morita, S; Ogata, Y; Ohge, H; Sadahiro, S; Sakamoto, J; Sakamoto, K; Sato, T; Taguri, M; Takahashi, K; Takahashi, T; Tsuchiya, T | 1 |
| Hanaoka, J; Kaku, R; Okamoto, K; Oshio, Y | 1 |
| Hayashi, D; Hirono, K; Ito, A; Miyamoto, M; Nishikawa, H; Nonaka, Y; Okada, T; Oshima, K; Shigemitsu, K; Shinoura, S; Tago, K; Takeda, N | 1 |
| Iwai, T; Kuriyama, S; Matsuda, A; Miyasaka, T; Ohta, R; Shinji, S; Sonoda, H; Takeda, K; Ueda, K; Yamada, T; Yonaga, K; Yoshida, H | 1 |
| Aoyama, A; Date, H; Date, N; Fujinaga, T; Fukada, T; Hamaji, M; Huang, CL; Ishikawa, M; Katakura, H; Kayawake, H; Kobayashi, M; Kono, T; Matsumoto, A; Menju, T; Miyahara, R; Miyamoto, E; Miyata, R; Morita, S; Nakagawa, T; Nakakura, A; Okumura, N; Sakaguchi, Y; Sakai, H; Shimazu, Y; Sonobe, M; Sumitomo, R; Takahashi, M | 1 |
| Chang, WH; Li, YT | 1 |
| Chen, JH; Chen, PH; Chien, WC; Chung, CH; Huang, TC; Jhou, HJ; Lee, CH; Wu, YY | 1 |
| Doi, T; Funakoshi, Y; Hojo, W; Hokka, D; Maniwa, Y; Minami, H; Mitsui, S; Nishikubo, M; Ohji, G; Sakai, H; Tanaka, Y; Yakushijin, K | 1 |
| Ito, Y; Kobuchi, S; Nakamura, T; Okamura, M; Tsuda, M | 1 |
| Fujimori, M; Ikeda, S; Ishizaki, Y; Kobayashi, H; Kodama, S; Miguchi, M; Nakahara, M; Ohdan, H; Oheda, M; Okuda, H; Saitoh, Y; Shimizu, W; Shimizu, Y; Shimomura, M; Sumitani, D; Takakura, Y; Toyota, K; Yoshimitsu, M | 1 |
| Ando, K; Baba, H; Fujimoto, Y; Harimoto, N; Iimori, M; Kakeji, Y; Kamahori, Y; Kataoka, Y; Kawazoe, T; Kitao, H; Maehara, Y; Makino, K; Matsuoka, K; Miyadera, K; Nakanishi, R; Nonaka, K; Ochiiwa, H; Oki, E; Ota, M; Saeki, H; Sagara, T; Shimada, M; Shirabe, K; Takechi, T; Tokunaga, E; Tsukihara, H; Wakasa, T; Yoshizumi, T | 1 |
| Aoki, T; Hachiya, H; Irisawa, A; Ishizuka, M; Iso, Y; Matsumoto, T; Miyashita, S; Mori, S; Niki, M; Nishi, Y; Sakuraoka, Y; Shibuya, N; Shimizu, T; Shiraki, T | 1 |
| Chang, CI; Chen, KY; Ho, CC; Keng, LT; Ko, JC; Lee, MR; Liang, SK; Liao, WY; Shih, JY; Wang, JY; Wu, CW; Yu, CJ | 1 |
| Chen, HH; Fan, CW; Liao, CK; Liaw, YW; Liu, YH; Tseng, WK; Yeh, CY; Yu, YL | 1 |
158 review(s) available for tegafur and uracil
| Article | Year |
|---|---|
Soviet antitumor preparations.
Topics: Animals; Antineoplastic Agents; Aziridines; Butylated Hydroxytoluene; Dactinomycin; Daunorubicin; Humans; Melphalan; Methylnitrosourea; Neoplasms, Experimental; Nitrogen Mustard Compounds; Olivomycins; Organophosphorus Compounds; Phenylalanine; Prospidium; Pyrimidines; Spiro Compounds; Streptonigrin; Tegafur; Triethylenephosphoramide; Uracil | 1977 |
[A case of advanced gastric cancer (Borrmann's type 2) that disappeared following short-term preoperative chemotherapy with UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrectomy; Humans; Male; Middle Aged; Preoperative Care; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[A case of liver metastasis of gastric cancer which was made resectable by hypertheromo-chemo-radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Hepatectomy; Humans; Hyperthermia, Induced; Liver Neoplasms; Middle Aged; Mitomycins; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Malignant fibrous histiocytoma of the scrotal wall--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Genital Neoplasms, Male; Histiocytoma, Benign Fibrous; Humans; Male; Middle Aged; Scrotum; Tegafur; Uracil | 1988 |
Studies of analogs of fluorinated pyrimidine in Japan.
Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Humans; Japan; Neoplasms; Neoplasms, Experimental; Tegafur; Uracil | 1981 |
[Metabolic modulation as a method in tumor chemotherapy].
Topics: Antineoplastic Agents; Cytarabine; Fluorouracil; Humans; Methotrexate; Neoplasms; Tegafur; Thymidine; Uracil | 1982 |
[Combined chemotherapy with 5-FU+cis-platin or UFT+cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Routes; Drug Administration Schedule; Fluorouracil; Humans; Stomach Neoplasms; Tegafur; Uracil | 1995 |
Concomitant salivary duct carcinoma of a minor buccal salivary gland and papillary cystadenoma lymphomatosum of a cervical lymph node: report of a case and review of the literature.
Topics: Adenolymphoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Humans; Lymphatic Diseases; Male; Middle Aged; Neck; Neck Dissection; Neoplasms, Multiple Primary; Picibanil; Salivary Gland Neoplasms; Salivary Glands, Minor; Tegafur; Uracil | 1995 |
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levoleucovorin; Mitomycin; Nimustine; Recombinant Proteins; Stomach Neoplasms; Tegafur; Uracil | 1994 |
Clinical experience with UFT in Japan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Japan; Neoplasms; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil | 1993 |
[Head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Methotrexate; Tegafur; Uracil | 1996 |
New anticancer agents in clinical development.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Enzyme Inhibitors; Fluorouracil; Gemcitabine; Humans; Neoplasms; Polysaccharides, Bacterial; Prodrugs; Quinazolines; Tegafur; Thiophenes; Thymidylate Synthase; Uracil | 1995 |
Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1996 |
Primary linitis plastica of the rectum: report of four cases and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Linitis Plastica; Male; Middle Aged; Mitomycins; Prognosis; Rectal Neoplasms; Tegafur; Time Factors; Uracil | 1996 |
[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Uracil | 1996 |
The role of chemotherapy in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maxillary Sinus Neoplasms; Peplomycin; Survival Rate; Tegafur; Uracil | 1997 |
Modulation of 5-FU and its related compounds.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyridines; Tegafur; Uracil | 1997 |
[Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma, Experimental; Mice; Mice, Nude; Rats; Rats, Inbred SHR; Semustine; Skin Neoplasms; Tegafur; Uracil | 1997 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Mitomycin; Randomized Controlled Trials as Topic; Tamoxifen; Tegafur; Uracil | 1997 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vindesine | 1997 |
Experience with UFT in Japan.
Topics: Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Combinations; Humans; Japan; Neoplasms; Tegafur; Treatment Outcome; Uracil | 1997 |
Current and future directions in adjuvant combined-modality therapy of rectal cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Fluorouracil; Forecasting; Humans; Leucovorin; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Rectal Neoplasms; Tegafur; Uracil | 1997 |
Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Head and Neck Neoplasms; Humans; Neoplasm Staging; Tegafur; Uracil | 1997 |
UFT in gastric cancer: current status and future developments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Humans; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1997 |
UFT: biochemical modulation for 5-fluorouracil (5-FU).
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Neoplasms; Tegafur; Uracil | 1997 |
Uracil-tegafur in gastric carcinoma: a comprehensive review.
Topics: Antineoplastic Agents; Drug Combinations; Humans; Stomach Neoplasms; Tegafur; Uracil | 1998 |
New drugs in the treatment of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Topotecan; Trimetrexate; Uracil | 1998 |
Oral 5-FU alternatives for the treatment of head and neck cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Etoposide; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Neoplasm Recurrence, Local; Tegafur; Uracil | 1998 |
Oral 5-FU analogues in the treatment of breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Enzyme Inhibitors; Female; Fluorouracil; Humans; Tegafur; Uracil | 1998 |
Chemotherapy for gastric carcinoma: new and old options.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Capecitabine; Deoxycytidine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Etoposide; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids; Tegafur; Uracil | 1998 |
The oral fluorouracil prodrugs.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 1998 |
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1998 |
Oral fluoropyrimidines in the treatment of colorectal cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Oxidoreductases; Pyridines; Tegafur; Uracil | 1998 |
[Gastrointestinal cancer and oral anticancer agents].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Drug Combinations; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Organoplatinum Compounds; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 1999 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[Oral fluoropyrimidines in oncology].
Topics: Administration, Oral; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Female; Floxuridine; Fluorouracil; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Neoplasms; Tegafur; Time Factors; Uracil | 1998 |
Fluoropyrimidines: a critical evaluation.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Leucovorin; Oxonic Acid; Pyridines; Tegafur; Uracil | 1999 |
Clinical implications of dihydropyrimidine dehydrogenase inhibition.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Dihydrouracil Dehydrogenase (NADP); Drug Evaluation; Enzyme Inhibitors; Fluorouracil; Humans; Neoplasms; Oxidoreductases; Tegafur; Uracil | 1999 |
Epirubicin, cyclophosphamide, and UFT plus oral calcium folinate in advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Routes; Drug Therapy, Combination; Epirubicin; Female; Humans; Leucovorin; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Humans; Tegafur; Treatment Outcome; Uracil; Urinary Bladder Neoplasms | 1999 |
The University of Texas M. D. Anderson Cancer Center Orzel/UFT Investigators' Workshop and Consensus Conference. October 15-18, 1998. Proceedings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Neoplasms; Tegafur; Uracil | 1999 |
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer.
Topics: Antineoplastic Agents; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Glutamates; Guanine; Humans; Pemetrexed; Platinum Compounds; Pyridines; Quinazolines; Tegafur; Thiophenes; Uracil | 1999 |
Oral fluoropyrimidines: a closer look at their toxicities.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Tegafur; Uracil | 1999 |
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Humans; Interferon-alpha; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1999 |
The role of UFT in combined-modality therapy.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Neoplasms; Radiation-Sensitizing Agents; Tegafur; Uracil | 1999 |
[Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Interferon-alpha; Kidney Neoplasms; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[A case of urothelial carcinoma associated with penile metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Lymphatic Metastasis; Male; Penile Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
New drugs in therapy of colorectal cancer: preclinical studies.
Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorouracil; Folic Acid Antagonists; Humans; Oxidoreductases; Prodrugs; Quinazolines; Tegafur; Thiophenes; Thymidine Phosphorylase; Thymidylate Synthase; Uracil | 1999 |
Oral fluoropoyrimidines.
Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Folic Acid Antagonists; Humans; Leucovorin; Oxidoreductases; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 1999 |
Oxaliplatin: a new therapeutic option in colorectal cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Drug Synergism; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Uracil | 1999 |
The role of tegafur/uracil in pulmonary malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Humans; Lung Neoplasms; Tegafur; Uracil | 1999 |
Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Humans; Leucovorin; Tegafur; Uracil | 1999 |
Recent developments in oral chemotherapy options for gastric carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Combinations; Etoposide; Humans; Stomach Neoplasms; Tegafur; Uracil | 1999 |
Oral therapy for colorectal cancer: how to choose.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biological Availability; Capecitabine; Colorectal Neoplasms; Decision Making; Deoxycytidine; Enzyme Inhibitors; Fluorouracil; Humans; Leucovorin; Tegafur; Uracil | 2000 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitomycin; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Oral fluoropyrimidines in the treatment of colorectal cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Pyrimidines; Tegafur; Uracil | 2000 |
Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Fluorouracil; Folic Acid Antagonists; Humans; Leucovorin; Prodrugs; Tegafur; Uracil | 2000 |
Oral fluoropyrimidines in colorectal cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Leucovorin; Oxonic Acid; Pyridines; Tegafur; Uracil | 2000 |
[Oral cancer chemotherapy in the clinic].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Floxuridine; Hematologic Neoplasms; Humans; Melphalan; Quality of Life; Tamoxifen; Tegafur; Uracil | 2000 |
[A noteworthy case of postoperative liver metastasis from gastric cancer which responded well to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Liver Neoplasms; Male; Postoperative Period; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Conceptual changes in cancer chemotherapy: from an oral fluoropyrimidine prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Synergism; Drug Therapy; Fluorouracil; Humans; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 2000 |
The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Humans; Leucovorin; Neoplasms; Oxidoreductases; Oxonic Acid; Pyridines; Radiation-Sensitizing Agents; Tegafur; Uracil | 2000 |
Adrenalectomy for solitary adrenal metastasis from colorectal carcinoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Floxuridine; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Pneumonectomy; Rectal Neoplasms; Tegafur; Uracil | 2000 |
UFT: mechanism of drug action.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Resistance, Neoplasm; Drug Therapy, Combination; Fluorouracil; Humans; Tegafur; Thymidylate Synthase; Uracil | 2000 |
Oral DPD-inhibitory fluoropyrimidine drugs.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Drug Resistance, Neoplasm; Fluorouracil; Humans; Leucovorin; Oxidoreductases; Oxonic Acid; Pyridines; Tegafur; Uracil | 2000 |
[Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Melphalan; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Semustine; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Oral fluoropyrimidines in cancer treatment.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Pyridines; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Fluorinated pyrimidines in oral treatment of advanced colorectal cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Leucovorin; Oxidoreductases; Prodrugs; Pyrimidines; Tegafur; Uracil | 2000 |
Novel oral chemotherapy agents.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Neoplasms; Tegafur; Temozolomide; Uracil | 2000 |
[Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Mitomycin; Randomized Controlled Trials as Topic; Semustine; Survival Rate; Tegafur; Uracil; Vincristine | 2000 |
Colorectal cancer: chemotherapy treatment overview.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Tegafur; Treatment Outcome; Uracil | 2000 |
UFT in the treatment of colorectal and breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Colorectal Neoplasms; Drug Therapy; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2001 |
UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Female; Humans; Leucovorin; Male; Neoplasms; Oxidoreductases; Tegafur; Uracil | 2001 |
The oral fluorinated pyrimidines.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Availability; Biotransformation; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Neoplasms; Oxidoreductases; Prodrugs; Tegafur; Uracil | 2001 |
Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Pyrimidines; Quinazolines; Tegafur; Thiophenes; Uracil | 2001 |
[5-fluorouracil and dihydropyrimidine dehydrogenase].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fluorouracil; Humans; Neoplasms; Oxidoreductases; Oxonic Acid; Pyridines; Tegafur; Uracil | 2001 |
New drugs and combinations in the palliative treatment of colon and rectal cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; DNA Topoisomerases, Type I; Female; Humans; Male; Neoplasm Staging; Palliative Care; Platinum Compounds; Prognosis; Sensitivity and Specificity; Survival Analysis; Tegafur; Thymidylate Synthase; Topoisomerase I Inhibitors; Uracil | 2001 |
New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Enzyme Inhibitors; Fluorouracil; Humans; Outpatients; Tegafur; Uracil | 2001 |
Oral uracil-tegafur: an alternative to intravenous 5-fluorouracil?
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Clinical Trials as Topic; Fluorouracil; Humans; Injections, Intravenous; Tegafur; Uracil | 2001 |
Answering patients' needs: oral alternatives to intravenous therapy.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Patient Satisfaction; Quality of Life; Tegafur; Uracil | 2001 |
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Tegafur; Treatment Outcome; Uracil | 2001 |
Nonsurgical treatment of hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Capecitabine; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cryosurgery; Deoxycytidine; Drug Combinations; Ethanol; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Injections, Intralesional; Interferons; Liver Cirrhosis; Liver Neoplasms; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Tamoxifen; Tegafur; Uracil | 2001 |
[New therapeutic options in chemotherapy of advanced colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Uracil | 2001 |
New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Fluorouracil; Forecasting; Humans; Irinotecan; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Trimetrexate; Uracil | 2001 |
[Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Pyrimidines; Tegafur; Uracil | 2002 |
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.
Topics: Administration, Oral; Antineoplastic Agents; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Neoplasms; Prodrugs; Pyridines; Tegafur; Treatment Outcome; Uracil | 2002 |
[Comparative clinical studies for head and neck cancer in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Combinations; Head and Neck Neoplasms; Humans; Japan; Tegafur; Uracil | 2002 |
[Chemotherapy of gastric cancer--a review of clinical trials in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Combinations; Floxuridine; Humans; Japan; Methotrexate; Mitomycin; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2002 |
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combinations; Female; Genital Neoplasms, Female; Humans; Japan; Multicenter Studies as Topic; Ovarian Neoplasms; Sizofiran; Survival Analysis; Tegafur; Uracil; Uterine Neoplasms | 2002 |
[Recent advance in adjuvant therapy for breast cancer].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Tamoxifen; Tegafur; Uracil | 2002 |
[Progress in adjuvant therapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Mitomycin; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasm Staging; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2003 |
Palliative treatment of patients with colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Camptothecin; Colorectal Neoplasms; Disease Progression; Enzyme Inhibitors; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Palliative Care; Quinazolines; Survival Analysis; Tegafur; Thiophenes; Thymidylate Synthase; Topoisomerase I Inhibitors; Treatment Outcome; Uracil | 2003 |
Practical considerations in the use of oral fluoropyrimidines.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 2003 |
[Oral fluoropyrimidines in the treatment of colorectal carcinoma].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Prodrugs; Tegafur; Uracil | 2003 |
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Administration Schedule; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Protein Precursors; Prothrombin; Tegafur; Uracil | 2003 |
UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrointestinal Neoplasms; Humans; Radiation-Sensitizing Agents; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[Chemotherapy for colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Tegafur; Treatment Outcome; Uracil | 2003 |
[Tegafur.uracil for treatment of colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leucovorin; Prognosis; Randomized Controlled Trials as Topic; Tegafur; Treatment Outcome; Tumor Cells, Cultured; Uracil | 2003 |
[Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Oxonic Acid; Prognosis; Pyridines; Tegafur; Thymidylate Synthase; Uracil | 2003 |
[Effect of systemic chemotherapy by 5-FU with low dose CDDP (in the hospital) and UFT with low dose CDDP (in outpatient clinic) in unresectable recurrent colorectal cancer].
Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Fluorouracil; Home Care Services, Hospital-Based; Hospitals; Humans; Neoplasm Recurrence, Local; Prognosis; Tegafur; Uracil | 2003 |
[Present status of chemotherapy for colorectal cancer in countries outside of Japan].
Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cetuximab; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Evidence-Based Medicine; Fluorouracil; Humans; Irinotecan; Japan; Leucovorin; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Pyridines; Tegafur; United States; Uracil | 2003 |
Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Neoplasm Metastasis; Tegafur; United Kingdom; Uracil | 2003 |
[Chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Tegafur; Uracil | 2003 |
New developments in systemic chemotherapy in advanced colorectal cancer.
Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Uracil | 2003 |
The role of new agents in the treatment of colorectal cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cetuximab; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Life Tables; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Neovascularization, Pathologic; Pneumonectomy; Postoperative Period; Prodrugs; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vascular Endothelial Growth Factor A | 2004 |
Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Neoplasms; Prodrugs; Pyrimidinones; Tegafur; Uracil | 2004 |
The role of uracil-tegafur (UFT) in elderly patients with colorectal cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Humans; Tegafur; Treatment Outcome; Uracil | 2004 |
[Recent progress in chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Disease Progression; Doxorubicin; Drug Interactions; Embolization, Therapeutic; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Interferon-alpha; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Tamoxifen; Tegafur; Uracil | 2004 |
[Advances in palliative and adjuvant chemotherapy of colon cancer].
Topics: Antineoplastic Agents; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Tegafur; Uracil | 2004 |
[Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Floxuridine; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Radiotherapy, Adjuvant; Tegafur; Uracil | 2004 |
[Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Postoperative Period; Quality of Life; Radiotherapy Dosage; Tegafur; Uracil | 2004 |
[Second-line chemotherapy for advanced colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Quality of Life; Survival Rate; Tegafur; Uracil | 2005 |
Commentary on Wang et al., "Pre-operative chemotherapy with oral tegafur-uracil and leucovorin for rectal cancer" (J Surg Oncol 89: 256-263).
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
Adjuvant chemotherapy for non-small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Tegafur; Uracil | 2003 |
Adjuvant chemotherapy for resected non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials as Topic; Humans; Lung Neoplasms; Meta-Analysis as Topic; Platinum Compounds; Tegafur; Uracil | 2005 |
[5 -fluoropyrimidines for treatment of biliary tract cancers].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Oxonic Acid; Pyridines; Pyrimidines; Tegafur; Uracil | 2006 |
Chemotherapy for colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Irinotecan; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Tegafur; Uracil; Vitamin B Complex | 2005 |
[Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Evidence-Based Medicine; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Staging; Pneumonectomy; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2006 |
[Adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Combinations; Evidence-Based Medicine; Fluorouracil; Guidelines as Topic; Humans; Leucovorin; Lymph Node Excision; Neoplasm Staging; Survival Rate; Tegafur; Uracil | 2006 |
The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Cost-Benefit Analysis; Deoxycytidine; Fluorouracil; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; State Medicine; Tegafur; Treatment Outcome; United Kingdom; Uracil | 2006 |
[Adjuvant treatment of colorectal cancer].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Irinotecan; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Tegafur; Uracil | 2006 |
[Pharmacokinetics of S-1].
Topics: Administration, Oral; Adult; Aged; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Humans; Kidney; Male; Middle Aged; Neoplasms; Oxonic Acid; Rats; Tegafur; Uracil | 2006 |
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials, Phase II as Topic; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Oxonic Acid; Tegafur; Uracil | 2006 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Pneumonectomy; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil; Vinblastine; Vinorelbine | 2006 |
[Standard chemotherapy for colonic neoplasms].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Tegafur; Uracil | 2007 |
An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Rectal Neoplasms; Tegafur; Uracil | 2007 |
Chemotherapy of advanced gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Drug Combinations; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Uracil | 2007 |
[Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Europe; Evidence-Based Medicine; Fluorouracil; Humans; Irinotecan; Japan; Leucovorin; Neoplasm Staging; Oxonic Acid; Practice Guidelines as Topic; Rectal Neoplasms; Tegafur; United States; Uracil | 2007 |
On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Humans; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil | 2007 |
UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Postoperative Care; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil | 2007 |
The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell Death; Cell Survival; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil; Vascular Endothelial Growth Factor A | 2007 |
The role of UFT in advanced gastric cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Fluorouracil; Humans; Pyrimidines; Stomach Neoplasms; Tegafur; Uracil | 2008 |
UFT (tegafur-uracil) in rectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Rectal Neoplasms; Tegafur; Uracil | 2008 |
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Tablets, Enteric-Coated; Tegafur; Treatment Outcome; Uracil | 2008 |
The role of UFT in metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Humans; Tegafur; Uracil | 2009 |
The role of meta-analysis in cancer clinical trials.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Humans; Meta-Analysis as Topic; Neoplasms; Rectal Neoplasms; Sample Size; Tegafur; Uracil | 2009 |
Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials as Topic; Humans; Lung Neoplasms; Meta-Analysis as Topic; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Fluorouracil; Humans; Infections; Leucovorin; Leukopenia; Mucositis; Neutropenia; Odds Ratio; Randomized Controlled Trials as Topic; Stomatitis; Survival Analysis; Tegafur; Uracil | 2011 |
UFT and S-1 for treatment of primary lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Drug Resistance, Neoplasm; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Lung Neoplasms; Oxonic Acid; Radiotherapy, Adjuvant; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Combinations; Female; Floxuridine; Fluorouracil; Humans; Japan; Methotrexate; Oxonic Acid; Tegafur; Uracil | 2010 |
Meta-analysis of late course accelerated hyperfractionated radiotherapy combined with FP chemotherapy for esophageal carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bronchitis; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophageal Stenosis; Esophagitis; Humans; Leukopenia; Nausea; Pulmonary Fibrosis; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil | 2010 |
[Two cases of the primary small intestine cancer successfully treated with S-1 and UFT/LV therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Jejunal Neoplasms; Leucovorin; Male; Middle Aged; Oxonic Acid; Tegafur; Uracil | 2010 |
[A case of long-term survival after resection of advanced undifferentiated rectal cancer treated by short-term preoperative chemoradiotherapy and postoperative adjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chemotherapy, Adjuvant; Humans; Leucovorin; Male; Neoplasm Staging; Rectal Neoplasms; Tegafur; Time Factors; Uracil | 2011 |
An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bacterial Infections; Biological Products; China; Cisplatin; Cytarabine; Dexamethasone; Evidence-Based Medicine; Humans; Immunosuppression Therapy; Japan; Neoplasms; Polysaccharides; Randomized Controlled Trials as Topic; Shiitake Mushrooms; Tegafur; United States; Uracil; Virus Diseases | 2011 |
[A case of drug-induced eosinophilic pneumonia due to tegafur-uracil(UFT®)].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lung Neoplasms; Neoplasm Staging; Pulmonary Eosinophilia; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Evidence-Based Medicine; Female; Humans; Postoperative Care; Tegafur; Uracil | 2013 |
Complete remission of primary retroperitoneal transitional cell carcinoma after radiotherapy and oral chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Humans; Remission Induction; Retroperitoneal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2013 |
Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Oxaloacetates; Oxonic Acid; Tegafur; Uracil | 2003 |
[Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Remission Induction; Tegafur; Uracil | 2013 |
[A case of para-aortic lymph node metastasis from colon cancer with complete response to uracil/tegafur plus leucovorin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Colonic Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Male; Remission Induction; Tegafur; Uracil | 2014 |
The development of fulminant type 1 diabetes during chemotherapy for rectal cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diagnosis, Differential; Humans; Hyperglycemia; Leucovorin; Male; Rectal Neoplasms; Tegafur; Uracil | 2015 |
Oral versus intravenous fluoropyrimidines for colorectal cancer.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Floxuridine; Fluorouracil; Humans; Injections, Intravenous; Irinotecan; Male; Neoadjuvant Therapy; Organoplatinum Compounds; Palliative Care; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Tegafur; Uracil | 2017 |
[A Case of Recurrent Rectal Cancer with Adrenal and Lung Metastasis with More than Ten-Year Survival after Surgery].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Recurrence; Tegafur; Uracil | 2017 |
430 trial(s) available for tegafur and uracil
| Article | Year |
|---|---|
[Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cystectomy; Doxorubicin; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Premedication; Tegafur; Uracil; Urinary Bladder Neoplasms | 1992 |
[Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Tegafur; Uracil | 1992 |
Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Doxorubicin; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Tegafur; Uracil; Vinblastine | 1992 |
A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tegafur; Thiotepa; Uracil; Urinary Bladder Neoplasms | 1992 |
[Multicenter cooperative study of pre- and post-operative adjuvant chemotherapy in the treatment of colorectal cancer. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Lymph Nodes; Rectal Neoplasms; Suppositories; Survival Rate; Tegafur; Uracil | 1992 |
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Ovarian Neoplasms; Survival Rate; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1992 |
[A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Doxorubicin; Humans; Neoplasm Recurrence, Local; Tegafur; Uracil; Urinary Bladder Neoplasms | 1992 |
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Picibanil; Prospective Studies; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1992 |
[Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Kidney Neoplasms; Prospective Studies; Survival Rate; Tegafur; Uracil | 1991 |
[Multihospital randomized study on pre- and post-operative adjuvant chemotherapy for colorectal cancer (Part 2)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Postoperative Care; Preoperative Care; Survival Rate; Tegafur; Uracil | 1991 |
[Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Humans; Lymphatic Metastasis; Mitomycin; Mitomycins; Postoperative Care; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1991 |
A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Postoperative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1991 |
[Clinical study of UFT chemotherapy in renal cancer. Kyushu University Cooperative Study Group of Renal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Survival Rate; Tegafur; Uracil | 1990 |
[Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Reoperation; Tegafur; Uracil | 1990 |
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dosage Forms; Drug Administration Schedule; Drug Evaluation; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multicenter Studies as Topic; Tegafur; Uracil | 1990 |
[Prophylactic effect of UFT on the recurrence of bladder cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Tegafur; Uracil; Urinary Bladder Neoplasms | 1990 |
[Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gall
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil | 1990 |
Fundamental study on the implantable LH-RH agonist/polymer and its use in a randomized trial for prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Implants; Drug Screening Assays, Antitumor; Humans; Lactates; Lactic Acid; Male; Polyesters; Polymers; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Receptors, LHRH; Tegafur; Uracil | 1990 |
[Investigation of UFT and radiation combination therapy of head and neck cancer--mainly in laryngeal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Japan; Laryngeal Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Tegafur; Uracil | 1990 |
[Clinical results of UFT enteric-coated granule therapy under cooperative study (phase II study). Tokyo Cancer Chemotherapy Cooperative Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Remission Induction; Tablets, Enteric-Coated; Tegafur; Tokyo; Uracil | 1990 |
[A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Combined Modality Therapy; Female; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil; Urinary Bladder Neoplasms | 1990 |
[Cooperative research of UFT E phase II study. Cooperative Study Group of UFT E in Tohoku Area].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Tablets, Enteric-Coated; Tegafur; Uracil; Vomiting | 1990 |
[Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Terminal Care; Uracil | 1990 |
[Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Picibanil; Remission Induction; Tegafur; Uracil | 1989 |
[Randomized-controlled study of treatment with UFT-MMC or UFT-ACR in advanced gastric cancer. Tohoku Study Group of Cancer Treatment for the Digestive Organs].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Random Allocation; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Gastrectomy; Humans; Japan; Male; Middle Aged; Mitomycins; Multicenter Studies as Topic; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Japan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): 3-year survival after surgery of non-curatively resected patients. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Humans; Japan; Mitomycin; Mitomycins; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[Combination therapy of renal cell carcinoma with interferon-alpha and UFT (or FT-207)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Interferon Type I; Kidney Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic; Tegafur; Uracil | 1989 |
[Efficacy of UFT in advanced gastric carcinoma under comparative study of MMC + UFT and MMC + tegafur therapies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Random Allocation; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[Combined UFTM for 140 patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Clinical trial of UFT in malignancies--an analysis of 337 patients. Co-operative Group for Clinical Study of UFT].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cardia; Child; Clinical Trials as Topic; Colonic Neoplasms; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer (Part 1). Comparison between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Clinical Trials as Topic; Double-Blind Method; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Long-term chemotherapy in patients with stage IV gastric cancer after surgical treatment--a randomized comparative study of FT-207 and UFT].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Prospective Studies; Random Allocation; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Phase II study of UFT in cancer of the uterine cervix].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
Clinical trials on UFT in the treatment of head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Clinical Trials as Topic; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Tegafur; Uracil | 1985 |
[Clinical trial of UFT against disseminated breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Tegafur; Uracil | 1984 |
[UFT/CDDP preoperative chemotherapy for progressive gastric cancer--histological antitumor effects and thymidylate synthase inhibition rate].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Preoperative Care; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1995 |
[Prophylactic combination therapy after TUR of superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bleomycin; Cystectomy; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil; Urinary Bladder Neoplasms | 1993 |
[Clinical study of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Interferons; Kidney Neoplasms; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1993 |
[Endocrine chemotherapy for prostatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Follow-Up Studies; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Japan; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1995 |
[Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1995 |
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1995 |
A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Combinations; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Remission Induction; Survival Analysis; Tegafur; Uracil | 1995 |
[Retrospective analysis of postoperative chemotherapy with UFT against pancreatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Postoperative Care; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tegafur; Uracil | 1995 |
[Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1995 |
A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1995 |
Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Leucovorin; Leukopenia; Middle Aged; Nausea; Rectal Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1994 |
A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1995 |
[Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Kidney Failure, Chronic; Male; Middle Aged; Postoperative Care; Renal Dialysis; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[Pharmacokinetic study in biochemical modulation therapy of UFT with leucovorin tablet].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Tablets; Tegafur; Uracil | 1995 |
[5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluorouracil; Humans; Lymph Nodes; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1995 |
[Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Research group of gastric cancer chemotherapy].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Proportional Hazards Models; Stomach Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting | 1995 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm, Residual; Portal Vein; Tegafur; Uracil | 1994 |
[Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Intravenous; Infusions, Parenteral; Lentinan; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1994 |
[Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Neoplasm Recurrence, Local; Ovariectomy; Postmenopause; Premenopause; Tamoxifen; Tegafur; Uracil | 1994 |
[Antitumor effect of UFT against differentiated thyroid cancer].
Topics: Adenocarcinoma, Follicular; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Drug Administration Schedule; Female; Humans; Middle Aged; Tegafur; Thyroid Neoplasms; Uracil | 1994 |
Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasm Metastasis; Tegafur; Uracil | 1994 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
Chemo-endocrine therapy for prostate cancer with bone metastasis. Nagasaki Prostate Cancer Research Group.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Epirubicin; Ethinyl Estradiol; Fluorouracil; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
[Multiple cooperative study of UFT-adjuvant chemotherapy for malignant tumor in the jaw and oral cavities. The Oral Surgery Malignant Tumor Research Association in Kanto Kohshinetsu District].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Jaw Neoplasms; Male; Middle Aged; Mouth Neoplasms; Tegafur; Uracil | 1994 |
Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Humans; Injections, Intradermal; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Picibanil; Postoperative Care; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1994 |
[A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Tegafur; Uracil | 1994 |
[Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Mitomycin; Quality of Life; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1994 |
[The usefulness of pre- and immediately postoperative chemotherapy in colorectal cancer].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Mitomycin; Postoperative Care; Preoperative Care; Tegafur; Uracil | 1994 |
[A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Middle Aged; Survival Rate; Tegafur; Uracil; Uterine Cervical Neoplasms | 1994 |
[Clinical results of UFT against ovarian carcinoma].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Middle Aged; Ovarian Neoplasms; Stomatitis; Tegafur; Uracil | 1994 |
Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Humans; Menopause; Middle Aged; Nausea; Receptors, Estrogen; Stomatitis; Tegafur; Thrombocytopenia; Uracil | 1994 |
[Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1994 |
[A double-blind comparison of FUra plasma concentration by oral (UFT) vs continuous intravenous infusion (5-FU)].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Fluorouracil; Humans; Infusions, Intravenous; Stomach Neoplasms; Tegafur; Uracil | 1993 |
Phase II trial of UFT activity in pretreated breast cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Bone Neoplasms; Breast Neoplasms; Capsules; Chemotherapy, Adjuvant; Diarrhea; Female; Humans; Middle Aged; Nausea; Remission Induction; Soft Tissue Neoplasms; Tegafur; Uracil; Vomiting | 1993 |
[UFTPM (UFT + CDDP + MMC) therapy for progressive stomach cancer. Research Association of Progressive Stomach Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1993 |
[Cooperative Study of Surgical Adjuvant Chemotherapy for Colorectal Cancer (fourth report): five-year results after surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Follow-Up Studies; Humans; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
Prophylactic oral UFT therapy for superficial bladder cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Mycobacterium bovis; Neoplasm Recurrence, Local; Tegafur; Uracil; Urinary Bladder Neoplasms | 1993 |
Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1993 |
[Evaluation of preoperative chemotherapy for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Proliferating Cell Nuclear Antigen; Survival Rate; Tegafur; Uracil | 1996 |
[Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Tegafur; Uracil | 1996 |
[Low-dose FP (5-FU+low-dose CDDP) therapy for far advanced upper gastro-intestinal carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Prognosis; Tegafur; Uracil | 1995 |
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hyperbilirubinemia; Leucovorin; Male; Middle Aged; Tegafur; Tetrahydrofolates; Uracil | 1996 |
[Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1996 |
Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1996 |
Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study.
Topics: Administration, Oral; Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Survival Rate; Tegafur; Uracil | 1995 |
[A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Picibanil; Prospective Studies; Survival Rate; Tegafur; Uracil; Vindesine | 1996 |
[Neoadjuvant therapy followed by administration of UFT for breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Leucovorin; Male; Neoplasm Staging; Prospective Studies; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1996 |
[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Tegafur; Uracil | 1996 |
[Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
Topics: Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Digestive System Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Home Care Services, Hospital-Based; Humans; Infusion Pumps; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Quality of Life; Tegafur; Uracil | 1995 |
[Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Neoplasms; Home Care Services, Hospital-Based; Humans; Infusion Pumps; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Male; Middle Aged; Quality of Life; Tegafur; Uracil | 1995 |
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1996 |
Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasms; Prodrugs; Tegafur; Uracil | 1996 |
A comparative, randomized trial of UFT and 5-fluorouracil in combination with cyclophosphamide and doxorubicin in the treatment of advanced breast cancer patients at The Philippines General Hospital.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil | 1997 |
Clinical application of biochemical modulation in cancer chemotherapy: biochemical modulation for 5-FU.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Humans; Japan; Tegafur; Uracil | 1997 |
Phase II study of UFT plus leucovorin in colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Neoplasm Metastasis; Survival Analysis; Tegafur; Uracil | 1997 |
UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Tegafur; Uracil | 1997 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1997 |
A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans; Kidney Function Tests; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Tegafur; Uracil | 1996 |
[Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 1997 |
Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dexamethasone; Diuresis; Drug Administration Schedule; Female; Gastrectomy; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil; Vomiting | 1996 |
Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Longitudinal Studies; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Postoperative Care; Prospective Studies; Tegafur; Uracil | 1997 |
Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Proteoglycans; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1997 |
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 1997 |
[Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Rats; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1997 |
[Evaluation of neo-adjuvant chemotherapy for oral squamous cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Peplomycin; Preoperative Care; Prognosis; Tegafur; Uracil; Vomiting | 1997 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Mitomycin; Postoperative Period; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
Scientific basis for the combination of tegafur with uracil.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Intestinal Absorption; Male; Middle Aged; Mitomycin; Postoperative Care; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1997 |
Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 1997 |
Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Leucovorin; Neoplasms; Tegafur; Tetrahydrofolates; Uracil | 1997 |
Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Rectal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
5-FU or UFT combined with leucovorin for previously untreated metastatic colorectal Ca.
Topics: Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Tegafur; Uracil | 1997 |
UFT plus leucovorin vs 5-FU plus leucovorin for metastatic colorectal cancer.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Middle Aged; Tegafur; Uracil | 1997 |
A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
Topics: Aged; Aged, 80 and over; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Leukopenia; Male; Nausea; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1997 |
Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Feasibility Studies; Fluorouracil; Humans; Leucovorin; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Uracil | 1997 |
UFT in combination as adjuvant therapy for breast cancer. Grupo Oncologico de Sevilla Seville, Spain.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Postmenopause; Prednimustine; Premenopause; Spain; Survival Analysis; Tamoxifen; Tegafur; Uracil | 1997 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Combinations; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Humans; Japan; Lung Neoplasms; Multivariate Analysis; Postoperative Care; Prognosis; Survival Rate; Tegafur; Uracil | 1997 |
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Combinations; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Tegafur; Thrombocytopenia; Uracil; Vomiting | 1997 |
UFT plus cisplatin for advanced gastric cancer.
Topics: Adolescent; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Drug Combinations; Humans; Leukopenia; Middle Aged; Mitomycins; Nausea; Pilot Projects; Stomach Neoplasms; Tegafur; Uracil | 1997 |
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
Topics: Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Combinations; Etoposide; Female; Forecasting; Humans; Leucovorin; Male; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Diarrhea; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Drug Combinations; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Quality of Life; Tegafur; Treatment Outcome; Uracil | 1997 |
Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Patient Compliance; Pilot Projects; Tegafur; Uracil | 1997 |
Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral UFT (uracil/tegafur) versus six-cycle CMF (cyclophosphamide/methotrexate/5-fluorouracil) in high-risk node-negative breast cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Tegafur; Uracil | 1998 |
[Phase I study of orally administered UFT plus l-leucovorin].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Nausea; Stomach Neoplasms; Tegafur; Uracil; Vomiting | 1998 |
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 1998 |
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Double-Blind Method; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1998 |
[Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Humans; Middle Aged; Picibanil; Rectal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1998 |
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over Studies; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastritis; Gastrointestinal Hemorrhage; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Nausea; Tegafur; Treatment Outcome; Uracil | 1998 |
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Diethylstilbestrol; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral uracil/tegafur versus 6-cycle cyclophosphamide/methotrexate/5-fluorouracil in high-risk node-negative breast cancer patients.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Risk; Survival Analysis; Tegafur; Uracil | 1998 |
Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Stem Cell Assay; Uracil | 1995 |
Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cohort Studies; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Nausea; Prodrugs; Tegafur; Uracil; Vomiting | 1996 |
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study.
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Male; Nausea; Pancreatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 1998 |
Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Colorectal Neoplasms; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 1999 |
Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Female; Gastrectomy; Humans; Intraoperative Care; Male; Middle Aged; Mitomycin; Postoperative Care; Prospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1999 |
A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Neoplasms; Organoplatinum Compounds; Tegafur; Treatment Outcome; Uracil; Vomiting | 1999 |
Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Postoperative Period; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vindesine | 1999 |
[Primary treatment for stage D2 prostate cancer: a randomized study of combined androgen blockade alone versus combined with UFT].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Flutamide; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 1999 |
Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycins; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1999 |
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Male; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1999 |
Impact of uracil/tegafur plus oral calcium folinate on resource utilization.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Health Resources; Health Services; Health Services Research; Hospitalization; Humans; Leucovorin; Outpatients; Tegafur; Uracil | 1999 |
UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1999 |
Oxaliplatin and UFT/oral calcium folinate for advanced colorectal carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT plus calcium folinate/irinotecan in colorectal cancer.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Therapy, Combination; Humans; Irinotecan; Leucovorin; Tegafur; Topoisomerase I Inhibitors; Treatment Outcome; Uracil | 1999 |
Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonoscopy; Colorectal Neoplasms; Disease-Free Survival; Drug Hypersensitivity; Fluorouracil; Humans; Necrosis; Neoplasm Staging; Preoperative Care; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Feasibility Studies; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Palliative Care; Retrospective Studies; Stomach Neoplasms; Tegafur; Uracil | 1999 |
Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Administration Routes; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil | 1999 |
Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Paclitaxel; Tegafur; Treatment Outcome; Uracil | 1999 |
Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Female; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Paclitaxel; Premedication; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leucovorin; Neoplasm Metastasis; Paclitaxel; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT plus oral calcium folinate/vinorelbine for advanced breast cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil; Vinblastine; Vinorelbine | 1999 |
UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Receptors, Estrogen; Retrospective Studies; Survival Rate; Tamoxifen; Tegafur; Treatment Outcome; Uracil | 1999 |
Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT/calcium folinate plus weekly paclitaxel for solid tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Routes; Female; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Neoplasms; Paclitaxel; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Humans; Tegafur; Treatment Outcome; Uracil; Urinary Bladder Neoplasms | 1999 |
Gemcitabine and UFT plus oral calcium folinate: phase I study.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; DNA, Neoplasm; Drug Administration Routes; Female; Follow-Up Studies; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Neoplasms; Ribonucleotide Reductases; Tegafur; Treatment Outcome; Uracil | 1999 |
Endocrine plus uracil/tegafur therapy for prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT plus calcium folinate plus radiotherapy for recurrent rectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Humans; Leucovorin; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rectal Neoplasms; Safety; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT/oral calcium folinate plus radiation in pancreatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Humans; Leucovorin; Middle Aged; Pancreatic Neoplasms; Radiotherapy, Adjuvant; Safety; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1999 |
Preoperative UFT and calcium folinate and radiotherapy in rectal cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Follow-Up Studies; Humans; Leucovorin; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 1999 |
Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antimetabolites, Antineoplastic; Diarrhea; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Tegafur; Uracil | 1999 |
[Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Quality of Life; Tegafur; Uracil | 1999 |
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Female; Gallbladder Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Time Factors; Treatment Outcome; Uracil | 1999 |
[Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Staging; Prospective Studies; Tegafur; Uracil | 1999 |
[Usefulness of pharmacokinetic modulating chemotherapy (PMC) for the postoperative adjuvant therapy of colorectal carcinoma: a preliminary report].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Random Allocation; Tegafur; Uracil | 1999 |
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2000 |
Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Survival Rate; Tegafur; Uracil | 1999 |
[Interim report on JFMTC Study no. 21 on the effectiveness of UFT as an adjuvant therapy for semi-advanced cancer of the stomach].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Postoperative Period; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Humans; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2000 |
A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diarrhea; Female; Humans; Leucovorin; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Tegafur; Uracil | 2000 |
[Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Prospective Studies; Quality of Life; Survival Rate; Tamoxifen; Tegafur; Uracil | 2000 |
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Prognosis; Severity of Illness Index; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2000 |
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2000 |
Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Patient Compliance; Tegafur; Uracil | 2000 |
Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Postoperative Care; Preoperative Care; Rectal Neoplasms; Surgical Procedures, Operative; Tegafur; Uracil | 2000 |
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pain; Pancreatic Neoplasms; Tegafur; Uracil | 2000 |
UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Tegafur; Treatment Outcome; Uracil | 2000 |
UFT/leucovorin plus irinotecan in advanced or metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Tegafur; Treatment Outcome; Uracil | 2000 |
UFT/leucovorin combined with mitomycin-C in metastatic colorectal Ca.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Tegafur; Uracil | 2000 |
Impact of UFT on tumoral TS and DPD levels in colorectal cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Oxidoreductases; Pilot Projects; Tegafur; Thymidylate Synthase; Uracil | 2000 |
UFT/leucovorin plus weekly irinotecan in advanced or metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2000 |
UFT plus leucovorin for metastatic colorectal cancer: Japanese experience.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2000 |
A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer.
Topics: Administration, Oral; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Leucovorin; Middle Aged; Paclitaxel; Tegafur; Uracil | 2000 |
UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epirubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Middle Aged; Neutropenia; Tegafur; Uracil | 2000 |
UFT/leucovorin plus vinorelbine combination for advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Leucovorin; Middle Aged; Tegafur; Treatment Outcome; Uracil; Vinblastine; Vinorelbine | 2000 |
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2000 |
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Leucovorin; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Uracil | 2000 |
UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fatigue; Female; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasms; Paclitaxel; Tegafur; Uracil | 2000 |
UFT plus carboplatin for head and neck cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Therapy, Combination; Humans; Maxillary Sinus Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2000 |
A phase I study of paclitaxel, UFT, and leucovorin.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasms; Paclitaxel; Tegafur; Uracil | 2000 |
UFT/leucovorin in advanced squamous cell carcinoma of the head and neck administered with radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2000 |
Evaluation of adjuvant UFT for gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Gastrectomy; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2000 |
Irinotecan and UFT/leucovorin in patients with advanced cancers.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasms; Tegafur; Uracil | 2000 |
[Optimal dosage of UFT in a weekday-on/weekend-off schedule as a postoperative adjuvant chemotherapy for colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Compliance; Rectal Neoplasms; Tegafur; Uracil | 2000 |
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Estramustine; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Tegafur; Treatment Outcome; Uracil; Urination | 2001 |
Methotrexate, uracil and tegafur, and leucovorin chemotherapy for patients with breast cancer in progression after high-dose chemotherapy with peripheral blood progenitor cell transplant: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Metastasis; Salvage Therapy; Survival Analysis; Tegafur; Uracil | 2000 |
[Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer--study report of JFMTC Study No. 10].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Humans; Mitomycin; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
Prospective and randomized comparison of combined androgen blockade versus combination with oral UFT as an initial treatment for prostate cancer.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Humans; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Quality of Life; Tegafur; Uracil | 2001 |
Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Colorectal Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Fasting; Female; Fluorouracil; Food; Humans; Leucovorin; Male; Middle Aged; Tegafur; Tetrahydrofolates; Time Factors; Uracil | 2001 |
Dual modulation of UFT with leucovorin and hydroxyurea in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Drug Interactions; Female; Humans; Hydroxyurea; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil | 2001 |
Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Survival Analysis; Tablets, Enteric-Coated; Tegafur; Uracil | 2001 |
Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Administration Schedule; Drug Tolerance; Epirubicin; Female; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil | 2001 |
A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Disease-Free Survival; Fatigue; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Pain; Palliative Care; Tegafur; Treatment Outcome; Uracil | 2001 |
UFT and leucovorin in first-line chemotherapy for patients with metastatic gastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2001 |
Phase I trial of weekly irinotecan combined with UFT as second-line treatment for advanced colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cohort Studies; Colorectal Neoplasms; Diarrhea; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Tegafur; Uracil | 2001 |
Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Severity of Illness Index; Tegafur; Time Factors; Treatment Outcome; Uracil | 2001 |
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Cross-Over Studies; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Surveys and Questionnaires; Tegafur; Uracil | 2002 |
Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Immunotherapy; Interleukin-10; Male; Middle Aged; Polysaccharides, Bacterial; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Male; Middle Aged; Postoperative Period; Prospective Studies; Recurrence; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2002 |
Dihydropyrimidine dehydrogenase-related enzymes predict efficacy and adverse reactions of UFT1+cisplatin neoadjuvant chemotherapy for gastric cancer.
Topics: Amidohydrolases; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dihydrouracil Dehydrogenase (NADP); Gastrectomy; Humans; Oxidoreductases; Predictive Value of Tests; Stomach Neoplasms; Tegafur; Uracil | 2002 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2002 |
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Fever; Gemcitabine; Hematologic Diseases; Humans; Kidney; Liver; Lung Neoplasms; Nausea; Neoplasm Staging; Tegafur; Uracil | 2002 |
Oral fluoropyrimidines in the treatment of advanced colorectal cancer--results of two consecutive phase II trials.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Drug Combinations; Fluorouracil; Humans; Leucovorin; Nausea; Survival Rate; Tegafur; Time Factors; Uracil | 2002 |
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Survival Analysis; Tegafur; Uracil | 2002 |
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.
Topics: Administration, Oral; Antineoplastic Agents; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Neoplasms; Prodrugs; Pyridines; Tegafur; Treatment Outcome; Uracil | 2002 |
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Quality of Life; Survival Rate; Tegafur; United States; Uracil | 2002 |
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Europe; Female; Fluorouracil; Humans; Infusions, Parenteral; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Quality of Life; Survival Rate; Tegafur; Uracil | 2002 |
Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer.
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cisplatin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Outcome Assessment, Health Care; Pharynx; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Tegafur; Time Factors; Uracil | 2002 |
Retrospective study on thymidylate synthase as a predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Retrospective Studies; Tegafur; Thymidylate Synthase; Uracil | 2002 |
Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2002 |
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Deoxycytidine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gemcitabine; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pancreatic Neoplasms; Probability; Statistics, Nonparametric; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2002 |
Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2002 |
Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2001 |
[Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dihydrouracil Dehydrogenase (NADP); Enzyme-Linked Immunosorbent Assay; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Neoplasm Recurrence, Local; Oxidoreductases; Tegafur; Uracil | 2002 |
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Japan; Male; Middle Aged; Mitomycin; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2003 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Postoperative Care; Prognosis; Prospective Studies; Pulmonary Surgical Procedures; Survival Rate; Tegafur; Uracil | 2003 |
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; Biological Availability; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Oxonic Acid; Pyridines; Tegafur; Tissue Distribution; Uracil | 2003 |
Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Middle Aged; Models, Biological; Neoplasm Metastasis; Tegafur; Uracil; Vinblastine; Vinorelbine | 2003 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Japan; Liver Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxidoreductases; Oxonic Acid; Peritoneal Neoplasms; Predictive Value of Tests; Pyridines; Retrospective Studies; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Treatment Outcome; Uracil | 2003 |
A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Risk Assessment; Survival Analysis; Tegafur; Treatment Outcome; United Kingdom; Uracil | 2003 |
Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Chi-Square Distribution; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Compliance; Proportional Hazards Models; Prospective Studies; Proteoglycans; Statistics, Nonparametric; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2003 |
A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Survival Analysis; Tegafur; Thrombocytopenia; Uracil | 2003 |
Pre- and post-operative adjuvant chemotherapy in colorectal cancer.
Topics: Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Recurrence; Tegafur; Time Factors; Uracil | 2003 |
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Gene Expression Regulation, Neoplastic; Humans; Leucovorin; Male; Middle Aged; Orotate Phosphoribosyltransferase; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2003 |
Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Palliative Care; Survival Rate; Tegafur; Uracil | 2003 |
Phase II study of gemcitabine, UFT and leucovorin in patients with advanced pancreatic cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2002 |
Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Pneumonectomy; Postoperative Complications; Tegafur; Uracil | 2003 |
Phase I trial of uracil-ftorafur, leucovorin, and etoposide: an active all-oral regimen for metastatic breast cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Maximum Tolerated Dose; Middle Aged; Tegafur; Uracil | 2003 |
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Diarrhea; Disease Progression; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Tegafur; Treatment Outcome; Uracil | 2004 |
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Female; Gemcitabine; Humans; Leukopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pancreatic Neoplasms; Tegafur; Uracil | 2004 |
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dose-Response Relationship, Drug; Female; Genotype; Hematologic Diseases; Humans; Irinotecan; Leucovorin; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Neoplasms; Polymorphism, Genetic; Tablets; Tegafur; Treatment Outcome; Uracil | 2004 |
Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Survival Analysis; Tegafur; Terminally Ill; Treatment Outcome; Uracil | 2004 |
Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Postoperative Care; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2004 |
A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Compliance; Prodrugs; Proportional Hazards Models; Survival Analysis; Tegafur; Treatment Failure; Uracil | 2004 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
[Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study].
Topics: Adult; Aged; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Laryngectomy; Life Tables; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Prospective Studies; Remission Induction; Risk Factors; Smoking; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vinblastine; Vinorelbine | 2003 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Routes; Drug Combinations; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Skin Neoplasms; Tegafur; Thrombocytopenia; Uracil | 2004 |
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Postoperative Period; Preoperative Care; Rectal Neoplasms; Tegafur; Uracil | 2004 |
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil; Vincristine | 2004 |
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable lo
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Proportional Hazards Models; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vinblastine; Vinorelbine | 2004 |
Uracil/tegafur plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiotherapy; Sex Factors; Tegafur; Time Factors; Treatment Outcome; Uracil | 2004 |
A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil | 2004 |
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Japan; Leucovorin; Male; Middle Aged; Tegafur; United States; Uracil | 2004 |
Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Male; Middle Aged; Preoperative Care; Prospective Studies; Tegafur; Uracil | 2004 |
A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Combined Modality Therapy; Female; Folic Acid; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy; Rectal Neoplasms; Tegafur; Treatment Outcome; Ultrasonography; Uracil | 2004 |
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Stomatitis; Survival Analysis; Tegafur; Uracil; Vomiting | 2004 |
A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)--the 4th study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2005 |
Phase I dose escalation study of oxaliplatin combined with oral tegafur-uracil and leucovorin in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2005 |
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Tegafur; Uracil | 2005 |
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome; Uracil | 2005 |
Phase II trial of cisplatin, tegafur plus uracil and leucovorin as neoadjuvant chemotherapy in patients with squamous cell carcinoma of the oropharynx and hypopharynx.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Hypopharyngeal Neoplasms; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Survival Analysis; Tamoxifen; Tegafur; Treatment Outcome; Uracil | 2005 |
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Radiation-Sensitizing Agents; Tegafur; Uracil | 2005 |
The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Epirubicin; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2005 |
Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experience.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Cross-Over Studies; Female; Fluorouracil; Humans; Injections, Intravenous; Leucovorin; Male; Patient Satisfaction; Prospective Studies; Tegafur; Uracil | 2005 |
Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2005 |
Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Palliative Care; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2005 |
Role of adjuvant chemotherapy in the treatment of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Neoplasm Metastasis; Survival Rate; Tegafur; United States; Uracil | 2005 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronotherapy; Colorectal Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Tegafur; Uracil | 2005 |
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Constipation; Cyclophosphamide; Deoxycytidine; Diarrhea; Dose-Response Relationship, Drug; Female; Fever; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Radiotherapy; Survival Rate; Tegafur; Thrombocytopenia; Treatment Outcome; Uracil | 2005 |
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Quality of Life; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2005 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Female; Hematologic Diseases; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2006 |
High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Diarrhea; Feasibility Studies; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2005 |
Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Infusions, Intravenous; Leucovorin; Male; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Tegafur; Treatment Outcome; Uracil | 2005 |
UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2005 |
[Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Nausea; Rectal Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2005 |
Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Tegafur; Uracil | 2005 |
A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Endpoint Determination; Humans; Middle Aged; Oxonic Acid; Paclitaxel; Pyridines; Pyrimidines; Stomach Neoplasms; Tegafur; Uracil | 2005 |
'A phase II study of oral uracil/ftorafur (UFT) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Female; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Peripheral Nervous System; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2006 |
Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Pain Measurement; Pancreatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 2006 |
Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CD11b Antigen; CD57 Antigens; CD8 Antigens; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Proportional Hazards Models; Proteoglycans; Receptors, IgG; Risk Factors; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2006 |
[Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil | 2006 |
Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Humans; Leucovorin; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Tegafur; Uracil | 2006 |
UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Tegafur; Treatment Outcome; Uracil | 2006 |
Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Tegafur; Uracil | 2006 |
A phase I study of oral uracil-tegafur prior to weekly intravenous gemcitabine in patients with advanced pancreatic cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pancreatic Neoplasms; Prodrugs; Tegafur; Uracil | 2006 |
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Quality of Life; Tegafur; Uracil | 2006 |
Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Topics: Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Leukopenia; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Pelvis; Rectal Neoplasms; Rectum; Survival Rate; Tegafur; Uracil | 2006 |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Paclitaxel; Prospective Studies; Safety; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2006 |
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Gallbladder Neoplasms; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nausea; Survival Rate; Tegafur; Uracil | 2006 |
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Endpoint Determination; Female; Humans; Lymph Node Excision; Male; Neoplasm Staging; Oxonic Acid; Proportional Hazards Models; Prospective Studies; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2006 |
Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Ploidies; Risk Factors; Sex Factors; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2006 |
A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: preliminary results.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Prospective Studies; Tegafur; Uracil; Uterine Cervical Neoplasms | 2007 |
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Tegafur; Uracil | 2006 |
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set
Topics: Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Survival Rate; Tamoxifen; Tegafur; Uracil; Vomiting, Anticipatory | 2006 |
Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Survival Analysis; Tegafur; Uracil | 2007 |
Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Dihydrouracil Dehydrogenase (NADP); Drug Synergism; Female; Humans; Middle Aged; Neoadjuvant Therapy; Tegafur; Thymidylate Synthase; Uracil | 2007 |
Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2007 |
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Tegafur; Uracil | 2007 |
Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Health Status; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Quality of Life; Tegafur; Uracil | 2007 |
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fever; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Survival Rate; Tegafur; Time Factors; Uracil; Vinblastine; Vinorelbine | 2007 |
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Leucovorin; Male; Middle Aged; Neoplasms; Tegafur; Uracil | 2007 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
Development of a pharmacokinetic model to optimize the dosage regimen of TS-1, a combination preparation of tegafur, gimeracil and oteracil potassium.
Topics: Administration, Oral; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Computer Simulation; Drug Combinations; Fluorouracil; Humans; Kidney; Kinetics; Models, Biological; Oxonic Acid; Pyridines; Renal Insufficiency; Tegafur; Time Factors; Uracil | 2007 |
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil | 2007 |
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronotherapy; Colorectal Neoplasms; Cross-Over Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Therapeutic Equivalency; Uracil | 2008 |
Phase I/II study of CPT-11 plus UFT in patients with advanced/recurrent colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Protocol 0102.
Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Humans; Infusions, Intravenous; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 2007 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Rate; Taxoids; Tegafur; Uracil | 2008 |
Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Tegafur; Treatment Outcome; Uracil | 2007 |
Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiotherapy Dosage; Rectal Neoplasms; Survival Analysis; Tegafur; Uracil; Vitamin B Complex | 2008 |
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Combinations; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Radiotherapy Dosage; Tegafur; Uracil | 2008 |
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Invasiveness; Proportional Hazards Models; Tegafur; Uracil; Vinblastine; Vinorelbine | 2008 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Portal Vein; Prospective Studies; Severity of Illness Index; Tablets, Enteric-Coated; Tegafur; Time Factors; Treatment Outcome; Uracil; Venous Thrombosis | 2007 |
Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Tegafur; Treatment Outcome; Uracil | 2007 |
A clinical pharmacokinetic analysis of tegafur-uracil (UFT) plus leucovorin given in a new twice-daily oral administration schedule.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Cross-Over Studies; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Prodrugs; Sex Factors; Tegafur; Therapeutic Equivalency; Uracil | 2007 |
Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Tegafur; Uracil | 2007 |
An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Survival Rate; Tegafur; Uracil | 2007 |
Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Humans; Leucovorin; Maximum Tolerated Dose; Middle Aged; Models, Theoretical; Neoplasm Metastasis; Paclitaxel; Tegafur; Uracil | 2007 |
Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Tegafur; Uracil | 2008 |
Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Neoplasm Metastasis; Tegafur; Uracil | 2007 |
A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiovascular Diseases; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Endosonography; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pyrazoles; Rectal Neoplasms; Sulfonamides; Tegafur; Treatment Outcome; Uracil | 2008 |
A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2008 |
Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2008 |
Phase I/II study of 24-hour infusion of irinotecan combined with oral UFT for metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2008 |
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Head and Neck Neoplasms; Hematologic Diseases; Humans; Leucovorin; Male; Middle Aged; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2008 |
Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Drug Combinations; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2008 |
[Phase I/II study of combination chemotherapy with gemcitabine and UFT for advanced pancreatic cancer in a multi-center trial].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Survival Rate; Tegafur; Uracil | 2008 |
Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Middle Aged; Necrosis; Proportional Hazards Models; Tegafur; Treatment Outcome; Uracil | 2008 |
Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Female; Humans; Irinotecan; Japan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Tegafur; Uracil | 2009 |
Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Necrosis; Neoplasm Staging; Postoperative Care; Preoperative Care; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2008 |
Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Intravenous; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2008 |
A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Treatment Outcome; Uracil; Young Adult | 2009 |
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2008 |
Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Middle Aged; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2008 |
Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cost-Benefit Analysis; Digestive System Surgical Procedures; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Quality-Adjusted Life Years; Rectal Neoplasms; Tegafur; Uracil | 2008 |
A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Pancreatic Ductal; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Survival Rate; Tegafur; Uracil | 2008 |
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2009 |
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Quality of Life; Risk Factors; Tegafur; Uracil | 2009 |
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Tegafur; Uracil | 2009 |
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biliary Tract Neoplasms; Cholangiocarcinoma; Common Bile Duct Neoplasms; Disease-Free Survival; Doxorubicin; Female; Gallbladder Neoplasms; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
A feasibility study of UFT/LV and irinotecan (TEGAFIRI) in advanced or metastatic colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) PROG 0304.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Combinations; Feasibility Studies; Female; Humans; Immunoenzyme Techniques; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Prognosis; Survival Rate; Tegafur; Uracil | 2009 |
Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Tamoxifen; Tegafur; Uracil | 2009 |
[Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Nitriles; Patient Compliance; Postmenopause; Tamoxifen; Tegafur; Triazoles; Uracil | 2009 |
Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N.SAS-BC 01 trial and CUBC trial).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Staging; Receptors, Estrogen; Tegafur; Uracil; Young Adult | 2010 |
Effects of a low-fat meal on the oral bioavailability of UFT and leucovorin in patients with colorectal cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Colorectal Neoplasms; Diet, Fat-Restricted; Female; Humans; Leucovorin; Male; Middle Aged; Prodrugs; Tegafur; Uracil | 2009 |
[Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2009 |
A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Recurrence; Retreatment; Tegafur; Uracil | 2010 |
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Recurrence; Tegafur; Uracil | 2010 |
PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD57 Antigens; Chemotherapy, Adjuvant; Chi-Square Distribution; Drug Combinations; Female; Fungal Proteins; Gastrectomy; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Polysaccharides; Stomach Neoplasms; T-Lymphocyte Subsets; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Diarrhea; Disease-Free Survival; Drug Eruptions; Fatigue; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Tegafur; Uracil | 2010 |
Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2011 |
Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival; Tegafur; Treatment Outcome; Uracil | 2010 |
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids; Tegafur; Uracil | 2010 |
Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Medication Adherence; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Pyrazoles; Sulfonamides; Tegafur; Uracil | 2011 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cohort Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Peritoneal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Biomarkers; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Pyridines; Sorafenib; Tegafur; Uracil; Young Adult | 2011 |
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Middle Aged; Preoperative Period; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Uracil; Young Adult | 2011 |
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Salvage Therapy; Taiwan; Tegafur; Treatment Failure; Uracil | 2011 |
Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Paclitaxel; Tegafur; Treatment Outcome; Uracil | 2011 |
Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Salvage Therapy; Taxoids; Tegafur; Uracil; Vinblastine; Vinorelbine | 2011 |
[Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Survival Rate; Tegafur; Uracil | 2011 |
Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Double-Blind Method; Eating; Female; Fluorouracil; Head and Neck Neoplasms; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Mitomycin; Mouthwashes; Phenylbutyrates; Pilot Projects; Radiation Injuries; Radiotherapy Dosage; Stomatitis; Taiwan; Tegafur; Uracil; Weight Loss | 2012 |
A phase I study of UFT-oral vinorelbine in metastatic breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Leucovorin; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil; Vinblastine; Vinorelbine | 2011 |
Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Neoplasm Staging; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2012 |
[Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil; Vaccines, Subunit | 2011 |
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gamma Rays; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Radiotherapy Dosage; Rectal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2012 |
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Oxonic Acid; Tegafur; Uracil | 2012 |
Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Chemoradiotherapy; Dose-Response Relationship, Radiation; Female; Humans; Logistic Models; Male; Middle Aged; Models, Biological; Neoplasm Staging; Patient Selection; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Tegafur; Tumor Burden; Uracil; Watchful Waiting | 2013 |
Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Protocols; Colonic Neoplasms; Humans; Neoplasm Staging; Tegafur; Uracil | 2012 |
A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Tegafur; Uracil | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Colorectal Neoplasms; Drug Combinations; Drug Monitoring; Female; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Salvage Therapy; Survival Analysis; Tegafur; Tumor Burden; Uracil | 2012 |
Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Immunotherapy, Active; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; T-Lymphocytes, Cytotoxic; Tegafur; Treatment Outcome; Uracil; Vaccines, Subunit | 2013 |
Phase II study of triplet chemotherapy using Tegafur-Uracil, Vinorelbine, Gemcitabine for advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Tegafur; Uracil; Vinblastine; Vinorelbine | 2013 |
Substitution of anti-androgens and tegafur-uracil combination therapy for castration-resistant prostate cancer: results of a multi-center randomized phase II study.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Orotate Phosphoribosyltransferase; Prostatic Neoplasms, Castration-Resistant; RNA, Messenger; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Uracil | 2013 |
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cetuximab; Colorectal Neoplasms; Disease-Free Survival; DNA Mutational Analysis; Drug Resistance, Neoplasm; Female; GTP Phosphohydrolases; Humans; Kaplan-Meier Estimate; Male; Membrane Proteins; Mutation; Nuclear Proteins; Organoplatinum Compounds; Oxaliplatin; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tegafur; Transcription Factors; Tumor Suppressor Protein p53; Uracil | 2014 |
Reduction in γ-glutamyl hydrolase expression is associated with response to uracil and tegafur/leucovorin chemotherapy in patients with colorectal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Folic Acid; gamma-Glutamyl Hydrolase; Gene Expression Regulation, Neoplastic; Humans; Leucovorin; Male; Middle Aged; Tegafur; Treatment Outcome; Uracil | 2013 |
5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Prevalence; Proteoglycans; Republic of Korea; Risk Factors; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2013 |
[Subset analysis of preoperative lymphocyte ratio in stage II or III colorectal cancer patients treated with oral tegafur-uracil and protein-bound polysaccharide K].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Humans; Lymphocyte Count; Neoplasm Staging; Polysaccharides; Prognosis; Tegafur; Uracil | 2013 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradiotherapy, Adjuvant; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Immunohistochemistry; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Prognosis; Pyrazoles; Rectal Neoplasms; Rectum; Sulfonamides; Tegafur; Uracil | 2014 |
[Treatment outcome of peptide vaccination for advanced colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Treatment Outcome; Uracil; Vaccines, Subunit | 2013 |
Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Male; Tegafur; Uracil | 2015 |
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Hepatectomy; Humans; Japan; Kaplan-Meier Estimate; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Time Factors; Treatment Outcome; Uracil | 2014 |
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Risk Factors; Tegafur; Uracil | 2014 |
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Tegafur; Uracil; Young Adult | 2014 |
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Republic of Korea; Salvage Therapy; Tegafur; Treatment Outcome; Uracil | 2014 |
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Combinations; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2014 |
Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final r
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Japan; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil; Young Adult | 2014 |
Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy, Adjuvant; Denmark; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy, Conformal; Rectal Neoplasms; Tegafur; Uracil | 2014 |
Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Middle Aged; Premenopause; Prospective Studies; Tamoxifen; Tegafur; Treatment Outcome; Uracil | 2014 |
[Clinical trial of a seven-peptide vaccine and tegafur-uracil/leucovorin as combination therapy for advanced colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil; Vaccines, Subunit | 2014 |
High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil; Uterine Cervical Neoplasms | 2015 |
Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Japan; Kaplan-Meier Estimate; Leucovorin; Male; Neutropenia; Tegafur; Treatment Outcome; Uracil | 2015 |
Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201).
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans; Leucovorin; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Risk Factors; Selection Bias; Tegafur; Uracil | 2015 |
Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Young Adult | 2016 |
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Time Factors; Uracil | 2015 |
Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLU
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Tegafur; Treatment Outcome; Uracil | 2016 |
miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Carcinoma, Pancreatic Ductal; Cetuximab; Chemoradiotherapy; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2016 |
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Rectal Neoplasms; Tegafur; Uracil | 2016 |
Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; DNA Mismatch Repair; Female; Genes, ras; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Neoplasm Staging; Prognosis; Tegafur; Treatment Outcome; Uracil | 2016 |
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/II Clinical Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; Tegafur; Uracil | 2016 |
Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tegafur; Treatment Outcome; Uracil | 2016 |
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant Chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Invasiveness; Prospective Studies; Tegafur; Uracil | 2016 |
Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Tegafur; Uracil; Young Adult | 2017 |
Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2017 |
Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Proteoglycans; Tegafur; Treatment Outcome; Uracil; Young Adult | 2018 |
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Tegafur; Treatment Outcome; Uracil | 2018 |
Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Proteoglycans; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2018 |
Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Oxaliplatin; Oxonic Acid; Tegafur; Uracil | 2018 |
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).
Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Follow-Up Studies; Humans; Japan; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Postmenopause; Prognosis; Tegafur; Uracil | 2018 |
A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Disease Progression; Disease-Free Survival; Female; Humans; Japan; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Tegafur; Time Factors; Treatment Outcome; Uracil | 2018 |
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Squamous Cell Carcinoma of Head and Neck; Tegafur; Treatment Outcome; Uracil | 2018 |
Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonoscopy; Disease-Free Survival; Drug Combinations; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uracil; Young Adult | 2019 |
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
Topics: Aged; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Tegafur; Treatment Outcome; Uracil | 2019 |
Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Tegafur; Treatment Outcome; Uracil | 2019 |
A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Gastrointestinal Diseases; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Vessels; Male; Middle Aged; Neoplasm Invasiveness; Neutropenia; Patient Compliance; Pneumonectomy; Prodrugs; Prospective Studies; Tegafur; Uracil | 2020 |
Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).
Topics: Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Tegafur; Uracil | 2021 |
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Japan; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Propensity Score; Prospective Studies; Risk Factors; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2022 |
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 2023 |
A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Feasibility Studies; Female; Humans; Leucovorin; Male; Prospective Studies; Tegafur; Uracil | 2023 |
961 other study(ies) available for tegafur and uracil
| Article | Year |
|---|---|
N-substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant.
Topics: Animals; Dose-Response Relationship, Drug; Hypnotics and Sedatives; Male; Mice; Phenobarbital; Sleep; Structure-Activity Relationship; Uridine | 1987 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the actions of 5-fluorouracil and ftorafur in Escherichia coli.
Topics: Drug Resistance, Microbial; Escherichia coli; Fluorouracil; Tegafur; Time Factors; Uracil | 1977 |
Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
Topics: Administration, Oral; Animals; Cytosine; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Sarcoma 180; Tegafur; Tissue Distribution; Uracil | 1979 |
[A effective combination preoperative intraarterial infusion chemotherapy and irradiation for advanced sigmoid colon cancer with bladder invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Humans; Infusions, Intra-Arterial; Iodized Oil; Male; Middle Aged; Neoplasm Invasiveness; Preoperative Care; Sigmoid Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1992 |
[A case of verrucous carcinoma of the tongue, effectively treated with preoperative chemotherapy (UFT, CDDP, PEP) and irradiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Papillary; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Humans; Male; Peplomycin; Preoperative Care; Radiotherapy Dosage; Tegafur; Tongue Neoplasms; Uracil | 1992 |
[Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Gastrectomy; Gastroscopy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Lymph Nodes; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
Topics: Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fluorouracil; Gastrectomy; Humans; Postoperative Period; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Compliance; Fluorouracil; Gastrectomy; Humans; Postoperative Period; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma; Drug Administration Schedule; Female; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Tegafur; Uracil | 1992 |
Can cytokines prolong survival in ampullary neuroendocrine carcinomas?
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Common Bile Duct Neoplasms; Female; Humans; Interferon-alpha; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Tegafur; Tumor Necrosis Factor-alpha; Uracil | 1992 |
[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Nephrectomy; Tegafur; Uracil | 1992 |
[Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Humans; Liver Neoplasms; Mice; Mice, Nude; Pancreatic Neoplasms; Proglumide; Tegafur; Tumor Cells, Cultured; Uracil | 1992 |
[Electron microscopic study on the method of evaluation of SRC assay].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Evaluation Studies as Topic; Humans; Mice; Mice, Nude; Microscopy, Electron; Subrenal Capsule Assay; Tegafur; Uracil | 1992 |
[Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Fluorouracil; Head and Neck Neoplasms; Immunohistochemistry; Male; Mice; Mice, Inbred C3H; Subrenal Capsule Assay; Tegafur; Uracil | 1992 |
[Effect of combined use of CR 1505 with UFT on tumor growth of transplanted pancreatic cancer in the Syrian golden hamster: preliminary report].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Cricetinae; Drug Synergism; Mesocricetus; Neoplasm Transplantation; Pancreatic Neoplasms; Proglumide; Tegafur; Uracil | 1992 |
[Combination therapy with 5-FU, etoposide and CDDP (FEP regimen) in advanced primary and recurrent gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of complete remission of lymph nodes metastasis from esophageal cancer with combination treatment of UFT and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Lymphatic Metastasis; Mediastinum; Radiotherapy Dosage; Remission Induction; Tegafur; Uracil | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neoplasms; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Effect of UFT on experimental spinal metastasis in the mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; FANFT; Female; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Spinal Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Thymidylate Synthase; Tissue Distribution; Uracil; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1991 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Hepatic Artery; Humans; Iodized Oil; Liver Neoplasms; Lung Neoplasms; Mitomycin; Picibanil; Prognosis; Remission Induction; Rupture, Spontaneous; Tegafur; Uracil | 1991 |
[A case report of multiple bone metastases of breast carcinoma effectively treated with mild chemo-endocrine therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Humans; Middle Aged; Radiography; Radionuclide Imaging; Remission Induction; Tamoxifen; Tegafur; Uracil | 1992 |
[Inhibitory effect of UFT on rat hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene and phenobarbital promotion].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Phenobarbital; Rats; Rats, Inbred Strains; Tegafur; Uracil | 1991 |
[A case of colon cancer with severe anal bleeding caused in a preoperative chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Adult; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Colon; Colonic Neoplasms; Gastrointestinal Hemorrhage; Humans; Male; Necrosis; Tegafur; Uracil | 1991 |
Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney; Kidney Neoplasms; Tegafur; Uracil | 1991 |
The carcinostatic effects of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil (UFT) on tongue carcinoma induced by 4-nitroquinoline 1-oxide (4NQO) in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Combined Chemotherapy Protocols; Male; Rats; Rats, Inbred Strains; Tegafur; Tongue Diseases; Uracil | 1991 |
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Iron; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies; Tegafur; Uracil | 1991 |
[Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Floxuridine; Fluorodeoxyuridylate; Liver Neoplasms; Mice; Mice, Inbred BALB C; Tegafur; Uracil | 1991 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluorouracil; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
[Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Humans; Lung Neoplasms; Middle Aged; Remission Induction; Tegafur; Uracil; Urinary Bladder Neoplasms | 1991 |
[Combination chemotherapy with orally administered UFT and leucovorin (LV)].
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Leucovorin; Male; Mice; Neoplasms, Experimental; Tegafur; Tumor Cells, Cultured; Uracil | 1991 |
[Experience of oral hormone-chemotherapy in prostatic cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1991 |
[Regional immunochemotherapy for liver metastasis of esophageal cancer in a patient with variant hepatic artery].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Injections, Intramuscular; Liver Neoplasms; Male; Middle Aged; Picibanil; Tegafur; Uracil | 1991 |
[Effect of UFT by oral administration using a murine hepatic metastasis model].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Interleukin-1; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Tegafur; Uracil | 1991 |
[Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Survival Rate; Tegafur; Uracil; Vinblastine | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Gastrectomy; Humans; Hyperthermia, Induced; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[A case of inoperable advanced gastric cancer with effective treatment by local administration of OK-432, intra-abdominal administration of CDDP, and long-term high-dose mitomycin C, and UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Infusions, Parenteral; Injections, Intralesional; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Male; Prostatectomy; Prostatic Neoplasms; Tegafur; Uracil | 1991 |
[Study of pre-operative chemotherapeutic methods for colonic cancer--the concentration in blood and tissues after pre-operative administration of UFT].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Preoperative Care; Tegafur; Uracil | 1991 |
[Effect of UFT with high dose leucovorin for transplantable bladder tumor (MBT-2) in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Drug Synergism; Leucovorin; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Urinary Bladder Neoplasms | 1991 |
Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycins; Tegafur; Uracil | 1991 |
[The usefulness of UFT administration in colorectal cancer with emphasis on postoperative administration (Part 3)].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplastic Cells, Circulating; Postoperative Period; Survival Rate; Tegafur; Uracil | 1991 |
[Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies].
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Mitomycin; Mouthwashes; Stomatitis; Tegafur; Uracil | 1991 |
[Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colon; Colorectal Neoplasms; Gas Chromatography-Mass Spectrometry; Humans; Tegafur; Thymidylate Synthase; Tumor Cells, Cultured; Uracil | 1991 |
[A case of local recurrence of rectal cancer successfully treated by UFT combined with two-route CDDP chemotherapy under the AT-II induced hypertension].
Topics: Adenocarcinoma; Administration, Oral; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Cisplatin; Drug Synergism; Female; Humans; Infusion Pumps; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 1991 |
[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 1990 |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Preoperative Care; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Colorectal Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1990 |
[Treatment with UFT as surgical adjuvant chemotherapy in carcinoma of large intestine. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Humans; Postoperative Care; Rectal Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Uracil | 1990 |
[Various questions concerning the treatment of renal cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Kidney Neoplasms; Tegafur; Uracil | 1990 |
[Experimental studies on the combined effect of radiation and UFT: 2. fractionated treatments combining UFT and X ray radiation].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Tegafur; Uracil | 1990 |
[A comparative study of UFT enteric-coated granules with UFT capsules on the occurrence of side effects in patients with head and neck cancers--a special attention to the upper gastrointestinal tract disorders].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capsules; Diarrhea; Head and Neck Neoplasms; Humans; Middle Aged; Nausea; Tegafur; Uracil; Vomiting | 1990 |
[Usage of urine FT levels for medication compliance in head and neck cancer with administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Tegafur; Uracil | 1990 |
[Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Infusions, Intravenous; Lorazepam; Metoclopramide; Nausea; Stomach Neoplasms; Tegafur; Uracil; Vomiting | 1990 |
[Analysis of the mechanism of increased antitumor activity of UFT after combined treatment with CDDP].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Mice; Tegafur; Tumor Cells, Cultured; Uracil | 1990 |
[Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Colonic Neoplasms; Drug Synergism; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil | 1990 |
[Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1990 |
[Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cyclophosphamide; Female; Genital Neoplasms, Female; Humans; Mice; Neoplasm Recurrence, Local; Neoplasm Transplantation; Predictive Value of Tests; Subrenal Capsule Assay; Tegafur; Uracil | 1990 |
Thymidylate synthase inhibition as a predictor of tumor sensitivity of fluorinated pyrimidines.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mice; Middle Aged; Subrenal Capsule Assay; Tegafur; Thymidylate Synthase; Uracil; Uterine Cervical Neoplasms | 1990 |
Acute phenytoin intoxication associated with the antineoplastic agent UFT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Drug Interactions; Female; Glioma; Humans; Male; Middle Aged; Phenytoin; Tegafur; Uracil | 1990 |
[Macrocytic anemia as a possible adverse effect of fluoropyrimidines].
Topics: Anemia, Macrocytic; Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Female; Fluorouracil; Folic Acid; Humans; Male; Retrospective Studies; Stomach Neoplasms; Tegafur; Uracil; Vitamin B 12 | 1990 |
[Evaluation of subselective intraarterial infusion chemotherapy in advanced gastric cancer and recurrence case-evaluated on factors other than direct effects].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Care; Tegafur; Uracil | 1990 |
Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Random Allocation; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1990 |
[Effects of combination chemotherapy with topical application of 5-FU ointment to mice's tongue and UFT].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Liver; Male; Mice; Ointments; Tegafur; Tongue; Uracil | 1990 |
[Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Doxorubicin; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1990 |
[Effects of hyperthermochemotherapy on activities of DNA-synthesizing enzymes in 1, 2-dimethylhydrazine (DMH)-induced colon carcinomas in rats].
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Dimethylhydrazines; Hyperthermia, Induced; Isoenzymes; Rats; Rats, Inbred Strains; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1990 |
[Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Interferon Type I; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil | 1990 |
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[UFT-MT therapy in advanced or recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Remission Induction; Tamoxifen; Tegafur; Uracil | 1990 |
[Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Floxuridine; Fluorouracil; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Plasmacytoma; Tegafur; Uracil | 1990 |
[Study of tissue drug concentration of fluorinated pyrimidine anticancer drugs--comparison of 5'DFUR and UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colon; Colonic Neoplasms; Drug Administration Schedule; Floxuridine; Humans; Lymph Nodes; Tegafur; Uracil | 1990 |
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cholestasis, Extrahepatic; Common Bile Duct Neoplasms; Etoposide; Female; Floxuridine; Humans; Male; Middle Aged; Picibanil; Remission Induction; Tegafur; Uracil | 1990 |
[Therapy on pulmonary metastasis of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Humans; Immunologic Factors; Interferon Type I; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Tegafur; Uracil | 1990 |
The effect of UFTM therapy on primary and metastatic colon cancer from the same human xenotransplanted into nude mice.
Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1990 |
[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Evaluation; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Tegafur; Uracil | 1990 |
[A case of brain metastasis from breast cancer responding to chemoendocrine therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Female; Humans; Mastectomy, Radical; Remission Induction; Tamoxifen; Tegafur; Uracil | 1990 |
[Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Female; Fluorouracil; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Survival Rate; Tegafur; Uracil | 1990 |
[A case of unresectable pancreatic cancer that responded to UFT chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Male; Pancreatic Neoplasms; Remission Induction; Tegafur; Uracil | 1990 |
[A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment].
Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone; Middle Aged; Neoplasm Recurrence, Local; Ointments; Remission Induction; Tegafur; Uracil | 1990 |
Phase II trial of UFT in advanced colorectal and gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Remission Induction; Tegafur; Uracil | 1990 |
[Transformation of ovarian yolk sac tumor to immature teratoma following chemotherapy].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Fluorouracil; Humans; Mesonephroma; Mitomycin; Mitomycins; Ovarian Neoplasms; Tegafur; Teratoma; Uracil | 1985 |
[Alpha-fetoprotein producing gastric cancer responding to combined chemotherapy with UFT and adriamycin].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Combined chemotherapy and radiotherapy in recurrent tumors of the head and neck region].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tegafur; Uracil | 1987 |
[The effect of a mixture of tegafur with uracil (UFT) on hepatocarcinogenesis in rats induced by 3'-methyl-4-dimethylaminoazobenzene. I. The influence on production of alpha-fetoprotein].
Topics: alpha-Fetoproteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Rats; Rats, Inbred Strains; Tegafur; Uracil | 1988 |
[Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Necrosis; Ovarian Neoplasms; Ovariectomy; Ovary; Postoperative Period; Tegafur; Uracil | 1988 |
[Lung metastases of prostatic cancer vanished by early combined hormonal and chemotherapy: report of a case].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Estramustine; Humans; Lung Neoplasms; Male; Methotrexate; Orchiectomy; Prostatic Neoplasms; Proteoglycans; Tegafur; Uracil | 1989 |
[Long-term administration of tegafur in postoperative adjuvant chemotherapy in gastric cancer patients. Serial analysis of serum tegafur and 5-fluorouracil concentrations, and influence from PSK combination].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Proteoglycans; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 1989 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Combined Modality Therapy; DNA Polymerase II; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Uterine Cervical Neoplasms | 1989 |
[UFT/CDDP treatment in advanced gastric cancer--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Lymphatic Metastasis; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 1989 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 1989 |
5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Male; Mice; Mice, Inbred C3H; Stomach Neoplasms; Subrenal Capsule Assay; Tegafur; Thymidylate Synthase; Uracil | 1989 |
[An autopsy study of immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma in a patient previously treated with chemotherapy in colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Humans; Immunoblastic Lymphadenopathy; Lymphoma; Male; Mitomycin; Mitomycins; Neoplasms, Multiple Primary; T-Lymphocytes; Tegafur; Uracil | 1989 |
[The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; Tegafur; Tissue Distribution; Uracil; Uterine Cervical Neoplasms | 1989 |
[Experimental study on combination chemotherapy of UFT and calcium antagonist in gastric cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Flow Cytometry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil; Verapamil; Weight Loss | 1989 |
[A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
Topics: Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Middle Aged; Radiography; Remission Induction; Tamoxifen; Tegafur; Uracil | 1989 |
[Clinical treatment of vulvar cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Humans; Organoplatinum Compounds; Tegafur; Uracil; Vulvar Neoplasms | 1989 |
[Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Biotransformation; Colonic Neoplasms; Fluorouracil; Humans; Lymphatic Metastasis; Picibanil; Stomach Neoplasms; Tegafur; Tissue Distribution; Uracil | 1989 |
[A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Catheters, Indwelling; Cholestasis; Cisplatin; Combined Modality Therapy; Doxorubicin; Drainage; Humans; Injections; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Depression, Chemical; Humans; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1989 |
Micro scale. Rapid and simple determination of tegafur (FT) by high pressure liquid chromatography in plasma.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Male; Mice; Mice, Inbred Strains; Tegafur; Uracil | 1989 |
[Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Humans; Menopause; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Tegafur; Uracil; Vincristine | 1989 |
[Timing of UFT administration combined with surgical operation in pulmonary metastasis of rat mammary carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Rats; Rats, Inbred SHR; Tegafur; Time Factors; Uracil | 1989 |
Pharmacokinetic modulation of plasma 5-fluorouracil concentrations to potentiate the antitumor activity of continuous venous infusion of 5-fluorouracil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Circadian Rhythm; Drug Synergism; Fluorouracil; Infusions, Intravenous; Kinetics; Leukocyte Count; Pyridines; Rats; Sarcoma, Yoshida; Tegafur; Uracil | 1989 |
[Anti-tumor effect of fluoropyrimidines on human tumor cell lines transplanted in nude mice with CCl4-induced liver dysfunction].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Tetrachloride; Cell Line; Colonic Neoplasms; Fluorouracil; Humans; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Transplantation, Heterologous; Uracil | 1989 |
[Changes in lymphocyte subsets with post-operative chemotherapy in breast carcinoma--a study of using two color analysis].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Humans; Hypersensitivity, Delayed; Lymphocytes; T-Lymphocytes; Tegafur; Tuberculin Test; Uracil | 1989 |
[Effect of uracil on the both reactions, 5-fluorouracil degradation into 2-fluoro-beta-alanine and 5-fluorouracil splitting from tegafur in human tumor].
Topics: Adenocarcinoma, Papillary; Alanine; beta-Alanine; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 1989 |
[COPU regimen in the treatment of 35 esophageal cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Tegafur; Uracil; Vincristine | 1989 |
Efficacy of UFT for the treatment of renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Prognosis; Tegafur; Uracil | 1989 |
[Combination chemotherapy with UFT, etoposide, CDDP, adriamycin (FEPA) in advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1989 |
[Experimental studies on the combined effect of radiation and UFT 1. Radiosensitizing effect of UFT under single X-ray exposure].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation Studies as Topic; Female; Lung Neoplasms; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tegafur; Uracil | 1989 |
[An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Female; Gastrectomy; Humans; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[A case of sigmoid carcinoma successfully treated with endoscopic topical infusion of OK-432 and UFT oral treatment].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Injections, Intralesional; Male; Picibanil; Remission Induction; Sigmoid Neoplasms; Sigmoidoscopy; Tegafur; Uracil | 1989 |
Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Topics: Animals; Calmodulin; Carcinoma; Drug Combinations; Drug Synergism; Female; Fluorouracil; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Sulfonamides; Tegafur; Time Factors; Uracil | 1989 |
[Combination effect of UFT and gamma-irradiation against nude mice transplanted KB cells].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gamma Rays; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Tegafur; Uracil | 1989 |
[Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile; Biliary Tract Neoplasms; Cholestasis; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Uracil | 1989 |
Synergistic antitumor activity of cisplatin and UFT in nude mice bearing transplantable nasopharyngeal hybridoma.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Synergism; Injections, Intraperitoneal; Mice; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Organoplatinum Compounds; Tegafur; Uracil | 1989 |
[Effect of UFT on nuclear DNA distribution of gastric and colorectal carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; DNA, Neoplasm; Humans; Stomach Neoplasms; Tegafur; Uracil | 1989 |
[The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Floxuridine; Fluorouracil; Humans; Lymph Nodes; Preoperative Care; Tegafur; Tissue Distribution; Uracil | 1989 |
[Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Mice; Mice, Nude; Specific Pathogen-Free Organisms; Tegafur; Thymidylate Synthase; Uracil; Uterine Neoplasms | 1989 |
[A case of cholangiocarcinoma with marked reduction of tumor after oral administration of UFT].
Topics: Adenoma, Bile Duct; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Humans; Male; Middle Aged; Tegafur; Uracil | 1989 |
[Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tegafur; Thymidylate Synthase; Uracil | 1989 |
[A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cryptorchidism; Humans; Infusions, Parenteral; Male; Mesothelioma; Mitomycin; Mitomycins; Peritoneal Neoplasms; Remission Induction; Tegafur; Testicular Hydrocele; Uracil | 1989 |
[Preoperative chemotherapy for head and neck cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Maxillary Neoplasms; Mouth Neoplasms; Peplomycin; Pharyngeal Neoplasms; Preoperative Care; Tegafur; Uracil | 1985 |
[Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung; Lung Neoplasms; Middle Aged; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Neoplasm Invasiveness; Portal Vein; Tegafur; Thrombosis; Uracil | 1987 |
[5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Tegafur; Uracil | 1987 |
[Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1987 |
[Cancer chemotherapy of scirrhous type gastric cancer and evaluation of chemotherapeutic efficacy].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; Humans; Injections, Intravenous; Mitomycin; Mitomycins; Radiography; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Therapeutic treatment of Borrmann type 4 (scirrhous) gastric cancer-chemotherapy and histopathological studies].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Gastric Mucosa; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Anticancer effect of UFT in intrahepatic recurrence with tumor embolus in the left portal vein after hepatectomy of hepatoma--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Hepatectomy; Humans; Liver Neoplasms; Male; Portal Vein; Postoperative Complications; Tegafur; Thrombosis; Uracil | 1988 |
[FEP and FAP combination chemotherapy in advanced gastric cancer. Research Group for Gastric Cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Brain Diseases; Carcinoma, Hepatocellular; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Risk Factors; Tegafur; Time Factors; Uracil | 1988 |
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Cytarabine; Fluorouracil; Leukemia L1210; Mice; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Streptozocin; Tegafur; Uracil | 1987 |
[Evaluation by multiple regression analysis of factors influencing the chemosensitivity of human tumors xenografted into nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colony-Forming Units Assay; Doxorubicin; Floxuridine; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Nimustine; Nitrosourea Compounds; Regression Analysis; Tegafur; Tumor Stem Cell Assay; Uracil | 1987 |
[BOF-A1 and BOF-A2, new 5-FU degradation-inhibitory agents].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Floxuridine; Fluorouracil; Liver; Mice; Pyridines; Pyrimidines; Rats; Sarcoma 180; Sarcoma, Experimental; Sarcoma, Yoshida; Tegafur; Uracil | 1987 |
[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Tegafur; Uracil; Vindesine | 1988 |
[Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT].
Topics: Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Female; Floxuridine; Intestines; Leukopenia; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Spleen; Tegafur; Thymus Gland; Uracil | 1988 |
[Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Floxuridine; Fluorouracil; Leukemia P388; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma 180; Tegafur; Uracil | 1988 |
[Effects of anti-tumor drugs and gastrointestinal hormones on the growth of pancreatic duct cell adenocarcinoma in homologous transplanted animal models].
Topics: Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Intraductal, Noninfiltrating; Cricetinae; Gastrointestinal Hormones; Male; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Tegafur; Uracil | 1985 |
Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Time Factors; Uracil | 1985 |
[PMU therapy of recurrent gastric cancer. A case report].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Maintenance chemotherapy by UFT after trans-arterial embolization for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Humans; Iodized Oil; Liver Neoplasms; Tegafur; Uracil | 1986 |
[Chemotherapy of Borrmann type 4 gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Drug Administration Schedule; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Penicillamine; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[A phase II study of UFT in non-small cell lung cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1986 |
[An unresectable case of hepatoma completely disappearing after oral administration of an anticancer drug (UFT)].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 1986 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Retrospective Studies; Tegafur; Uracil | 1987 |
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bile; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1987 |
[UFT in the treatment of primary lung cancer--5-FU concentration in the tissue and side effects].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1987 |
[Effects of preoperative administration of UFT in gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Kinetics; Liver Neoplasms; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Ovary; Tegafur; Uracil; Uterine Cervical Neoplasms | 1986 |
[Effects of oral administration of UFT in unresectable gastric cancer with liver metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Liver Neoplasms; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1986 |
[Cancer chemotherapy against human tumor cell lines transplanted in nude mice. 1. The effect of a new anti-cancer agent, UFT].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tegafur; Uracil | 1986 |
[The concentration in the tissue and antitumor effect of anticancer drug--assessment of breast cancer with UFT or FT-207].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Tegafur; Uracil | 1986 |
[Clinical study of THP-adriamycin in patients with advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1986 |
Phase II study of UFT in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1986 |
[5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Male; Rats; Rats, Inbred Strains; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Female; Fluorouracil; Humans; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil; Uterine Cervical Neoplasms | 1986 |
[Serum and tissue concentrations of UFT in patients with lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Tegafur; Uracil | 1986 |
[Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line; Cells, Cultured; Humans; Kidney; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil | 1986 |
[A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Picibanil; Portal System; Stomach Neoplasms; Tegafur; Uracil | 1986 |
[Thymidylate synthase inhibition in malignant tumors after oral administration of UFT].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1986 |
[In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colonic Neoplasms; Colony-Forming Units Assay; Humans; Mice; Mice, Nude; Stomach Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil | 1987 |
UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Immunity, Cellular; Immunocompetence; Lymphocytes; Middle Aged; Tegafur; Tissue Distribution; Uracil | 1987 |
[Experimental studies on the antitumor effect of oral antitumor agents on gynecological malignant tumors].
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endometriosis; Female; Mice; Mice, Nude; Tegafur; Uracil; Uterine Neoplasms | 1987 |
[Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colony-Forming Units Assay; Fluorouracil; Humans; Lung Neoplasms; Stomach Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil | 1987 |
[Concentration of 5-FU and tegafur in the ascites fluid in patients with peritonitis carcinomatosa after UFT oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Fluorouracil; Gastrointestinal Neoplasms; Humans; Peritonitis; Tegafur; Uracil | 1987 |
Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Topics: Combined Modality Therapy; Drug Combinations; Fluorouracil; Humans; Lymph; Male; Metabolic Clearance Rate; Middle Aged; Stomach Neoplasms; Tablets, Enteric-Coated; Tegafur; Uracil | 1987 |
[Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Male; Middle Aged; Mucous Membrane; Tegafur; Uracil; Urinary Bladder; Urinary Bladder Neoplasms | 1986 |
[UFT therapy of experimental gastric cancer in beagles induced by ENNG].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Dogs; Male; Methylnitronitrosoguanidine; Stomach Neoplasms; Tegafur; Tissue Distribution; Uracil | 1987 |
Thymidylate synthetase and thymidine kinase activities in DMH-induced colon carcinomas in rats and effects of UFT.
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Combined Chemotherapy Protocols; Colon; Colonic Neoplasms; Dimethylhydrazines; Male; Rats; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1986 |
[The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Postoperative Period; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capsules; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colony-Forming Units Assay; Female; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Tumor Stem Cell Assay; Uracil | 1987 |
[Effect of combination of UFT and MMC (UFT-M therapy) on human colonic cancer xenotransplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colonic Neoplasms; Drug Administration Schedule; Humans; Male; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1987 |
[Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Two cases of unresectable pancreatic cancer responding to combined chemotherapy with cisplatin, PSK and UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Male; Middle Aged; Pancreatic Neoplasms; Proteoglycans; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Futraful and UFT, their metabolic characteristics].
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lung; Lymph Nodes; Pyrimidines; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Neo-adjuvant chemotherapy with UFT and adriamycin in head and neck cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Prognosis; Tegafur; Uracil | 1987 |
[A study on UFT concentration in tissues and serum of patients with malignant gynecologic tumors following oral administration].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Genital Neoplasms, Female; Humans; Lymph Nodes; Ovary; Tegafur; Uracil; Uterus | 1987 |
[Combination chemotherapy of UFT, etoposide and CDDP in advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia L1210; Male; Mice; Middle Aged; Radiography; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[A case report of successful immunochemotherapy of metastatic renal cell carcinoma using UFT and PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Clavicle; Humans; Kidney Neoplasms; Male; Proteoglycans; Tegafur; Thoracic Neoplasms; Uracil | 1987 |
[Interactions between UFT and anticoagulants].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NAD+); Drug Interactions; Drug Synergism; Humans; Lung Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Tegafur; Uracil; Warfarin | 1987 |
[The effect of combined chemotherapy with UFT, cis-platinum and aclarubicin in metastatic brain tumors].
Topics: Aclarubicin; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Naphthacenes; Tegafur; Tomography, X-Ray Computed; Uracil | 1987 |
[5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Report on nationwide pooled data and cohort investigation in UFT phase II study].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Nausea; Neoplasms; Prognosis; Tegafur; Uracil | 1987 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Lentinan; Male; Mitomycin; Mitomycins; Peritonitis; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Multimodal therapy using hyperthermia for gastric cancer--with special reference to histological studies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; Hyperthermia, Induced; Mitomycin; Mitomycins; Models, Structural; Radiotherapy, High-Energy; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Clinical results of UFT fine granule therapy by cooperative study. Osaka UFT Granulation Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capsules; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Tegafur; Uracil | 1987 |
[Combination chemotherapy of UFT with adriamycin in advanced gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Colonic Neoplasms; Doxorubicin; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[UFT in esophageal cancer: a report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Tegafur; Uracil | 1987 |
[UFTM therapy in patients with unresectable pancreatic cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Tegafur; Uracil | 1987 |
[The effect of UFT on lymphocyte subsets and lymphocyte response to PHA].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Immunocompetence; Lymphocyte Activation; Lymphocytes; Middle Aged; Phytohemagglutinins; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Complete regression of pulmonary metastasis from renal cell carcinoma following treatment with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nephrectomy; Remission Induction; Tegafur; Uracil | 1987 |
[Tegafur and 5-FU concentrations in cancerous and normal tissues in nude mice after oral administration of UFT].
Topics: Animals; Drug Combinations; Female; Fluorouracil; Kidney; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tegafur; Time Factors; Tissue Distribution; Transplantation, Heterologous; Uracil; Urologic Neoplasms | 1987 |
[Study on the preoperative adjuvant therapy of cancer--relation between serum and tumor tissue levels of UFT and OK-432 after administration, and skin reactions to Su-polysaccharide (Su-Ps)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Combined Modality Therapy; Humans; Intradermal Tests; Middle Aged; Neoplasms; Picibanil; Polysaccharides, Bacterial; Preoperative Care; Tegafur; Uracil | 1987 |
[Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1987 |
[Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nausea; Tegafur; Uracil; Vomiting | 1988 |
[The effect of UFT on thymidine kinase and thymidylate synthetase activities and autoradiograph in DMH-induced colon cancer in rat].
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Combined Chemotherapy Protocols; Autoradiography; Colonic Neoplasms; Dimethylhydrazines; DNA, Neoplasm; Male; Rats; Tegafur; Thymidine; Thymidine Kinase; Thymidylate Synthase; Uracil | 1987 |
[Drug distribution to lymph and blood in adjuvant chemotherapy with combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil after surgery in gastric cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Humans; Lymph; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1987 |
[Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Subrenal Capsule Assay; Tegafur; Tumor Cells, Cultured; Uracil; Urogenital Neoplasms | 1988 |
[Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tissue Distribution; Uracil | 1988 |
[Antitumor effect of intermittent oral administration of UFT against human rectal cancer xenografted in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Drug Administration Schedule; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Rectal Neoplasms; Tegafur; Uracil | 1988 |
[Combination chemotherapy with cisplatin and UFT malignant tumors of the head and neck--experimental study of human nasopharyngeal carcinoma (A2L/AH) xenografted to nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
[Intraperitoneal (Ip) administration of cisplatin in combination with systemic chemotherapy in patients with malignant ascites of gastrointestinal cancer: clinical evaluation and pharmacokinetics].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Doxorubicin; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Peritoneal Cavity; Tegafur; Thiosulfates; Uracil | 1988 |
[A case of colon cancer with pulmonary metastasis treated effectively by uracil futraful].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Middle Aged; Tegafur; Uracil | 1988 |
[A case of recurrent sigmoid colon cancer successfully treated with 5-FU and UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 1988 |
[Clinical study of UFT in far-advanced renal cell carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Prognosis; Tegafur; Uracil | 1988 |
[Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Tegafur; Uracil; Urinary Bladder Neoplasms | 1987 |
[Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nephrectomy; Picibanil; Remission Induction; Tegafur; Thrombosis; Uracil; Vena Cava, Inferior | 1987 |
[Effect of PMU therapy (CDDP, MMC and UFT) against terminal gastric carcinoma. Hokuriku Cisplatin Round-table Conference].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Clinical study on the effect of chemotherapy in the treatment of pancreatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Tegafur; Uracil | 1988 |
[Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Kidney Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
[Effects of SSM (purified polysaccharides from human tubercle bacillus, maruyama vaccine) and UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in 1,2-dimethylhydrazine (DMH)-induced rat colon carcinomas].
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Colonic Neoplasms; Dimethylhydrazines; DNA, Neoplasm; Lipids; Mannans; Rats; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1987 |
[Evaluation of a combination of UFT, MMC, and OK-432 for advanced gastro-intestinal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1987 |
Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kidney; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Subrenal Capsule Assay; Tegafur; Uracil | 1988 |
[Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Humans; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
[Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Mastectomy; Mitomycin; Mitomycins; Postoperative Period; Tegafur; Tomography, X-Ray Computed; Uracil | 1988 |
[Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Fluorouracil; Lentinan; Lung Neoplasms; Mammary Neoplasms, Experimental; Rats; Rats, Inbred SHR; Tegafur; Uracil | 1988 |
[Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Drug Synergism; Female; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Ovarian Neoplasms; Sulfonamides; Tegafur; Uracil | 1988 |
[Effects of OK-432 on UFT activation].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Fluorouracil; Humans; Liver Neoplasms, Experimental; Male; Middle Aged; Neoplasms; Picibanil; Rats; Rats, Inbred Strains; Tegafur; Uracil | 1988 |
[Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Immune Tolerance; Immunity, Cellular; Liver Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Tegafur; Uracil | 1988 |
[A case of colorectal cancer showing complete response to UFT].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Humans; Lymph Node Excision; Male; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 1988 |
Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Transformed; Colonic Neoplasms; Drug Synergism; Esophageal Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Neoplasm Transplantation; Stomach Neoplasms; Subrenal Capsule Assay; Tegafur; Uracil | 1988 |
[Clinical effect of UFT in advanced renal cell carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1988 |
Interactions between UFT and anticoagulants in lung cancer patients.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Therapy, Combination; Humans; Lung Neoplasms; Postoperative Care; Tegafur; Ticlopidine; Uracil; Warfarin | 1988 |
[A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
[Experimental and clinical study of interactions between fluorinated pyrimidine derivatives and anticoagulants].
Topics: Animals; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Fluorouracil; Humans; Lung Neoplasms; Neoplasm Transplantation; Pyrimidines; Rats; Rats, Inbred Strains; Tegafur; Ticlopidine; Uracil; Warfarin | 1988 |
[Clinical results of UFT plus anticoagulants as a postoperative adjuvant in lung cancer patients].
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Humans; Lung Neoplasms; Postoperative Period; Prognosis; Random Allocation; Tegafur; Uracil | 1988 |
[The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[AUFRAP therapy: combined modality treatment of malignant gliomas with intraarterial infusion of ACNU].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carotid Artery, Internal; Combined Modality Therapy; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Proteoglycans; Radiotherapy Dosage; Remission Induction; Tegafur; Uracil; Vitamin A | 1988 |
[Clinical study of combination chemotherapy using carboquone, cisplatin, UFT and OK-432 in 7 cases of advanced gastric cancers and a relapsed gastric cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbazilquinone; Celiac Artery; Cisplatin; Drug Evaluation; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local; Picibanil; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carbazilquinone; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Tegafur; Uracil | 1988 |
[Effect of combined BCG and UFT therapy of human maxillary cancer transplanted into nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Body Weight; Humans; Maxillary Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil; Vaccines, Attenuated | 1988 |
[Effect of UFTM therapy on primary and metastatic colon cancer of human xenotransplanted in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Infusions, Parenteral; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Tegafur; Uracil | 1988 |
Report on nationwide pooled data and cohort investigation in UFT phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Compounding; Drug Evaluation; Humans; Neoplasms; Tegafur; Uracil | 1988 |
A nine-month chronic toxicity study of tegafur-uracil mixture (UFT) in dogs.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Dogs; Electrocardiography; Female; Heart; Male; Tegafur; Time Factors; Uracil; Vacuoles | 1988 |
[Effect of fluoropyrimidine, drugs of tegafur and UFT on transplanted tumor in liver-damaged mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Sarcoma 180; Tegafur; Uracil | 1988 |
[Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Ovary; Postoperative Period; Progesterone; Tamoxifen; Tegafur; Uracil | 1988 |
[Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Interferon-gamma; Kidney Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Recombinant Proteins; Tegafur; Transplantation, Heterologous; Uracil | 1988 |
[Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Results of drug sensitivity test of UFT, doxorubicin and cisplatin using human urogenital cancers transplanted subcutaneously into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Drug Synergism; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil; Urogenital Neoplasms | 1988 |
[The experimental chemotherapy by the combination of cisplatin and UFT on Human salivary gland adenocarcinoma grown in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Salivary Gland Neoplasms; Tegafur; Uracil | 1988 |
[Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Postoperative Period; Tegafur; Uracil | 1988 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Prognosis; Tegafur; Uracil; Urinary Bladder Neoplasms | 1988 |
UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Male; Mice; Stomach Neoplasms; Subrenal Capsule Assay; Tegafur; Uracil | 1988 |
[Level of 5-fluorouracil in cancerous and normal tissues of nude mice bearing human endometrial carcinoma after administration of UFT coadministered with nicardipin].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nicardipine; Tegafur; Transplantation, Heterologous; Uracil; Uterine Neoplasms | 1988 |
[Morphologic evaluation of systemic chemotherapy for gastric cancer--using new criteria of the Research Society for Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1988 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabine; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Silicone Elastomers; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney Neoplasms; Tegafur; Uracil | 1985 |
[Clinical study of UFT in renal cell carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Capsules; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1985 |
[Preoperative treatment with UFT for patients with ovarian malignant tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Preoperative Care; Tegafur; Uracil | 1985 |
[Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Uracil; Uterine Neoplasms | 1985 |
[5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Female; Fluorouracil; Humans; Lymph Nodes; Preoperative Care; Tegafur; Uracil | 1985 |
[Phase II study of UFT for head and neck cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Tegafur; Uracil | 1985 |
[UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrium; Female; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Ovary; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1985 |
[Clinical effect of UFT on prostatic cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Humans; Male; Middle Aged; Nausea; Prostatic Neoplasms; Tegafur; Uracil | 1985 |
[A case of gastric cancer successfully treated with hyperthermo-chemo-radiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hot Temperature; Humans; Lymphatic Metastasis; Middle Aged; Mitomycin; Mitomycins; Radiotherapy Dosage; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1985 |
Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Antineoplastic Agents; Corpus Striatum; Dopamine; Fluorouracil; Haloperidol; Homovanillic Acid; Male; Methyltyrosines; Motor Activity; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Substantia Nigra; Tegafur; Time Factors; Uracil | 1985 |
[Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Drug Administration Schedule; Male; Rats; Rats, Inbred F344; Tegafur; Uracil; Urinary Bladder Neoplasms | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[UFT, UFTM, and UFTM-Dpc treatment of gastric cancer].
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia L1210; Male; Mice; Mitomycin; Mitomycins; Penicillamine; Stomach Neoplasms; Tegafur; Uracil | 1985 |
[A trial of hormonochemotherapy of prostate cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diethylstilbestrol; Humans; Male; Prostatic Neoplasms; Tegafur; Uracil | 1985 |
[Effects of UFT in advanced renal cell cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1985 |
[A study on plasma and tissue 5-FU concentrations in patients with cervical cancer treated with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
[Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cervix Uteri; Female; Fluorouracil; Humans; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms | 1985 |
[5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Levamisole; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 1985 |
[Pharmacokinetics study of UFT in malignant brain tumor patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Combinations; Female; Fluorouracil; Glioma; Humans; Kinetics; Male; Middle Aged; Tegafur; Uracil | 1983 |
[Cancer of the maxillary antrum--a new multidisciplinary treatment containing neo-adjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Male; Maxillary Neoplasms; Middle Aged; Peplomycin; Tegafur; Uracil | 1984 |
[Pharmacological and pharmacodynamic aspects of cancer chemotherapy, with special reference to 5-fluorouracil and its derivatives].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Floxuridine; Fluorouracil; Humans; Kinetics; Neoplasms; Tegafur; Uracil | 1982 |
[Development of fluoropyrimidine derivatives].
Topics: Animals; DNA Replication; Floxuridine; Fluorouracil; Mice; Phosphorylation; Pyrimidine Nucleotides; Rats; Sarcoma, Experimental; Tegafur; Uracil | 1984 |
[5-FU concentration in brain tumors after co-administration of FT and uracil].
Topics: Brain Neoplasms; Drug Therapy, Combination; Fluorouracil; Glioblastoma; Humans; Meningeal Neoplasms; Meningioma; Tegafur; Uracil | 1983 |
[Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
Topics: Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cricetinae; Drug Therapy, Combination; Fluorouracil; Male; Mesocricetus; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Tegafur; Tissue Distribution; Transplantation, Homologous; Uracil | 1982 |
[Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorouracil; Head and Neck Neoplasms; Humans; Lymph Nodes; Tegafur; Uracil | 1983 |
[UFT concentration in various tissues from cancer patients].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capsules; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms; Stomach Neoplasms; Tegafur; Tissue Distribution; Uracil | 1983 |
[Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur; Uracil | 1983 |
[Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Fluorouracil; Humans; Kinetics; Male; Middle Aged; Nausea; Neoplasms; Tegafur; Uracil | 1983 |
[Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Tegafur; Uracil; Uterine Neoplasms | 1984 |
Effect of coadministration of uracil on the toxicity of tegafur.
Topics: Animals; beta-Alanine; Cats; Dogs; Female; Fluorouracil; Heart Diseases; Lethal Dose 50; Male; Mice; Nervous System Diseases; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Tegafur; Uracil | 1984 |
[Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
Topics: Administration, Oral; Animals; Deoxyuridine; Dihydrouracil Dehydrogenase (NAD+); DNA, Neoplasm; Drug Synergism; Fluorouracil; Neoplasms, Experimental; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pentosyltransferases; Phosphorylation; Pyrimidines; Sarcoma, Yoshida; Tegafur; Thymidine; Thymine; Uracil; Uridine | 1984 |
[UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Staging; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Division; DNA, Neoplasm; Drug Combinations; Fluorouracil; Male; Methyltransferases; Mice; Sarcoma 180; Tegafur; Thymidylate Synthase; Uracil | 1984 |
[Clinical effect of UFT on urogenital tumors].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Carcinoma, Transitional Cell; Drug Combinations; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Tegafur; Uracil; Urinary Bladder Neoplasms | 1984 |
[Phase II study of UFT for malignant tumors of urinary organs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms; Urologic Neoplasms | 1984 |
[Chemotherapy of unresectable Borrmann type 4 gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1984 |
Pharmacodynamics of co-administration of uracil and 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) for malignant brain tumors.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Drug Combinations; Female; Humans; Kinetics; Male; Middle Aged; Tegafur; Uracil | 1983 |
[Experimental chemotherapy of human gastrointestinal and breast cancers in nude mice and its correlation to clinical effect].
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Male; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Rectal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1984 |
[UFT].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Nausea; Neoplasms; Tegafur; Uracil; Vomiting | 1984 |
Enhanced accumulation of 5-fluorouracil in human tumors in athymic mice by co-administration of Ftorafur and uracil.
Topics: Animals; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Time Factors; Transplantation, Heterologous; Uracil | 1984 |
[Pharmacokinetics of fluoropyrimidines].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Fluorouracil; Humans; Infusions, Parenteral; Kinetics; Mice; Neoplasms; Rabbits; Tegafur; Uracil | 1984 |
[Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
[Clinical effects of oral administration of UFT on gynecological malignant tumors].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Tegafur; Uracil; Uterine Neoplasms | 1984 |
Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biodegradation, Environmental; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Liver; Male; Mice; Phosphorylation; Rats; Sarcoma 180; Sarcoma, Yoshida; Tegafur; Thymidine; Thymidine Phosphorylase; Thymine; Uracil; Uridine; Uridine Phosphorylase | 1980 |
Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2'-tetrahydrofuryl)-5-fluorouracil.
Topics: Female; Fluorouracil; Humans; In Vitro Techniques; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 1980 |
High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Fluorouracil; Gas Chromatography-Mass Spectrometry; Male; Neoplasms, Experimental; Rats; Tegafur; Uracil | 1980 |
Determination of 5-fluorouracil and pyrimidine bases in plasma by gas chromatography-chemical ionization-mass fragmentography.
Topics: Cytosine; Fluorouracil; Gas Chromatography-Mass Spectrometry; Humans; Ions; Pyrimidines; Tegafur; Thymine; Uracil | 1980 |
Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Drug Combinations; Fluorouracil; Intestinal Absorption; Neoplasms, Experimental; Rats; Tegafur; Uracil | 1980 |
General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Topics: Analgesics; Animals; Anticonvulsants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Behavior, Animal; Body Temperature; Brain Chemistry; Digestive System; Dogs; Drug Combinations; Electroencephalography; Female; Fluorouracil; Guinea Pigs; Hemodynamics; Male; Mice; Postural Balance; Rabbits; Rats; Respiration; Tegafur; Uracil | 1981 |
[Effects of UFT administered preoperatively in cases of gastric cancer (author's transl)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1981 |
[Clinical trial of UFT in recurrent or advanced cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms; Sigmoid Neoplasms; Tegafur; Uracil | 1982 |
[Two cases of carcinoid tumor of the stomach which responded to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1982 |
[Clinical effect of UFT on bladder cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Uracil; Urinary Bladder Neoplasms | 1982 |
[Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Preoperative Care; Tegafur; Uracil | 1982 |
[Clinical experiences with UFD-1].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1982 |
[Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Floxuridine; Humans; Leucovorin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil | 1995 |
[Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Folic Acid; Humans; Leucovorin; Tegafur; Tumor Cells, Cultured; Uracil | 1995 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
Effects of UFT (mixed compound of tegafur and uracil) on cell kinetics and inhibition of thymidylate synthase in L1210 ascites tumor.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Deoxyuridine; Drug Combinations; Leukemia L1210; Male; Mice; Tegafur; Thymidylate Synthase; Uracil | 1995 |
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Node Excision; Picibanil; Remission Induction; Tegafur; Uracil; Uterine Cervical Neoplasms | 1995 |
[Light and electron microscopic examination compared to evaluation by tumor size in subrenal capsule assay for chemosensitivity testing in esophageal cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Humans; Mice; Mice, Nude; Microscopy, Electron; Subrenal Capsule Assay; Tegafur; Uracil | 1995 |
Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Colonic Neoplasms; Drug Combinations; Female; Humans; Tegafur; Uracil | 1995 |
[A case of interstitial pneumonia due to UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Lung Diseases, Interstitial; Middle Aged; Tegafur; Uracil | 1995 |
The number of 5-fluoro-2'-deoxyuridine-5'-monophosphate binding sites and reduced folate pool in human colorectal carcinoma tissues: changes after tegafur and uracil treatment.
Topics: Base Sequence; Binding Sites; Colorectal Neoplasms; Fluorodeoxyuridylate; Humans; Molecular Sequence Data; RNA, Messenger; Tegafur; Tetrahydrofolates; Thymidylate Synthase; Uracil | 1995 |
A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diagnostic Imaging; Humans; Interferon-alpha; Kidney Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Ribs; Spinal Neoplasms; Tegafur; Uracil | 1994 |
[Blood levels of 5-FU and uracil on additional use of uracil in UFT therapy in gastrectomized patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Male; Stomach Neoplasms; Tegafur; Uracil | 1995 |
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Disease-Free Survival; Epirubicin; Feasibility Studies; Female; Fluorouracil; Hepatectomy; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prospective Studies; Survival Rate; Tegafur; Uracil | 1995 |
[Antiproliferative and antimetastatic effects of UFT on MKL-4 human breast cancer cells transplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Humans; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil | 1995 |
The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Topics: Animals; Combined Modality Therapy; Fluorouracil; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Tegafur; Uracil | 1995 |
[Case report of long-term survivor of advanced gastric cancer associated with peritoneal dissemination successfully treated with cancer chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Methotrexate; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Gastrectomy; Humans; Infusions, Intravenous; Liver Neoplasms; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1995 |
[Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Tegafur; Tongue Neoplasms; Uracil | 1995 |
[A case of bilateral multiple lung metastases from breast cancer successfully treated with carboplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone; Middle Aged; Tegafur; Uracil | 1995 |
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Male; Neoplasm, Residual; Stomach Neoplasms; Tegafur; Uracil | 1995 |
[A case of huge liver metastasis from jejunal leiomyosarcoma completely controlled by intra-arterial and intra-portal vein infusion chemotherapy following hepatectomy].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Epirubicin; Female; Hepatectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Jejunal Neoplasms; Leiomyosarcoma; Liver Neoplasms; Portal Vein; Remission Induction; Tegafur; Uracil | 1994 |
[A case of small cell carcinoma of the stomach with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Neoplasm Invasiveness; Picibanil; Stomach Neoplasms; Tegafur; Uracil | 1994 |
[Prevention of drug interactions and its countermeasure].
Topics: Animals; Arabinofuranosyluracil; Drug Interactions; Fluorouracil; Humans; Rats; Tegafur; Uracil | 1994 |
[Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Subrenal Capsule Assay; Tegafur; Tumor Cells, Cultured; Uracil | 1994 |
Effects of preoperative chemotherapy on DNA ploidy patterns, cell cycle, and histological findings in gastric and colonic cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Chemotherapy, Adjuvant; Colonic Neoplasms; DNA, Neoplasm; Female; Humans; Male; Middle Aged; Ploidies; Prospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1994 |
[Improvement of clinical symptoms by UFT and TAM and a case of bone metastasis from breast carcinoma during pregnancy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Mastectomy; Ovariectomy; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third; Quality of Life; Tamoxifen; Tegafur; Uracil | 1994 |
In vivo 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Fluorine; Fluorouracil; Liver; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Sarcoma 180; Tegafur; Uracil | 1994 |
[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplastic Cells, Circulating; Tegafur; Uracil; Vena Cava, Inferior | 1994 |
Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Combinations; Drug Interactions; Fluorouracil; Lung; Lung Neoplasms; Male; Neoplasm Transplantation; Pyridines; Rats; Sarcoma, Yoshida; Tegafur; Transplantation, Heterologous; Uracil | 1994 |
[Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Retrospective Studies; Tegafur; Uracil; Urinary Bladder Neoplasms | 1994 |
[Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Fluorouracil; Male; Rats; Sarcoma, Yoshida; Tegafur; Thymidylate Synthase; Uracil | 1994 |
[Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cachexia; Colonic Neoplasms; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Tegafur; Uracil | 1994 |
[Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Middle Aged; Portal Vein; Tegafur; Uracil | 1994 |
Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Gastrectomy; Humans; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 1994 |
[The effect of induction chemotherapy with CBDCA, 5-FU and UFT in head and neck cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Tegafur; Uracil | 1994 |
[A comparative study on the serum and tissue 5-FU concentrations in patients with hepatocellular carcinoma after preoperative oral administration of UFT and 5'-DFUR].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1994 |
[Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Male; Recurrence; Tegafur; Uracil; Urinary Bladder Neoplasms | 1994 |
[A case of retroperitoneal lymph node recurrence with gallbladder cancer responding to UFT and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Tegafur; Uracil | 1994 |
[Experimental evaluation of combination chemotherapy with UFT and cisplatin for lung cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Mice; Neoplasm Transplantation; Tegafur; Uracil; Vindesine | 1994 |
[Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Middle Aged; Tegafur; Uracil; Urinary Bladder Neoplasms | 1993 |
[Effect of UFT and CBDCA combined therapy on human laryngeal cancer transplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Humans; Laryngeal Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil | 1993 |
[A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1993 |
[Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report].
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Embolization, Therapeutic; Humans; Iodized Oil; Liver Neoplasms; Male; Neoplastic Cells, Circulating; Tegafur; Uracil; Vena Cava, Inferior | 1993 |
[A case of early gastric cancer with Virchow's node metastasis, effectively treated by high dose of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of giant hepatocellular carcinoma effectively treated by UFT].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Protein Precursors; Prothrombin; Remission Induction; Tegafur; Uracil | 1993 |
[A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone].
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Neoplasm Invasiveness; Portal System; Tegafur; Uracil | 1994 |
Suppression of mammary tumors by oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil in SHN virgin mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Female; Fluorouracil; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Organ Size; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1993 |
The significance of preoperative chemotherapy for early gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Ifosfamide in combined hormonochemotherapy on prostate cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Humans; Ifosfamide; Infusions, Intravenous; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
[CDDP.UFT therapy for advanced or metastatic gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Humans; Lymphatic Metastasis; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Clinical efficacy of cis-diamminedichloroplatinum [II] and 5-fluorouracil (UFT) in advanced cancer of the alimentary tract].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Picibanil; Tegafur; Uracil | 1993 |
[A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus orally UFT in plasma of same patients].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1993 |
Effect of 5-fluorouracil and UFT on experimental liver metastasis model of colorectal cancer using mouse colon 26 cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tegafur; Uracil | 1993 |
[Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Humans; Interferon-alpha; Kidney Neoplasms; Male; Nephrectomy; Remission Induction; Tegafur; Uracil | 1993 |
[Pharmacodynamic study on the effectiveness of UFT against cancer of gastro-intestinal (GI) tract].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Fluorouracil; Gastrointestinal Neoplasms; Humans; Nucleolus Organizer Region; Tegafur; Uracil | 1993 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Delivery Systems; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Survival Rate; Tegafur; Uracil | 1993 |
[Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1993 |
A pharmacodynamic and pharmacokinetic study of fluoropyrimidines in a nude mouse system and in postoperative patients with gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Animals; Colonic Neoplasms; Fluorouracil; Gastrectomy; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil | 1993 |
Effects of 5-fluorouracil and a combination of tegafur and uracil (UFT) on nucleotide metabolism in L1210 ascites tumor.
Topics: Animals; Deoxyribonucleotides; Fluorouracil; Injections, Intraperitoneal; Leukemia L1210; Male; Mice; Tegafur; Uracil | 1993 |
[Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Female; Fluorouracil; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Tegafur; Uracil | 1993 |
[A case of secondary leukemia induced by chemotherapy with a CDDP-based regimen for gastric cancer 5 years following radical resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Gastrectomy; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mitomycin; Neoplasms, Second Primary; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Subrenal capsule assay of nude mice for testing the effectiveness of UFT for rat prostatic carcinoma (R3327)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Rats; Rats, Inbred F344; Subrenal Capsule Assay; Tegafur; Uracil | 1993 |
[Experimental study on the combined treatment of UFT with etoposide against mouse Lewis lung carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; DNA, Neoplasm; Etoposide; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil | 1993 |
[A case of breast cancer with thrombosis during treatment of lung metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intravenous; Lentinan; Lung Neoplasms; Medroxyprogesterone Acetate; Pulmonary Embolism; Radiography; Tamoxifen; Tegafur; Thrombophlebitis; Uracil | 1993 |
[Clinico-pharmacological study on UFT enteric-coated granules for gastric cancer patients].
Topics: Administration, Oral; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Dogs; Dosage Forms; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1993 |
Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation.
Topics: Alanine; Animals; Dihydrouracil Dehydrogenase (NAD+); Drug Interactions; Fluorouracil; Liver; Magnetic Resonance Spectroscopy; Male; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pyridines; Rats; Rats, Wistar; Tegafur; Uracil | 1993 |
[Changes of the number of FdUMP binding sites of thymidylate synthase and folate pools in human colorectal carcinomas following the administration of tegafur and uracil: preliminary report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Binding Sites; Colorectal Neoplasms; Fluorodeoxyuridylate; Folic Acid; Humans; Tegafur; Thymidylate Synthase; Uracil | 1993 |
[A case of giant dumbbell tumor treated by one-stage operation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Mediastinal Neoplasms; Neurilemmoma; Tegafur; Uracil; Vincristine | 1993 |
[Evaluation of long-term administration of oral anti-cancer agent].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case report of adenosquamous cell carcinoma of the stomach responding well to combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Humans; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Remission Induction; Tegafur; Uracil | 1993 |
[Effect of neoadjuvant chemotherapy (CDDP.UFT therapy) upon cell DNA analysis by flow cytometry in gastric carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; DNA, Neoplasm; Drug Administration Schedule; Female; Flow Cytometry; Humans; Male; Middle Aged; Ploidies; Stomach Neoplasms; Tegafur; Uracil | 1993 |
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Prognosis; Remission Induction; Tegafur; Uracil | 1993 |
[Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon-alpha; Kidney Neoplasms; Lung Neoplasms; Male; Remission Induction; Tegafur; Uracil | 1993 |
[Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Cricetinae; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Proglumide; Tegafur; Uracil | 1993 |
5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
Topics: Animals; Carcinoma; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Synergism; Enzyme Inhibitors; Fluorouracil; Male; Neoplasm Transplantation; Oxidoreductases; Prodrugs; Rats; Tegafur; Uracil | 1995 |
Long-term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis: report of a case.
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fatal Outcome; Gastrectomy; Humans; Hyperthermia, Induced; Male; Middle Aged; Palliative Care; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Tomography, X-Ray Computed; Uracil | 1995 |
[A case of common bile duct cancer responding to MMC leucovorin, 5-FU, and UFT combination chemotherapy and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Mitomycin; Remission Induction; Tegafur; Uracil | 1996 |
Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: have we made progress?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Humans; Lung Neoplasms; Research Design; Tegafur; Treatment Outcome; Uracil | 1996 |
Prolongation of survival period and improvement of cancer cachexia by long-term administration of UFT.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Dogs; Drug Administration Schedule; Drug Combinations; Interleukin-6; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Ethanol; Fluorouracil; Gastrectomy; Humans; Injections, Intralesional; Liver Neoplasms; Male; Picibanil; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Colorectal Neoplasms; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Stomach Neoplasms; Subrenal Capsule Assay; Tegafur; Uracil | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
[Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Colonic Neoplasms; Dinoprostone; Doxorubicin; Drug Combinations; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mitomycin; Survival Analysis; Tegafur; Tumor Cells, Cultured; Uracil | 1996 |
[A case of hepatocellular carcinoma responding to oral administration of UFT].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Protein Precursors; Prothrombin; Tegafur; Uracil | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Liver Neoplasms; Lymphoma; Male; Neoplasms, Second Primary; Prednisolone; Stomach Neoplasms; Tegafur; Uracil; Vincristine | 1996 |
The modulating effect of interferon alpha-2a on the antitumor activity of UFT against a human gastric carcinoma xenograft, SC-1-NU, in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Combined Modality Therapy; DNA Replication; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; Recombinant Proteins; RNA, Neoplasm; Stomach; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Transplantation, Heterologous; Uracil | 1996 |
[Acute lymphoblastic leukemia with marked morphologic abnormalities after chemotherapy for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case report of concomitant UFT-E and CDDP against lung epidermoid carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Combinations; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer remarkably responding to preoperative UFT-E therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1996 |
1-(2-Tetrahydrofuryl)-5-fluorouracil in combination with uracil suppresses mammary carcinogenesis and growth of tumors induced with 7,12-dimethylbenz[a]anthracene in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bromodeoxyuridine; Female; Hormones; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Organ Size; Rats; Rats, Sprague-Dawley; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1996 |
[Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Parenteral Nutrition, Home; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[An elderly patient with gastric cancer surviving long after chemotherapy using UFT alone].
Topics: Activities of Daily Living; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Male; Stomach Neoplasms; Survivors; Tegafur; Uracil | 1996 |
[Inhibition of prostate cancer growth in nude mice by hormone and chemotherapy].
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Combinations; Drug Synergism; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseases; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Mitomycin; Oxidoreductases; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Usefulness of contrast-enhanced CT of the peritoneum to evaluate efficacy of neoadjuvant chemotherapy for peritoneal dissemination in an advanced gastric cancer case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Humans; Male; Peritoneal Neoplasms; Peritoneum; Radiographic Image Enhancement; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 1996 |
Biochemical modulation: its pharmacological basis and clinical applications. Proceedings of a meeting. Singapore, October 19, 1995.
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Fluorouracil; Humans; Prodrugs; Tegafur; Uracil | 1997 |
Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Drug Synergism; Fluorouracil; Leucovorin; Prodrugs; Rats; Tegafur; Uracil | 1997 |
[Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
Topics: Animals; Body Weight; Drug Combinations; Floxuridine; Leukemia L5178; Liver Neoplasms; Male; Mice; Tegafur; Uracil | 1996 |
[Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU].
Topics: Animals; Antibody Formation; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Fluorouracil; Immune System; Immune Tolerance; Immunologic Tests; Mice; Mice, Inbred BALB C; Organ Size; Oxonic Acid; Pyridines; Spleen; Tegafur; Thymus Gland; Uracil | 1996 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embolization, Therapeutic; Humans; Interferon-alpha; Kidney Neoplasms; Male; Neoplastic Cells, Circulating; Renal Artery; Tegafur; Uracil | 1997 |
Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ambulatory Care; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Clinical Protocols; Colonic Neoplasms; Diarrhea; Feasibility Studies; Female; Humans; Injections, Intravenous; Leucovorin; Male; Nausea; Rectal Neoplasms; Remission Induction; Sex Factors; Tegafur; Uracil; Vomiting | 1997 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Combinations; Female; Floxuridine; Fluorodeoxyuridylate; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tegafur; Uracil | 1997 |
Preventive effect of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil on colonic carcinogenesis induced by 1,2-dimethylhydrazine in rats.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Differentiation; Colorectal Neoplasms; Dimethylhydrazines; Fluorouracil; Male; Rats; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1997 |
[A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Leucovorin; Male; Neoplasm Invasiveness; Portal Vein; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Leucovorin; Rectal Neoplasms; Tegafur; Uracil | 1997 |
UFT: East meets West in drug development.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Therapy, Combination; Humans; Japan; Leucovorin; Neoplasms; Tegafur; United States; Uracil | 1997 |
Rationale for phase I study of UFT plus leucovorin and oral JM-216.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Combinations; Drug Therapy, Combination; Humans; Leucovorin; Organoplatinum Compounds; Tegafur; Uracil | 1997 |
Future directions in the adjuvant treatment of colon cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Forecasting; Humans; Leucovorin; Tegafur; Uracil | 1997 |
Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
Topics: Adult; Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diarrhea; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neutropenia; Survival Rate; Tegafur; Uracil | 1997 |
A pharmacoeconomic comparison of UFT and 5-FU chemotherapy for colorectal cancer in South America.
Topics: Argentina; Brazil; Chemotherapy, Adjuvant; Colorectal Neoplasms; Costs and Cost Analysis; Drug Combinations; Drug Costs; Fluorouracil; Humans; Monte Carlo Method; South America; Tegafur; Uracil | 1997 |
The University of Texas M.D. Anderson Cancer Center Investigators' Workshop and Consensus Conference on UFT. January 17-18, 1997.
Topics: Drug Combinations; Humans; Tegafur; Uracil | 1997 |
[Successful eradication of H. pylori in an elderly patient with gastric cancer after effective UFT-E therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Diterpenes; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Neoplasms; Tegafur; Uracil | 1997 |
[Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pentosyltransferases; Prognosis; Pyrimidine Phosphorylases; S Phase; Survival Rate; Tamoxifen; Tegafur; Uracil | 1998 |
[A case of advanced gastric cancer successfully treated by UFT and CDDP followed by surgical resection proving cancer cell disappearance in the stomach].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Stomach; Stomach Neoplasms; Tegafur; Uracil | 1998 |
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Drug Combinations; Etoposide; Female; Humans; Mesothelioma; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
Topics: Administration, Oral; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Tablets; Tegafur; Uracil | 1998 |
[Pulmonary metastasis from renal cell carcinoma diagnosed by using thoracoscopic biopsy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Renal Cell; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Lung; Lung Neoplasms; Recombinant Proteins; Tegafur; Thoracoscopy; Uracil | 1998 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Drainage; Drug Combinations; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1998 |
Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Basidiomycota; Cell Survival; Drug Combinations; Female; Killer Cells, Natural; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Nitric Oxide; Polysaccharides; Rats; Rats, Inbred SHR; Spleen; T-Lymphocytes; Tegafur; Uracil | 1998 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1998 |
[Complete disappearance of metastatic pulmonary tumors in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[A case of giant hepatocellular carcinoma effectively treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Male; Remission Induction; Tegafur; Uracil | 1998 |
[Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1998 |
[Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Tegafur; Uracil | 1998 |
Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma; Cell Division; Colonic Neoplasms; Gastrointestinal Neoplasms; Humans; Immunohistochemistry; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uracil | 1998 |
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Interactions; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Prodrugs; Tegafur; Uracil | 1998 |
[Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil | 1998 |
[A case of advanced gastric carcinoma with disappearance of cancer cells by neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Humans; Lymphatic Metastasis; Male; Stomach Neoplasms; Tegafur; Uracil | 1998 |
[Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 1998 |
Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.
Topics: Animals; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Japan; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Tegafur; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Uracil | 1997 |
Complete response of early gastric cancer to uracil and tegafur.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Humans; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil | 1998 |
Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cricetinae; Drug Combinations; Lymphatic Metastasis; Male; Mouth Neoplasms; Neoplasm Transplantation; Tegafur; Uracil | 1998 |
Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Injections, Intravenous; Liver Neoplasms; Male; Medical Records; Middle Aged; Mitomycin; Multivariate Analysis; Retrospective Studies; Tegafur; Uracil | 1998 |
[A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
[Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Tegafur; Uracil | 1999 |
[A case of multiple early gastric cancer showing complete response to UFT-E after endoscopic mucosal resection].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Endoscopy; Gastric Mucosa; Gastroscopy; Humans; Male; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1999 |
[Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Gastrectomy; Humans; Immunohistochemistry; Male; Middle Aged; Mitomycin; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Thymidine Phosphorylase; Tumor Suppressor Protein p53; Uracil | 1999 |
[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Duodenum; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Hepatectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pancreatectomy; Tegafur; Uracil | 1999 |
[A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Combinations; Humans; Infusions, Intravenous; Laryngeal Neoplasms; Male; Tegafur; Uracil | 1999 |
[A case of carcinoma of lower lip showing excellent response to chemotherapy with UFT].
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Humans; Lip; Lip Neoplasms; Tegafur; Uracil | 1999 |
[Effective treatment of AFP-producing lung cancer with UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Tegafur; Uracil | 1999 |
[A case in which palatal squamous cell carcinoma responded to UFT therapy].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Female; Humans; Palatal Neoplasms; Remission Induction; Tegafur; Uracil | 1999 |
[Tegafur/uracil and oral calcium folinate in colorectal cancer].
Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Humans; Tegafur; Uracil | 1998 |
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotaxis; Cisplatin; Clone Cells; Drug Combinations; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; RNA, Messenger; RNA, Neoplasm; Tegafur; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Uracil | 1999 |
Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma.
Topics: Administration, Oral; Antidotes; Antimetabolites, Antineoplastic; Carcinoma; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Humans; Infusions, Intravenous; Leucovorin; Prodrugs; Prospective Studies; Tegafur; Treatment Outcome; Uracil | 1999 |
[A case of esophageal cancer with excellent response to oral UFT treatment].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Esophagoscopy; Humans; Male; Tegafur; Uracil | 1999 |
Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Neoplasms, Multiple Primary; Remission Induction; Tablets, Enteric-Coated; Tegafur; Tomography, X-Ray Computed; Uracil | 1999 |
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cholestasis; Cyclophosphamide; Doxorubicin; Drainage; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tamoxifen; Tegafur; Toremifene; Uracil | 1999 |
[Giant metastatic neck tumor responding to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasms, Unknown Primary; Tegafur; Uracil | 1999 |
Chemosensitivity of micrometastases and circulating tumor cells to uracil and tegafur as evaluated using LacZ gene-tagged Lewis lung carcinoma cell.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Cinnamates; Hygromycin B; Lac Operon; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tegafur; Uracil | 1999 |
Combination therapy for advanced breast cancer: cyclophosphamide, doxorubicin, UFT, and tamoxifen.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Routes; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Survival Rate; Tamoxifen; Tegafur; Treatment Outcome; Uracil | 1999 |
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Floxuridine; Fluorouracil; Hydroxybutyrates; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neovascularization, Pathologic; Tegafur; Tumor Cells, Cultured; Uracil | 1999 |
[Comparative study of histopathological effects of preoperative chemotherapy using UFT and in vitro MTT assay of colonoscopy specimens from patients with colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonoscopy; Colorectal Neoplasms; Drug Administration Schedule; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Tegafur; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Uracil | 1999 |
[UFT-E granule compliance in postoperative adjuvant chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Compliance; Stomach Neoplasms; Tegafur; Uracil | 1999 |
[A case of rectal cancer with lymph node metastasis (N4) successfully treated with low-dose cisplatin and UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Rectal Neoplasms; Tegafur; Uracil | 1999 |
[Evaluation of dissolution behavior for the products containing tegafur and uracil].
Topics: Capsules; Drug Combinations; Drugs, Generic; Solubility; Tegafur; Uracil | 1999 |
[Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Tegafur; Uracil | 1999 |
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Neoplasms; Cyclophosphamide; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Tegafur; Uracil | 1999 |
[Case of stage IVb gastric cancer in which favorable anti-tumor effect and good QOL were observed due to UFTP therapy after low-dose CDDP-tegafur therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1999 |
[A case of uterine cervical cancer in which UFT was an effective preoperative treatment].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Preoperative Care; Tegafur; Uracil; Uterine Cervical Neoplasms | 1999 |
[Consideration of cancer home chemotherapy with cooperation between hospital and clinic].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cooperative Behavior; Drug Administration Schedule; Fluorouracil; Home Care Services, Hospital-Based; Humans; Neoplasms; Quality of Life; Tegafur; Uracil | 1999 |
[PMC (pharmacokinetic modulating chemotherapy) for advanced gastric cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1999 |
[Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Tegafur; Uracil | 1999 |
[Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2000 |
[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Pyloric Stenosis; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Long-term complete response in a case of unresectable rectal cancer following chemoradiation].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2000 |
Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Middle Aged; Scleroderma, Systemic; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Inversion; Chromosomes, Human, Pair 3; Fatal Outcome; Gastrectomy; Humans; Hydroxyurea; Karyotyping; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Stomach Neoplasms; Tegafur; Thrombocythemia, Essential; Uracil | 2000 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Male; Mitomycin; Neoadjuvant Therapy; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Gastrectomy; Humans; Lentinan; Liver Neoplasms; Lymphatic Metastasis; Male; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Peritonitis; Pleurisy; Quality of Life; Tegafur; Uracil | 2000 |
Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model.
Topics: Amputation, Surgical; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Lewis Lung; Chemotherapy, Adjuvant; Colonic Neoplasms; Foot; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Postoperative Period; Survival Rate; Tegafur; Time Factors; Uracil | 2000 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Protein Precursors; Prothrombin; Tegafur; Uracil | 2000 |
Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Hepatectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Peritoneal Neoplasms; Remission Induction; Splenic Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2000 |
Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Follow-Up Studies; Gastrectomy; Gastroscopy; Humans; Male; Neoplasm Invasiveness; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2000 |
[A case of epithelial cancer of the alveoli which responded favorably to the additional administration of UFT for refractory cancer after administration of carboplatin and docetaxel].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Paclitaxel; Pulmonary Alveoli; Taxoids; Tegafur; Uracil | 2000 |
[A case of AFP-producing gastric cancer after curative operation effectively treated with chemotherapies including hepatic arterial infusion therapy].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Efficacy of UFT in the treatment of para-aortic lymph node metastasis following gastric cancer surgery: case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Comparison of pharmacokinetics of 5-FU and alpha-fluoro-beta-alanine, a metabolite of 5-FU, in plasma after administration of UFT, tegafur, 5-FU or doxifluridine to rats].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; beta-Alanine; Floxuridine; Fluorouracil; Male; Rats; Rats, Sprague-Dawley; Tegafur; Uracil | 2000 |
[An successful case of combined daily oral administration of UFT and low-dose etoposide for multiple metastases of lung cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Tegafur; Uracil | 2000 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Oxonic Acid; Pyridines; Survival Rate; Tegafur; Transplantation, Heterologous; Tumor Cells, Cultured; Uracil | 2000 |
Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats.
Topics: Administration, Oral; Allopurinol; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Biotransformation; Carbon Radioisotopes; Chlorpromazine; Drug Combinations; Drugs, Chinese Herbal; Fluorouracil; Glycyrrhiza; Intestine, Small; Male; Microsomes, Liver; Oxonic Acid; Paeonia; Pyridines; Rats; Rats, Inbred Strains; Sarcoma, Yoshida; Tegafur; Tissue Distribution; Triazines; Uracil; Xanthine Oxidase | 2000 |
[5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Mouth Neoplasms; Tegafur; Uracil | 2000 |
[A case of postoperative lung and pleural recurrence after 20 years in a breast cancer patient with marked response to orally administered UFT and cyclophosphamide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Middle Aged; Pleural Neoplasms; Tegafur; Time Factors; Uracil | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Middle Aged; Mitomycin; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2000 |
[A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Peritoneal Neoplasms; Prognosis; Quality of Life; Remission Induction; Tegafur; Uracil | 2000 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2000 |
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colorectal Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Female; HT29 Cells; Humans; Leucovorin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Tegafur; Transplantation, Heterologous; Uracil | 2000 |
[Antitumor activity of UFT and docetaxel on human breast carcinoma xenografts].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Paclitaxel; Succinate Dehydrogenase; Taxoids; Tegafur; Transplantation, Heterologous; Uracil; Xenograft Model Antitumor Assays | 2000 |
[A successful case of preoperative intermittent hepatic arterial infusion of high-dose 5-FU and pharmacokinetic modulating chemotherapy against unresectable liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2000 |
UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Topics: Air Sacs; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Carcinoma, Renal Cell; Disease Models, Animal; Endothelial Growth Factors; Endothelium; Kidney Neoplasms; Lung Neoplasms; Lymphokines; Mice; Neovascularization, Pathologic; Tegafur; Umbilical Veins; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
A novel weekday-on/weekend-off UFT schedule.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; Humans; Male; Rats; Sarcoma; Survival Analysis; Tegafur; Uracil | 2000 |
[A patient with recurrent uterine cervical cancer successfully treated by combined modality therapy including local injection of anticancer agents based on CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Muscle Neoplasms; Tegafur; Uracil; Uterine Cervical Neoplasms | 2000 |
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Lymphatic Metastasis; Middle Aged; Peritoneal Neoplasms; Skin Neoplasms; Tegafur; Uracil | 2000 |
Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Drug Administration Schedule; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasms, Multiple Primary; Tegafur; Time Factors; Uracil | 2000 |
[Oral chemotherapeutic agents: the roles in cancer chemotherapy].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorouracil; Humans; Neoplasms; Oxonic Acid; Pyridines; Tegafur; Uracil | 1999 |
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer.
Topics: Tegafur; Uracil | 2000 |
[A case of pulmonary metastases of breast cancer responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Lung Neoplasms; Mastectomy; Middle Aged; Tegafur; Uracil | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Tamoxifen; Tegafur; Uracil | 2000 |
[Three cases of liver metastasis of colon cancer responding to systemic combination chemotherapy utilizing CPT-11].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Irinotecan; Liver Neoplasms; Male; Tegafur; Uracil | 2000 |
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Rectal Neoplasms; Tegafur; Uracil; Vomiting, Anticipatory | 2000 |
Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; Combined Modality Therapy; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Tegafur; Treatment Outcome; Tumor Suppressor Protein p53; Uracil | 2001 |
Juvenile hyaline fibromatosis complicated with oral squamous cell carcinoma: a case report.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Contracture; Fatal Outcome; Female; Fibroma; Gingival Hypertrophy; Humans; Malocclusion; Middle Aged; Neoplasms, Multiple Primary; Palatal Neoplasms; Palate, Hard; Skin Neoplasms; Tegafur; Uracil | 2001 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; Hepatic Artery; Home Care Services; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2000 |
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Topics: Administration, Oral; Adult; Angiography; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Interferon-alpha; Liver Neoplasms; Magnetic Resonance Imaging; Male; Tegafur; Tomography, X-Ray Computed; Uracil | 2000 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Rectal Neoplasms; Reoperation; Tegafur; Uracil | 2001 |
Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Division; Colorectal Neoplasms; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Fluorouracil; Humans; Infusions, Intravenous; Tegafur; Tumor Cells, Cultured; Uracil | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Tegafur; Uracil | 2001 |
[A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; Liver Neoplasms; Male; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Long-term survival of hormone-refractory prostate cancer: a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Androgen Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Enzyme Inhibitors; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survivors; Tegafur; Uracil | 2001 |
UFT-induced haemolytic anaemia.
Topics: Aged; Aged, 80 and over; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Male; Tegafur; Uracil | 2001 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Transplantation; Rats; Rats, Nude; Tegafur; Transplantation, Heterologous; Uracil | 2001 |
A pharmacological study of the weekday-on/weekend-off oral UFT schedule in colorectal cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Uracil | 2001 |
Animal model of para-aortic lymph node metastasis.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Squamous Cell; Disease Models, Animal; Female; HT29 Cells; Humans; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rectal Neoplasms; Tegafur; Transplantation, Heterologous; Tumor Cells, Cultured; Uracil | 2001 |
[A case of advanced gastric cancer with multiple liver metastases in an elderly patient that responded dramatically to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Liver Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Etoposide; Female; Humans; Mitomycin; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
[A case of nonresectable scirrhous type gastric cancer treated by hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Humans; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Mitomycin; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Combinations; Floxuridine; Fluorouracil; Intestinal Mucosa; Leukemia L1210; Male; Mice; Tegafur; Uracil | 2001 |
[Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Female; Humans; Kidney Neoplasms; Male; Middle Aged; Oxidoreductases; Tegafur; Uracil; Urinary Bladder Neoplasms; Urologic Neoplasms | 2001 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Taxoids; Tegafur; Uracil | 2001 |
[A case of squamous cell carcinoma of the oral floor showing a complete response to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Mouth Neoplasms; Remission Induction; Tegafur; Uracil | 2001 |
Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, SCID; Models, Biological; Neoplasm Metastasis; Survival; Tegafur; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Uracil | 2001 |
Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Infusions, Intravenous; Tegafur; Uracil | 2001 |
Treatment of tamoxifen-refractory breast cancer--approach by animal models.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclohexanes; Disease Models, Animal; Female; Mammary Neoplasms, Experimental; Mice; Mice, Nude; O-(Chloroacetylcarbamoyl)fumagillol; Picibanil; Prognosis; Rats; Receptors, Estrogen; Risk Assessment; Sesquiterpenes; Tamoxifen; Tegafur; Treatment Failure; Uracil | 2001 |
[A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Tegafur; Uracil | 2002 |
[Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Drug Combinations; Endothelial Growth Factors; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Sodium Oxybate; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung].
Topics: Aminoacridines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Disease Models, Animal; Drug Combinations; Female; Floxuridine; Humans; Lung Neoplasms; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasm Transplantation; Taxoids; Tegafur; Uracil | 2002 |
Assessment of the intestinal permeability after a gastrectomy and the oral administration of anticancer drugs in rats: nitric oxide release in response to gut injury.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Dextrans; Fluorescein-5-isothiocyanate; Gastrectomy; Intestinal Absorption; Intestinal Mucosa; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Stress, Physiological; Tegafur; Uracil | 2002 |
[Primary signet ring cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 2001 |
[Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2002 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Chemotaxis; Colonic Neoplasms; DNA Replication; Drug Combinations; Endothelial Growth Factors; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Floxuridine; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Lung Neoplasms; Lymphokines; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasm Proteins; Neovascularization, Pathologic; Prodrugs; Prostheses and Implants; Recombinant Proteins; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays | 2001 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to preoperative chemotherapy and surviving 4 years and 4 months after total gastrectomy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2002 |
[A case of complete response (CR) persisting for 2 years and 10 months from UFT-E in a patient with liver metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Node Excision; Male; Methotrexate; Middle Aged; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[A case of liver metastasis of rectal cancer demonstrating complete response to 5-FU + Leucovorin + UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2002 |
Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Drug Approval; European Union; Humans; Leucovorin; Neoplasm Staging; Tegafur; Uracil | 2002 |
[Capsule instead of infusion--new oral chemotherapy option].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Palliative Care; Tegafur; Uracil | 2002 |
[A case of rectal cancer with multiple liver metastases that responded dramatically to pharmacokinetic modulating chemotherapy/CPT-11 therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Liver Neoplasms; Male; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Humans; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Oxidoreductases; Paclitaxel; Pyrimidines; Tegafur; Uracil | 2002 |
Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cadherins; Cytoskeletal Proteins; Female; Gastrectomy; Gastric Mucosa; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur; Trans-Activators; Uracil | 2002 |
[Evaluation of preoperative simultaneous radiochemotherapy combined with carboplatin and tegafur.uracil].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Preoperative Care; Radiotherapy Dosage; Tegafur; Uracil | 2002 |
Of what value is uracil/tegafur plus leucovorin to colorectal cancer patients?
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Approval; Health Services Accessibility; Humans; Leucovorin; Tegafur; United States; United States Food and Drug Administration; Uracil | 2002 |
[CPT-11 hepatic arterial injection plus oral UFT administration for liver metastasis of rectal cancer--report of two cases].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Hepatic Artery; Humans; Injections, Intra-Arterial; Irinotecan; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxidoreductases; Postoperative Care; Prognosis; Retrospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2002 |
[A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusion Pumps, Implantable; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Quality of Life; Rectal Neoplasms; Tegafur; Uracil | 2002 |
[Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
[A case of preoperative concurrent chemoradiotherapy and curative resection for locally advanced non-small-cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Preoperative Care; Tegafur; Uracil | 2002 |
[A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
[A case of colon metastasis to the lung treated successfully with combined chemotherapy of CPT-11 and 5'-DFUR].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Floxuridine; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Salvage Therapy; Tegafur; Uracil | 2002 |
Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Combinations; Female; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Postoperative Care; Prognosis; Survival Analysis; Tegafur; Treatment Outcome; Tumor Suppressor Protein p53; Uracil | 2002 |
Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Dihydrouracil Dehydrogenase (NADP); Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oxidoreductases; Tegafur; Thymidylate Synthase; Uracil | 2002 |
[A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Peritoneum; Tegafur; Uracil | 2002 |
[A case of advanced gastric cancer showing complete response to chemotherapy of peroral carcinostatic only].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[A case of multiple liver metastases from colon cancer successfully treated with modified pharmacokinetic modulating chemotherapy using Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2002 |
[Two patients with recurrent colon cancer who underwent surgery following a combination of irinotecan and UFT].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Irinotecan; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Tegafur; Uracil | 2002 |
[A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Tegafur; Uracil | 2002 |
[Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
[A case of unresectable advanced gastric cancer with peritoneal dissemination responding to UET/low-dose CDDP combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Neoplasms, Multiple Primary; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2002 |
Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Colonic Neoplasms; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Mitomycin; Neoplasms, Second Primary; Tegafur; Treatment Failure; Uracil | 2003 |
[Cardiac toxicity and UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Humans; Tegafur; Uracil | 2003 |
Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Cisplatin; Dexamethasone; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Follow-Up Studies; Hormones; Humans; Male; Middle Aged; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Risk Assessment; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2003 |
[A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Ducts, Extrahepatic; Cholecystectomy; Drug Administration Schedule; Drug Combinations; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Tegafur; Uracil | 2003 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Disease Progression; Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Japan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Oxidoreductases; Oxonic Acid; Peritoneal Neoplasms; Prognosis; Pyridines; Statistics as Topic; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2003 |
NICE recommends new treatment for breast and bowel cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Colonic Neoplasms; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Paclitaxel; Practice Guidelines as Topic; Taxoids; Tegafur; Uracil | 2003 |
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tegafur; Uracil | 2003 |
[A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pyridines; Remission Induction; Tegafur; Tongue Neoplasms; Uracil | 2003 |
[Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lung Neoplasms; Male; Pleural Effusion, Malignant; Tegafur; Uracil; Vinblastine; Vinorelbine | 2003 |
[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Combinations; Epirubicin; Female; Humans; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Taxoids; Tegafur; Trastuzumab; Uracil | 2003 |
[UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Radiotherapy Dosage; Survival Rate; Tegafur; Uracil | 2003 |
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Imidazoles; Luciferases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Osteoclasts; Tegafur; Uracil; Zoledronic Acid | 2003 |
[A case of multiple lung metastases from colon cancer after sigmoidectomy treated effectively by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Sigmoid Neoplasms; Tegafur; Uracil | 2003 |
Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; beta-Alanine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Oxidoreductases; Oxonic Acid; Pyridines; Tegafur; Uracil | 2003 |
A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Canada; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Female; Fluorouracil; Health Care Costs; Humans; Infusions, Parenteral; Leucovorin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Tegafur; Uracil | 2003 |
Oral tegafur-uracil plus leucovorin in metastatic colorectal cancer: clinical insights. Proceedings of a roundtable expert meeting. October 2002, Nice, France.
Topics: Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Neoplasm Metastasis; Tegafur; Uracil | 2003 |
[A case of multiple liver metastases from colon cancer successfully treated with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Middle Aged; Tegafur; Uracil | 2003 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
[Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Orotate Phosphoribosyltransferase; Proportional Hazards Models; RNA, Messenger; Tegafur; Thymidylate Synthase; Tumor Suppressor Protein p53; Uracil | 2003 |
[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Proteoglycans; Radiosurgery; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[Long-term survival after neck lymph node metastases from sigmoid colon cancer--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Neck; Sigmoid Neoplasms; Survivors; Tegafur; Uracil | 2003 |
Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Differentiation; Female; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Prognosis; Retrospective Studies; Statistics, Nonparametric; Tegafur; Thymidylate Synthase; Uracil | 2003 |
Modified pharmacokinetic modulating chemotherapy using 5-fluorouracil, UFT, and taxotere (docetaxel) for advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome; Uracil | 2003 |
[Support of TS-1, 5-FU preparation containing potent DPD inhibitor by determination of urinary uracil/serum 5-FU clearance].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding completely to hepatic arterial infusion and systemic chemotherapies].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Common Bile Duct; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Male; Radiotherapy, High-Energy; Remission Induction; Tegafur; Uracil | 2004 |
[Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Apoptosis; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Tegafur; Thymidylate Synthase; Uracil | 2004 |
[A case of huge submandibular malignant tumor treated successfully with UFT chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Submandibular Gland Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2004 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Lentinan; Middle Aged; Neoplasm Invasiveness; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2004 |
Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.
Topics: Antineoplastic Agents; Colonic Diseases; Colonoscopy; Drug Combinations; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Skull Neoplasms; Tegafur; Temporal Bone; Uracil | 2004 |
Concurrent chemo-radiotherapy for nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Disease-Free Survival; Evaluation Studies as Topic; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tegafur; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2004 |
[A case of gastric cancer with a synchronous hepatic metastasis responding to postoperative oral administration of UFT and intermittent intrahepatic arterial chemotherapy of 5-FU].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Male; Neoplasms, Multiple Primary; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2004 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pleurisy; Quality of Life; Tegafur; Uracil | 2004 |
Adjuvant chemotherapy for adenocarcinoma of the lung--is the standard of care ready for change?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Prodrugs; Tegafur; Uracil | 2004 |
[Renal transplantation surgery is closely linked with treatment for bilateral synchronous renal cell carcinomas or renal tumors in solitary kidney].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Female; Humans; Interferon-alpha; Kidney; Kidney Neoplasms; Kidney Transplantation; Living Donors; Male; Middle Aged; Neoplasms, Multiple Primary; Nephrectomy; Postoperative Care; Tegafur; Transplantation, Autologous; Uracil | 2004 |
[Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Home Care Services, Hospital-Based; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Postoperative Care; Tegafur; Uracil; Vomiting, Anticipatory | 2004 |
[Nedaplatin for recurrent cancer of the head and neck].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organoplatinum Compounds; Survival Rate; Tegafur; Uracil | 2004 |
[Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2004 |
[Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Drug Administration Routes; Female; Humans; Hysterotomy; Ovarian Neoplasms; Ovariectomy; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 2004 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Gemcitabine; Heart Failure; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Stents; Survivors; Tegafur; Uracil | 2004 |
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Disease-Free Survival; Endpoint Determination; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Reoperation; Reproducibility of Results; Tegafur; Treatment Outcome; Uracil | 2004 |
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer.
Topics: Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans; Neoplasm Staging; Proteoglycans; Tegafur; Uracil | 2004 |
Uracil-tegafur in early-stage lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
Uracil-tegafur in early-stage lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Lymph Nodes; Multivariate Analysis; Neoplasm Staging; Prognosis; Tegafur; Uracil | 2004 |
Spontaneous regression of recurrent squamous cell carcinoma of the tongue.
Topics: Aged; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Tegafur; Tongue Neoplasms; Uracil | 2004 |
[A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab].
Topics: Administration, Oral; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Segmental; Taxoids; Tegafur; Trastuzumab; Uracil | 2004 |
[A case of giant hepatocellular carcinoma treatable with radio frequent ablation therapy after effective UFT administration].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheter Ablation; Combined Modality Therapy; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Etoposide; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Globins; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Polymerase Chain Reaction; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gemcitabine; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Pancreatic Neoplasms; Quality of Life; Tegafur; Uracil | 2004 |
[Variation of cytokines with administration of chemotherapeutic and immuno-therapeutic drugs for colorectal cancer].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-2; Interleukin-4; Interleukin-6; Proteoglycans; Tegafur; Transforming Growth Factor beta; Uracil | 2004 |
[Case report--Complete response of liver metastasis of rectal cancer after combination chemotherapy of CPT-11 + UFT-E].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2004 |
[A case of successful treatment with combined 5-fluorouracil, adriamycin, cisplatin (FAP) therapy followed by Gemcitabine, UFT therapy and intra-arterial FAP therapy for unresectable advanced gallbladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Middle Aged; Tegafur; Uracil | 2004 |
[The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined Modality Therapy; Drug Combinations; Duodenal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Palliative Care; Stents; Tegafur; Uracil | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinations; Fluorouracil; Hepatectomy; Humans; Interferon-alpha; Interferon-beta; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Tegafur; Time Factors; Uracil | 2004 |
[Urachal carcinoma treated with neoadjuvant intra-arterial chemotherapy: a case report].
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intra-Arterial; Male; Tegafur; Urachus; Uracil | 2004 |
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Drug Combinations; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Period; Rectal Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 2004 |
Multiple ground-glass opacity in metastasis of malignant melanoma diagnosed by lung biopsy.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Dacarbazine; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Melanocytes; Melanoma; Middle Aged; Nasal Cavity; Nose Neoplasms; Picibanil; Tegafur; Tomography, X-Ray Computed; Uracil | 2005 |
[A case of synchronous double cancer responding to UFT--dermoid cyst with secondary malignant transformation and uterine endometrial adenocarcinoma].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Adenosquamous; Combined Modality Therapy; Dermoid Cyst; Drug Combinations; Endometrial Neoplasms; Female; Humans; Hysterotomy; Neoplasms, Multiple Primary; Ovarian Neoplasms; Ovariectomy; Quality of Life; Salpingostomy; Tegafur; Uracil | 2005 |
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[A case of liver metastases from cecal cancer successfully treated with fluorouracil and folinic acid (UFT/LV)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, Adjuvant; Colectomy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Tegafur; Uracil | 2005 |
[Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Rectal Neoplasms; Tegafur; Uracil | 2005 |
UFT inhibits lung metastases in spontaneous metastasis model of lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Humans; Hydroxybutyrates; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tegafur; Uracil | 2005 |
[Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Methotrexate; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Female; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Quality of Life; Tegafur; Uracil | 2005 |
Radiation therapy with UFT and low dose weekly cisplatin for nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Tegafur; Uracil | 2005 |
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil | 2005 |
Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Fatty Liver; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Tegafur; Tomography, X-Ray Computed; Uracil | 2005 |
Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell Line, Tumor; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Floxuridine; Fluorouracil; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Orotate Phosphoribosyltransferase; Oxonic Acid; Pyridines; Tegafur; Thymidine Phosphorylase; Treatment Outcome; Uracil; Xenograft Model Antitumor Assays | 2005 |
Leflunomide and peripheral neuropathy: a potential interaction between uracil/tegafur and leflunomide.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Comorbidity; Disease Progression; Drug Administration Schedule; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fluorouracil; Humans; Isoxazoles; Leflunomide; Male; Peripheral Nervous System Diseases; Polyneuropathies; Rectal Neoplasms; Tegafur; Time Factors; Uracil | 2005 |
[Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2005 |
Pulmonary cryptococcosis mimicking pulmonary metastases in a patient treated with Tegafur-uracil after lung cancer surgery.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cryptococcosis; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Lung Neoplasms; Male; Tegafur; Uracil | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2006 |
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Male; Pancreaticoduodenectomy; Tegafur; Treatment Outcome; Uracil | 2005 |
Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Middle Aged; Neoadjuvant Therapy; Rectal Neoplasms; Tegafur; Uracil | 2005 |
[A case of colorectal cancer effectively treated with UFT/LV].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Humans; Leucovorin; Male; Peritoneal Neoplasms; Tegafur; Uracil | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Irinotecan; Liver Neoplasms; Lung Neoplasms; Middle Aged; Tegafur; Uracil | 2005 |
[Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Rectal Neoplasms; Tegafur; Uracil | 2005 |
[A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Peritoneal Neoplasms; Quality of Life; Remission Induction; Tegafur; Uracil | 2005 |
[A case of multiple lung metastases of sigmoid colon cancer responding well to oral UFT+leucovorin therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Pneumonectomy; Quality of Life; Sigmoid Neoplasms; Tegafur; Uracil | 2005 |
[A case of rectal cancer treated by preoperative chemoradiation].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colostomy; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Rectum; Remission Induction; Tegafur; Uracil | 2005 |
[Usefulness in predicting parameters for the selection of responders who received immunochemotherapy with PSK in patients with colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; CD4-Positive T-Lymphocytes; Colorectal Neoplasms; Drug Combinations; Female; Humans; Interleukin-10; Interleukin-6; Male; Middle Aged; Proteoglycans; Tegafur; Uracil | 2005 |
[Hepatic arterial infusion (HAI) chemotherapy achieved a complete response (CR) for multiple liver metastases of colorectal cancer--two case reports].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2005 |
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Pneumonectomy; Tegafur; Treatment Outcome; Uracil | 2005 |
[A case of advanced pancreatic cancer treated with chemoradiation].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2005 |
[Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Stomatitis; Survival Rate; Tegafur; Uracil | 2005 |
[A case of recurrent colon cancer responding completely to uracil/tegafur (UFT) plus oral leucovorin (LV) therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lymph Node Excision; Neoplasm Recurrence, Local; Remission Induction; Tegafur; Uracil | 2005 |
Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Camptothecin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Organoplatinum Compounds; Quinazolines; Tegafur; Thiophenes; Treatment Outcome; Uracil | 2005 |
[A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Gastric Fundus; Humans; Liver Neoplasms; Male; Proteoglycans; Quality of Life; Survivors; Tegafur; Uracil | 2006 |
Prognostic factors for disease-free survival in pT2N0 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2006 |
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Mice; Mice, SCID; Neoplasm Metastasis; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2006 |
Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy).
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Risk Assessment; Tegafur; Uracil | 2006 |
[Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Topics: Aged; Antineoplastic Agents; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 2006 |
[A case of unresectable non-small cell lung cancer with pleural dissemination successfully treated with DIF].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lung Neoplasms; Oxonic Acid; Pleural Effusion, Malignant; Pyridines; Quality of Life; Tegafur; Uracil | 2006 |
[Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Female; Humans; Hyperbilirubinemia; Male; Middle Aged; Postoperative Care; Taurine; Tegafur; Uracil | 2006 |
[A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Sigmoid Neoplasms; Tegafur; Uracil | 2006 |
[New treatment strategies for patients with primary non-resectable rectal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Uracil; Vitamin B Complex | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2006 |
[Complete response to CPT-11 and UFT/LV combination therapy in a case with simultaneous multiple lung metastases from colon cancer].
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Irinotecan; Leucovorin; Leukopenia; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Neutropenia; Remission Induction; Tegafur; Uracil; Vomiting, Anticipatory | 2006 |
[Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Colostomy; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Omentum; Peritoneal Neoplasms; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Female; Gemcitabine; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pancreatic Neoplasms; Pyridines; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Rectal Neoplasms; Remission Induction; Retrospective Studies; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2006 |
[24 hour infusion of CPT-11/oral UFT/LV].
Topics: Administration, Oral; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Tegafur; Uracil | 2006 |
Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2006 |
[Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimidine Dehydrogenase Deficiency; Drug Combinations; Fatal Outcome; Humans; Liver Neoplasms; Male; Nausea; Oxonic Acid; Stomach Neoplasms; Tegafur; Uracil | 2006 |
Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Equilibrative Nucleoside Transporter 1; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; RNA, Messenger; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2006 |
Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Survival Analysis; Tegafur; Uracil | 2006 |
[Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Mice; Neoplasm Transplantation; Neoplasms; Oxonic Acid; Pharmaceutical Preparations; Rats; Sarcoma, Yoshida; Tegafur; Uracil | 2006 |
[Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Topics: beta-Alanine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Kidney; Oxonic Acid; Stomach Neoplasms; Tegafur; Uracil | 2006 |
[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Remission Induction; Stents; Tegafur; Trachea; Tracheal Stenosis; Tracheoesophageal Fistula; Uracil | 2006 |
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Gemcitabine; Humans; Liver Neoplasms; Male; Pancreatectomy; Pancreatic Neoplasms; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[A case of advanced rectal cancer responding to oral UFT and Leucovorin-based preoperative chemoradiation therapy].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Male; Quality of Life; Radiotherapy Dosage; Rectal Neoplasms; Rectum; Tegafur; Uracil | 2006 |
[A case of gemcitabine-based chemo-radiation therapy for locally advanced unresectable pancreatic cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Gemcitabine; Humans; Male; Middle Aged; Oxonic Acid; Pancreatic Neoplasms; Quality of Life; Radiotherapy Dosage; Survivors; Tegafur; Uracil | 2006 |
Complete response of highly advanced colon cancer with multiple lymph node metastases to irinotecan combined with UFT: report of a case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Colonoscopy; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Irinotecan; Lymphatic Metastasis; Middle Aged; Prodrugs; Tegafur; Tomography, X-Ray Computed; Uracil | 2006 |
Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Enterocolitis, Necrotizing; Fatal Outcome; Humans; Male; Mixed Function Oxygenases; Multiple Organ Failure; Polymorphism, Single Nucleotide; Sepsis; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
Targeted intra-arterial carboplatin chemoradiotherapy and tegafur/uracil for oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Delivery Systems; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2006 |
[The relationship between gene expression of Bcl-2 and Bax and the therapeutic effect in oral cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Gene Expression; Genes, bcl-2; Humans; Interferon-gamma; Killer Cells, Natural; Mouth Neoplasms; Picibanil; Survival Rate; Tegafur; Uracil | 2006 |
[Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Epirubicin; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Quality of Life; Tegafur; Tomography, X-Ray Computed; Uracil | 2006 |
[A case of effective chemoradiation therapy against anal fistula carcinoma recurred 10 years after surgery].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Humans; Lymph Nodes; Male; Quality of Life; Rectal Fistula; Tegafur; Time Factors; Uracil | 2006 |
Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
Topics: Animals; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Synergism; Female; Gefitinib; Gemcitabine; Humans; In Vitro Techniques; Irinotecan; Lung Neoplasms; Mice; Mice, Nude; Quinazolines; Random Allocation; Stomach Neoplasms; Tegafur; Trastuzumab; Uracil; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays | 2007 |
Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Enzyme Activation; Female; Humans; Immunohistochemistry; Male; Middle Aged; Orotate Phosphoribosyltransferase; Prognosis; Proportional Hazards Models; Survival Rate; Tegafur; Uracil | 2007 |
Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pneumonectomy; Retrospective Studies; Survival Rate; Tegafur; Time Factors; Treatment Outcome; Uracil | 2007 |
[A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Mastectomy; Neoplasm Invasiveness; Oxonic Acid; Skin Neoplasms; Tegafur; Uracil | 2007 |
[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Second-Look Surgery; Sigmoid Neoplasms; Survivors; Tegafur; Uracil | 2007 |
[A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
Topics: Adenocarcinoma; Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Pelvic Neoplasms; Quality of Life; Rectal Neoplasms; Tegafur; Uracil | 2007 |
The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Tegafur; United Kingdom; Uracil | 2007 |
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Pneumonectomy; Tegafur; Thoracoscopy; Uracil; Urinary Bladder Neoplasms | 2007 |
[Comparison the standard therapies of gastric cancer in Japan with those in the West].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Europe; Fluorouracil; Gastrectomy; Humans; Japan; Lymph Node Excision; Mitomycin; Neoplasm Staging; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate; Tegafur; United States; Uracil | 2007 |
[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Europe; Female; Gefitinib; Humans; Japan; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines; Tegafur; United States; Uracil | 2007 |
[A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxonic Acid; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2007 |
Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Larynx; Neoplasm Recurrence, Local; Radiotherapy Dosage; Salvage Therapy; Tegafur; Treatment Outcome; Uracil | 2007 |
Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Lung; Mice; Mice, Inbred C57BL; Postoperative Care; Survival Analysis; Tegafur; Time Factors; Treatment Outcome; Tumor Burden; Uracil | 2007 |
Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Preoperative Care; Prognosis; Radiation Tolerance; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Middle Aged; Neoplastic Cells, Circulating; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[Hand-foot syndrome associated with uracil/tegafur and docetaxel in a patient with lung cancer].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Interactions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Lung Neoplasms; Paresthesia; Syndrome; Taxoids; Tegafur; Uracil | 2007 |
Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Epirubicin; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Prognosis; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2007 |
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
Topics: Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Quality of Health Care; Taxoids; Tegafur; Uracil | 2007 |
[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Combined Modality Therapy; Drug Administration Routes; Drug Combinations; Gastric Bypass; Hepatectomy; Humans; Jejunum; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Second-Look Surgery; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nephrectomy; Pneumonectomy; Quality of Life; Remission Induction; Tegafur; Uracil | 2007 |
Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; ErbB Receptors; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Mutation; Retrospective Studies; Survival Rate; Tegafur; Tumor Cells, Cultured; Uracil | 2007 |
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease Progression; Disease-Free Survival; Female; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Rectal Neoplasms; Retrospective Studies; Salvage Therapy; Tegafur; Uracil | 2007 |
Enhancement of antitumor effect of tegafur/uracil (UFT) plus leucovorin by combined treatment with protein-bound polysaccharide, PSK, in mouse models.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Colonic Neoplasms; Disease Models, Animal; Drug Therapy, Combination; Female; Leucovorin; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Proteoglycans; Sarcoma; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2007 |
[Two cases of stage IV gastric cancer responding to chemotherapy with S-1 or UFT].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[The fourth report from Sapporo Tsukisamu Hospital - chemotherapy and its regimen as second choice for patients with early gastric cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2007 |
[A case of metastatic rectal cancer showing a sustained complete response to chemotherapy with FOLFIRI followed by UFT].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Rectal Neoplasms; Tegafur; Uracil | 2007 |
Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Remission Induction; Tegafur; Uracil | 2007 |
Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Humans; Male; Middle Aged; Prospective Studies; Tegafur; Time Factors; Uracil | 2007 |
UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Topics: 4-Butyrolactone; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Immunohistochemistry; Middle Aged; Tegafur; Uracil; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Remission Induction; Tegafur; Uracil | 2007 |
[A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
UFT as maintenance therapy in patients with advanced colorectal cancer responsive to the FOLFOX4 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Quality of Life; Remission Induction; Tegafur; Uracil | 2007 |
[A case of complete remission(CR)persisting from UFT-E in an old patient with liver metastasis of gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; Remission Induction; Stomach Neoplasms; Tegafur; Tomography Scanners, X-Ray Computed; Uracil | 2008 |
[A case of sigmoid colon cancer in a patient undergoing hemodialysis treated by tegafur/uracil/folinate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonoscopy; Humans; Leucovorin; Male; Middle Aged; Renal Dialysis; Sigmoid Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[A long-term surviving patient with unresectable lung metastasis from colon cancer treated with intravenous administration of activated autologous lymphocytes and low-dose chemotherapy--a case report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Female; Humans; Immunotherapy; Injections, Intravenous; Irinotecan; Lung Neoplasms; Lymphocyte Activation; Lymphocyte Transfusion; Lymphocytes; Oxonic Acid; Sigmoid Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Transplantation, Autologous; Uracil | 2007 |
[A long-term survival case of advanced sigmoid colon cancer with massive metastases to the para-aortic lymph nodes].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Biomarkers, Tumor; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sigmoid Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2007 |
Pharmacokinetics of gamma-hydroxybutylic acid (GHB) and gamma-butyrolactone (GBL), the anti-angiogenic metabolites of oral fluoropyrimidine UFT, in patients with gastric cancer.
Topics: 4-Butyrolactone; Administration, Oral; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Drug Combinations; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NAD+); Dihydrouracil Dehydrogenase (NADP); Humans; Male; Rectal Neoplasms; Tegafur; Uracil | 2008 |
Metronomic chemotherapy using weekly low-dosage CPT-11 and UFT as postoperative adjuvant therapy in colorectal cancer at high risk to recurrence.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Rate; Tegafur; Uracil | 2007 |
[Effective treatment with oral administration of UFT and leucovorin (Uzel) in a patient with liver metastasis and peritoneal dissemination from cecal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Female; Humans; Leucovorin; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[Two cases of recurrent colorectal cancer treated successfully with folinate/tegafur/uracil (UFT/LV) chemotherapy on an outpatient basis].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Female; Humans; Leucovorin; Lung Neoplasms; Recurrence; Tegafur; Tomography, X-Ray Computed; Treatment Failure; Uracil | 2008 |
[A case of lumbar metastases from rectal cancer successfully treated by UFT plus oral leucovorin (LV) therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Humans; Leucovorin; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Treatment Failure; Uracil | 2008 |
5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Rats; Rats, Inbred F344; RNA, Neoplasm; Tegafur; Uracil; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Remission Induction; Salvage Therapy; Tegafur; Treatment Outcome; Uracil | 2009 |
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-alpha, and tegafur-uracil: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Female; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Tegafur; Uracil | 2008 |
[Study of a relationship between a change in the urinary uracil value after a S-1 long-term administration and the recurrence of stomach cancer].
Topics: Aged; Drug Combinations; Female; Health; Humans; Male; Middle Aged; Oxonic Acid; Recurrence; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 2008 |
[A patient in whom oral UFT/Leucovorin therapy proved markedly effective for lung metastasis after surgery for colon cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Leucovorin; Lung Neoplasms; Male; Radiography; Tegafur; Uracil | 2008 |
[A case of simultaneous hepatic metastases of ascending colon cancer responding completely to tegafur/uracil plus oral Leucovorin therapy after primary lesion resection].
Topics: Administration, Oral; Aged, 80 and over; Colonic Neoplasms; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Tegafur; Uracil | 2008 |
[Case of esophageal cancer successfully performed in early response evaluation for preoperative chemotherapy by FDG-PET].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Esophagectomy; Fatal Outcome; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Tegafur; Uracil | 2008 |
[A case of long survival with unresectable duodenal papilla cancer treated with oral chemotherapy using combination UFT and cyclophosphamide].
Topics: Adenoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Duodenal Neoplasms; Duodenoscopy; Female; Humans; Tegafur; Time Factors; Tomography, X-Ray Computed; Uracil | 2008 |
Immunochemotherapy with PSK and fluoropyrimidines improves long-term prognosis for curatively resected colorectal cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Floxuridine; Fluorouracil; Humans; Immunotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Proteoglycans; Retrospective Studies; Tegafur; Uracil | 2008 |
Gemcitabine plus UFT combination chemotherapy as second- or third-line therapy in non-small cell lung cancer: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Evidence-Based Medicine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Salvage Therapy; Tegafur; Uracil | 2008 |
A combined pharmacokinetic-pharmacodynamic (PK-PD) model for tumor growth in the rat with UFT administration.
Topics: Algorithms; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Biotransformation; Dihydrouracil Dehydrogenase (NADP); Models, Statistical; Rats; Regional Blood Flow; Tegafur; Tissue Distribution; Uracil | 2009 |
[A case of multiple liver metastases of sigmoid colon cancer responding well to UFT+Leucovorin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Radiography; Sigmoid Neoplasms; Tegafur; Ultrasonography; Uracil | 2008 |
[Two cases of squamous cell carcinoma of upper urinary tract with hypercalcemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Fatal Outcome; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Hypercalcemia; Kidney Neoplasms; Kidney Pelvis; Male; Middle Aged; Neoplasm Recurrence, Local; Parathyroid Hormone-Related Protein; Radiotherapy; Tegafur; Uracil; Ureteral Neoplasms | 2008 |
[Two cases of advanced hepatocellular carcinoma (HCC) effectively treated by oral UFT administration].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[Three cases of complete response after treatment with UFT and leucovorin for recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
[A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Fluorouracil; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Drug Combinations; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Palliative Care; Pyrimidinones; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2008 |
The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Maxillary Sinus; Methotrexate; Middle Aged; Neoadjuvant Therapy; Organ Preservation; Paranasal Sinus Neoplasms; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2009 |
[Regression of metastatic hepatic cancer from gastric cancer by polysaccharide K and UFT administration--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Humans; Liver Neoplasms; Male; Polysaccharides; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2008 |
Pharmacokinetic study of S-1.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Area Under Curve; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fasting; Fluorouracil; Food; Gastric Acidity Determination; Half-Life; Humans; Hydrogen-Ion Concentration; Oxonic Acid; Pantoprazole; Pyridines; Tegafur; Triazines; Uracil | 2009 |
[Retrospective analysis of uracil/tegafur, cyclophosphamide and gemcitabine compared with gemcitabine monotherapy in unresectable pancreatic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2009 |
Efficacy of postoperative UFT (Tegafur/Uracil) plus PSK therapies in elderly patients with resected colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Neoplasm Recurrence, Local; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2009 |
[A case report--complete disappearance of multiple intrahepatic recurrences and portal thrombus in a case of hepatocellular carcinoma treated with UFT-E].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Male; Recurrence; Tegafur; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome; Uracil | 2009 |
Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Tegafur; Thyroid Gland; Uracil | 2009 |
Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Combined Modality Therapy; Female; HLA-A Antigens; HLA-A2 Antigen; HLA-A24 Antigen; Humans; Interferon-gamma; Leucovorin; Male; Middle Aged; T-Lymphocytes, Cytotoxic; Tegafur; Uracil; Vaccination | 2009 |
Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2009 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Hormone Replacement Therapy; Humans; Lymphatic Metastasis; Nitriles; Pleural Neoplasms; Radiography; Recurrence; Skin Neoplasms; Tamoxifen; Tegafur; Time Factors; Triazoles; Uracil | 2009 |
Protective effects of water-soluble low-molecular-weight beta-(1,3-1,6)d-glucan purified from Aureobasidium pullulans GM-NH-1A1 against UFT toxicity in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Basidiomycota; beta-Glucans; Cell Line, Tumor; Drug Synergism; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Mucositis; Neoplasm Transplantation; Tegafur; Uracil | 2009 |
Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Leucovorin; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3 | 2009 |
[A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2009 |
[Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Pancreaticoduodenectomy; Tegafur; Uracil | 2009 |
[A case of anaplastic carcinoma of thyroid administered peroral fluorinated pyrimidine for long-term survival during three years].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Combinations; Female; Humans; Oxonic Acid; Tegafur; Thyroid Neoplasms; Uracil | 2009 |
Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Floxuridine; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Rectal Neoplasms; Retrospective Studies; Tegafur; Uracil | 2009 |
Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres
Topics: Administration, Oral; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Orotate Phosphoribosyltransferase; RNA, Messenger; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Uracil; Vena Cava, Inferior | 2009 |
The effect of neoadjuvant therapy on the 5-fluorouracil metabolic and relative enzymes of oral squamous cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Orotate Phosphoribosyltransferase; Tegafur; Thymidine Phosphorylase; Thymidylate Synthase; Uracil | 2009 |
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
Topics: AC133 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Glycoproteins; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Octamer Transcription Factor-3; Peptides; Prognosis; Radiotherapy Dosage; Rectal Neoplasms; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; SOXB1 Transcription Factors; Survival Rate; Tegafur; Tumor Cells, Cultured; Uracil | 2009 |
Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Constriction, Pathologic; Cyclophosphamide; Deoxycytidine; Female; Gemcitabine; Humans; Hypertension, Portal; Liver Diseases; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Radiotherapy Dosage; Stents; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
[A case of disease-free survival with low-dose chemotherapy after resection of hepatic and pulmonary metastases from rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Rectal Neoplasms; Tegafur; Uracil | 2009 |
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
The necessity of chemotherapy in T3N0M0 colon cancer without risk factors.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2009 |
[A case of simultaneous bilateral metastatic ovarian tumor of colon cancer followed by FOLFOX4 Regimen and oral tegafur/uracil+oral leucovorin after R0 operation].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Ovarian Neoplasms; Tegafur; Uracil; Vitamin B Complex | 2009 |
UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
Topics: Administration, Oral; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Injections, Intravenous; Leucovorin; Retrospective Studies; Taxoids; Tegafur; Treatment Outcome; Uracil; Vinblastine; Vinorelbine | 2009 |
[Gemcitabine in combination with S-1 or UFT in patients with advanced pancreatic cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2009 |
[Drug-induced liver injury associated with uracil/tegafur + folinate therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Female; Folic Acid; Humans; Tegafur; Uracil | 2009 |
[A case of effective treatment with UFT/LV chemotherapy for para-aortic lymph node metastasis from colonic cancer 8 years after colectomy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Colectomy; Colonic Neoplasms; Female; Humans; Leucovorin; Lymphatic Metastasis; Positron-Emission Tomography; Tegafur; Time Factors; Uracil | 2009 |
Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1?
Topics: Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Breath Tests; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2A6; Drug Combinations; Female; Gas Chromatography-Mass Spectrometry; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms; Oxonic Acid; Polymorphism, Genetic; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tegafur; Uracil | 2010 |
A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Retrospective Studies; Stomach Neoplasms; Tegafur; Uracil | 2010 |
[A Case of gastric endocrine cell carcinoma successfully treated by FU plus irinotecan(CPT-11)adjuvant therapy against recurrent metastases].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Fluorouracil; Gastrectomy; Humans; Irinotecan; Lymph Node Excision; Male; Neoplasm Metastasis; Stomach Neoplasms; Tegafur; Uracil | 2009 |
[Preoperative chemoradiotherapy for resectable lower rectal cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Rectal Neoplasms; Tegafur; Uracil | 2009 |
[A case report of multiple liver metastases from colorectal cancer effectively treated with systemic chemotherapy and hepatic arterial infusion].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Hepatectomy; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Sigmoid Neoplasms; Tegafur; Uracil | 2009 |
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Tegafur; Uracil | 2009 |
Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Health Status; Humans; Japan; Leucovorin; Likelihood Functions; Male; Middle Aged; Prospective Studies; Quality of Life; Tegafur; Uracil | 2010 |
[Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Catheter Ablation; Combined Modality Therapy; Humans; Leucovorin; Liver Neoplasms; Male; Microspheres; Remission Induction; Sigmoid Neoplasms; Starch; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of complete response after treatment with UFT and leucovorin for synchronous multiple liver metastases of rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
The unusual presentation of gastric adenocarcinoma as a testicular mass: a favorable response to docetaxel and Cisplatin plus oral tegafur/uracil and leucovorin.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Leucovorin; Male; Stomach Neoplasms; Taxoids; Tegafur; Testicular Neoplasms; Uracil | 2010 |
Health-related quality of life of colorectal cancer patients receiving oral UFT plus leucovorin compared with those with surgery alone.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chemotherapy, Adjuvant; Chi-Square Distribution; Colectomy; Colorectal Neoplasms; Colostomy; Drug Combinations; Female; Humans; Leucovorin; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Doxorubicin; Female; Humans; Injections, Subcutaneous; Liver Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Survival Rate; Tegafur; Treatment Outcome; Uracil; Xenograft Model Antitumor Assays | 2010 |
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Patient Selection; Small Cell Lung Carcinoma; Tegafur; Uracil; Vinblastine; Vinorelbine | 2010 |
[A case of effective chemotherapy using S-1 and CPT-11 following chemoradiotherapy with UFT and Leucovorin for unresectable advanced sigmoid colon cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Oxonic Acid; Sigmoid Neoplasms; Tegafur; Uracil | 2010 |
[Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Recurrence; Remission Induction; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Resistance, Neoplasm; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Neoplasm Staging; Recurrence; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Hepatocellular; Hepatitis, Autoimmune; Humans; Liver Neoplasms; Male; Radiography; Tegafur; Uracil | 2010 |
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug Combinations; Drug Evaluation, Preclinical; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Mice; Middle Aged; Oxonic Acid; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2010 |
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphocyte Count; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Radiotherapy, Adjuvant; Rectal Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2010 |
[Immunohistochemical and clinicopathological study of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyl transferase expression in oral cancer patients responding to UFT].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Dihydrouracil Dehydrogenase (NADP); Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Orotate Phosphoribosyltransferase; Tegafur; Thymidylate Synthase; Uracil | 2010 |
[Compliance of oral UFT plus leucovorin adjuvant chemotherapy in patients who underwent curative resection for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Diarrhea; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2010 |
[A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Staging; Portal Vein; Remission Induction; Tegafur; Thrombosis; Tomography, X-Ray Computed; Uracil | 2010 |
Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Gene Frequency; Glucuronosyltransferase; Humans; Leucovorin; Multivariate Analysis; Polymorphism, Genetic; Prospective Studies; Tegafur; Uracil | 2011 |
[A case of rectal cancer combined with intraperitoneal abscess responding completely to uracil/tegafur (UFT) plus oral leucovorin (LV) therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colostomy; Combined Modality Therapy; Humans; Leucovorin; Male; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Combinations; Estrogen Receptor alpha; Estrogens; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Oxonic Acid; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tegafur; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured; Uracil | 2011 |
[European Organization for Research and Treatment of Cancer QLQ-C30 and functional assessment of cancer therapy- general for measurement of quality of life in colorectal cancer patients who received adjuvant chemotherapy- a comparison].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Europe; Female; Humans; Japan; Leucovorin; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Tegafur; Uracil | 2010 |
[A case of advanced rectal cancer with multiple liver metastases successfully treated by perioperative administration of UFT and oral leucovorin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Male; Neoplasm Staging; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Prospective Studies; Radiotherapy Dosage; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2010 |
[Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2010 |
[Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug Resistance, Neoplasm; Humans; Interferons; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
Uracil-Tegafur-induced pleural effusion following lung cancer surgery.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Female; Humans; Lung Neoplasms; Pleural Effusion; Pneumonectomy; Tegafur; Uracil | 2010 |
Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Survival Analysis; Tegafur; Uracil | 2011 |
Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tegafur; Time Factors; Treatment Outcome; Uracil; Xenograft Model Antitumor Assays | 2010 |
Combined chemoradiotherapy for early glottic cancer in clinical practice in Japan: analysis of 10 institutions.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorouracil; Glottis; Humans; Japan; Laryngeal Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2010 |
[An elderly patient with advanced gastric cancer maintaining complete response for over 3 years by oral administration of UFT following short span of S-1].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Oxonic Acid; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2010 |
[A case of lung metastases of colon cancer demonstrating complete response for more than five years after treatment with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Remission Induction; Tegafur; Time Factors; Uracil | 2010 |
[A case of ovarian metastasis from colon cancer successfully treated with multidisciplinary therapy].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Female; Humans; Hysterectomy; Krukenberg Tumor; Ovarian Neoplasms; Ovariectomy; Oxonic Acid; Sigmoid Neoplasms; Tegafur; Uracil | 2010 |
[A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Combined Modality Therapy; Fluorouracil; Humans; Irinotecan; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Rectal Neoplasms; Tegafur; Uracil | 2010 |
[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bevacizumab; Camptothecin; Combined Modality Therapy; Female; Fluorouracil; Hepatectomy; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Sigmoid Neoplasms; Tegafur; Uracil | 2010 |
[Hepatic resection after systemic chemotherapy for liver metastasis of colorectal cancer].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Hepatectomy; Humans; Irinotecan; Length of Stay; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Tegafur; Uracil | 2010 |
[An experience of curative resection of local recurrent rectal cancer with high-level sacrectomy after preoperative chemo-radiation therapy].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Humans; Irinotecan; Length of Stay; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Rectal Neoplasms; Sacrum; Tegafur; Uracil; Vitamin B Complex | 2010 |
[A case of local relapsed rectal cancer responding to low-dose S-1].
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Oxonic Acid; Rectal Neoplasms; Tegafur; Uracil | 2010 |
[A case of salvage treatment for local recurrence of squamous cell anal carcinoma after chemoradiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Neoplasm Recurrence, Local; Salvage Therapy; Tegafur; Uracil | 2010 |
[A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Female; Humans; Lymph Node Excision; Mastectomy; Neoplasm Recurrence, Local; Paclitaxel; Tamoxifen; Taxoids; Tegafur; Trastuzumab; Uracil | 2010 |
[A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Leucovorin; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[Combination chemotherapy of docetaxel and UFT against hormone refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Feasibility Studies; Hormones; Humans; Male; Middle Aged; Prostatic Neoplasms; Taxoids; Tegafur; Uracil | 2011 |
[A case of drug-induced interstitial pneumonitis after chemotherapy with UFT and leucovorin for multiple lung metastases of rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Lung Diseases, Interstitial; Lung Neoplasms; Male; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Recurrence; Tegafur; Tomography, X-Ray Computed; Uracil; Urinary Bladder Neoplasms | 2011 |
Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Capecitabine; Chemotherapy, Adjuvant; Cholecystectomy; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2011 |
Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients.
Topics: AC133 Antigen; Adult; Aged; Aged, 80 and over; Antigens, CD; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Chi-Square Distribution; Colonoscopy; Cyclooxygenase 2; ErbB Receptors; Female; Glycoproteins; Humans; Immunoenzyme Techniques; Logistic Models; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Peptides; Predictive Value of Tests; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Treatment Outcome; Uracil | 2011 |
[A case of UFT-induced complete response against multiple lung metastases of hepatocarcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Neoplasms; Male; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
Long-term survival results of surgery alone versus surgery plus UFT (Uracil and Tegafur)-based adjuvant therapy in patients with stage II colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Retrospective Studies; Taiwan; Tegafur; Treatment Outcome; Uracil | 2011 |
[A case of synchronous multiple liver metastases of rectal cancer successfully treated with tegafur/uracil and oral leucovorin chemotherapy].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Leucovorin; Liver Neoplasms; Male; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Electrocoagulation; Female; Humans; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Survival Rate; Tegafur; Uracil | 2011 |
Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclin-Dependent Kinase Inhibitor p21; Female; Gastrectomy; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Stomach Neoplasms; Tegafur; Treatment Outcome; Tumor Suppressor Protein p53; Uracil | 2012 |
Prognostic factors for survival and resection in patients with initial nonresectable locally advanced pancreatic cancer treated with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemoradiotherapy; Deoxycytidine; Dose Fractionation, Radiation; Female; Gemcitabine; Humans; Leucovorin; Logistic Models; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Tegafur; Tumor Burden; Uracil | 2012 |
Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Down-Regulation; Doxorubicin; Etoposide; Floxuridine; Fluorescent Antibody Technique; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Irinotecan; Metaphase; Paclitaxel; Polymerase Chain Reaction; Predictive Value of Tests; Protein Array Analysis; Reproducibility of Results; Tegafur; Tissue Array Analysis; Tumor Cells, Cultured; Up-Regulation; Uracil | 2012 |
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Leucovorin; Liver Neoplasms; Middle Aged; Remission Induction; Tegafur; Uracil | 2011 |
[A case of laparoscopic radiofrequency ablation for liver metastatic tumor from colorectal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Colonic Neoplasms; Female; Humans; Laparoscopy; Leucovorin; Liver Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[An example of metastasis to the iliopsoas muscle from sigmoid colon cancer].
Topics: Abdominal Muscles; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Male; Neoplasms, Muscle Tissue; Positron-Emission Tomography; Sigmoid Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2011 |
[A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Tegafur; Time Factors; Tomography, X-Ray Computed; Uracil | 2011 |
[Oral antineoplastic agents for prostate cancer].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Estramustine; Humans; Male; Oxonic Acid; Prostatic Neoplasms; Tegafur; Uracil | 2011 |
Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2012 |
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclophosphamide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Pyrazoles; Sulfonamides; Tegafur; Uracil; Vascular Endothelial Growth Factor A | 2012 |
[Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Humans; Leucovorin; Liver Neoplasms; Male; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
[A retrospective study of UFT and oral leucovorin plus PSK combination adjuvant chemotherapy in patients with stage III colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Leucovorin; Neoplasm Staging; Polysaccharides; Recurrence; Retrospective Studies; Tegafur; Uracil | 2012 |
[Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Gene Expression; Gene Expression Profiling; Genetic Association Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Prognosis; Tegafur; Thymidine Phosphorylase; Uracil | 2012 |
[A case of stage IV colon cancer effectively treated with tegafur uracil/calcium folinate in a patient on hemodialysis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Humans; Kidney Failure, Chronic; Leucovorin; Male; Middle Aged; Neoplasm Staging; Renal Dialysis; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
Multi-institutional analysis of early glottic cancer from 2000 to 2005.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Glottis; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Tegafur; Time Factors; Uracil | 2012 |
Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
[A case of liver metastases of sigmoid colon cancer treated effectively by oral UFT/LV].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Sigmoid Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2012 |
Ten-year survival of curability B gastric cancer patients treated by tegafur-uracil as postoperative adjuvant chemotherapy in a common public hospital: univariate and multivariate analyses.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Digestive System Surgical Procedures; Female; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Postoperative Care; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Uracil | 2012 |
[A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Granulocyte Colony-Stimulating Factor; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Tegafur; Uracil | 2012 |
[Trends in drug-induced liver injury based on reports of adverse reactions to PMDA in Japan].
Topics: Adverse Drug Reaction Reporting Systems; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Humans; Incidence; Japan; Liver Failure, Acute; Tegafur; Time Factors; Uracil | 2012 |
[Clinical study of Peptide-cocktail vaccination with tegafur-uracil/leucovorin for advanced colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil; Vaccines, Subunit | 2012 |
[Pharmacokinetics of S-1 capsule in patients with advanced gastric cancer].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capsules; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur; Uracil | 2012 |
Surgical resection of a metastatic skull tumor from lung cancer.
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Humans; Lung Neoplasms; Skull; Skull Neoplasms; Tegafur; Uracil | 2012 |
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prognosis; Rectal Neoplasms; Remission Induction; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2013 |
The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Lymphocyte Count; Male; Middle Aged; Nutritional Status; Oxonic Acid; Predictive Value of Tests; Retrospective Studies; Serum Albumin; Stomach Neoplasms; Tegafur; Time Factors; Uracil; Young Adult | 2013 |
Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Asian People; Carcinoma, Hepatocellular; Cytochrome P-450 CYP2A6; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Genotype; Hepatitis C; Humans; Japan; Liver Neoplasms; Male; Minisatellite Repeats; Polymorphism, Genetic; Tegafur; Thymidylate Synthase; Uracil | 2013 |
[A retrospective study of UFT and oral leucovorin combination adjuvant chemotherapy for patients over 76 years old with stage III colon cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Female; Humans; Leucovorin; Male; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 2013 |
[A case of metastatic acsending colon cancer showing sustained complete response to chemotherapy with SOX and followed UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; Humans; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Quality of Life; Tegafur; Tomography, X-Ray Computed; Uracil | 2013 |
Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Topics: Acetates; Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclopentanes; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Injections, Intraperitoneal; Liver Neoplasms; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Oxylipins; Survival Analysis; Tegafur; Uracil; Verapamil | 2013 |
Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Palliative Care; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prognosis; Proportional Hazards Models; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C-Reactive Protein; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Chemoradiotherapy; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphocytes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutrophils; Prognosis; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2013 |
Metachronous, colitis-associated rectal cancer that developed after sporadic adenocarcinoma in an adenoma in a patient with longstanding Crohn's disease: a case report.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Crohn Disease; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Prognosis; Rectal Neoplasms; Tegafur; Uracil | 2013 |
Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Disease Progression; Drug Combinations; Estramustine; Exanthema; Humans; Male; Middle Aged; Nausea; Neoplasm Grading; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Tegafur; Uracil | 2014 |
Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Preoperative Period; Rectal Neoplasms; Taiwan; Tegafur; Treatment Outcome; Uracil | 2014 |
Assessment of the value of carcinoembryonic antigen reduction ratio as a prognosis factor in rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Multivariate Analysis; Prognosis; Rectal Neoplasms; Rectum; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
[Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Etoposide; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Prostatic Neoplasms, Castration-Resistant; Salvage Therapy; Streptonigrin; Taxoids; Tegafur; Uracil | 2013 |
CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Chemoradiotherapy; Female; Follow-Up Studies; Forkhead Transcription Factors; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Observer Variation; Prognosis; Rectal Neoplasms; Survival Rate; T-Lymphocytes, Regulatory; Tegafur; Uracil | 2014 |
Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colorectal Neoplasms; Digestive System Surgical Procedures; Female; Humans; Lymphocyte Activation; Male; Middle Aged; Neoplasm Proteins; Prognosis; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2013 |
Repeat hepatectomy for intrahepatic recurrence of cholangiolocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Fatal Outcome; Hepatectomy; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Reoperation; Tegafur; Uracil | 2013 |
Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy, Adjuvant; Cisplatin; DNA, Viral; Drug Combinations; Epirubicin; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Leucovorin; Male; Middle Aged; Mitomycin; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2014 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Tegafur; Triple Negative Breast Neoplasms; Uracil | 2014 |
[A case of severe enteritis induced by adjuvant chemotherapy for colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clostridioides difficile; Enteritis; Fatal Outcome; Humans; Leucovorin; Male; Neoplasm Staging; Sigmoid Neoplasms; Tegafur; Uracil | 2014 |
Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil; Young Adult | 2014 |
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Lung Neoplasms; Male; Recurrence; Tegafur; Time Factors; Treatment Outcome; Uracil; Zoledronic Acid | 2014 |
Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; DNA, Neoplasm; Humans; Immunohistochemistry; Leucovorin; Mutation; Neoadjuvant Therapy; Rectal Neoplasms; Retrospective Studies; Sequence Analysis, DNA; Tegafur; Tumor Suppressor Protein p53; Uracil | 2014 |
Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Male; Oxonic Acid; Tegafur; Uracil | 2015 |
Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Male; Oxonic Acid; Tegafur; Uracil | 2015 |
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Patient Selection; Postoperative Period; Prodrugs; Proportional Hazards Models; Tegafur; Uracil | 2015 |
[A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Tegafur; Uracil | 2014 |
Efficacy of tegafur-uracil in advanced urothelial cancer patients after the treatment failure of platinum-based chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Platinum; Retrospective Studies; Tegafur; Uracil; Urologic Neoplasms | 2015 |
Volume-reserving Surgery after Photodynamic Therapy for Biliary Papillomatosis: A Case Report.
Topics: Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Embolization, Therapeutic; Gamma Rays; Hepatectomy; Hepatic Duct, Common; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Photochemotherapy; Tegafur; Uracil | 2015 |
[Results of a Special Drug Use-Results Survey on Compliance to Tegafur/Uracil(UFT)Adjuvant Chemotherapy for Non-Small Cell Lung Cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Data Collection; Female; Humans; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil; Young Adult | 2015 |
[A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cystoscopy; Female; Humans; Tegafur; Treatment Outcome; Uracil; Urinary Bladder Neoplasms | 2015 |
[A Case of Peritoneal Metastasis of Breast Cancer Diagnosed by Laparoscopic-Assisted Right Hemicolectomy].
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal; Colectomy; Female; Humans; Laparoscopy; Peritoneal Neoplasms; Recurrence; Tamoxifen; Tegafur; Uracil | 2015 |
[A Case of Ascending Colon Cancer with Extra Iliac Lymph Node Metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, Ascending; Colonic Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Prognosis; Tegafur; Uracil | 2015 |
[A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Humans; Leucovorin; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2015 |
[Study of the Postoperative Adjuvant Chemotherapy with UFT/LV or Capecitabine for Stage III Colorectal Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 2016 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Floxuridine; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Uracil | 2016 |
Increase in Gene Expression of TYMP, DPYD and HIF1A Are Associated with Response to Preoperative Chemoradiotherapy Including S-1 or UFT for Rectal Cancer.
Topics: Adult; Aged; Chemoradiotherapy; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Oxonic Acid; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tegafur; Thymidine Phosphorylase; Uracil | 2016 |
Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil | 2016 |
[An Elderly Patient with Multiple Lung Metastases after Colectomy Successfully Treated with a Combination Oral UFT/LV Chemotherapy Regimen].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Female; Humans; Leucovorin; Lung Neoplasms; Sigmoid Neoplasms; Tegafur; Treatment Outcome; Uracil | 2016 |
A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Female; Humans; Male; Rectal Neoplasms; Remission Induction; Survival Rate; Tegafur; Uracil | 2016 |
[A Case of Primary Acinic Cell Carcinoma(ACC)of the Breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Acinar Cell; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 2016 |
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2017 |
Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2017 |
The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neoplasm Staging; Prognosis; Proportional Hazards Models; Survival Rate; Tegafur; Uracil | 2017 |
Tegafur-uracil-induced rapid development of advanced hepatic fibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Carcinoma, Hepatocellular; Diuretics; Female; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Uracil; Withholding Treatment | 2017 |
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Cytomegalovirus; Drug Resistance, Neoplasm; Fluorouracil; Head and Neck Neoplasms; Humans; Immunotherapy, Adoptive; Interferon-gamma; Myeloid-Derived Suppressor Cells; Neoplasm Staging; Phosphoproteins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tegafur; Tumor Microenvironment; Uracil; Viral Matrix Proteins | 2017 |
Feasibility Trial of Oral UFT after Platinum-based Adjuvant Chemotherapy in Patients with Resected Non-small Cell Lung Cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Tegafur; Uracil | 2017 |
The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Capecitabine; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Gemcitabine; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Neutrophils; Pancreatic Neoplasms; Platelet Count; Prognosis; Retrospective Studies; Tegafur; Tumor Burden; Uracil | 2018 |
The Tradition of the Rising Sun: When Geography Counts.
Topics: Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Geography; Humans; Lung Neoplasms; Paclitaxel; Tegafur; Uracil | 2018 |
The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Postoperative Care; Prognosis; Survival Rate; Tegafur; Uracil | 2018 |
[Renal Cancer after Spontaneous Rupture Successfully Treated with Low-Dose Oral UFT - A Case Report].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Kidney Diseases; Kidney Neoplasms; Male; Rupture, Spontaneous; Tegafur; Treatment Outcome; Uracil | 2018 |
Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Circadian Rhythm; Drug Administration Schedule; Drug Chronotherapy; Drug Combinations; Male; Models, Biological; Rats, Wistar; Tegafur; Uracil | 2018 |
Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2019 |
Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Postoperative Period; Retrospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2018 |
Cost minimization comparison of oral UFT/leucovorin versus 5-fluorouracil/leucovorin as adjuvant therapy for colorectal cancer in Taiwan.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Cost Control; Female; Fluorouracil; Health Care Costs; Humans; Leucovorin; Male; Middle Aged; Taiwan; Tegafur; Treatment Outcome; Uracil; Vitamin B Complex | 2019 |
[A Case of Spontaneous Esophageal Rupture That Required Operation during Adjuvant Chemotherapy for Transverse Colon Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, Transverse; Colonic Neoplasms; Esophageal Diseases; Humans; Leucovorin; Male; Neoplasm Recurrence, Local; Rupture, Spontaneous; Tegafur; Uracil | 2018 |
Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Colorectal Neoplasms; CTLA-4 Antigen; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Leucovorin; Lymphocyte Activation Gene 3 Protein; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; T-Lymphocytes; Tegafur; Uracil | 2019 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Gamma Rays; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Mitomycin; Tegafur; Uracil | 2019 |
Fluoropyrimidines and DPD testing: is there truly an inexorable link?
Topics: Antineoplastic Agents; Dihydropyrimidine Dehydrogenase Deficiency; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Fluorouracil; Genotype; Humans; Neoplasms; Oxonic Acid; Pharmacogenomic Testing; Phenotype; Point-of-Care Testing; Pyrrolidines; Tegafur; Thymine; Trifluridine; Uracil | 2019 |
Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Choice Behavior; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Oxaloacetates; Predictive Value of Tests; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2019 |
Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinoma.
Topics: Administration, Metronomic; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Chemoradiotherapy; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2019 |
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cyclophosphamide; Female; Fluorouracil; Humans; Mice; Mice, SCID; Neoplasm Invasiveness; Neovascularization, Pathologic; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2019 |
[A Case Report of a Patient Over 90 Years of Age with Liver Metastasis after Sigmoid Colectomy Controlled by a Combination Oral UFT/LV Chemotherapy Regimen].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Female; Humans; Leucovorin; Liver Neoplasms; Sigmoid Neoplasms; Tegafur; Uracil | 2019 |
Population Pharmacokinetic Model-Based Evaluation of Circadian Variations in Plasma 5-Fluorouracil Concentrations During Long-Term Infusion in Rats: A Comparison With Oral Anticancer Prodrugs.
Topics: Administration, Oral; Animals; Fluorouracil; Prodrugs; Rats; Tegafur; Uracil | 2020 |
Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Taiwan; Tegafur; Uracil | 2021 |
Abnormal Neuronal Response to Rectal and Anal Stimuli in Patients Treated for Distal Rectal Cancer With High-Dose Chemoradiotherapy Followed By Watchful Waiting.
Topics: Adenocarcinoma; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chemoradiotherapy; Evoked Potentials, Somatosensory; Female; Humans; Male; Manometry; Middle Aged; Neural Conduction; Rectal Neoplasms; Rectum; Tegafur; Uracil; Visceral Afferents; Watchful Waiting | 2020 |
Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
Topics: Adenocarcinoma of Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Male; Middle Aged; Pericardial Effusion; Tegafur; Uracil | 2021 |
Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Calibration; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Drug Monitoring; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver; Liver Neoplasms; Sensitivity and Specificity; Tandem Mass Spectrometry; Tegafur; Uracil | 2021 |
Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Drug Combinations; Female; Humans; Middle Aged; Neoplasm Staging; Oxonic Acid; Prognosis; Stomach Neoplasms; Tegafur; Treatment Outcome; Uracil | 2021 |
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Topics: Actinin; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Female; Gene Amplification; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2022 |
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Esophagus; Female; Humans; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tegafur; Treatment Outcome; Uracil | 2022 |
[A Case of UFT/LV-Induced Acute Liver Failure after Surgery for Sigmoid Colon Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Failure, Acute; Sigmoid Neoplasms; Tegafur; Uracil | 2022 |
[Long-Term Response to UFT/UZEL/Bevacizumab Therapy for Lung Metastasis after Surgery for Early-Stage Colon Cancer in a Late-Stage Elderly Patient].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Humans; Leucovorin; Lung Neoplasms; Male; Sigmoid Neoplasms; Tegafur; Uracil | 2022 |
The impact of adding mitomycin-C to radiotherapy plus oral tegafur-uracil on advanced-stage rectal cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Humans; Leucovorin; Mitomycin; Rectal Neoplasms; Tegafur; Uracil | 2023 |
Benefit of Uracil-Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Colonic Neoplasms; Disease-Free Survival; Humans; Neoplasm Staging; Tegafur; Uracil | 2022 |
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; COVID-19; COVID-19 Vaccines; Humans; Immunoglobulin G; Lung Neoplasms; Neoplasm Staging; Prospective Studies; SARS-CoV-2; Tegafur; Uracil | 2023 |
A Pharmacokinetic-Pharmacodynamic Model Predicts Uracil-tegafur Effect on Tumor Shrinkage and Myelosuppression in a Colorectal Cancer Rat Model.
Topics: Administration, Oral; Animals; Colorectal Neoplasms; Fluorouracil; Rats; Tegafur; Uracil | 2023 |
Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii.
Topics: Antineoplastic Agents; Gabexate; Humans; Japan; Male; Pyrimidines; Tegafur; Uracil | 2023 |
N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur-uracil/leucovorin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans; Leucovorin; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Tegafur; Uracil | 2023 |
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Small Cell Lung Carcinoma; Tegafur; Uracil | 2023 |
Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Humans; Leucovorin; Propensity Score; Retrospective Studies; Taiwan; Tegafur; Treatment Outcome; Uracil | 2023 |